rearrangement	amino_acid	frame_type	rearrangement_type	templates	reads	frequency	productive_frequency	cdr3_length	v_family	v_gene	v_allele	d_family	d_gene	d_allele	j_family	j_gene	j_allele	v_deletions	d5_deletions	d3_deletions	j_deletions	n2_insertions	n1_insertions	v_index	n1_index	n2_index	d_index	j_index	v_family_ties	v_gene_ties	v_allele_ties	d_family_ties	d_gene_ties	d_allele_ties	j_family_ties	j_gene_ties	j_allele_ties	sequence_tags	v_shm_count	v_shm_indexes	antibody	bio_identity	v_resolved	d_resolved	j_resolved	sample_name	species	locus	product_subtype	kit_pool	sku	test_name	sample_catalog_tags	sample_rich_tags	sample_rich_tags_json	kit_control	total_templates	productive_templates	outofframe_templates	stop_templates	dj_templates	total_rearrangements	productive_rearrangements	outofframe_rearrangements	stop_rearrangements	dj_rearrangements	total_reads	total_productive_reads	total_outofframe_reads	total_stop_reads	total_dj_reads	productive_clonality	productive_entropy	sample_clonality	sample_entropy	sample_amount_ng	sample_cells_mass_estimate	fraction_productive_of_cells_mass_estimate	sample_cells	fraction_productive_of_cells	max_productive_frequency	max_frequency	counting_method	primer_set	sequence_result_status	release_date	upload_date	sample_tags	fraction_productive	order_name	kit_id	total_t_cells	total_templates_agg
GACTCGGCCATGTATCGCTGTGCCAGCAGCTCGTTGACAGGGGGCGGGGAGACCCAGTACTTCGGGCCA	CASSSLTGGGETQYF	In	VDJ	1	13	3.0506191583576405E-5	3.8294650826428025E-5	45	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	2	0	5	4	3	18	31	45	35	48														CASSSLTGGGETQYF+TCRBV07-06+TCRBJ02-05	TCRBV07-06*01	TCRBD01-01*01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTAAAATCCCACGGCCAGGGCGCAGACTATGGCTACACCTTCGGTTCG	CASSLKSHGQGADYGYTF	In	VDJ	1	13	3.0506191583576405E-5	3.8294650826428025E-5	54	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	4	3	3	12	5	18	33	50	45	55														CASSLKSHGQGADYGYTF+TCRBV07-06+TCRBJ01-02	TCRBV07-06*01	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTATTGTTAGCCCGGGGGATGGGGCTACACCTTCGGTTCG		Out	VDJ	1	13	3.0506191583576405E-5		46	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	2	8	2	8	9	4	18	33	48	42	52														X+TCRBV07-06+TCRBJ01-02	TCRBV07-06*01	TCRBD02-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTACTTGGTTTCGTTGCGGGAGGATACAATGAGCAGTTCTTCGGGCCA	CASSLLGFVAGGYNEQFF	In	VDJ	1	16	3.7546081949017114E-5	4.7131877940219106E-5	54	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	7	1	4	12	1	18	33	53	45	54														CASSLLGFVAGGYNEQFF+TCRBV07-06+TCRBJ02-01	TCRBV07-06*01	TCRBD02-01*02	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTAGACAGCAGGGGCTCTGGGGCCAATGTCCTGACTTTCGGGGCC	CASSLDSRGSGANVLTF	In	VDJ	1	16	3.7546081949017114E-5	4.7131877940219106E-5	51	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	1	4	2	13	4	13	18	34	44	38	57														CASSLDSRGSGANVLTF+TCRBV07-06+TCRBJ02-06	TCRBV07-06*01	TCRBD01-01*01	TCRBJ02-06*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGACAACCCCTGACTAGTGGGAGGTCAGATACGCAGTATTTTGGCCCA	CASRQPLTSGRSDTQYF	In	VDJ	1	17	3.989271207083068E-5	5.00776203114828E-5	51	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	2	8	4	9	8	18	29	44	38	52						01,02								CASRQPLTSGRSDTQYF+TCRBV07-06+TCRBJ02-03	TCRBV07-06*01	TCRBD02-01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTGCGGGGGGGCCGGGATACGCAGTATTTTGGCCCA	CASSLRGGRDTQYF	In	VDJ	1	20	4.693260243627139E-5	5.891484742527388E-5	42	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	7	0	6	0	4	18	-1	41	32	45														CASSLRGGRDTQYF+TCRBV07-06+TCRBJ02-03	TCRBV07-06*01	TCRBD02-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCATGTATCGCTGTGCCAGCACCCAGGGAAATTCCAACTATGGCTACACCTTCGGTTCG	CASTQGNSNYGYTF	In	VDJ	1	23	5.39724928017121E-5	6.775207453906497E-5	42	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	4	3	2	2	7	18	28	35	30	42														CASTQGNSNYGYTF+TCRBV07-06+TCRBJ01-02	TCRBV07-06*01	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGTACCGCTTGGGGGACTAGCGGGACCTATGAGCAGTACTTCGGGCCG	CASSTAWGTSGTYEQYF	In	VDJ	1	26	6.101238316715281E-5	7.658930165285605E-5	51	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	0	3	7	10	5	18	29	52	39	57														CASSTAWGTSGTYEQYF+TCRBV07-06+TCRBJ02-07	TCRBV07-06*01	TCRBD02-01*02	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCATGTATCGCTGTGCCAGCACCCGTGGGGGCAATAATTCACCCCTCCACTTTGGGAAC	CASTRGGNNSPLHF	In	VDJ	1	30	7.03989036544071E-5	8.837227113791082E-5	42	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	7	6	0	5	5	1	18	28	39	33	40														CASTRGGNNSPLHF+TCRBV07-06+TCRBJ01-06	TCRBV07-06*01	TCRBD01-01*01	TCRBJ01-06*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTAGTTGGAGACAGCGAAAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	32	7.509216389803423E-5		47	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	1	2	5	3	5	4	18	34	44	39	48														X+TCRBV07-06+TCRBJ02-05	TCRBV07-06*01	TCRBD01-01*01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTAGAACTAGCGGGTGAGACCCAGTACTTCGGGCCA	CASSLELAGETQYF	In	VDJ	1	44	1.0325172535979707E-4	1.2961266433560254E-4	42	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	1	3	4	5	1	1	18	34	44	35	45						01,02								CASSLELAGETQYF+TCRBV07-06+TCRBJ02-05	TCRBV07-06*01	TCRBD02-01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTAGGAGGGCAGGCCAGCTCTGGAAACACCATATATTTTGGAGAG	CASSLGGQASSGNTIYF	In	VDJ	1	48	1.1263824584705134E-4	1.413956338206573E-4	51	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	1	11	0	0	0	8	18	-1	39	34	47														CASSLGGQASSGNTIYF+TCRBV07-06+TCRBJ01-03	TCRBV07-06*01	TCRBD02-01*02	TCRBJ01-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCGGTGGACAGGGAAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSGGQGSSYNEQFF	In	VDJ	1	49	1.1498487596886492E-4	1.4434137619192102E-4	48	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	1	3	0	3	3	18	30	41	33	44														CASSGGQGSSYNEQFF+TCRBV07-06+TCRBJ02-01	TCRBV07-06*01	TCRBD01-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTAGAGGCGGGGGGGCTGGAGACCCAGTACTTCGGGCCA	CASSLEAGGLETQYF	In	VDJ	2	89	2.0885008084140769E-4	2.621710710424688E-4	45	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	1	7	0	5	2	3	18	34	45	36	48														CASSLEAGGLETQYF+TCRBV07-06+TCRBJ02-05	TCRBV07-06*01	TCRBD02-01*01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCCTGGGACTTAGCCCGGCGGAGACCCAGTACTTCGGGCCA	CASSLGLSPAETQYF	In	VDJ	10	503	0.0011803549512722255	0.001481708412745638	45	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	0	10	5	2	10	18	30	38	32	48						01,02								CASSLGLSPAETQYF+TCRBV07-06+TCRBJ02-05	TCRBV07-06*01	TCRBD02-01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTGGGACAGCCTTCTAGGGCCCCAGCATTTTGGTGAT	CASSWDSLLGPQHF	In	VDJ	23	1131	0.002654038667771147	0.003331634621899238	42	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	0	5	9	0	9	18	-1	38	31	47														CASSWDSLLGPQHF+TCRBV07-06+TCRBJ01-05	TCRBV07-06*01	TCRBD01-01*01	TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CGACTCGGCTGTGTATCTCTGTGCCAACAGCCTCGACAGGGGGCGTGATGGCTACACCTTCGGTTCG	CANSLDRGRDGYTF	In	VDJ	1	19	4.4585972314457824E-5	5.596910505401019E-5	42	TCRBV07	TCRBV07-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	9	2	0	6	8	3	19	26	44	34	47														CANSLDRGRDGYTF+TCRBV07-05+TCRBJ01-02	TCRBV07-05*01	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCTTGTATTCGGGACATGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	22	5.162586267989853E-5		46	TCRBV07	TCRBV07-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	0	6	0	6	0	19	33	-1	39	45														X+TCRBV07-05+TCRBJ01-01	TCRBV07-05*01	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCTTGGTTGGGTCGAGCCTCCCTGGCACAGATACGCAGTATTTTGGCCCA	CASSLVGSSLPGTDTQYF	In	VDJ	1	23	5.39724928017121E-5	6.775207453906497E-5	54	TCRBV07	TCRBV07-05	01				TCRBJ02	TCRBJ02-03	01	2	0	9	1	4	13	19	33	40	37	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLVGSSLPGTDTQYF+TCRBV07-05+TCRBJ02-03	TCRBV07-05*01		TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCACCGGACAGGGGACCTACGAGCAGTACGTCGGGCCG	CASSTGQGTYEQYV	In	VDJ	1	33	7.74387940198478E-5	9.72094982517019E-5	42	TCRBV07	TCRBV07-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	1	2	17	3	16	19	31	43	34	59														CASSTGQGTYEQYV+TCRBV07-05+TCRBJ02-07	TCRBV07-05*01	TCRBD01-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCTTTGGTGGCGGGAACCCCTACGAGCAGTACTTCGGGCCG	CASSFGGGNPYEQYF	In	VDJ	1	74	1.7365062901420416E-4	2.1798493547351336E-4	45	TCRBV07	TCRBV07-05	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	7	3	2	5	3	19	33	44	38	47														CASSFGGGNPYEQYF+TCRBV07-05+TCRBJ02-07	TCRBV07-05*01	TCRBD02-01*02	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAACCGGGACAGGTAACTACGAGCAGTACTTCGGGCCG	CASSVTGTGNYEQYF	In	VDJ	1	13	3.0506191583576405E-5	3.8294650826428025E-5	45	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	0	4	3	3	3	23	38	49	41	52			01,02										Vb 1	CASSVTGTGNYEQYF+TCRBV09-01+TCRBJ02-07	TCRBV09-01	TCRBD01-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGACACGGGGGCAGATGAAAAACTGTTTTTTGGCAGT	CASSDTGADEKLFF	In	VDJ	1	14	3.285282170538997E-5	4.1240393197691716E-5	42	TCRBV09	TCRBV09-01					TCRBJ01	TCRBJ01-04	01	3	6	0	6	4	2	23	36	46	40	48			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSDTGADEKLFF+TCRBV09-01+TCRBJ01-04	TCRBV09-01		TCRBJ01-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTATCCGGTTCCTCTGGAAACACCATATATTTTGGAGAG	CASSVSGSSGNTIYF	In	VDJ	1	14	3.285282170538997E-5	4.1240393197691716E-5	45	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	1	8	5	0	2	3	23	38	43	40	46			01,02			01,02							Vb 1	CASSVSGSSGNTIYF+TCRBV09-01+TCRBJ01-03	TCRBV09-01	TCRBD02-01	TCRBJ01-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGCATCGAACAGGGTAGAGGCCTACACCTTCGGTTCG	CASSASNRVEAYTF	In	VDJ	1	15	3.519945182720355E-5	4.418613556895541E-5	42	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	3	3	10	6	7	23	36	48	42	55			01,02										Vb 1	CASSASNRVEAYTF+TCRBV09-01+TCRBJ01-02	TCRBV09-01	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGAGGTCCAGGGCACTGAAGCTTTCTTTGGACAA	CASSVEVQGTEAFF	In	VDJ	1	15	3.519945182720355E-5	4.418613556895541E-5	42	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	4	3	4	5	0	23	39	-1	44	49			01,02										Vb 1	CASSVEVQGTEAFF+TCRBV09-01+TCRBJ01-01	TCRBV09-01	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGTACCGGGACGTCGAGTTGGGCTTTCTTTGGACAA	CASSTGTSSWAFF	In	VDJ	1	16	3.7546081949017114E-5	4.7131877940219106E-5	39	TCRBV09	TCRBV09-01					TCRBJ01	TCRBJ01-01	01	5	0	7	11	4	10	23	34	43	38	53			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSTGTSSWAFF+TCRBV09-01+TCRBJ01-01	TCRBV09-01		TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGATCGGCTAGCGGGGAAAGAGACCCAGTACTTCGGGCCA	CASSVDRLAGKETQYF	In	VDJ	1	18	4.2239342192644256E-5	5.302336268274649E-5	48	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	0	4	3	3	5	1	23	39	53	44	54			01,02										Vb 1	CASSVDRLAGKETQYF+TCRBV09-01+TCRBJ02-05	TCRBV09-01	TCRBD02-01*01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTTACTCCCGGGGGCTCCTACGAGCAGTACTTCGGGCCG	CASSVTPGGSYEQYF	In	VDJ	1	18	4.2239342192644256E-5	5.302336268274649E-5	45	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	2	8	2	0	6	0	23	37	-1	43	49			01,02										Vb 1	CASSVTPGGSYEQYF+TCRBV09-01+TCRBJ02-07	TCRBV09-01	TCRBD02-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCCCAGGAGGGACCGCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSPGGTANTGELFF	In	VDJ	1	19	4.4585972314457824E-5	5.596910505401019E-5	48	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	4	10	0	0	3	4	23	35	44	38	48			01,02										Vb 1	CASSPGGTANTGELFF+TCRBV09-01+TCRBJ02-02	TCRBV09-01	TCRBD02-01*02	TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGGAGAAGCGGGAGGGAGTGCAGATACGCAGTATTTTGGCCCA	CASSGEAGGSADTQYF	In	VDJ	1	22	5.162586267989853E-5	6.480633216780127E-5	48	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	6	0	4	4	4	23	36	50	40	54			01,02										Vb 1	CASSGEAGGSADTQYF+TCRBV09-01+TCRBJ02-03	TCRBV09-01	TCRBD02-01*02	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGGAGGTAATGAGCTCCTCGGTGAGCAGTTCTTCGGGCCA	CASSVGGNELLGEQFF	In	VDJ	1	22	5.162586267989853E-5	6.480633216780127E-5	48	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	11	1	9	0	15	23	-1	43	39	58			01,02										Vb 1	CASSVGGNELLGEQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01	TCRBD02-01*02	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGGATCCTCCGAAAGGGCAGATACGCAGTATTTTGGCCCA	CASSGSSERADTQYF	In	VDJ	1	24	5.631912292352567E-5	7.069781691032865E-5	45	TCRBV09	TCRBV09-01					TCRBJ02	TCRBJ02-03	01	3	5	3	4	11	0	23	36	-1	47	51			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSGSSERADTQYF+TCRBV09-01+TCRBJ02-03	TCRBV09-01		TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGGATTAAGTAGCGTGAACACTGAAGCTTTCTTTGGACAA	CASSVGLSSVNTEAFF	In	VDJ	1	24	5.631912292352567E-5	7.069781691032865E-5	48	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	0	5	6	0	7	0	23	39	-1	46	51			01,02			01,02							Vb 1	CASSVGLSSVNTEAFF+TCRBV09-01+TCRBJ01-01	TCRBV09-01	TCRBD02-01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGCCTCTAAAGTCATGAACACTGAAGCTTTCTTTGGACAA	CASSASKVMNTEAFF	In	VDJ	1	25	5.866575304533924E-5	7.364355928159235E-5	45	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	3	4	9	0	3	6	23	36	42	39	48			01,02			01,02							Vb 1	CASSASKVMNTEAFF+TCRBV09-01+TCRBJ01-01	TCRBV09-01	TCRBD02-01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGGCAAGGGGGGACGAGCAGTACGTCGGGCCG		Out	VDJ	1	26	6.101238316715281E-5		37	TCRBV09	TCRBV09-01					TCRBJ02	TCRBJ02-07	01	3	5	1	17	3	13	23	36	45	39	58			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	X+TCRBV09-01+TCRBJ02-07	TCRBV09-01		TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGCTCCGGGGCCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSVAPGPNTGELFF	In	VDJ	1	27	6.335901328896638E-5	7.953504402411973E-5	48	TCRBV09	TCRBV09-01					TCRBJ02	TCRBJ02-02	01	0	7	0	0	4	0	23	39	-1	43	48			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSVAPGPNTGELFF+TCRBV09-01+TCRBJ02-02	TCRBV09-01		TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGCTAAGGAACCCCAGCGGGAGTAGTTCTCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	28	6.570564341077994E-5		59	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	6	2	3	12	7	22	38	58	50	65			01,02										Vb 1	X+TCRBV09-01+TCRBJ02-07	TCRBV09-01	TCRBD02-01*02	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGAAGGAATAGATACGCAGTATTTTGGCCCA	CASSVEGIDTQYF	In	VDJ	1	29	6.805227353259351E-5	8.542652876664713E-5	39	TCRBV09	TCRBV09-01					TCRBJ02	TCRBJ02-03	01	0	1	8	5	2	2	23	39	44	41	46			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSVEGIDTQYF+TCRBV09-01+TCRBJ02-03	TCRBV09-01		TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGCGGGTCCCTCGGAGGTAGCCGGGGAGCTGTTTTTTGGAGAA	CASSAGPSEVAGELFF	In	VDJ	1	30	7.03989036544071E-5	8.837227113791082E-5	48	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	3	10	1	6	10	3	23	36	51	46	54			01,02										Vb 1	CASSAGPSEVAGELFF+TCRBV09-01+TCRBJ02-02	TCRBV09-01	TCRBD02-01*02	TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCTCAGGGAGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASGSSGANVLTF	In	VDJ	1	30	7.03989036544071E-5	8.837227113791082E-5	39	TCRBV09	TCRBV09-01					TCRBJ02	TCRBJ02-06	01	10	4	3	0	1	2	23	29	35	30	37			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASGSSGANVLTF+TCRBV09-01+TCRBJ02-06	TCRBV09-01		TCRBJ02-06*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGGGGATAATCTCAATGAGCAGTTCTTCGGGCCA	CASSVGDNLNEQFF	In	VDJ	1	31	7.274553377622066E-5	9.131801350917451E-5	42	TCRBV09	TCRBV09-01					TCRBJ02	TCRBJ02-01	01	0	0	8	6	0	6	23	-1	43	39	49			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSVGDNLNEQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01		TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCACGGCGGGGGCCGCAGATACGCAGTATTTTGGCCCA	CASTAGAADTQYF	In	VDJ	1	33	7.74387940198478E-5	9.72094982517019E-5	39	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	7	2	4	2	3	23	33	42	35	45			01,02										Vb 1	CASTAGAADTQYF+TCRBV09-01+TCRBJ02-03	TCRBV09-01	TCRBD02-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCCCCCCGGGACTGATGGCAGTACGTCGGGCCG		Out	VDJ	1	34	7.978542414166136E-5		37	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	0	10	17	5	12	23	35	46	40	58			01,02			01,02							Vb 1	X+TCRBV09-01+TCRBJ02-07	TCRBV09-01	TCRBD02-01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGAGGGAGGTACAGGGTACAATGAGCAGTTCTTCGGGCCA	CASSEGGTGYNEQFF	In	VDJ	1	35	8.213205426347493E-5	1.031009829942293E-4	45	TCRBV09	TCRBV09-01					TCRBJ02	TCRBJ02-01	01	3	3	3	4	8	0	23	36	-1	44	50			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSEGGTGYNEQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01		TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTCAGCGGGAGCGCGGGAAATGAGCAGTTCTTCGGGCCA	CASSVSGSAGNEQFF	In	VDJ	1	35	8.213205426347493E-5	1.031009829942293E-4	45	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	6	2	7	1	7	23	37	46	38	53			01,02										Vb 1	CASSVSGSAGNEQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01	TCRBD02-01*02	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGCGGGACTAGCGGCTTACAATGAGCAGTTCTTCGGGCCA	CASSAGLAAYNEQFF	In	VDJ	1	41	9.621183499435635E-5	1.2077543722181146E-4	45	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	0	5	4	1	2	23	36	48	37	50			01,02			01,02							Vb 1	CASSAGLAAYNEQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01	TCRBD02-01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGACAGGTCCGGGACAGGGTTTCCCGGGGAGCTGTTTTTTGGAGAA	CASSDRSGTGFPGELFF	In	VDJ	1	44	1.0325172535979707E-4	1.2961266433560254E-4	51	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	0	3	6	8	4	23	36	53	44	57			01,02										Vb 1	CASSDRSGTGFPGELFF+TCRBV09-01+TCRBJ02-02	TCRBV09-01	TCRBD01-01*01	TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAAGAGAGCGGCACACAGATACGCAGTATTTTGGCCCA	CASSVRERHTDTQYF	In	VDJ	1	44	1.0325172535979707E-4	1.2961266433560254E-4	45	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	1	6	5	2	4	2	23	38	47	42	49			01,02			01,02							Vb 1	CASSVRERHTDTQYF+TCRBV09-01+TCRBJ02-03	TCRBV09-01	TCRBD02-01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCACTGGACAGGGTATAGGCAATGAGCAGTTCTTCGGGCCA	CASSTGQGIGNEQFF	In	VDJ	1	46	1.079449856034242E-4	1.3550414907812994E-4	45	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	1	3	6	3	6	23	35	46	38	52			01,02										Vb 1	CASSTGQGIGNEQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01	TCRBD01-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGGTCAGGCAGGGGGTAGGGGGACGCAGTATTTTGGCCCA	CASSGQAGGRGTQYF	In	VDJ	1	46	1.079449856034242E-4	1.3550414907812994E-4	45	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	4	1	9	6	7	23	36	49	42	56			01,02										Vb 1	CASSGQAGGRGTQYF+TCRBV09-01+TCRBJ02-03	TCRBV09-01	TCRBD01-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGTCGGGGCGGGCCGCCCTTCCTACACCTTCGGTTCG	CASSVVGAGRPSYTF	In	VDJ	1	47	1.1029161572523777E-4	1.3844989144939362E-4	45	TCRBV09	TCRBV09-01					TCRBJ01	TCRBJ01-02	01	0	7	0	10	2	12	23	39	46	41	58			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSVVGAGRPSYTF+TCRBV09-01+TCRBJ01-02	TCRBV09-01		TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGGGGGACAACAGGGAACCTCGGGGAGCTGTTTTTTGGAGAA	CASRGTTGNLGELFF	In	VDJ	1	49	1.1498487596886492E-4	1.4434137619192102E-4	45	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	0	6	7	1	11	23	34	41	35	52			01,02										Vb 1	CASRGTTGNLGELFF+TCRBV09-01+TCRBJ02-02	TCRBV09-01	TCRBD01-01*01	TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGCCACACAGGTGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSATQVNTGELFF	In	VDJ	1	50	1.1733150609067848E-4	1.472871185631847E-4	45	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	3	4	1	4	1	23	36	45	40	46			01,02										Vb 1	CASSATQVNTGELFF+TCRBV09-01+TCRBJ02-02	TCRBV09-01	TCRBD01-01*01	TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTACGTACACCGGCCCCAGCATTTTGGTGAT		Out	VDJ	1	52	1.2202476633430562E-4		37	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	1	3	6	9	3	3	23	38	44	41	47			01,02										Vb 1	X+TCRBV09-01+TCRBJ01-05	TCRBV09-01	TCRBD01-01*01	TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTATTTGGGGTCGGGGAGACCCAGTACTTCGGGCCA	CASSVFGVGETQYF	In	VDJ	1	52	1.2202476633430562E-4	1.531786033057121E-4	42	TCRBV09	TCRBV09-01					TCRBJ02	TCRBJ02-05	01	1	6	2	5	3	5	23	38	45	41	50			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSVFGVGETQYF+TCRBV09-01+TCRBJ02-05	TCRBV09-01		TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGGGGCTAGCGTAGAGACCCAGTACTTCGGGCCA	CASSVGASVETQYF	In	VDJ	1	55	1.2906465669974634E-4	1.6201583041950318E-4	42	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	0	4	6	4	3	1	23	39	48	42	49			01,02			01,02							Vb 1	CASSVGASVETQYF+TCRBV09-01+TCRBJ02-05	TCRBV09-01	TCRBD02-01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGTGCCGGGGGCTCTGGAAACACCATATATTTTGGAGAG	CASSAGGSGNTIYF	In	VDJ	1	57	1.3375791694337347E-4	1.6790731516203055E-4	42	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-03	01	5	8	2	0	3	0	23	34	-1	37	43			01,02										Vb 1	CASSAGGSGNTIYF+TCRBV09-01+TCRBJ01-03	TCRBV09-01	TCRBD02-01*01	TCRBJ01-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGGAGGAGCGGGAGGGCCGTTTGGGGAGCTGTTTTTTGGAGAA	CASSGGAGGPFGELFF	In	VDJ	1	63	1.4783769767425488E-4	1.8558176938961271E-4	48	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	3	6	0	8	4	6	23	36	50	40	56			01,02										Vb 1	CASSGGAGGPFGELFF+TCRBV09-01+TCRBJ02-02	TCRBV09-01	TCRBD02-01*02	TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGGGGGAGATAGGGGCTACACCTTCGGTTCG	CASSVGGDRGYTF	In	VDJ	1	65	1.5253095791788204E-4	1.914732541321401E-4	39	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	0	9	2	8	1	5	23	39	45	40	50			01,02										Vb 1	CASSVGGDRGYTF+TCRBV09-01+TCRBJ01-02	TCRBV09-01	TCRBD02-01*02	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCCGGGACAGTAGCACAGATACGCAGTATTTTGGCCCA	CASRDSSTDTQYF	In	VDJ	1	70	1.6426410852694986E-4	2.062019659884586E-4	39	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	7	0	5	0	1	1	23	32	40	33	41			01,02										Vb 1	CASRDSSTDTQYF+TCRBV09-01+TCRBJ02-03	TCRBV09-01	TCRBD01-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCTCGCCGCCAAACTTCAGGTGGACGCGAGCAGTTCTTCGGGCCA		Out	VDJ	2	79	1.85383779623272E-4		49	TCRBV09	TCRBV09-01					TCRBJ02	TCRBJ02-01	01	4	1	7	10	19	2	23	35	58	54	60			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	X+TCRBV09-01+TCRBJ02-01	TCRBV09-01		TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGGTCTGTCAGGGAGCGACACTGAAGCTTTCTTTGGACAA	CASSVGLSGSDTEAFF	In	VDJ	2	99	2.323163820595434E-4	2.916284947551057E-4	48	TCRBV09	TCRBV09-01					TCRBJ01	TCRBJ01-01	01	0	4	3	3	6	4	23	39	50	45	54			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSVGLSGSDTEAFF+TCRBV09-01+TCRBJ01-01	TCRBV09-01		TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGCTACGACAGTTACTGAAGCTTTCTTTGGACAA	CASSVATTVTEAFF	In	VDJ	2	100	2.3466301218135697E-4	2.945742371263694E-4	42	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	2	5	5	4	2	23	39	48	43	50			01,02										Vb 1	CASSVATTVTEAFF+TCRBV09-01+TCRBJ01-01	TCRBV09-01	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGAAGCAGGGGGTTCCACAGATACGCAGTATTTTGGCCCA	CASSVEAGGSTDTQYF	In	VDJ	2	111	2.6047594352130625E-4	3.2697740321027E-4	48	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	4	1	2	3	3	23	39	49	42	52			01,02										Vb 1	CASSVEAGGSTDTQYF+TCRBV09-01+TCRBJ02-03	TCRBV09-01	TCRBD01-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGCCCAACAGGTGCCACTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	2	118	2.769023543740012E-4		46	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	3	4	0	4	5	23	36	45	40	50			01,02										Vb 1	X+TCRBV09-01+TCRBJ02-07	TCRBV09-01	TCRBD01-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGCCGATCCCCTCCCTAGCTCGGGGCAGTTCTTCGGGCCA	CASSADPLPSSGQFF	In	VDJ	2	121	2.839422447394419E-4	3.56434826922907E-4	45	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	4	7	12	12	5	23	36	53	48	58			01,02			01,02							Vb 1	CASSADPLPSSGQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01	TCRBD02-01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTTTCACAGGGCGACGAGCAGTACTTCGGGCCG	CASSVSQGDEQYF	In	VDJ	3	134	3.1444843632301835E-4	3.94729477749335E-4	39	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	3	3	5	3	2	23	37	46	40	48			01,02										Vb 1	CASSVSQGDEQYF+TCRBV09-01+TCRBJ02-07	TCRBV09-01	TCRBD01-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGCCTTTGGAGTCTCAGATACGCAGTATTTTGGCCCA	CASSAFGVSDTQYF	In	VDJ	3	141	3.308748471757133E-4	4.1534967434818084E-4	42	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	10	2	4	5	3	23	36	45	41	48			01,02										Vb 1	CASSAFGVSDTQYF+TCRBV09-01+TCRBJ02-03	TCRBV09-01	TCRBD02-01*02	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGCCGTAGCTTGGGACGAACCCTCGGAGAGACCCAGTACTTCGGGCCA		Out	VDJ	3	149	3.496478881502219E-4		53	TCRBV09	TCRBV09-01					TCRBJ02	TCRBJ02-05	01	3	0	7	4	9	10	23	36	50	45	60			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	X+TCRBV09-01+TCRBJ02-05	TCRBV09-01		TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGAGGCAGGGGGCCAAGAGACCCAGTACTTCGGGCCA	CASSVEAGGQETQYF	In	VDJ	3	151	3.54341148393849E-4	4.448070980608178E-4	45	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	0	4	1	1	3	0	23	39	-1	42	49			01,02										Vb 1	CASSVEAGGQETQYF+TCRBV09-01+TCRBJ02-05	TCRBV09-01	TCRBD01-01*01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCCCTAGTAGCGGGAGAGTAGGGGACGAGCAGTACTTCGGGCCG	CASSPSSGRVGDEQYF	In	VDJ	3	155	3.637276688811033E-4	4.565900675458726E-4	48	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	5	2	5	5	8	23	35	49	40	57			01,02										Vb 1	CASSPSSGRVGDEQYF+TCRBV09-01+TCRBJ02-07	TCRBV09-01	TCRBD02-01*02	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGGGGGCAGCTCCCAAGAGACCCAGTACTTCGGGCCA	CASSVGGSSQETQYF	In	VDJ	3	158	3.70767559246544E-4	4.6542729465966367E-4	45	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	0	7	0	1	0	5	23	-1	44	39	49			01,02										Vb 1	CASSVGGSSQETQYF+TCRBV09-01+TCRBJ02-05	TCRBV09-01	TCRBD01-01*01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCACCCGGGGCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	3	163	3.825007098556119E-4		37	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	8	3	2	2	0	23	33	-1	35	40			01,02										Vb 1	X+TCRBV09-01+TCRBJ02-01	TCRBV09-01	TCRBD02-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCCCCCGGGACAGGGGCAATGAGCAGTTCTTCGGGCCA	CASSPRDRGNEQFF	In	VDJ	3	169	3.9658049058649325E-4	4.978304607435643E-4	42	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	0	2	6	4	0	23	35	-1	39	49			01,02										Vb 1	CASSPRDRGNEQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01	TCRBD01-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGACGGGGAGCCTAACTATGGCTACACCTTCGGTTCG	CASSVDGEPNYGYTF	In	VDJ	4	211	4.951389557026632E-4	6.215516403366394E-4	45	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	0	8	3	0	1	3	23	39	45	40	48			01,02			01,02							Vb 1	CASSVDGEPNYGYTF+TCRBV09-01+TCRBJ01-02	TCRBV09-01	TCRBD02-01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGCTAGGACAGGGGGGTCCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSARTGGSSYNEQFF	In	VDJ	5	242	5.678844894788838E-4	7.12869653845814E-4	51	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	1	1	0	3	3	23	36	49	39	52			01,02										Vb 1	CASSARTGGSSYNEQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01	TCRBD01-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGATTTCGGGCGGGAGAGCACAGATACGCAGTATTTTGGCCCA	CASSVDFGRESTDTQYF	In	VDJ	5	245	5.749243798443246E-4	7.217068809596051E-4	51	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	0	7	2	0	7	0	23	39	-1	46	53			01,02										Vb 1	CASSVDFGRESTDTQYF+TCRBV09-01+TCRBJ02-03	TCRBV09-01	TCRBD02-01*02	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTGGGGGCTGGGGCCAACGTCCTGACTTTTGGGGCC	CASSVGAGANVLTF	In	VDJ	6	276	6.476699136205452E-4	8.130248944687795E-4	42	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	2	6	0	25	0	22	23	-1	43	37	65			01,02										Vb 1	CASSVGAGANVLTF+TCRBV09-01+TCRBJ02-06	TCRBV09-01	TCRBD01-01*01	TCRBJ02-06*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCTCGGGACAGGCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSSGQANTGELFF	In	VDJ	6	309	7.25108707640393E-4	9.102343927204815E-4	45	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	0	4	0	2	0	23	35	-1	37	45			01,02										Vb 1	CASSSGQANTGELFF+TCRBV09-01+TCRBJ02-02	TCRBV09-01	TCRBD01-01*01	TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGGCGGGAGCACCTACAATGAGCAGTTCTTCGGGCCA	CASSVGGSTYNEQFF	In	VDJ	6	325	7.626547895894101E-4	9.573662706607005E-4	45	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	7	2	2	0	2	23	-1	46	39	48			01,02										Vb 1	CASSVGGSTYNEQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01	TCRBD02-01*02	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCTCACGGACTAGCGGGGGCATCGTTGATGAGCAGTTCTTCGGGCCA	CASSSRTSGGIVDEQFF	In	VDJ	7	358	8.400935836092579E-4	0.0010545757689124024	51	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	1	2	8	4	8	23	35	52	39	60			01,02										Vb 1	CASSSRTSGGIVDEQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01	TCRBD02-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGACGACCCTACTAGCGGGATTCTAGGGGAGACCCAGTACTTCGGGCCA	CASSDDPTSGILGETQYF	In	VDJ	13	650	0.0015253095791788202	0.001914732541321401	54	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	3	3	3	5	8	8	23	36	54	44	62			01,02										Vb 1	CASSDDPTSGILGETQYF+TCRBV09-01+TCRBJ02-05	TCRBV09-01	TCRBD02-01*02	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGATCTAGGCGAGCAGTACTTCGGGCCG	CASSVDLGEQYF	In	VDJ	33	1664	0.00390479252269778	0.004901715305782787	36	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	4	8	6	2	1	23	39	45	41	46			01,02			01,02							Vb 1	CASSVDLGEQYF+TCRBV09-01+TCRBJ02-07	TCRBV09-01	TCRBD02-01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCCCAAGACTAGCGGGAGATGATGAGCAGTTCTTCGGGCCA	CASSPRLAGDDEQFF	In	VDJ	33	1670	0.003918872303428661	0.004919389760010369	45	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	2	2	8	4	3	23	35	51	39	54			01,02										Vb 1	CASSPRLAGDDEQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01	TCRBD02-01*02	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCAAAGGACCGGCGGACACTGAAGCTTTCTTTGGACAA	CASSKGPADTEAFF	In	VDJ	67	3378	0.007926916551486238	0.009950717730128759	42	TCRBV09	TCRBV09-01					TCRBJ01	TCRBJ01-01	01	4	1	7	3	3	6	23	35	42	38	48			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSKGPADTEAFF+TCRBV09-01+TCRBJ01-01	TCRBV09-01		TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCATGTATCTCTGTGCCAGCAGCTTATGGACTAGGGATAACAATGAGCAGTTCTTCGGGCCA	CASSLWTRDNNEQFF	In	VDJ	1	14	3.285282170538997E-5	4.1240393197691716E-5	45	TCRBV11	TCRBV11-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	1	8	5	1	5	19	34	42	35	47						01,02								CASSLWTRDNNEQFF+TCRBV11-01+TCRBJ02-01	TCRBV11-01*01	TCRBD02-01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCATGTATCTCTGTGCCAGCAGCCAAGGGGTGGCGGGACTAGCGGACAATGAGCAGTTCTTCGGGCCA	CASSQGVAGLADNEQFF	In	VDJ	1	15	3.519945182720355E-5	4.418613556895541E-5	51	TCRBV11	TCRBV11-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	0	5	5	11	0	19	31	-1	42	53						01,02								CASSQGVAGLADNEQFF+TCRBV11-01+TCRBJ02-01	TCRBV11-01*01	TCRBD02-01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCATGTATCTCTGTGCCAGCAACCCGGGACCGCATGCGAATACGCAGTATTTTGGCCCA	CASNPGPHANTQYF	In	VDJ	1	21	4.927923255808496E-5	6.186058979653757E-5	42	TCRBV11	TCRBV11-01	01				TCRBJ02	TCRBJ02-03	01	7	0	7	7	4	9	19	29	38	33	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASNPGPHANTQYF+TCRBV11-01+TCRBJ02-03	TCRBV11-01*01		TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCATGTATCTCTGTGCCAGCAGGTTAGCGGGGGCTTCTTACAATGAGCAGTTCTTCGGGCCA	CASRLAGASYNEQFF	In	VDJ	1	51	1.1967813621249205E-4	1.502328609344484E-4	45	TCRBV11	TCRBV11-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	6	0	4	0	4	19	-1	42	36	46														CASRLAGASYNEQFF+TCRBV11-01+TCRBJ02-01	TCRBV11-01*01	TCRBD01-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGGAATTGTCGTCGTGGACAGGGCATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	13	3.0506191583576405E-5		55	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	1	1	3	6	13	1	26	42	63	55	64													Vb 16	X+TCRBV14-01+TCRBJ01-04	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGATCCCAGTCCCCTTCGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	13	3.0506191583576405E-5		49	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	0	4	5	4	3	8	29	46	52	49	60													Vb 16	X+TCRBV14-01+TCRBJ01-03	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ACGTTTGGTGGCAGAACTGGAGGATTCTGGAGTTTATTCTGTGCCAGCAGCCAAGTTCTGGGAGAGGGTTTGCAGTACGTCGGGCCG		Out	VDJ	1	16	3.7546081949017114E-5		41	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	19	9	2	17	21	15	40	38	64	59	79													Vb 16	X+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01	TCRBD02-01*02	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCACAGCAGGGGGCTGTTAACTGAAGCTTTCTTTGGACAA	CASSHSRGLLTEAFF	In	VDJ	1	16	3.7546081949017114E-5	4.7131877940219106E-5	45	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	4	0	5	3	5	29	43	54	46	59													Vb 16	CASSHSRGLLTEAFF+TCRBV14-01+TCRBJ01-01	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCTCGGGGCAGGGGATAATATGAACACTGAAGCTTTCTTTGGACAA	CASSLGAGDNMNTEAFF	In	VDJ	1	18	4.2239342192644256E-5	5.302336268274649E-5	51	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	4	2	0	6	6	29	42	54	48	60													Vb 16	CASSLGAGDNMNTEAFF+TCRBV14-01+TCRBJ01-01	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ACGTTTGGTGGCAGAACTGRGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGTTCTGGGAGAGGGTTTGCAGTACGTCGGGCCG	CASSQVLGEGLQYV	In	VDJ	1	19	4.4585972314457824E-5	5.596910505401019E-5	42	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	1	9	2	17	4	15	39	55	64	59	79													Vb 16	CASSQVLGEGLQYV+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01	TCRBD02-01*02	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGTATCCTGGTCTCAATTGTAAAACTCCTACGAGCAGTACGTCGGGCCG	CASSQVSWSQL*NSYEQYV	Stop	VDJ	1	19	4.4585972314457824E-5		57	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-07	01	1	4	5	17	32	4	18	34	69	66	73				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSQVSWSQL*NSYEQYV+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01		TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGTTGGGGCTAGCGGGAGGTACGAGCAGTACTTCGGGCCG	CASSQVGASGRYEQYF	In	VDJ	1	21	4.927923255808496E-5	6.186058979653757E-5	48	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	1	4	1	4	6	0	29	45	-1	51	62													Vb 16	CASSQVGASGRYEQYF+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01	TCRBD02-01*02	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAGGTAAACAGGTACACTGAAGCTTTCTTTGGACAA	CASSQVNRYTEAFF	In	VDJ	1	22	5.162586267989853E-5	6.480633216780127E-5	42	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	3	4	3	5	1	29	43	53	48	54													Vb 16	CASSQVNRYTEAFF+TCRBV14-01+TCRBJ01-01	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ACGTTTGGTGGCAGAACTGGAGGATTCTGGAGTTATTTCTGTGCCAGCAGCCAAGTTCTGGGAGAGGGTTTGCAGTACGTCGGGCCG		Out	VDJ	1	24	5.631912292352567E-5		41	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	23	9	2	17	25	15	40	34	64	59	79													Vb 16	X+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01	TCRBD02-01*02	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCGAAGCGTGAGTTCCCCGGGTTCCAACATTCAGTACTTCGGCGCC	CASSRSVSSPGSNIQYF	In	VDJ	1	26	6.101238316715281E-5	7.658930165285605E-5	51	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	4	6	6	7	2	17	29	42	48	44	65						01,02							Vb 16	CASSRSVSSPGSNIQYF+TCRBV14-01+TCRBJ02-04	TCRBV14-01*01	TCRBD02-01	TCRBJ02-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCCCCGCCGGGAGTTCAACACCATATATTTTGGAGAG	CASSPRREFNTIYF	In	VDJ	1	27	6.335901328896638E-5	7.953504402411973E-5	42	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	4	8	2	7	5	3	29	42	53	47	56													Vb 16	CASSPRREFNTIYF+TCRBV14-01+TCRBJ01-03	TCRBV14-01*01	TCRBD02-01*02	TCRBJ01-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGGCGGACAGGGGTTTACGAGCAGTACTTCGGGCCG	CASRRTGVYEQYF	In	VDJ	1	33	7.74387940198478E-5	9.72094982517019E-5	39	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	1	2	4	2	2	29	40	51	42	53													Vb 16	CASRRTGVYEQYF+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGGACCGTCGGTCGGTTCGTGACCCAGTACTTCGGGCCA		Out	VDJ	1	34	7.978542414166136E-5		47	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-05	01	1	2	7	7	0	15	29	-1	48	45	63				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	X+TCRBV14-01+TCRBJ02-05	TCRBV14-01*01		TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCACGTGTCAGGGGGCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	49	1.1498487596886492E-4		41	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	4	1	4	6	0	29	41	-1	47	54													Vb 16	X+TCRBV14-01+TCRBJ01-02	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAAGGCAAAATATGAACACTGAAGCTTTCTTTGGACAA	CASSQRQNMNTEAFF	In	VDJ	1	56	1.314112868215599E-4	1.6496157279076687E-4	45	TCRBV14	TCRBV14-01	01				TCRBJ01	TCRBJ01-01	01	2	5	4	0	0	7	29	-1	47	44	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSQRQNMNTEAFF+TCRBV14-01+TCRBJ01-01	TCRBV14-01*01		TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGTAAGGAGCTCCTACGAGCAGTACTTCGGGCCG	CASSQVRSSYEQYF	In	VDJ	1	60	1.407978073088142E-4	1.7674454227582163E-4	42	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	1	10	2	0	3	0	29	45	-1	48	52													Vb 16	CASSQVRSSYEQYF+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01	TCRBD02-01*02	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCGACAAAACTATGGCTACACCTTCGGTTCG	CASSRQNYGYTF	In	VDJ	1	68	1.5957084828332273E-4	2.003104812459312E-4	36	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	2	6	2	0	1	29	-1	46	42	47													Vb 16	CASSRQNYGYTF+TCRBV14-01+TCRBJ01-02	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGGCGAGGGGTAAGGGACCCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	2	77	1.8069051937964485E-4		50	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-07	01	1	0	7	2	11	1	29	45	61	56	62				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	X+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01		TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCCGGGCCTTTATGGCTACACCTTCGGTTCG	CASSPGLYGYTF	In	VDJ	2	110	2.5812931339949267E-4	3.2403166083900636E-4	36	TCRBV14	TCRBV14-01	01				TCRBJ01	TCRBJ01-02	01	4	8	0	5	1	3	29	42	47	43	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSPGLYGYTF+TCRBV14-01+TCRBJ01-02	TCRBV14-01*01		TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGTCGGGGGGGGCTGGCAGTTCTTCGGGCCA	CASSQVGGGWQFF	In	VDJ	2	121	2.839422447394419E-4	3.56434826922907E-4	39	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	1	8	0	12	1	4	29	45	54	46	58													Vb 16	CASSQVGGGWQFF+TCRBV14-01+TCRBJ02-01	TCRBV14-01*01	TCRBD02-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGGCGACAGGGGATTTGCAGATACGCAGTATTTTGGCCCA	CASSQGDRGFADTQYF	In	VDJ	3	135	3.167950664448319E-4	3.9767522012059867E-4	48	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	1	2	2	4	2	5	29	45	55	47	60													Vb 16	CASSQGDRGFADTQYF+TCRBV14-01+TCRBJ02-03	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGAAATTGGTAAGGGGGAAGCTTTCTTTGGACAA	CASSQEIGKGEAFF	In	VDJ	3	158	3.70767559246544E-4	4.6542729465966367E-4	42	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	5	2	8	8	0	29	46	-1	54	59													Vb 16	CASSQEIGKGEAFF+TCRBV14-01+TCRBJ01-01	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGATCGAAGGAGACCCAGTACTTCGGGCCA		Out	VDJ	5	256	6.007373111842738E-4		38	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-05	01	0	2	8	5	2	2	29	46	50	48	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	X+TCRBV14-01+TCRBJ02-05	TCRBV14-01*01		TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCATTACTCAGACCCTTTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	5	256	6.007373111842738E-4		46	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-01	01	3	2	7	4	7	4	29	43	53	50	57				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	X+TCRBV14-01+TCRBJ02-01	TCRBV14-01*01		TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGTACCGCTGTACTATGGCTACACCTTCGGTTCG	CASSQVPLYYGYTF	In	VDJ	6	288	6.758294750823081E-4	8.483738029239438E-4	42	TCRBV14	TCRBV14-01	01				TCRBJ01	TCRBJ01-02	01	1	3	7	3	1	6	29	45	48	46	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSQVPLYYGYTF+TCRBV14-01+TCRBJ01-02	TCRBV14-01*01		TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCGGGGATCGGTGCTGGGTGGCTACACCTTCGGTTCG	CASSRGSVLGGYTF	In	VDJ	7	375	8.799862956800886E-4	0.0011046533892238853	42	TCRBV14	TCRBV14-01	01				TCRBJ01	TCRBJ01-02	01	4	0	8	7	1	11	29	42	47	43	58				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSRGSVLGGYTF+TCRBV14-01+TCRBJ01-02	TCRBV14-01*01		TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAGGCCTGGGGGGATCGCTATAGCTACACCTTCGGTTCG	CASSQAWGDRYSYTF	In	VDJ	8	394	9.245722679945464E-4	0.0011606224942778953	45	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	3	9	1	9	5	9	29	43	54	48	63													Vb 16	CASSQAWGDRYSYTF+TCRBV14-01+TCRBJ01-02	TCRBV14-01*01	TCRBD02-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCGGAGTCAGGGATGGAACACTGAAGCTTTCTTTGGACAA	CASSRSQGWNTEAFF	In	VDJ	10	514	0.0012061678826121747	0.0015141115788295388	45	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	4	3	1	5	3	29	42	52	47	55													Vb 16	CASSRSQGWNTEAFF+TCRBV14-01+TCRBJ01-01	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCATTCCCGGGGACAGGCTCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	11	537	0.001260140375413887		49	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	0	4	3	6	2	29	43	57	49	59													Vb 16	X+TCRBV14-01+TCRBJ01-05	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGACAAGAAGCAGTTCTTCGGGCCA	CASSQDKKQFF	In	VDJ	12	594	0.0013938982923572603	0.0017497709685306343	33	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-01	01	0	2	8	11	3	0	29	46	-1	49	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSQDKKQFF+TCRBV14-01+TCRBJ02-01	TCRBV14-01*01		TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGTTTGGGGCACAGATACGCAGTATTTTGGCCCA	CASSQVWGTDTQYF	In	VDJ	14	708	0.0016614141262440074	0.0020855855988546955	42	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-03	01	1	0	9	1	3	0	29	45	-1	48	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSQVWGTDTQYF+TCRBV14-01+TCRBJ02-03	TCRBV14-01*01		TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGTTCTGGGAGAGGGTTTGCAGTACGTCGGGCCG	CASSQVLGEGLQYV	In	VDJ	76	3803	0.008924234353257005	0.011202658237915828	42	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	1	9	2	17	4	15	29	45	54	49	69													Vb 16	CASSQVLGEGLQYV+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01	TCRBD02-01*02	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCTTTTATCAGGGAGCATATGGGGCCAACGTCCTGACTTTCGGGGCC	CASSFYQGAYGANVLTF	In	VDJ	1	16	3.7546081949017114E-5	4.7131877940219106E-5	51	TCRBV21	TCRBV21-or09_02	01				TCRBJ02	TCRBJ02-06	01	5	4	3	3	6	6	24	36	47	42	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFYQGAYGANVLTF+TCRBV21-or09_02+TCRBJ02-06	TCRBV21-or09_02*01		TCRBJ02-06*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTATACGGGGGTCAAGAGACCCAGTACTTCGGGCCA	CASSVYGGQETQYF	In	VDJ	6	292	6.852159955695623E-4	8.601567724089987E-4	42	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	5	8	2	2	5	1	24	36	47	41	48														CASSVYGGQETQYF+TCRBV21-or09_02+TCRBJ02-05	TCRBV21-or09_02*01	TCRBD02-01*01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGTCTATAGGACCGACTAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	7	337	7.90814351051173E-4		44	TCRBV21	TCRBV21-or09_02	01				TCRBJ02	TCRBJ02-03	01	10	1	7	0	7	5	24	31	42	38	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV21-or09_02+TCRBJ02-03	TCRBV21-or09_02*01		TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCAAGTGGGGGGCACACGGCTGACGAGCAGTACTTCGGGCCG		Out	VDJ	8	389	9.128391173854785E-4		46	TCRBV21	TCRBV21-or09_02	01				TCRBJ02	TCRBJ02-07	01	3	6	0	5	3	9	24	38	47	41	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV21-or09_02+TCRBJ02-07	TCRBV21-or09_02*01		TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGGGACAGCACGGGCTCGGGAAAAACTGTTTTTTGGCAGT	CASSEGTARAREKLFF	In	VDJ	1	16	3.7546081949017114E-5	4.7131877940219106E-5	48	TCRBV06	TCRBV06-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	1	1	5	8	0	11	23	-1	45	39	56														CASSEGTARAREKLFF+TCRBV06-01+TCRBJ01-04	TCRBV06-01*01	TCRBD01-01*01	TCRBJ01-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGACGGGGATACGCAGTATTTTGGCCCA	CASSEDGDTQYF	In	VDJ	1	40	9.386520487254278E-5	1.1782969485054776E-4	36	TCRBV06	TCRBV06-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	1	8	4	6	1	0	23	39	-1	40	44						01,02								CASSEDGDTQYF+TCRBV06-01+TCRBJ02-03	TCRBV06-01*01	TCRBD02-01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGAGGGATTGACGTCTAACTATGGCTACACCTTCGGTTCG	CASSEEGLTSNYGYTF	In	VDJ	1	48	1.1263824584705134E-4	1.413956338206573E-4	48	TCRBV06	TCRBV06-01	01				TCRBJ01	TCRBJ01-02	01	1	0	8	0	1	7	23	39	44	40	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEEGLTSNYGYTF+TCRBV06-01+TCRBJ01-02	TCRBV06-01*01		TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGGGGACTCAGCTGTGTATCTCTGTGCCAGCAGCTTACAGGGGGACTATAAAGACAATGAGCAGTTCTTCGGGCCA	CASSLQGDYKDNEQFF	In	VDJ	1	13	3.0506191583576405E-5	3.8294650826428025E-5	48	TCRBV07	TCRBV07-04	01				TCRBJ02	TCRBJ02-01	01	2	4	1	5	0	9	22	-1	44	37	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLQGDYKDNEQFF+TCRBV07-04+TCRBJ02-01	TCRBV07-04*01		TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGGGGACTCAGCTGTGTATCTCTGTGCCAGCAGCTCGGACTAAGGACAGTGGCCCCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	16	3.7546081949017114E-5		53	TCRBV07	TCRBV07-04	01				TCRBJ02	TCRBJ02-01	01	4	1	5	2	8	6	22	35	49	43	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV07-04+TCRBJ02-01	TCRBV07-04*01		TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGGGGACTCAGCTGTGTATCTCTGTGCCAGCAGAGCGGGCCTCACCGGGACGCAGTATTTTGGCCCA	CASRAGLTGTQYF	In	VDJ	1	22	5.162586267989853E-5	6.480633216780127E-5	39	TCRBV07	TCRBV07-04	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	6	4	9	0	10	22	-1	39	33	49						01,02								CASRAGLTGTQYF+TCRBV07-04+TCRBJ02-03	TCRBV07-04*01	TCRBD02-01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAGCCACGTTTGGTGCTTCTCAGTGACTCTGGYTCTATCTCTGTGCCTACGCCGGGACTAGTAAGTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	13	3.0506191583576405E-5		38	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	24	0	8	4	21	4	43	33	62	54	66						01,02							Vb 20	X+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01	TCRBD02-01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTAGTACAGGGGGGCGAGCAGTACTTCGGGCCG	CAWSVVQGGEQYF	In	VDJ	1	13	3.0506191583576405E-5	3.8294650826428025E-5	39	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	3	1	6	3	1	26	40	51	43	52													Vb 20	CAWSVVQGGEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*02	TCRBD01-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGCCTGACTCATGATTCACCCCTCCACTTTGGGAAC	CAWSLTHDSPLHF	In	VDJ	1	13	3.0506191583576405E-5	3.8294650826428025E-5	39	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-06	01	3	2	10	8	3	4	26	37	44	40	48			unresolved			01,02							Vb 20	CAWSLTHDSPLHF+TCRBV30-01+TCRBJ01-06	TCRBV30-01*01	TCRBD02-01	TCRBJ01-06*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGGGGTATCGGAGGGGACAGTGAAGCTTTCTTTGGACAA		Out	VDJ	1	13	3.0506191583576405E-5		35	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	10	0	5	7	11	0	26	30	-1	41	48			unresolved										Vb 20	X+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGCCCAGTGTGTGGGTGGGGGAGAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	15	3.519945182720355E-5		43	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-05	01	6	6	1	8	14	2	26	34	53	48	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	X+TCRBV30-01+TCRBJ01-05	TCRBV30-01*01		TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCCCGGGGGCCTTGAAGCTTTCTTTGGACAA	CAWSPGGLEAFF	In	VDJ	1	16	3.7546081949017114E-5	4.7131877940219106E-5	36	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-01	01	2	6	0	7	3	2	26	38	47	41	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSPGGLEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01		TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAACCAAAGACAGGGTCGTATCGGGACTGAAGCTTTCTTTGGACAA	CAWNQRQGRIGTEAFF	In	VDJ	1	18	4.2239342192644256E-5	5.302336268274649E-5	48	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	2	3	5	6	10	26	36	49	42	59													Vb 20	CAWNQRQGRIGTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTACGACAGGGGGCGACAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	21	4.927923255808496E-5		41	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	2	0	7	2	2	26	38	50	40	52													Vb 20	X+TCRBV30-01+TCRBJ01-05	TCRBV30-01*02	TCRBD01-01*01	TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGAGGTCAGGGGGAGCCAGCCCCAGCATTTTGGTGAT	CAWSEVRGSQPQHF	In	VDJ	1	22	5.162586267989853E-5	6.480633216780127E-5	42	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	1	4	1	7	4	3	26	39	50	43	53			unresolved										Vb 20	CAWSEVRGSQPQHF+TCRBV30-01+TCRBJ01-05	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGGGTCAGGTTACACCGGGGAGCTGTTTTTTGGAGAA	CAWGSGYTGELFF	In	VDJ	1	25	5.866575304533924E-5	7.364355928159235E-5	39	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	4	4	3	4	2	26	35	43	39	45													Vb 20	CAWGSGYTGELFF+TCRBV30-01+TCRBJ02-02	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGATCCGGGGACGCTCGGACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	26	6.101238316715281E-5		41	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-01	01	6	0	7	3	5	6	26	34	44	39	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	X+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01		TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGACCGGGACTAGCAAATACGAGCAGTACTTCGGGCCG	CAWTGTSKYEQYF	In	VDJ	1	26	6.101238316715281E-5	7.658930165285605E-5	39	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	0	7	4	2	3	26	36	47	38	50			unresolved			01,02							Vb 20	CAWTGTSKYEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01	TCRBD02-01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGTCTGGAGTGTATTAACCGGACAGAACTATGGCTACACCTTCGGTTCG	CVWSVLTGQNYGYTF	In	VDJ	1	26	6.101238316715281E-5	7.658930165285605E-5	45	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	1	5	2	7	0	26	40	-1	47	53			unresolved										Vb 20	CVWSVLTGQNYGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCTCTGTGCCTGGAGTACTTACTGGACAGGGGGCGTCCCCGTTCTCTAGGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	33	7.74387940198478E-5		65	TCRBV30	TCRBV30-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	2	1	0	4	7	14	5	17	35	24	49			01,02										Vb 20	X+TCRBV30-01+TCRBJ02-06	TCRBV30-01	TCRBD01-01*01	TCRBJ02-06*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCGATGGGGCATCTCCTATGGCTACACTTTCGGTTCG	CAWSRWGISYGYTF	In	VDJ	1	33	7.74387940198478E-5	9.72094982517019E-5	42	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	7	0	17	4	18	26	38	47	42	65			unresolved										Vb 20	CAWSRWGISYGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAACCCTCCCGGGACCCTCTCTGAAAAACTGTTTTTTGGCAGT	CAWNPPGTLSEKLFF	In	VDJ	1	34	7.978542414166136E-5	1.001552406229656E-4	45	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-04	01	4	0	7	7	8	6	26	36	49	44	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWNPPGTLSEKLFF+TCRBV30-01+TCRBJ01-04	TCRBV30-01*01		TCRBJ01-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGTTTGGGACTGTCCCTCTACACCTTCGGTTCG	CACLGLSLYTF	In	VDJ	1	34	7.978542414166136E-5	1.001552406229656E-4	33	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	6	0	10	10	3	6	26	34	43	37	49						01,02							Vb 20	CACLGLSLYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01	TCRBD02-01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAAGGTGCAAGGGGGCACAGAGACCCAGTACTTCGGGCCA	CAWKVQGGTETQYF	In	VDJ	1	36	8.447868438528851E-5	1.0604672536549298E-4	42	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	5	0	4	7	2	26	36	50	43	52			unresolved										Vb 20	CAWKVQGGTETQYF+TCRBV30-01+TCRBJ02-05	TCRBV30-01*02	TCRBD01-01*01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGAAGACAGATACTATGGCTACACCTTCGGTTCG	CAWSEDRYYGYTF	In	VDJ	1	45	1.0559835548161063E-4	1.3255840670686622E-4	39	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	2	5	3	2	2	26	39	46	41	48													Vb 20	CAWSEDRYYGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGATGCGGGGAGTCAGCACCGGGGAGCTGTTTTTTGGAGAA	CAWMRGVSTGELFF	In	VDJ	1	45	1.0559835548161063E-4	1.3255840670686622E-4	42	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	4	7	3	4	1	6	26	36	43	37	49													Vb 20	CAWMRGVSTGELFF+TCRBV30-01+TCRBJ02-02	TCRBV30-01*01	TCRBD02-01*01	TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGAGCCGGGCCCCGGACCCTACGAGCAGTACTTCGGGCCG	CAWEPGPGPYEQYF	In	VDJ	1	46	1.079449856034242E-4	1.3550414907812994E-4	42	TCRBV30	TCRBV30-01	01				TCRBJ02	TCRBJ02-07	01	5	1	7	2	12	0	26	35	-1	47	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWEPGPGPYEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01		TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGGGGGAGGAGATACGCAGTATTTTGGCCCA	CAWSGGGDTQYF	In	VDJ	1	51	1.1967813621249205E-4	1.502328609344484E-4	36	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	1	9	1	5	1	0	26	39	-1	40	46													Vb 20	CAWSGGGDTQYF+TCRBV30-01+TCRBJ02-03	TCRBV30-01*01	TCRBD02-01*02	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTTCTTCAGGGAGCGATGGCTACACCTTCGGTTCG	CAWSSSGSDGYTF	In	VDJ	1	52	1.2202476633430562E-4	1.531786033057121E-4	39	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-02	01	2	4	3	6	4	4	26	38	47	42	51			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSSSGSDGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01		TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCCTGGAGACACCGGCCGCTACGCTTTCTTTGGACAA	CAWSPGDTGRYAFF	In	VDJ	1	53	1.243713964561192E-4	1.5612434567697578E-4	42	TCRBV30	TCRBV30-01	02				TCRBJ01	TCRBJ01-01	01	2	2	6	11	6	11	26	38	48	44	59				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSPGDTGRYAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*02		TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGCCACAGGGGAACTATGGCTACACCTTCGGTTCG	CAWPQGNYGYTF	In	VDJ	1	53	1.243713964561192E-4	1.5612434567697578E-4	36	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	3	2	2	2	0	26	35	-1	37	44			unresolved										Vb 20	CAWPQGNYGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*02	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGACCCCCCGGTGGACAGCTAACACTGAAGCTTTCTTTGGACAA	CAWTPRWTANTEAFF	In	VDJ	1	54	1.2671802657793275E-4	1.5907008804823947E-4	45	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	1	5	2	9	2	26	36	51	45	53													Vb 20	CAWTPRWTANTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGACCCGGACAGGCCCGGAGATACGCAGTATTTTGGCCCA	CAWSDPDRPGDTQYF	In	VDJ	1	56	1.314112868215599E-4	1.6496157279076687E-4	45	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	1	1	4	5	4	5	26	39	50	43	55													Vb 20	CAWSDPDRPGDTQYF+TCRBV30-01+TCRBJ02-03	TCRBV30-01*02	TCRBD01-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGTCGGTGGTCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CAWSVVSGANVLTF	In	VDJ	1	59	1.384511771870006E-4	1.7379879990455795E-4	42	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	5	8	5	0	1	4	26	35	39	36	43						01,02							Vb 20	CAWSVVSGANVLTF+TCRBV30-01+TCRBJ02-06	TCRBV30-01*02	TCRBD02-01	TCRBJ02-06*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGACAGGGAGGGGAACAATGAGCAGTTCTTCGGGCCA	CAWDREGNNEQFF	In	VDJ	1	62	1.4549106755244132E-4	1.8263602701834903E-4	39	TCRBV30	TCRBV30-01	01				TCRBJ02	TCRBJ02-01	01	5	2	3	5	0	6	26	-1	42	35	48			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWDREGNNEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*01		TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGGCGCTCCGCTAGCACAGATACGCAGTATTTTGGCCCA	CAWRRSASTDTQYF	In	VDJ	1	63	1.4783769767425488E-4	1.8558176938961271E-4	42	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	7	6	0	0	7	26	-1	40	37	47			unresolved			01,02							Vb 20	CAWRRSASTDTQYF+TCRBV30-01+TCRBJ02-03	TCRBV30-01*02	TCRBD02-01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTACATCGGCAGGGATCCGCCTCTGGAAACACCATATATTTTGGAGAG	CAWSVHRQGSASGNTIYF	In	VDJ	1	64	1.5018432779606846E-4	1.8852751176087643E-4	54	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	0	4	3	0	7	6	26	40	52	47	58													Vb 20	CAWSVHRQGSASGNTIYF+TCRBV30-01+TCRBJ01-03	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTACTGAGACAGGGTAAGGGAGTGAGATACGAGCAGTACTTCGGGCCG	CAWSVLRQGKGVRYEQYF	In	VDJ	1	71	1.6661073864876344E-4	2.0914770835972227E-4	54	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	2	3	4	5	13	26	40	52	45	65			unresolved										Vb 20	CAWSVLRQGKGVRYEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGAGAGGACAAACACCATATATTTTGGAGAG	CAWERTNTIYF	In	VDJ	2	85	1.9946356035415342E-4	2.50388101557414E-4	33	TCRBV30	TCRBV30-01	02				TCRBJ01	TCRBJ01-03	01	5	1	7	6	4	0	26	35	-1	39	43			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWERTNTIYF+TCRBV30-01+TCRBJ01-03	TCRBV30-01*02		TCRBJ01-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGAGTTCGGGGAATTGAGCTGTTTTTTGGAGAA	CAWRVRGIELFF	In	VDJ	2	90	2.1119671096322127E-4	2.6511681341373245E-4	36	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	3	8	3	11	4	4	26	37	46	41	50													Vb 20	CAWRVRGIELFF+TCRBV30-01+TCRBJ02-02	TCRBV30-01*02	TCRBD02-01*01	TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCAACGGACTAGCGGGAGATCTCCCCACGAGCAGTATTTCGGGCCG	CAWSQRTSGRSPHEQYF	In	VDJ	2	95	2.2292986157228912E-4	2.7984552527005095E-4	51	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	1	2	16	4	19	26	38	55	42	74			unresolved										Vb 20	CAWSQRTSGRSPHEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01	TCRBD02-01*02	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCTTGTCGACAGGGGGCTGTATGGCTACACCTTCGGTTCG	CAWSLVDRGLYGYTF	In	VDJ	2	98	2.2996975193772983E-4	2.8868275238384204E-4	45	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	2	0	5	6	2	26	38	54	44	56			unresolved										Vb 20	CAWSLVDRGLYGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*02	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAACCAGGGGCTTAGCAATCAGCCCCAGCATTTTGGTGAT	CAWNQGLSNQPQHF	In	VDJ	2	100	2.3466301218135697E-4	2.945742371263694E-4	42	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	4	2	0	2	2	26	36	44	38	46													Vb 20	CAWNQGLSNQPQHF+TCRBV30-01+TCRBJ01-05	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGACAAAAGGACAGGGGTGGACCGGGGAGCTGTTTTTTGGAGAA	CAWTKGQGWTGELFF	In	VDJ	2	101	2.3700964230317052E-4	2.975199794976331E-4	45	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	1	2	5	5	3	26	36	50	41	53			unresolved										Vb 20	CAWTKGQGWTGELFF+TCRBV30-01+TCRBJ02-02	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGTCGGTGGAGGGAACAGATACGCAGTATTTTGGCCCA	CAWSVEGTDTQYF	In	VDJ	2	111	2.6047594352130625E-4	3.2697740321027E-4	39	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	10	0	3	5	1	26	35	46	40	47			unresolved										Vb 20	CAWSVEGTDTQYF+TCRBV30-01+TCRBJ02-03	TCRBV30-01*01	TCRBD02-01*02	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTAAAGGGAGATGCGACTGAAGCTTTCTTTGGACAA	CAWSVKGDATEAFF	In	VDJ	2	123	2.8863550498306906E-4	3.6232631166543435E-4	42	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	0	9	2	5	3	5	26	40	48	43	53			unresolved										Vb 20	CAWSVKGDATEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD02-01*02	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGGACCGCCGTAGCGCCACTCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	3	137	3.2148832668845904E-4		47	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	5	6	0	9	5	26	35	49	44	54						01,02							Vb 20	X+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01	TCRBD02-01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGGTCGGGTCGGAGAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	3	139	3.261815869320862E-4		43	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	8	4	1	3	5	26	35	42	38	47			unresolved			01,02							Vb 20	X+TCRBV30-01+TCRBJ02-02	TCRBV30-01*02	TCRBD02-01	TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTATGGGGGCGGGCGAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	3	140	3.285282170538997E-4		46	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	2	6	0	0	2	3	26	38	46	40	49			unresolved										Vb 20	X+TCRBV30-01+TCRBJ02-02	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTTTCTGGCCGCCCGACAGGGGAACAAAACTGTTTTTTGGCAGT	CAWSFWPPDRGTKLFF	In	VDJ	3	146	3.4260799778478116E-4	4.3007838620449934E-4	48	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	2	2	2	10	12	3	26	38	58	50	61			unresolved										Vb 20	CAWSFWPPDRGTKLFF+TCRBV30-01+TCRBJ01-04	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGCAAGGGACAGAGCTCTGGAAACACCATATATTTTGGAGAG	CAWSKGQSSGNTIYF	In	VDJ	3	150	3.5199451827203543E-4	4.418613556895541E-4	45	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	3	0	5	0	3	2	26	37	47	40	49													Vb 20	CAWSKGQSSGNTIYF+TCRBV30-01+TCRBJ01-03	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAATAGGCAGGGACACAATGAGCAGTTCTTCGGGCCA	CAWNRQGHNEQFF	In	VDJ	3	154	3.613810387592897E-4	4.536443251746089E-4	39	TCRBV30	TCRBV30-01	01				TCRBJ02	TCRBJ02-01	01	4	0	7	5	7	0	26	36	-1	43	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWNRQGHNEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*01		TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGTCTGGGACGGTTGCTCTTCGAAAAACTGTTTTTTGGCAGT		Out	VDJ	3	155	3.637276688811033E-4		38	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-04	01	5	2	7	8	0	11	26	-1	38	35	49			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	X+TCRBV30-01+TCRBJ01-04	TCRBV30-01*01		TCRBJ01-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTTCTGACAAGGTAGCTTTCTTTGGACAA	CAWSSDKVAFF	In	VDJ	3	160	3.7546081949017113E-4	4.7131877940219104E-4	33	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	2	6	10	3	4	26	38	45	41	49													Vb 20	CAWSSDKVAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGGATTGGGGCCGGGACTTTCTTTGGACAA	CAWRIGAGTFF	In	VDJ	3	174	4.083136411955611E-4	5.125591725998827E-4	33	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-01	01	3	7	0	12	4	5	26	37	46	41	51			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWRIGAGTFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01		TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGGAGACAGGGGGCGTTAGCGGGGATCCCCGGGGAGCTGTTTTTTGGAGAA	CAWRRQGALAGIPGELFF	In	VDJ	4	189	4.4351309302276466E-4	5.567453081688382E-4	54	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	2	0	6	2	14	26	37	49	39	63			unresolved										Vb 20	CAWRRQGALAGIPGELFF+TCRBV30-01+TCRBJ02-02	TCRBV30-01*02	TCRBD01-01*01	TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGAGCCGGGACAGGGATCGGAGATACGCAGTATTTTGGCCCA	CAWRAGTGIGDTQYF	In	VDJ	4	209	4.90445695459036E-4	6.15660155594112E-4	45	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	0	3	5	4	5	26	37	50	41	55			unresolved										Vb 20	CAWRAGTGIGDTQYF+TCRBV30-01+TCRBJ02-03	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGACACCGGGACCCCTACGTGGTGGCTACACCTTCGGTTCG	CAWTPGPLRGGYTF	In	VDJ	4	213	4.998322159462903E-4	6.274431250791668E-4	42	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-02	01	4	0	7	7	4	10	26	36	45	40	55			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWTPGPLRGGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01		TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTAGATAGGGAGAACACTGAAGCTTTCTTTGGACAA	CAWSVDRENTEAFF	In	VDJ	4	213	4.998322159462903E-4	6.274431250791668E-4	42	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-01	01	0	0	8	1	5	0	26	40	-1	45	49			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSVDRENTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01		TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCCACGGTCGACCTACGAGCAGTACGTCGGGCCG	CAWSPRSTYEQYV	In	VDJ	5	227	5.326850376516804E-4	6.686835182768585E-4	39	TCRBV30	TCRBV30-01	01				TCRBJ02	TCRBJ02-07	01	2	2	7	17	8	14	26	38	49	46	63			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSPRSTYEQYV+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01		TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGAGATAAATGAGCAGTTCTTCGGGCCA	CAWSEINEQFF	In	VDJ	5	227	5.326850376516804E-4	6.686835182768585E-4	33	TCRBV30	TCRBV30-01	01				TCRBJ02	TCRBJ02-01	01	1	2	8	7	1	2	26	39	42	40	44			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSEINEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*01		TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGGACTCCACCGGGGTTCTATGGCTACACCTTCGGTTCG	CAWRTPPGFYGYTF	In	VDJ	5	235	5.514580786261889E-4	6.922494572469681E-4	42	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	3	8	3	4	8	2	26	37	50	45	52			unresolved										Vb 20	CAWRTPPGFYGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01	TCRBD02-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGGGTGGGTTGGGAATGAGCAGTTCTTCGGGCCA	CAWGWVGNEQFF	In	VDJ	5	251	5.89004160575206E-4	7.393813351871873E-4	36	TCRBV30	TCRBV30-01	01				TCRBJ02	TCRBJ02-01	01	5	0	9	7	0	9	26	-1	38	35	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWGWVGNEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*01		TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGTGCGCAGGGGGCCCGGTATGGCTACACCTTCGGTTCG	CACAQGARYGYTF	In	VDJ	5	258	6.05430571427901E-4	7.60001531786033E-4	39	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	4	0	5	4	4	26	34	46	38	50													Vb 20	CACAQGARYGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTACGCGGGAGAGGGTCCTACAATGAGCAGTTCTTCGGGCCA	CAWSVRGRGSYNEQFF	In	VDJ	5	270	6.335901328896637E-4	7.953504402411973E-4	48	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	7	2	1	2	4	26	40	49	42	53			unresolved										Vb 20	CAWSVRGRGSYNEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*01	TCRBD02-01*02	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTTGGATCCCTAGCGAATGAGCAGTTCTTCGGGCCA	CAWSVGSLANEQFF	In	VDJ	6	305	7.157221871531387E-4	8.984514232354267E-4	42	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	4	6	7	7	0	26	40	-1	47	53						01,02							Vb 20	CAWSVGSLANEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*02	TCRBD02-01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTATGGGCGGGAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CAWSMGGSSYNEQFF	In	VDJ	6	320	7.509216389803423E-4	9.426375588043821E-4	45	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	7	2	0	4	0	26	38	-1	42	49			unresolved										Vb 20	CAWSMGGSSYNEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*01	TCRBD02-01*02	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAACCTTCAGGGGGCGGAGACCCAGTACTTCGGGCCA	CAWNLQGAETQYF	In	VDJ	7	338	7.931609811729865E-4	9.956609214871286E-4	39	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	4	0	5	5	1	26	36	49	41	50			unresolved										Vb 20	CAWNLQGAETQYF+TCRBV30-01+TCRBJ02-05	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCTAAGACAGACCTCGAACACTGAAGCTTTCTTTGGACAA	CAWSLRQTSNTEAFF	In	VDJ	8	413	9.691582403090043E-4	0.0012165915993319057	45	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	2	5	1	4	5	26	38	47	42	52			unresolved										Vb 20	CAWSLRQTSNTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCGGCAAGTCAGACAGGATGAACGGCTACACCTTCGGTTCG	CAGKSDRMNGYTF	In	VDJ	8	423	9.926245415271399E-4	0.0012460490230445426	39	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	8	2	4	8	9	6	26	32	47	41	53			unresolved										Vb 20	CAGKSDRMNGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*02	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGACCTAAACCACAGGGGCTTCCTAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	9	430	0.001009050952379835		49	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	4	3	2	6	8	5	26	36	51	44	56			unresolved										Vb 20	X+TCRBV30-01+TCRBJ01-06	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-06*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTCGACCCCGGGGCCCTCCTCCTACGAGCAGTACTTCGGGCCG	CASTPGPSSYEQYF	In	VDJ	9	431	0.0010113975825016485	0.001269614962014652	42	TCRBV30	TCRBV30-01	01				TCRBJ02	TCRBJ02-07	01	7	7	0	0	7	4	26	33	45	40	49			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CASTPGPSSYEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01		TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGTCCGACAGGGGGCGGCTATGGCTACACCTTCGGTTCG	CACPTGGGYGYTF	In	VDJ	11	538	0.0012624870055357004	0.0015848093957398675	39	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	2	0	4	3	2	26	34	47	37	49			unresolved										Vb 20	CACPTGGGYGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGCGGACAGGGGGCTGGGGAGACCCAGTACTTCGGGCCA	CACGQGAGETQYF	In	VDJ	12	626	0.0014689904562552945	0.0018440347244110724	39	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	1	0	5	1	4	26	34	46	35	50			unresolved										Vb 20	CACGQGAGETQYF+TCRBV30-01+TCRBJ02-05	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGACTAGGACTAGCGGATACGAGCAGTACTTCGGGCCG	CAWTRTSGYEQYF	In	VDJ	13	653	0.001532349469544261	0.0019235697684351922	39	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	1	5	4	3	1	26	36	49	39	50			unresolved			01,02							Vb 20	CAWTRTSGYEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01	TCRBD02-01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGACGACGGTCAAGAGACCCAGTACTTCGGGCCA	CAWDDGQETQYF	In	VDJ	17	849	0.0019922889734197207	0.0025009352732028763	36	TCRBV30	TCRBV30-01	01				TCRBJ02	TCRBJ02-05	01	5	2	7	2	0	6	26	-1	38	35	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWDDGQETQYF+TCRBV30-01+TCRBJ02-05	TCRBV30-01*01		TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGCTAGCGGGGTGGGATAAGCAGTTCTTCGGGCCA	CAWLAGWDKQFF	In	VDJ	25	1246	0.002923901131779708	0.003670394994594563	36	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	4	3	11	0	7	26	-1	44	35	51			unresolved										Vb 20	CAWLAGWDKQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*01	TCRBD02-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTACTACAGGAGCGGGATGGGAGCAGTACTTCGGGCCG	CAWSTTGAGWEQYF	In	VDJ	26	1314	0.0030834719800630307	0.003870705475840494	42	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	6	3	7	8	3	26	38	53	46	56			unresolved										Vb 20	CAWSTTGAGWEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01	TCRBD02-01*02	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTACGCCGGGACTAGTAAGTACGAGCAGTACTTCGGGCCG	CAYAGTSKYEQYF	In	VDJ	33	1672	0.003923565563672288	0.004925281244752896	39	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	7	0	8	4	5	4	26	33	46	38	50			unresolved			01,02							Vb 20	CAYAGTSKYEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01	TCRBD02-01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTCTACGACGGGACCAAGCTCCTACGAGCAGTACTTCGGGCCG	CASTTGPSSYEQYF	In	VDJ	38	1918	0.004500836573638427	0.005649933868083765	42	TCRBV30	TCRBV30-01	01				TCRBJ02	TCRBJ02-07	01	7	0	7	0	7	4	26	33	45	40	49			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CASTTGPSSYEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01		TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCATCAGAGGTTGTTCTCCCTCCAATGTGGCATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	13	3.0506191583576405E-5		49	TCRBV01	TCRBV01-01	01				TCRBJ02	TCRBJ02-01	01	6	5	4	8	0	21	23	-1	37	34	58				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV01-01+TCRBJ02-01	TCRBV01-01*01		TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCGAACTCCGGGACAGGGGGAGAACTATGGCTACACCTTCGGTTCG	CASSRTPGQGENYGYTF	In	VDJ	1	14	3.285282170538997E-5	4.1240393197691716E-5	51	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	0	1	2	7	2	23	36	54	43	56														CASSRTPGQGENYGYTF+TCRBV01-01+TCRBJ01-02	TCRBV01-01*01	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGCGTATCTCTGCGCCAGCAGCCAAGATGACTTGGTGGCAGCCGCGGGCCCCCTGGCCAAAAACATTCAGTACTTCGGCGCC	CASSQDDLVAAAGPLAKNIQYF	In	VDJ	1	17	3.989271207083068E-5	5.00776203114828E-5	66	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	0	7	4	1	16	7	10	27	48	43	55						01,02								CASSQDDLVAAAGPLAKNIQYF+TCRBV01-01+TCRBJ02-04	TCRBV01-01*01	TCRBD02-01	TCRBJ02-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCTCCCGAGCGGGGGCTGTGAACACTGAAGCTTTCTTTGGACAA	CASSSRAGAVNTEAFF	In	VDJ	1	18	4.2239342192644256E-5	5.302336268274649E-5	48	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	5	6	2	0	5	3	23	35	48	40	51														CASSSRAGAVNTEAFF+TCRBV01-01+TCRBJ01-01	TCRBV01-01*01	TCRBD02-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCTGTATTTCGGGGGGGATGAGCAGTTCTTCGGGCCA	CASSLYFGGDEQFF	In	VDJ	1	19	4.4585972314457824E-5	5.596910505401019E-5	42	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	8	0	8	7	0	23	36	-1	43	51														CASSLYFGGDEQFF+TCRBV01-01+TCRBJ02-01	TCRBV01-01*01	TCRBD02-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCTCCGGGACTAGCGGGAGTTACAATGAGCAGTTCTTCGGGCCA	CASSSGTSGSYNEQFF	In	VDJ	1	20	4.693260243627139E-5	5.891484742527388E-5	48	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	0	2	4	3	1	23	35	52	38	53														CASSSGTSGSYNEQFF+TCRBV01-01+TCRBJ02-01	TCRBV01-01*01	TCRBD02-01*02	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGATATGGTACCCCGGGGCACCGGGGAGCTGTTTTTTGGAGAA	CASSQDMVPRGTGELFF	In	VDJ	1	23	5.39724928017121E-5	6.775207453906497E-5	51	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	0	8	3	4	10	0	23	40	-1	50	55														CASSQDMVPRGTGELFF+TCRBV01-01+TCRBJ02-02	TCRBV01-01*01	TCRBD02-01*01	TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AAGAAGACTCAGCTGCGTATCTCTGCACCAGCAGCCAAGAGGAGGGAGTCGCCTACAATGAGCAGTTCTTCGGGCCA	CTSSQEEGVAYNEQFF	In	VDJ	1	26	6.101238316715281E-5	7.658930165285605E-5	48	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	10	0	2	0	5	23	-1	46	40	51														CTSSQEEGVAYNEQFF+TCRBV01-01+TCRBJ02-01	TCRBV01-01*01	TCRBD02-01*02	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAGCAGTACAGGGTCGAAGGTGGCTACACCTTCGGTTCG	CASSQQYRVEGGYTF	In	VDJ	1	26	6.101238316715281E-5	7.658930165285605E-5	45	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	3	3	7	5	7	23	37	48	42	55														CASSQQYRVEGGYTF+TCRBV01-01+TCRBJ01-02	TCRBV01-01*01	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCATCGGGACAGAAGCGGGGGAGCTTTCTTTGGACAA	CASSHRDRSGGAFF	In	VDJ	1	28	6.570564341077994E-5	8.248078639538343E-5	42	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	3	6	2	10	10	0	23	37	-1	47	55														CASSHRDRSGGAFF+TCRBV01-01+TCRBJ01-01	TCRBV01-01*01	TCRBD02-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAACAAGACAGGGGGAGCAATCAGCCCCAGCATTTTGGTGAT	CASSQQDRGSNQPQHF	In	VDJ	1	30	7.03989036544071E-5	8.837227113791082E-5	48	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	2	1	1	3	0	23	38	-1	41	50														CASSQQDRGSNQPQHF+TCRBV01-01+TCRBJ01-05	TCRBV01-01*01	TCRBD01-01*01	TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAACTTTTCGCGGGGGGGCTCGTCGCGGAGCAGTTCTTCGGGCCA	CASSQLFAGGLVAEQFF	In	VDJ	1	30	7.03989036544071E-5	8.837227113791082E-5	51	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	2	7	0	10	6	9	23	38	53	44	62														CASSQLFAGGLVAEQFF+TCRBV01-01+TCRBJ02-01	TCRBV01-01*01	TCRBD02-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCGCACCGGGACAGGGATTTACACTGAAGCTTTCTTTGGACAA	CASSRTGTGIYTEAFF	In	VDJ	1	31	7.274553377622066E-5	9.131801350917451E-5	48	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	0	3	3	5	4	23	36	50	41	54														CASSRTGTGIYTEAFF+TCRBV01-01+TCRBJ01-01	TCRBV01-01*01	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAAACCGGGACATGGAGCGCTATGGCTACACCTTCGGTTCG	CASSQNRDMERYGYTF	In	VDJ	1	32	7.509216389803423E-5	9.426375588043821E-5	48	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	0	6	4	4	7	23	38	48	42	55														CASSQNRDMERYGYTF+TCRBV01-01+TCRBJ01-02	TCRBV01-01*01	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGATTTACAGGGGGCGGGTGATGAGACCCAGTACTTCGGGCCA	CASSQDLQGAGDETQYF	In	VDJ	1	33	7.74387940198478E-5	9.72094982517019E-5	51	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	0	3	0	5	3	7	23	40	52	43	59														CASSQDLQGAGDETQYF+TCRBV01-01+TCRBJ02-05	TCRBV01-01*01	TCRBD01-01*01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCTCGGACAGGGAAGAACTGAAGCTTTCTTTGGACAA	CASSLGQGRTEAFF	In	VDJ	1	34	7.978542414166136E-5	1.001552406229656E-4	42	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	1	3	5	2	4	23	36	46	38	50														CASSLGQGRTEAFF+TCRBV01-01+TCRBJ01-01	TCRBV01-01*01	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGAGAGAACGGTGAATGAGCAGTTCTTCGGGCCA	CASSQERTVNEQFF	In	VDJ	1	37	8.682531450710208E-5	1.0899246773675668E-4	42	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	8	5	7	5	2	23	40	48	45	50						01,02								CASSQERTVNEQFF+TCRBV01-01+TCRBJ02-01	TCRBV01-01*01	TCRBD02-01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAGGGGGGGTTCGCGTCAGATACGCAGTATTTTGGCCCA	CASSQGGFASDTQYF	In	VDJ	1	38	8.917194462891565E-5	1.1193821010802038E-4	45	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	9	0	4	0	7	23	-1	44	37	51														CASSQGGFASDTQYF+TCRBV01-01+TCRBJ02-03	TCRBV01-01*01	TCRBD02-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAGGACGCTCATCAGCCCCAGCATTTTGGTGAT	CASSQDAHQPQHF	In	VDJ	1	58	1.3610454706518703E-4	1.7085305753329426E-4	39	TCRBV01	TCRBV01-01	01				TCRBJ01	TCRBJ01-05	01	3	1	7	5	0	4	23	-1	41	37	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDAHQPQHF+TCRBV01-01+TCRBJ01-05	TCRBV01-01*01		TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGGGACTCTATACGAGCAGTACTTCGGGCCG	CASSQGTLYEQYF	In	VDJ	1	66	1.548775880396956E-4	1.944189965034038E-4	39	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	1	1	10	4	0	3	23	-1	44	39	47						01,02								CASSQGTLYEQYF+TCRBV01-01+TCRBJ02-07	TCRBV01-01*01	TCRBD02-01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGAGCAGGGGGCCAGGCACAATGAGCAGTTCTTCGGGCCA	CASSQEQGARHNEQFF	In	VDJ	1	70	1.6426410852694986E-4	2.062019659884586E-4	48	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	4	0	5	1	5	23	40	49	41	54														CASSQEQGARHNEQFF+TCRBV01-01+TCRBJ02-01	TCRBV01-01*01	TCRBD01-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCATCCACTGAACACTGAAGCTTTCTTTGGACAA	CASSHPLNTEAFF	In	VDJ	1	73	1.7130399889239058E-4	2.1503919310224967E-4	39	TCRBV01	TCRBV01-01	01				TCRBJ01	TCRBJ01-01	01	3	3	7	0	3	0	23	37	-1	40	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSHPLNTEAFF+TCRBV01-01+TCRBJ01-01	TCRBV01-01*01		TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAGGGACAGATAGGAGAGACCCAGTACTTCGGGCCA	CASSQGQIGETQYF	In	VDJ	2	81	1.9007703986689915E-4	2.386051320723592E-4	42	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	0	5	4	0	5	23	-1	44	37	49														CASSQGQIGETQYF+TCRBV01-01+TCRBJ02-05	TCRBV01-01*01	TCRBD01-01*01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCTACCCCAGGCCCCAGAGGGGGGACTGAAGCTTTCTTTGGACAA		Out	VDJ	2	84	1.9711693023233983E-4		49	TCRBV01	TCRBV01-01	01				TCRBJ01	TCRBJ01-01	01	5	5	1	5	15	1	23	35	56	50	57				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV01-01+TCRBJ01-01	TCRBV01-01*01		TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCCACTAGCGAGGGACACCGGGGAGCTGTTTTTTGGAGAA	CASSPLARDTGELFF	In	VDJ	2	98	2.2996975193772983E-4	2.8868275238384204E-4	45	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	4	3	6	3	1	4	23	36	44	37	48						01,02								CASSPLARDTGELFF+TCRBV01-01+TCRBJ02-02	TCRBV01-01*01	TCRBD02-01	TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGATCGGGGGGGCTACGAGCAGTACTTCGGGCCG	CASSQDRGGYEQYF	In	VDJ	2	100	2.3466301218135697E-4	2.945742371263694E-4	42	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	0	8	0	3	1	0	23	40	-1	41	49														CASSQDRGGYEQYF+TCRBV01-01+TCRBJ02-07	TCRBV01-01*01	TCRBD02-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AAGAAGACTCAGCTGCGTATCTCTGCACCAGCAGTGCTCGAAGTCGGGCCAACGTCCTGACTTTCGGGGCC	CTSSARSRANVLTF	In	VDJ	2	101	2.3700964230317052E-4	2.975199794976331E-4	42	TCRBV01	TCRBV01-01	01				TCRBJ02	TCRBJ02-06	01	6	2	8	5	5	4	23	34	41	39	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CTSSARSRANVLTF+TCRBV01-01+TCRBJ02-06	TCRBV01-01*01		TCRBJ02-06*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCCCCACAGGGGCCCAAACACTGAAGCTTTCTTTGGACAA	CASSPHRGPNTEAFF	In	VDJ	2	122	2.862888748612555E-4	3.593805692941707E-4	45	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	3	2	2	3	4	23	36	46	39	50														CASSPHRGPNTEAFF+TCRBV01-01+TCRBJ01-01	TCRBV01-01*01	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AAGAAGACTCAGCTGCGTATCTCTGCACCAGCAGCCAGACGAAACGGAGGGGACTAGCCAAAAACATTCAGTACTTCGGCGCC	CTSSQTKRRGLAKNIQYF	In	VDJ	4	180	4.2239342192644253E-4	5.302336268274649E-4	54	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	3	0	10	0	12	0	23	37	-1	49	55						01,02								CTSSQTKRRGLAKNIQYF+TCRBV01-01+TCRBJ02-04	TCRBV01-01*01	TCRBD02-01	TCRBJ02-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGTCAAGGACAGGGACTCAATCAGCCCCAGCATTTTGGTGAT	CASSQGQGLNQPQHF	In	VDJ	4	225	5.279917774080532E-4	6.627920335343312E-4	45	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	1	2	3	3	0	3	23	-1	46	39	49														CASSQGQGLNQPQHF+TCRBV01-01+TCRBJ01-05	TCRBV01-01*01	TCRBD01-01*01	TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGGACTAGCGGGAGGCCCAGGCTACGAGCAGTACTTCGGGCCG	CASSQGLAGGPGYEQYF	In	VDJ	5	252	5.913507906970195E-4	7.423270775584509E-4	51	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	1	2	1	3	0	6	23	-1	52	39	58														CASSQGLAGGPGYEQYF+TCRBV01-01+TCRBJ02-07	TCRBV01-01*01	TCRBD02-01*02	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGGAGAACTCTACGAGCAGTACTTCGGGCCG	CASSQGELYEQYF	In	VDJ	6	292	6.852159955695623E-4	8.601567724089987E-4	39	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	1	3	10	3	4	0	23	39	-1	43	46						01,02								CASSQGELYEQYF+TCRBV01-01+TCRBJ02-07	TCRBV01-01*01	TCRBD02-01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCGGCGGATCCCACACGACAGATACGCAGTATTTTGGCCCA	CASSGGSHTTDTQYF	In	VDJ	1	13	3.0506191583576405E-5	3.8294650826428025E-5	45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	7	5	3	1	10	19	31	36	32	46						01,02							Vb 5.1	CASSGGSHTTDTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01	TCRBD02-01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGAAATGGGGGCTAAAGAACGAGCAGTACTTCGGGCCG	CASSLKWGLKNEQYF	In	VDJ	1	13	3.0506191583576405E-5	3.8294650826428025E-5	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	6	0	5	4	6	19	34	44	38	50													Vb 5.1	CASSLKWGLKNEQYF+TCRBV05-01+TCRBJ02-07	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGGAGCCTCTGGAAACACCATATATTTTGGAGAG	CASSLGASGNTIYF	In	VDJ	1	13	3.0506191583576405E-5	3.8294650826428025E-5	42	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	0	6	7	0	1	0	19	35	-1	36	39						01,02							Vb 5.1	CASSLGASGNTIYF+TCRBV05-01+TCRBJ01-03	TCRBV05-01*01	TCRBD02-01	TCRBJ01-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTAAGGTGCTCTGACGGTGTTAAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	14	3.285282170538997E-5		52	TCRBV05	TCRBV05-01	01				TCRBJ01	TCRBJ01-01	01	2	2	7	2	10	7	19	33	46	43	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	X+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01		TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCCAGCGGAACCGCTGAAGAATGAGCAGTTCTTCGGGCCA	CASSPAEPLKNEQFF	In	VDJ	1	15	3.519945182720355E-5	4.418613556895541E-5	45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	6	5	7	2	11	19	31	38	33	49						01,02							Vb 5.1	CASSPAEPLKNEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD02-01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCCTCAGACCGAAGAGTATGAAAAACTGTTTTTTGGCAGT	CASSPQTEEYEKLFF	In	VDJ	1	15	3.519945182720355E-5	4.418613556895541E-5	45	TCRBV05	TCRBV05-01	01				TCRBJ01	TCRBJ01-04	01	4	2	7	6	5	8	19	31	39	36	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSPQTEEYEKLFF+TCRBV05-01+TCRBJ01-04	TCRBV05-01*01		TCRBJ01-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGAGTGGACTAGCGACGGGCAATGAGCAGTTCTTCGGGCCA	CASSLSGLATGNEQFF	In	VDJ	1	15	3.519945182720355E-5	4.418613556895541E-5	48	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	1	6	6	3	5	19	34	46	37	51						01,02							Vb 5.1	CASSLSGLATGNEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD02-01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGCCGGGACGGTGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSLAGTVNTGELFF	In	VDJ	1	15	3.519945182720355E-5	4.418613556895541E-5	48	TCRBV05	TCRBV05-01	01				TCRBJ02	TCRBJ02-02	01	0	0	7	1	2	3	19	35	42	37	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSLAGTVNTGELFF+TCRBV05-01+TCRBJ02-02	TCRBV05-01*01		TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTTGGGGGAAACACAGATACGCAGTATTTTGGCCCA	CASSFGGNTDTQYF	In	VDJ	1	15	3.519945182720355E-5	4.418613556895541E-5	42	TCRBV05	TCRBV05-01	01				TCRBJ02	TCRBJ02-03	01	2	6	1	2	1	3	19	33	39	34	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSFGGNTDTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01		TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCGGAGTAGCGGGAGCGGGTACGAGCAGTACTTCGGGCCG	CASSRSSGSGYEQYF	In	VDJ	1	17	3.989271207083068E-5	5.00776203114828E-5	45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	5	2	4	5	4	19	31	45	36	49													Vb 5.1	CASSRSSGSGYEQYF+TCRBV05-01+TCRBJ02-07	TCRBV05-01*01	TCRBD02-01*02	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTATAGGACTAGCACCCGAGCAGTACGTCGGGCCG		Out	VDJ	1	17	3.989271207083068E-5		41	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	2	1	7	17	3	14	19	33	44	36	58						01,02							Vb 5.1	X+TCRBV05-01+TCRBJ02-07	TCRBV05-01*01	TCRBD02-01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGAGCGTCAGGGAGTGGATGAGCAGTTCTTTGGGCCA	CASSLERQGVDEQFF	In	VDJ	1	17	3.989271207083068E-5	5.00776203114828E-5	45	TCRBV05	TCRBV05-01	01				TCRBJ02			0	4	3	22	5	19	19	35	45	40	64				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01			TCRBJ02-01,TCRBJ02-05					Vb 5.1	CASSLERQGVDEQFF+TCRBV05-01+TCRBJ02-X	TCRBV05-01*01		TCRBJ02	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGACGAAGCGGGAGGGCCTCGGATGAGCAGTTCTTCGGGCCA	CASRRSGRASDEQFF	In	VDJ	1	18	4.2239342192644256E-5	5.302336268274649E-5	45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	6	0	8	4	6	19	30	44	34	50													Vb 5.1	CASRRSGRASDEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD02-01*02	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGGGCAGGCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	18	4.2239342192644256E-5		40	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	0	4	4	2	2	0	19	35	-1	37	41													Vb 5.1	X+TCRBV05-01+TCRBJ02-05	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGCCGGTGGTTCTGGTGAAAAACTGTTTTTTGGCAGT	CASSLAGGSGEKLFF	In	VDJ	1	19	4.4585972314457824E-5	5.596910505401019E-5	45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	0	8	5	7	1	9	19	35	39	36	48						01,02							Vb 5.1	CASSLAGGSGEKLFF+TCRBV05-01+TCRBJ01-04	TCRBV05-01*01	TCRBD02-01	TCRBJ01-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCTAATGGGACAGGGCCTACCCATATCACCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	19	4.4585972314457824E-5		52	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	0	3	2	4	13	19	28	41	32	54													Vb 5.1	X+TCRBV05-01+TCRBJ02-07	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCCGGCGGCATCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSPAASNTGELFF	In	VDJ	1	20	4.693260243627139E-5	5.891484742527388E-5	45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	4	7	5	0	3	3	19	31	38	34	41						01,02							Vb 5.1	CASSPAASNTGELFF+TCRBV05-01+TCRBJ02-02	TCRBV05-01*01	TCRBD02-01	TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTAGGACAGGGCTTCGCCTACGAGCAGTACTTCGGGCCG	CASSLGQGFAYEQYF	In	VDJ	1	21	4.927923255808496E-5	6.186058979653757E-5	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	1	3	2	1	5	19	33	42	34	47													Vb 5.1	CASSLGQGFAYEQYF+TCRBV05-01+TCRBJ02-07	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTCGGGGATGGCGGCACTGAAGCTTTCTTTGGACAA	CASSFGDGGTEAFF	In	VDJ	1	21	4.927923255808496E-5	6.186058979653757E-5	42	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	2	8	3	4	0	7	19	-1	38	33	45													Vb 5.1	CASSFGDGGTEAFF+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01	TCRBD02-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGCCACAGGGAGCTATGGCTACACCTTCGGTTCG	CASSLATGSYGYTF	In	VDJ	1	23	5.39724928017121E-5	6.775207453906497E-5	42	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	3	3	4	2	2	19	35	43	37	45													Vb 5.1	CASSLATGSYGYTF+TCRBV05-01+TCRBJ01-02	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGTCCCACAGGGGGACAATGGGAGACCCAGTATTTCGGGCCA	CASSPTGGQWETQYF	In	VDJ	1	23	5.39724928017121E-5	6.775207453906497E-5	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02			5	3	1	19	4	19	19	30	42	34	61								TCRBJ02-01,TCRBJ02-05					Vb 5.1	CASSPTGGQWETQYF+TCRBV05-01+TCRBJ02-X	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCACCGGCGGAGGGAGGGCTAGCACAGATACGCAGTATTTTGGCCCA	CASTGGGRASTDTQYF	In	VDJ	1	24	5.631912292352567E-5	7.069781691032865E-5	48	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	9	0	0	8	2	19	29	44	37	46													Vb 5.1	CASTGGGRASTDTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01	TCRBD02-01*02	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGCGCTCGGTGAACACTGAAGCTTTCTTTGGACAA	CASSLRSVNTEAFF	In	VDJ	1	26	6.101238316715281E-5	7.658930165285605E-5	42	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	1	8	5	0	4	0	19	34	-1	38	41						01,02							Vb 5.1	CASSLRSVNTEAFF+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01	TCRBD02-01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGTCAGGGGGGGAGCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	26	6.101238316715281E-5		44	TCRBV05	TCRBV05-01	01				TCRBJ01	TCRBJ01-02	01	0	4	1	4	1	4	19	35	43	36	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	X+TCRBV05-01+TCRBJ01-02	TCRBV05-01*01		TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCACCAGCGGGGGGGTGCGAGATACGCAGTATTTTGGCCCA	CASTSGGVRDTQYF	In	VDJ	1	27	6.335901328896638E-5	7.953504402411973E-5	42	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	6	0	5	2	4	19	29	41	31	45													Vb 5.1	CASTSGGVRDTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01	TCRBD02-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGGAGGAGGACAGGGCCTCGAGCAGTACTTCGGGCCG	CASSLGGGQGLEQYF	In	VDJ	1	29	6.805227353259351E-5	8.542652876664713E-5	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	1	3	6	5	3	19	35	48	40	51													Vb 5.1	CASSLGGGQGLEQYF+TCRBV05-01+TCRBJ02-07	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCCTTTATCTTTGCGCCAGTAAACGGGACTGAAAAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	29	6.805227353259351E-5		41	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	8	0	10	2	5	4	19	27	38	32	42						01,02							Vb 5.1	X+TCRBV05-01+TCRBJ01-02	TCRBV05-01*01	TCRBD02-01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGAGTATGTCTAGTATAAGAAGGGGTGAGCAGTTCTTCGGGCCA	CASSLSMSSIRRGEQFF	In	VDJ	1	30	7.03989036544071E-5	8.837227113791082E-5	51	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	1	5	2	9	18	0	19	34	-1	52	57													Vb 5.1	CASSLSMSSIRRGEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCGGGAGGTTCAGGGGGCGAACACTGAAGCTTTCTTTGGACAA	CASSREVQGANTEAFF	In	VDJ	1	32	7.509216389803423E-5	9.426375588043821E-5	48	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	4	0	1	9	0	19	31	-1	40	48													Vb 5.1	CASSREVQGANTEAFF+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCAGGGAAGACAGCCGTAACTCTGGAAACACCATATATTTTGGAGAG	CASSREDSRNSGNTIYF	In	VDJ	1	33	7.74387940198478E-5	9.72094982517019E-5	51	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	4	2	5	0	6	6	19	31	42	37	48													Vb 5.1	CASSREDSRNSGNTIYF+TCRBV05-01+TCRBJ01-03	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGGGGGCGACGGGGCCAACGTCCTGACTTTCGGGGCC	CASSLGGDGANVLTF	In	VDJ	1	33	7.74387940198478E-5	9.72094982517019E-5	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	0	7	0	4	0	3	19	-1	40	35	43													Vb 5.1	CASSLGGDGANVLTF+TCRBV05-01+TCRBJ02-06	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-06*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTGGGATTTCAGGCAGGGCGGCGAGCAGTACTTCGGGCCG	CASSWDFRQGGEQYF	In	VDJ	1	34	7.978542414166136E-5	1.001552406229656E-4	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	4	3	6	11	3	19	32	48	43	51													Vb 5.1	CASSWDFRQGGEQYF+TCRBV05-01+TCRBJ02-07	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCCCAGGACGCTTCAAGGGTCACCCCTCCACTTTGGGAAC	CASSPRTLQGSPLHF	In	VDJ	1	35	8.213205426347493E-5	1.031009829942293E-4	45	TCRBV05	TCRBV05-01	01				TCRBJ01	TCRBJ01-06	01	4	1	7	10	4	10	19	31	39	35	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSPRTLQGSPLHF+TCRBV05-01+TCRBJ01-06	TCRBV05-01*01		TCRBJ01-06*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGACTAGCGGATCCCAAGAGACCCAGTACTTCGGGCCA	CASSLTSGSQETQYF	In	VDJ	1	35	8.213205426347493E-5	1.031009829942293E-4	45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	1	3	5	1	0	3	19	-1	42	34	45						01,02							Vb 5.1	CASSLTSGSQETQYF+TCRBV05-01+TCRBJ02-05	TCRBV05-01*01	TCRBD02-01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGAACAGGGGTTCAGAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	36	8.447868438528851E-5		50	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	3	2	1	1	5	19	35	43	36	48													Vb 5.1	X+TCRBV05-01+TCRBJ01-05	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGGAACCTGAGGAACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	37	8.682531450710208E-5		40	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	5	11	1	4	6	3	19	30	40	36	43													Vb 5.1	X+TCRBV05-01+TCRBJ01-02	TCRBV05-01*01	TCRBD02-01*02	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCCTTTATCTTTGCGCCAGTACGTTCCGGGACAGGGCGGGAAAACTGTTTTTTGGCAGT	CASTFRDRAGKLFF	In	VDJ	1	37	8.682531450710208E-5	1.0899246773675668E-4	42	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	8	0	3	10	8	4	19	27	44	35	48													Vb 5.1	CASTFRDRAGKLFF+TCRBV05-01+TCRBJ01-04	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCGGGGGACGTACACGATGGGAGCAGTACTTCGGGCCG	CASSGGRTRWEQYF	In	VDJ	1	41	9.621183499435635E-5	1.2077543722181146E-4	42	TCRBV05	TCRBV05-01	01				TCRBJ02	TCRBJ02-07	01	4	0	7	7	2	11	19	31	38	33	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSGGRTRWEQYF+TCRBV05-01+TCRBJ02-07	TCRBV05-01*01		TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCACCCAAAGATTAGCGGGTCACTCCTCGGGGTACAATGAGCAGTTCTTCGGGCCA	CASTQRLAGHSSGYNEQFF	In	VDJ	1	43	1.009050952379835E-4	1.2666692196433885E-4	57	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	5	4	4	9	13	19	29	45	38	58						01,02							Vb 5.1	CASTQRLAGHSSGYNEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD02-01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTAGATCTAAGTGGGCGATCCTACGAGCAGTACTTCGGGCCG	CASSLDLSGRSYEQYF	In	VDJ	1	43	1.009050952379835E-4	1.2666692196433885E-4	48	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	8	0	1	10	2	19	33	47	43	49													Vb 5.1	CASSLDLSGRSYEQYF+TCRBV05-01+TCRBJ02-07	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGGGGGTGACTACAATGAGCAGTTCTTCGGGCCA	CASSLGGDYNEQFF	In	VDJ	1	43	1.009050952379835E-4	1.2666692196433885E-4	42	TCRBV05	TCRBV05-01	01				TCRBJ02	TCRBJ02-01	01	0	6	2	3	0	3	19	-1	39	35	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSLGGDYNEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01		TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTTAACAGGGTTGAGAACACTGAAGCTTTCTTTGGACAA	CASSFNRVENTEAFF	In	VDJ	1	43	1.009050952379835E-4	1.2666692196433885E-4	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	3	3	1	2	4	19	33	41	35	45													Vb 5.1	CASSFNRVENTEAFF+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCACGGTGGTGTGAATCAGCCCCAGCATTTTGGTGAT	CASSHGGVNQPQHF	In	VDJ	1	44	1.0325172535979707E-4	1.2961266433560254E-4	42	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	4	8	5	4	2	7	19	31	36	33	43						01,02							Vb 5.1	CASSHGGVNQPQHF+TCRBV05-01+TCRBJ01-05	TCRBV05-01*01	TCRBD02-01	TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTCCTTGGACAGGGGGAATTCACCCCTCCACTTTGGGAAC	CASSSLDRGNSPLHF	In	VDJ	1	46	1.079449856034242E-4	1.3550414907812994E-4	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	3	1	1	7	4	0	19	32	-1	36	46													Vb 5.1	CASSSLDRGNSPLHF+TCRBV05-01+TCRBJ01-06	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-06*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGGGACAGGGGATGGAGGCTACACCTTCGGTTCG	CASSLGTGDGGYTF	In	VDJ	1	47	1.1029161572523777E-4	1.3844989144939362E-4	42	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	1	2	8	0	5	19	-1	44	35	49													Vb 5.1	CASSLGTGDGGYTF+TCRBV05-01+TCRBJ01-02	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGGGACGGGGAGCAATCAGCCCCAGCATTTTGGTGAT	CASSLGTGSNQPQHF	In	VDJ	1	68	1.5957084828332273E-4	2.003104812459312E-4	45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	0	8	3	1	3	0	19	35	-1	38	43													Vb 5.1	CASSLGTGSNQPQHF+TCRBV05-01+TCRBJ01-05	TCRBV05-01*01	TCRBD02-01*01	TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCCGAACGGGGGAGGTTTACAATGAGCAGTTCTTCGGGCCA	CASRTGEVYNEQFF	In	VDJ	1	68	1.5957084828332273E-4	2.003104812459312E-4	42	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	7	8	2	4	4	5	19	28	38	32	43						01,02							Vb 5.1	CASRTGEVYNEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD02-01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCATAGTATCGACAGGGGGCTATGGCTACACCTTCGGTTCG	CASSIVSTGGYGYTF	In	VDJ	1	74	1.7365062901420416E-4	2.1798493547351336E-4	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	2	1	4	8	0	19	31	-1	39	48													Vb 5.1	CASSIVSTGGYGYTF+TCRBV05-01+TCRBJ01-02	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGATCTAGCGGTCAAAGGCGGGGAGCTGTTTTTTGGAGAA	CASSLDLAVKGGELFF	In	VDJ	2	78	1.8303714950145843E-4	2.2976790495856812E-4	48	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	0	4	5	7	2	7	19	35	44	37	51						01,02							Vb 5.1	CASSLDLAVKGGELFF+TCRBV05-01+TCRBJ02-02	TCRBV05-01*01	TCRBD02-01	TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGAACTAACTAACAATGAGCAGTTCTTCGGGCCA	CASSLELTNNEQFF	In	VDJ	2	79	1.85383779623272E-4	2.3271364732983183E-4	42	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	3	9	5	1	4	19	35	40	36	44						01,02							Vb 5.1	CASSLELTNNEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD02-01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGCAGGGGGTCAGACCGGAAACCAAGAGACCCAGTACTTCGGGCCA	CASSLAGGQTGNQETQYF	In	VDJ	2	84	1.9711693023233983E-4	2.474423591861503E-4	54	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	0	4	1	0	0	11	19	-1	42	35	53													Vb 5.1	CASSLAGGQTGNQETQYF+TCRBV05-01+TCRBJ02-05	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCCCGGAGAGGGGAGGACTAGCTCCACTGAAGCTTTCTTTGGACAA	CASSPGEGRTSSTEAFF	In	VDJ	2	87	2.0415682059778055E-4	2.5627958629994137E-4	51	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	4	1	7	4	13	2	19	31	52	44	54						01,02							Vb 5.1	CASSPGEGRTSSTEAFF+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01	TCRBD02-01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGTTGCGGGGATCCTACGAGCAGTACTTCGGGCCG	CASSLLRGSYEQYF	In	VDJ	2	87	2.0415682059778055E-4	2.5627958629994137E-4	42	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	1	7	3	1	2	1	19	34	42	36	43													Vb 5.1	CASSLLRGSYEQYF+TCRBV05-01+TCRBJ02-07	TCRBV05-01*01	TCRBD02-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGATCTAGGTGGGCGATCCTACGAGCAGTACTTCGGGCCG	CASSLDLGGRSYEQYF	In	VDJ	2	92	2.158899712068484E-4	2.7100829815625987E-4	48	TCRBV05	TCRBV05-01	01				TCRBJ02	TCRBJ02-07	01	0	8	0	1	8	2	19	35	47	43	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSLDLGGRSYEQYF+TCRBV05-01+TCRBJ02-07	TCRBV05-01*01		TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTCAGGGGTTAGGGGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	2	93	2.1823660132866198E-4		44	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	4	2	1	0	6	19	-1	38	32	44													Vb 5.1	X+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGGGAATTCCTACAATGAGCAGTTCTTCGGGCCA	CASSLGNSYNEQFF	In	VDJ	2	98	2.2996975193772983E-4	2.8868275238384204E-4	42	TCRBV05	TCRBV05-01	01				TCRBJ02	TCRBJ02-01	01	0	1	8	1	0	2	19	-1	38	35	40				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSLGNSYNEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01		TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTGGGGACAGCCCGAAGCCTACAATGAGCAGTTCTTCGGGCCA	CASSWGQPEAYNEQFF	In	VDJ	2	107	2.5108942303405193E-4	3.151944337252153E-4	48	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	0	5	2	1	7	19	32	40	33	47													Vb 5.1	CASSWGQPEAYNEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCCTTTATCTTTGCGTCAGCAGCTACCGTAGCGGGTCATCATATGAGCAGTTCTTCGGGCCA	CVSSYRSGSSYEQFF	In	VDJ	2	120	2.815956146176284E-4	3.5348908455164326E-4	45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	5	4	8	4	7	19	32	43	36	50						01,02							Vb 5.1	CVSSYRSGSSYEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD02-01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGAATTGATCCGCGGGAAAACTGTTTTTTGGCAGT		Out	VDJ	2	124	2.9098213510488264E-4		43	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	0	7	4	10	9	0	19	35	-1	44	49						01,02							Vb 5.1	X+TCRBV05-01+TCRBJ01-04	TCRBV05-01*01	TCRBD02-01	TCRBJ01-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTACAGGGTCCGAACACTGAAGCTTTCTTTGGACAA	CASSLQGPNTEAFF	In	VDJ	3	126	2.9567539534850975E-4	3.7116353877922543E-4	42	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	3	3	1	0	3	19	-1	39	33	42													Vb 5.1	CASSLQGPNTEAFF+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCGGGACGTTAGGTGCTCCAGGCTCCGAGCAGTACTTCGGGCCG	CASSGTLGAPGSEQYF	In	VDJ	3	132	3.097551760793912E-4	3.888379930068076E-4	48	TCRBV05	TCRBV05-01	01				TCRBJ02	TCRBJ02-07	01	4	0	7	6	0	18	19	-1	36	31	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSGTLGAPGSEQYF+TCRBV05-01+TCRBJ02-07	TCRBV05-01*01		TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGGGACTAGCGGGGGGATATGGTCCTACAATGAGCAGTTCTTCGGGCCA	CASSLGTSGGIWSYNEQFF	In	VDJ	3	132	3.097551760793912E-4	3.888379930068076E-4	57	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	1	1	1	0	6	19	-1	49	35	55													Vb 5.1	CASSLGTSGGIWSYNEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD02-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTAAGGACGGGTAGCACAGATACGCAGTATTTTGGCCCA	CASSLRTGSTDTQYF	In	VDJ	3	140	3.285282170538997E-4	4.124039319769172E-4	45	TCRBV05	TCRBV05-01	01				TCRBJ02	TCRBJ02-03	01	2	1	7	0	2	4	19	33	39	35	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSLRTGSTDTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01		TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTAGGGGTAGTGATAGCGGAACAAGAGACCCAGTACTTCGGGCCA	CASSLGVVIAEQETQYF	In	VDJ	3	140	3.285282170538997E-4	4.124039319769172E-4	51	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	2	5	5	2	11	2	19	33	50	44	52						01,02							Vb 5.1	CASSLGVVIAEQETQYF+TCRBV05-01+TCRBJ02-05	TCRBV05-01*01	TCRBD02-01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTTGGGGGGTCTGGTGAAAAACTGTTTTTTGGCAGT	CASSFGGSGEKLFF	In	VDJ	3	145	3.402613676629676E-4	4.2713264383323563E-4	42	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	2	9	1	7	1	5	19	33	40	34	45													Vb 5.1	CASSFGGSGEKLFF+TCRBV05-01+TCRBJ01-04	TCRBV05-01*01	TCRBD02-01*01	TCRBJ01-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCACCAGGACTAGCGGGGGCTACAATGAGCAGTTCTTCGGGCCA	CASTRTSGGYNEQFF	In	VDJ	3	156	3.6607429900291686E-4	4.5953580991713624E-4	45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	1	2	3	3	0	19	29	-1	32	45													Vb 5.1	CASTRTSGGYNEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD02-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCCCCGTTGGGGGGGATCGCAGGCAGATACGCARTATTTTGGCCCA	CASSPRWGGSQADTQYF	In	VDJ	3	166	3.8954060022105256E-4	4.889932336297733E-4	51	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	9	0	4	7	8	19	31	45	38	53													Vb 5.1	CASSPRWGGSQADTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01	TCRBD02-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCACCTCCGGGACAGGGGCGCGTGAGCAGTTCTTCGGGCCA	CASTSGTGAREQFF	In	VDJ	3	167	3.9188723034286614E-4	4.919389760010369E-4	42	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	0	2	9	5	4	19	29	44	34	48													Vb 5.1	CASTSGTGAREQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGACACAGGGGGCTATGGCTACACCTTCGGTTCG	CASSLDTGGYGYTF	In	VDJ	4	177	4.1535353156100185E-4	5.213963997136739E-4	42	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	3	1	4	2	0	19	35	-1	37	45													Vb 5.1	CASSLDTGGYGYTF+TCRBV05-01+TCRBJ01-02	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGGRGACAGTAGCAATCAGCCCCAGCATTTTGGTGAT	CASSLGDSSNQPQHF	In	VDJ	4	203	4.7636591472815463E-4	5.979857013665298E-4	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	0	5	0	0	0	19	-1	-1	35	42													Vb 5.1	CASSLGDSSNQPQHF+TCRBV05-01+TCRBJ01-05	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTCGGACAGGGGGCGGAATGGCTACACCTTCGGTTCG	CASSSDRGRNGYTF	In	VDJ	4	217	5.092187364335447E-4	6.392260945642216E-4	42	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	1	0	6	1	3	19	32	44	33	47													Vb 5.1	CASSSDRGRNGYTF+TCRBV05-01+TCRBJ01-02	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGTGGGAGGGAGCACAGATACGCAGTATTTTGGCCCA	CASSLVGGSTDTQYF	In	VDJ	9	461	0.0010817964861560556	0.001357987233152563	45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	0	9	0	0	1	0	19	35	-1	36	43													Vb 5.1	CASSLVGGSTDTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01	TCRBD02-01*02	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AACCAGACATCTATGTACCTCTGTGCCAGCAGTTTCCCCCTCCGACTAGCGGGAGGCCGTGGGGTCTACGAGCAGTACTTCGGGCCG	CASSFPLRLAGGRGVYEQYF	In	VDJ	1	13	3.0506191583576405E-5	3.8294650826428025E-5	60	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	2	1	3	8	9	21	35	56	43	65													Vb 3	CASSFPLRLAGGRGVYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCACCCCTGGGGACAGGGGGCTTGTCGGCATTCAGTACTTCGGCGCC	CASTPGDRGLVGIQYF	In	VDJ	1	13	3.0506191583576405E-5	3.8294650826428025E-5	48	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	7	0	0	9	6	7	25	35	53	41	60													Vb 3	CASTPGDRGLVGIQYF+TCRBV28-01+TCRBJ02-04	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGATCGGCCGGGACAGGGGGGACCCAGTACTTCGGGCCA	CASRSAGTGGTQYF	In	VDJ	1	13	3.0506191583576405E-5	3.8294650826428025E-5	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	0	1	7	7	0	25	36	-1	43	54													Vb 3	CASRSAGTGGTQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCCCCCTTCTCTGGAAACACCATATATTTTGGAGAG	CASSSPFSGNTIYF	In	VDJ	1	13	3.0506191583576405E-5	3.8294650826428025E-5	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	4	4	10	0	4	1	25	38	44	42	45						01,02							Vb 3	CASSSPFSGNTIYF+TCRBV28-01+TCRBJ01-03	TCRBV28-01*01	TCRBD02-01	TCRBJ01-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCACCACGGGCAGGGTGGCCGGGGAGCTGTTTTTTGGAGAA	CASTTGRVAGELFF	In	VDJ	1	14	3.285282170538997E-5	4.1240393197691716E-5	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	7	4	3	6	7	3	25	35	47	42	50													Vb 3	CASTTGRVAGELFF+TCRBV28-01+TCRBJ02-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTCTGGGCTAGCGGATACAATGAGCAGTTCTTCGGGCCA	CASSFWASGYNEQFF	In	VDJ	1	14	3.285282170538997E-5	4.1240393197691716E-5	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	4	5	4	5	1	25	39	51	44	52						01,02							Vb 3	CASSFWASGYNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAACAGTTTCCCCCGTTTGGGGATGAACACTGAAGCTTTCTTTGGACAA	CANSFPRLGMNTEAFF	In	VDJ	1	15	3.519945182720355E-5	4.418613556895541E-5	48	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-01	01	3	0	8	0	10	0	25	39	-1	49	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CANSFPRLGMNTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01		TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCTCCGGGCCGCCGGGCCATCAGCCCCAGCATTTTGGTGAT	CASSSGPPGHQPQHF	In	VDJ	1	16	3.7546081949017114E-5	4.7131877940219106E-5	45	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-05	01	6	8	0	5	4	9	25	36	44	40	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSSGPPGHQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01		TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTAGTCACCATTCTTGACACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	16	3.7546081949017114E-5		56	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	2	6	5	13	7	25	37	54	50	61													Vb 3	X+TCRBV28-01+TCRBJ02-06	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-06*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTGGCACAGGGACCCTACGAGCAGTACTTCGGGCCG	CASSLAQGPYEQYF	In	VDJ	1	16	3.7546081949017114E-5	4.7131877940219106E-5	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	3	3	2	3	2	25	39	48	42	50													Vb 3	CASSLAQGPYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATGGGGCCAGACCCAGTACTTCGGGCCA	CASSLWGQTQYF	In	VDJ	1	17	3.989271207083068E-5	5.00776203114828E-5	36	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	0	8	0	6	0	1	25	-1	46	42	47													Vb 3	CASSLWGQTQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCGGGGGAAGGGGGGGCCAAGAGACCCAGTACTTCGGGCCA	CASGGRGGQETQYF	In	VDJ	1	17	3.989271207083068E-5	5.00776203114828E-5	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	8	9	0	1	7	0	25	34	-1	41	48													Vb 3	CASGGRGGQETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCTCCCGGCGGAACCCCTACGAGCAGTACTTCGGGCCG	CASSRRNPYEQYF	In	VDJ	1	18	4.2239342192644256E-5	5.302336268274649E-5	39	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	8	7	5	2	5	4	25	34	43	39	47						01,02							Vb 3	CASSRRNPYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGGTCACCCCCGGGACAGGGGACAGGAGATACGCAGTATTTTGGCCCA	CASRSPPGQGTGDTQYF	In	VDJ	1	19	4.4585972314457824E-5	5.596910505401019E-5	51	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	0	2	5	9	5	25	36	55	45	60													Vb 3	CASRSPPGQGTGDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCCTACAGGGAAGGTAATTCACCCCTCCACTTTGGGAAC	CASSPYREGNSPLHF	In	VDJ	1	19	4.4585972314457824E-5	5.596910505401019E-5	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	3	3	6	4	4	25	37	47	41	51													Vb 3	CASSPYREGNSPLHF+TCRBV28-01+TCRBJ01-06	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-06*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCCTTGGGAGATACGCAGTATTTTGGCCCA	CASSSLGDTQYF	In	VDJ	1	19	4.4585972314457824E-5	5.596910505401019E-5	36	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-03	01	4	0	9	5	4	0	25	38	-1	42	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSSLGDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01		TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCACCCCCGGACAGGGAACCATTCAGTACTTCGGCGCC	CASTPGQGTIQYF	In	VDJ	1	21	4.927923255808496E-5	6.186058979653757E-5	39	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	7	1	3	9	5	3	25	35	48	40	51													Vb 3	CASTPGQGTIQYF+TCRBV28-01+TCRBJ02-04	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTAACCGCCTTGGGGGGGGCTACACCTTCGGTTCG	CASSNRLGGGYTF	In	VDJ	1	22	5.162586267989853E-5	6.480633216780127E-5	39	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	5	9	1	8	9	0	25	37	-1	46	52													Vb 3	CASSNRLGGGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD02-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CACCAACCAGACATCTATGTACCTCTGTGCCGGATAAAGCCGGGACACCTAATGGGCACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	22	5.162586267989853E-5		47	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	11	0	6	4	10	9	25	31	47	41	56													Vb 3	X+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCGACAGGGGCTCCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	23	5.39724928017121E-5		44	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	2	2	3	1	3	25	38	47	39	50													Vb 3	X+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGTACCTCTGTGCCAGCAGTTTCCAACCTGGGACTAGCGGGAGGGCCATCGGCACAGATACGCAGTATTTTGGCCCA	CASSFQPGTSGRAIGTDTQYF	In	VDJ	1	23	5.39724928017121E-5	6.775207453906497E-5	63	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	0	0	1	7	6	8	22	45	29	51													Vb 3	CASSFQPGTSGRAIGTDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCGACGACAGGGAGGGCAGCCCCAGCATTTTGGTGAT	CASSRRQGGQPQHF	In	VDJ	1	24	5.631912292352567E-5	7.069781691032865E-5	42	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-05	01	6	2	3	7	5	4	25	36	48	41	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSRRQGGQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01		TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTGAACTAGGCGGGTCTTTATCAGATACGCAGTATTTTGGCCCA	CASSELGGSLSDTQYF	In	VDJ	1	24	5.631912292352567E-5	7.069781691032865E-5	48	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	3	8	4	2	12	25	37	44	39	56						01,02							Vb 3	CASSELGGSLSDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAAGGAGAGCGGAAAACGAGCAGTACTTCGGGCCG	CASSLRRAENEQYF	In	VDJ	1	24	5.631912292352567E-5	7.069781691032865E-5	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	2	6	5	5	5	3	25	40	50	45	53						01,02							Vb 3	CASSLRRAENEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAAACAGGGGAATCAGCCCCAGCATTTTGGTGAT	CASKQGNQPQHF	In	VDJ	1	25	5.866575304533924E-5	7.364355928159235E-5	36	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	7	3	2	4	1	0	25	35	-1	36	43													Vb 3	CASKQGNQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCTGGGGACTGCCTACGAGCAGTACTTCGGGCCG	CASSLGTAYEQYF	In	VDJ	1	25	5.866575304533924E-5	7.364355928159235E-5	39	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	0	10	2	4	1	25	36	46	40	47						01,02							Vb 3	CASSLGTAYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCCGGGACATCGAACACTGAAGCTTTCTTTGGACAA	CASSPGTSNTEAFF	In	VDJ	1	29	6.805227353259351E-5	8.542652876664713E-5	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	6	1	3	2	25	37	46	40	48													Vb 3	CASSPGTSNTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTACCGGACAGGGTTCTATGGCTACACCTTCGGTTCG	CASSYRTGFYGYTF	In	VDJ	1	29	6.805227353259351E-5	8.542652876664713E-5	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	1	3	4	3	2	25	38	49	41	51													Vb 3	CASSYRTGFYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTACAGGTGGTTGGGACTGAAGCTTTCTTTGGACAA	CASSLQVVGTEAFF	In	VDJ	1	29	6.805227353259351E-5	8.542652876664713E-5	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	4	4	5	0	8	25	-1	44	40	52													Vb 3	CASSLQVVGTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTATTCTAACAGGGGGTTATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSILTGGYSNQPQHF	In	VDJ	1	30	7.03989036544071E-5	8.837227113791082E-5	51	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	3	1	0	6	3	25	37	51	43	54													Vb 3	CASSILTGGYSNQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCCAGGGGGTGGGACTCCAAGCAATACTTCGGGCCG	CASSPRGWDSKQYF	In	VDJ	1	31	7.274553377622066E-5	9.131801350917451E-5	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	4	1	13	2	15	25	37	46	39	61													Vb 3	CASSPRGWDSKQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCTGCGAGGGCTTTGCGGAAGAGCAGTACTTCGGGCCG	CASCEGFAEEQYF	In	VDJ	1	31	7.274553377622066E-5	9.131801350917451E-5	39	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	8	11	0	7	3	10	25	34	42	37	52													Vb 3	CASCEGFAEEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTGGACAGAAATGAACACTGAAGCTTTCTTTGGACAA	CASSWTEMNTEAFF	In	VDJ	1	32	7.509216389803423E-5	9.426375588043821E-5	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	1	5	0	0	3	25	-1	44	38	47													Vb 3	CASSWTEMNTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGGAGTACTAGCGGGAGGGTAGGCGAGCAGTACTTCGGGCCG	CASRSTSGRVGEQYF	In	VDJ	1	33	7.74387940198478E-5	9.72094982517019E-5	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	3	0	6	4	4	25	36	53	40	57													Vb 3	CASRSTSGRVGEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGGGGGACTAGCGGGAGGGACACCGCCTACGAGCAGTACTTCGGGCCG	CASRGTSGRDTAYEQYF	In	VDJ	1	34	7.978542414166136E-5	1.001552406229656E-4	51	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	0	0	2	1	6	25	36	53	37	59													Vb 3	CASRGTSGRDTAYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTAGGGACAGGGTCACTGAAGCTTTCTTTGGACAA	CASSRDRVTEAFF	In	VDJ	1	34	7.978542414166136E-5	1.001552406229656E-4	39	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	3	4	1	1	25	37	47	38	48													Vb 3	CASSRDRVTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATGGAGGGGTCCCAAAAACACTGAAGCTTTCTTTGGACAA	CASSLWRGPKNTEAFF	In	VDJ	1	34	7.978542414166136E-5	1.001552406229656E-4	48	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-01	01	0	5	2	2	1	7	25	42	48	43	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSLWRGPKNTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01		TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CACCAACCAGACATCTATGTACCTCTGTGTCAGCAGTTTCCCGACAGGACACTATGGCTACACCTTCGGTTCG	CVSSFPTGHYGYTF	In	VDJ	1	35	8.213205426347493E-5	1.031009829942293E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	2	4	3	3	2	25	39	48	42	50													Vb 3	CVSSFPTGHYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGAAGATTGAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASRRLSSYNEQFF	In	VDJ	1	36	8.447868438528851E-5	1.0604672536549298E-4	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	11	2	0	6	0	25	36	-1	42	45													Vb 3	CASRRLSSYNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCGTTAGCACAGATACGCAGTATTTTGGCCCA	CASSVSTDTQYF	In	VDJ	1	36	8.447868438528851E-5	1.0604672536549298E-4	36	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	8	6	0	0	2	25	-1	38	36	40						01,02							Vb 3	CASSVSTDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGAGTCACAGGGATGAACACTGAAGCTTTCTTTGGACAA	CASRVTGMNTEAFF	In	VDJ	1	37	8.682531450710208E-5	1.0899246773675668E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	3	3	0	4	1	25	36	46	40	47													Vb 3	CASRVTGMNTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTGAAGGACGGTCCCTCAATCAGCCCCAGCATTTTGGTGAT	CASSEGRSLNQPQHF	In	VDJ	1	40	9.386520487254278E-5	1.1782969485054776E-4	45	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-05	01	5	1	7	3	3	7	25	37	44	40	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSEGRSLNQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01		TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCATCTCTCCGAGGTCCGAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	40	9.386520487254278E-5		43	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	7	11	1	5	7	4	25	35	46	42	50													Vb 3	X+TCRBV28-01+TCRBJ01-04	TCRBV28-01*01	TCRBD02-01*02	TCRBJ01-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCACTAAGCTCCTACGAGCAGTACTTCGGGCCG	CASSSLSSYEQYF	In	VDJ	1	41	9.621183499435635E-5	1.2077543722181146E-4	39	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	3	9	0	1	2	25	38	43	39	45						01,02							Vb 3	CASSSLSSYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCGCTCCCCGACAGGGGTCAATGGCTACACCTTCGGTTCG	CASSRSPTGVNGYTF	In	VDJ	1	42	9.855846511616992E-5	1.2372117959307514E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	2	2	6	9	3	25	36	53	45	56													Vb 3	CASSRSPTGVNGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTACTAGGACTAGCGACCTACGAGCAGTACTTCGGGCCG	CASSLLGLATYEQYF	In	VDJ	1	44	1.0325172535979707E-4	1.2961266433560254E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	2	1	6	2	3	1	25	40	52	43	53						01,02							Vb 3	CASSLLGLATYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTACACAGGGGGTCCTACGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSTQGVLRSGANVLTF	In	VDJ	1	47	1.1029161572523777E-4	1.3844989144939362E-4	54	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	3	1	0	2	7	25	37	47	39	54													Vb 3	CASSTQGVLRSGANVLTF+TCRBV28-01+TCRBJ02-06	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-06*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTGGCCGGGACAGGGGATTTCTTTACGAGCAGTACTTCGGGCCG	CASSGRDRGFLYEQYF	In	VDJ	1	51	1.1967813621249205E-4	1.502328609344484E-4	48	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	2	4	4	7	25	37	51	41	58													Vb 3	CASSGRDRGFLYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTGTAAGACTAGCGGTATACAATGAGCAGTTCTTCGGGCCA	CASSVRLAVYNEQFF	In	VDJ	1	52	1.2202476633430562E-4	1.531786033057121E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	2	5	4	4	2	25	37	50	41	52						01,02							Vb 3	CASSVRLAVYNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTCCCCGGAGGGTGAAACACTGAAGCTTTCTTTGGACAA	CASSFPGG*NTEAFF	Stop	VDJ	1	53	1.243713964561192E-4		45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	3	10	0	2	4	3	25	39	49	43	52													Vb 3	CASSFPGG*NTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD02-01*02	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGGCTCCGGACTAGCGGGAATAATGAGCAGTTCTTCGGGCCA	CASRLRTSGNNEQFF	In	VDJ	1	55	1.2906465669974634E-4	1.6201583041950318E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	1	3	7	5	2	25	36	53	41	55													Vb 3	CASRLRTSGNNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCGACAGGGCGAGACCCAGTACTTCGGGCCA	CASSRQGETQYF	In	VDJ	1	58	1.3610454706518703E-4	1.7085305753329426E-4	36	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	2	3	5	1	1	25	37	45	38	46													Vb 3	CASSRQGETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TCTATGTACCTCTGTGCCAGCAGTTTAAAGGGGATGAACTAGCGGGGGCGATGAGCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	59	1.384511771870006E-4		62	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	2	3	2	0	10	7	12	27	48	37	55													Vb 3	X+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATCACTCAATAAGCAGTTCTTCGGGCCA	CASSLSLNKQFF	In	VDJ	1	60	1.407978073088142E-4	1.7674454227582163E-4	36	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	3	10	11	1	5	25	41	45	42	50						01,02							Vb 3	CASSLSLNKQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCTACCCGTAGGACAGGGGTTACCTACGAGCAGTACGTCGGGCCG	CASSPTRRTGVTYEQYV	In	VDJ	1	68	1.5957084828332273E-4	2.003104812459312E-4	51	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	1	2	17	10	18	25	37	56	47	74													Vb 3	CASSPTRRTGVTYEQYV+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTGGTGGGAGGCGGGGGGGATACAATGAGCAGTTCTTCGGGCCA	CASSGGRRGGYNEQFF	In	VDJ	1	70	1.6426410852694986E-4	2.062019659884586E-4	48	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	7	0	4	8	1	25	37	54	45	55													Vb 3	CASSGGRRGGYNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAGGGGGTGCCGAGCAGTACTTCGGGCCG	CASSLGGAEQYF	In	VDJ	1	72	1.6895736877057702E-4	2.1209345073098596E-4	36	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-07	01	2	6	1	6	0	3	25	-1	45	40	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSLGGAEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01		TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCCAGTGAGGGCAGGGGACAATCAGCCCCAGCATTTTGGTGAT	CASSPVRAGDNQPQHF	In	VDJ	1	74	1.7365062901420416E-4	2.1798493547351336E-4	48	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	4	2	3	11	1	25	36	53	47	54													Vb 3	CASSPVRAGDNQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAAGGGCCGTGGGGGCGGAGTACCAAGAGACCCAGTACTTCGGGCCA	CASSLRAVGAEYQETQYF	In	VDJ	2	86	2.01810190475967E-4	2.533338439286777E-4	54	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	6	0	0	8	5	25	40	54	48	59													Vb 3	CASSLRAVGAEYQETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTTTAAGCAGGGAATATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	2	93	2.1823660132866198E-4		44	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	4	3	5	5	3	25	39	49	44	52													Vb 3	X+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAACCCCGGCTGGGGGCTATGGCTACACCTTCGGTTCG	CASSLTPAGGYGYTF	In	VDJ	2	95	2.2292986157228912E-4	2.7984552527005095E-4	45	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-02	01	2	6	1	4	9	0	25	40	-1	49	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSLTPAGGYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01		TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTGGGTTCAGGGGGGAAGCATTTTGGTGAT	CASSLGSGGKHF	In	VDJ	2	97	2.2762312181591625E-4	2.857370100125783E-4	36	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	4	1	14	5	2	25	39	51	44	53													Vb 3	CASSLGSGGKHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAAATGTAGTAAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSLNVVSSYNEQFF	In	VDJ	2	102	2.393562724249841E-4	3.004657218688968E-4	48	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	5	8	0	4	4	25	40	47	44	51						01,02							Vb 3	CASSLNVVSSYNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTCTCCGCCTACGAGCAGTACTTCGGGCCG	CASSFSAYEQYF	In	VDJ	2	103	2.4170290254679766E-4	3.034114642401605E-4	36	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	3	4	10	2	0	3	25	-1	41	39	44						01,02							Vb 3	CASSFSAYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTGGGGGACAGGGGAGGTACGAGCAGTACTTCGGGCCG	CASSGGQGRYEQYF	In	VDJ	2	115	2.698624640085605E-4	3.387603726953248E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	2	4	2	3	25	37	49	39	52													Vb 3	CASSGGQGRYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGACCGGGACCCAGTGACGAGCAGTACTTCGGGCCG	CASRPGPSDEQYF	In	VDJ	2	116	2.7220909413037405E-4	3.417061150665885E-4	39	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-07	01	6	0	7	5	3	6	25	36	44	39	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASRPGPSDEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01		TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTGGGTGGTTGGAACACTGAAGCTTTCTTTGGACAA	CASSLGGWNTEAFF	In	VDJ	2	123	2.8863550498306906E-4	3.6232631166543435E-4	42	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-01	01	3	0	9	1	0	6	25	-1	42	39	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSLGGWNTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01		TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAGCGGGAAGCCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	3	127	2.9802202547032333E-4		43	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	7	3	0	0	3	25	-1	46	40	49													Vb 3	X+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCGCCCTGAGGATAGGTCAGCCCCAGCATTTTGGTGAT	CASALRIGQPQHF	In	VDJ	3	150	3.5199451827203543E-4	4.418613556895541E-4	39	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	8	11	1	6	5	5	25	34	43	39	48													Vb 3	CASALRIGQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD02-01*02	TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAGGGACAGGGGGCATGGAGACCCAGTACTTCGGGCCA	CASSLGTGGMETQYF	In	VDJ	3	154	3.613810387592897E-4	4.536443251746089E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	0	0	5	0	3	25	-1	52	40	55													Vb 3	CASSLGTGGMETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCCCGAGGGACAGGGGGCGAGAGATACGCAGTATTTTGGCCCA	CASSPEGQGARDTQYF	In	VDJ	3	160	3.7546081949017113E-4	4.7131877940219104E-4	48	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	0	0	5	6	3	25	36	54	42	57													Vb 3	CASSPEGQGARDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCARCTTTAGACCTGGGGTATACCAAGAGACCCAGTACTTCGGGCCA	CASXFRPGVYQETQYF	In	VDJ	3	160	3.7546081949017113E-4	4.7131877940219104E-4	48	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-05	01	6	6	2	0	10	3	25	36	50	46	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASXFRPGVYQETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01		TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCGGGTAGCGGGAGGGCCGGGCAGTTCTTCGGGCCA	CASSSGSGRAGQFF	In	VDJ	4	186	4.3647320265732397E-4	5.479080810550471E-4	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	5	0	12	4	4	25	38	53	42	57													Vb 3	CASSSGSGRAGQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGACCCCGGGCCTTTAGCAATCAGCCCCAGCATTTTGGTGAT	CASRPRAFSNQPQHF	In	VDJ	5	234	5.491114485043753E-4	6.893037148757044E-4	45	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-05	01	6	8	0	0	5	3	25	36	45	41	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASRPRAFSNQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01		TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCCCGGAGACAGGGGAACACTGAAGCTTTCTTTGGACAA	CASSSRRQGNTEAFF	In	VDJ	5	242	5.678844894788838E-4	7.12869653845814E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	2	3	1	6	0	25	38	-1	44	51													Vb 3	CASSSRRQGNTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCGTTTTCCTACGAGCAGTACTTCGGGCCG	CASSPFSYEQYF	In	VDJ	5	258	6.05430571427901E-4	7.60001531786033E-4	36	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	8	6	1	1	3	25	37	40	38	43						01,02							Vb 3	CASSPFSYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CACCAACCAGACATCTATGTACCTCTGTGCTAGCAGTCCCCCTAGTGGGAGGGCCCGGGAGACCCAGTACTTCGGGCCA	CASSPPSGRARETQYF	In	VDJ	6	277	6.500165437423588E-4	8.159706368400432E-4	48	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	5	9	0	5	9	5	25	37	53	46	58													Vb 3	CASSPPSGRARETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTTGGGACCGGCAAAGAAGCTTTCTTTGGACAA	CASSFGTGKEAFF	In	VDJ	6	296	6.946025160568166E-4	8.719397418940534E-4	39	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-01	01	3	0	7	8	1	7	25	39	45	40	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSFGTGKEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01		TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCACTGGGCAGGAGGCCGATAGCGGTAACTATGGCTACACCTTCGGTTCG	CASTGQEADSGNYGYTF	In	VDJ	6	301	7.063356666658845E-4	8.866684537503719E-4	51	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	7	5	5	1	16	0	25	35	-1	51	57						01,02							Vb 3	CASTGQEADSGNYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD02-01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTACGGCTAGTCAATGAGCAGTTCTTCGGGCCA	CASSLRLVNEQFF	In	VDJ	7	327	7.673480498330373E-4	9.63257755403228E-4	39	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	4	8	6	3	1	25	40	47	43	48						01,02							Vb 3	CASSLRLVNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTCAATCAGGGTACCTATGGCTACACCTTCGGTTCG	CASSFNQGTYGYTF	In	VDJ	7	330	7.74387940198478E-4	9.72094982517019E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	4	3	4	4	3	25	39	48	43	51													Vb 3	CASSFNQGTYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTGAGCCGGGGCAGAAACCCTACGAGCAGTACTTCGGGCCG	CASSEPGQKPYEQYF	In	VDJ	7	351	8.236671727565629E-4	0.0010339555723135566	45	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-07	01	5	7	0	2	5	6	25	37	47	42	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSEPGQKPYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01		TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCCGGCCAGGGACAGGAGAGTCTATGGCTACACCTTCGGTTCG	CASSPARDRRVYGYTF	In	VDJ	7	355	8.330536932438172E-4	0.0010457385417986115	48	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	0	4	4	8	5	25	36	52	44	57													Vb 3	CASSPARDRRVYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTACCCCCCGTCGAGCAGTACTTCGGGCCG	CASSLPPVEQYF	In	VDJ	8	379	8.893728161673428E-4	0.00111643635870894	36	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	2	8	6	6	5	1	25	40	47	45	48						01,02							Vb 3	CASSLPPVEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCTTACATGGGGCGCTCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSLHGALSGANVLTF	In	VDJ	8	388	9.10492487263665E-4	0.0011429480400503133	51	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	2	7	0	0	3	3	25	40	48	43	51													Vb 3	CASSLHGALSGANVLTF+TCRBV28-01+TCRBJ02-06	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-06*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCGGGACGGGAGGGAAGGTTACAGATACGCAGTATTTTGGCCCA	CASGTGGKVTDTQYF	In	VDJ	9	471	0.0011052627873741913	0.0013874446568651999	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	8	8	0	3	4	6	25	34	46	38	52													Vb 3	CASGTGGKVTDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCTACAGGGGACAGGGCAGCTACACCTTCGGTTCG	CASYRGQGSYTF	In	VDJ	9	471	0.0011052627873741913	0.0013874446568651999	36	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	8	0	3	9	5	2	25	34	48	39	50													Vb 3	CASYRGQGSYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTTAGCGGGGGCAGAGATACGCAGTATTTTGGCCCA	CASSFSGGRDTQYF	In	VDJ	10	499	0.0011709684307849712	0.0014699254432605834	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	5	2	5	0	3	25	-1	48	39	51													Vb 3	CASSFSGGRDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCCAAGCGGGAGGCGTACTACAATGAGCAGTTCTTCGGGCCA	CASSSKREAYYNEQFF	In	VDJ	12	581	0.001363392100773684	0.0017114763177042062	48	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	6	1	3	3	4	25	38	50	41	54													Vb 3	CASSSKREAYYNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCGGACTAGCGCAAAGATGGGTGAGCAGTTCTTCGGGCCA	CASSRTSAKMGEQFF	In	VDJ	14	696	0.0016332545647822444	0.002050236690399531	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	1	6	9	1	10	25	37	47	38	57						01,02							Vb 3	CASSRTSAKMGEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCCCCTAGCGGGAGGGCCCGGGAGACCCAGTACTTCGGGCCA	CASSPPSGRARETQYF	In	VDJ	15	735	0.0017247731395329737	0.0021651206428788153	48	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	5	4	0	5	4	5	25	37	53	41	58													Vb 3	CASSPPSGRARETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGATCCAGTTCTCTACGAGCAGTACTTCGGGCCG		Out	VDJ	25	1259	0.002954407323363284		37	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	4	5	3	3	4	25	36	42	39	46													Vb 3	X+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCTGACTAGCGCGGCCGGGGAGCTGTTTTTTGGAGAA	CASSLTSAAGELFF	In	VDJ	27	1333	0.003128057952377488	0.003926674580894504	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	2	6	6	2	3	25	37	47	39	50						01,02							Vb 3	CASSLTSAAGELFF+TCRBV28-01+TCRBJ02-02	TCRBV28-01*01	TCRBD02-01	TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCCAACTTGACACCACCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASQLDTTSGANVLTF	In	VDJ	28	1406	0.003299361951269879	0.004141713773996754	48	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	8	2	6	0	6	4	25	34	44	40	48													Vb 3	CASQLDTTSGANVLTF+TCRBV28-01+TCRBJ02-06	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-06*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGTAGACGACAGGGTGATATCTATGGCTACACCTTCGGTTCG	CASRRQGDIYGYTF	In	VDJ	1	17	3.989271207083068E-5	5.00776203114828E-5	42	TCRBV12	TCRBV12-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	8	2	3	4	4	6	18	27	38	31	44														CASRRQGDIYGYTF+TCRBV12-02+TCRBJ01-02	TCRBV12-02*01	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCAAGTCGCTTAGATGCGTCGGCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	20	4.693260243627139E-5		44	TCRBV12	TCRBV12-02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	1	7	6	3	2	4	18	34	39	36	43						01,02								X+TCRBV12-02+TCRBJ02-04	TCRBV12-02*01	TCRBD02-01	TCRBJ02-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCAAGTCGCGCACTAGCGGGAGAATCCAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	29	6.805227353259351E-5		46	TCRBV12	TCRBV12-02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	3	2	4	2	4	18	30	43	32	47														X+TCRBV12-02+TCRBJ02-03	TCRBV12-02*01	TCRBD02-01*02	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCAAGTCGCTTAGTCGGGGGACAGGCTAAATGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	31	7.274553377622066E-5		53	TCRBV12	TCRBV12-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	0	4	0	4	5	18	34	46	38	51														X+TCRBV12-02+TCRBJ01-01	TCRBV12-02*01	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCAAGCCTGCCTTACCGCCGGTGCATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	40	9.386520487254278E-5		44	TCRBV12	TCRBV12-02	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	9	8	5	6	13	3	18	26	42	39	45						01,02								X+TCRBV12-02+TCRBJ01-04	TCRBV12-02*01	TCRBD02-01	TCRBJ01-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCAAGTCGCCCCCTAGCGGGGGTCCTCACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	9	463	0.0010864897463996827		47	TCRBV12	TCRBV12-02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	4	2	5	3	5	18	30	43	33	48														X+TCRBV12-02+TCRBJ02-01	TCRBV12-02*01	TCRBD02-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCAACCAGACCTCTCTGTACTTCTGTGCCAGCAGTCTACAGACCGGGGAGCTGTTTTTTGGAGAA	CASSLQTGELFF	In	VDJ	1	13	3.0506191583576405E-5	3.8294650826428025E-5	36	TCRBV27	TCRBV27-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	3	5	5	2	0	23	35	-1	37	41													Vb 14	CASSLQTGELFF+TCRBV27-01+TCRBJ02-02	TCRBV27-01*01	TCRBD01-01*01	TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCAACCAGACCTCTCTGTACTTCTGTGCCAGCAGGGAGGACCAAAACTATGGCTACACCTTCGGTTCG	CASREDQNYGYTF	In	VDJ	1	15	3.519945182720355E-5	4.418613556895541E-5	39	TCRBV27	TCRBV27-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	6	10	1	2	0	5	23	-1	39	34	44													Vb 14	CASREDQNYGYTF+TCRBV27-01+TCRBJ01-02	TCRBV27-01*01	TCRBD02-01*02	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCAACCAGACCTCTCTGTACTTCTGTGCCAGCAGTCATATCCCCCCAGAGGTACACTGTTTTTTGGCAGT		Out	VDJ	1	15	3.519945182720355E-5		41	TCRBV27	TCRBV27-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	5	11	1	13	12	3	23	35	51	47	54													Vb 14	X+TCRBV27-01+TCRBJ01-04	TCRBV27-01*01	TCRBD02-01*02	TCRBJ01-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCAACCAGACCTCTCTGTACTTCTGTGCCAGCAGTTTAACGGCGGACAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSLTADSSYNEQFF	In	VDJ	1	17	3.989271207083068E-5	5.00776203114828E-5	48	TCRBV27	TCRBV27-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	1	5	0	5	0	23	38	-1	43	49													Vb 14	CASSLTADSSYNEQFF+TCRBV27-01+TCRBJ02-01	TCRBV27-01*01	TCRBD01-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCAACCAGACCTCTCTGTACTTCTGTGCCAGCAGTCCGGCAAGTGGGAACTATGGCTACACCTTCGGTTCG	CASSPASGNYGYTF	In	VDJ	1	26	6.101238316715281E-5	7.658930165285605E-5	42	TCRBV27	TCRBV27-01	01				TCRBJ01	TCRBJ01-02	01	5	0	9	2	9	0	23	35	-1	44	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 14	CASSPASGNYGYTF+TCRBV27-01+TCRBJ01-02	TCRBV27-01*01		TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCAACCAGACCTCTCTGTACTTCTGTGCCAGCATCGACTAGCGGGGCAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	28	6.570564341077994E-5		40	TCRBV27	TCRBV27-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	7	2	3	4	2	0	23	33	-1	35	46													Vb 14	X+TCRBV27-01+TCRBJ02-03	TCRBV27-01*01	TCRBD02-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCAACCAGACCTCTCTGTACTTCTGTGCCAGCAGTGGTAATAGGGTTCCTTGGTCTCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	55	1.2906465669974634E-4		53	TCRBV27	TCRBV27-01	01				TCRBJ01	TCRBJ01-03	01	5	5	3	0	6	9	23	35	45	41	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 14	X+TCRBV27-01+TCRBJ01-03	TCRBV27-01*01		TCRBJ01-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCAACCAGACCTCTCTGTACTTCTGTGCCAGCAGTTTTTATTCGGGACAGGGAGCGCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	65	1.5253095791788204E-4		49	TCRBV27	TCRBV27-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	0	3	4	6	4	23	37	52	43	56													Vb 14	X+TCRBV27-01+TCRBJ01-02	TCRBV27-01*01	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGTGGCCCTGAAGACAGCAGCAATATCTCTGCAGCGTCAGGGGTGACGCGGGGGCTCGGGCTTTCCTACGAGCAGTACGTCGGGCCG	AASGVTRGLGLSYEQYV	In	VDJ	1	13	3.0506191583576405E-5	3.8294650826428025E-5	51	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	22	7	2	17	25	25	30	22	54	47	79													Vb 4	AASGVTRGLGLSYEQYV+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD02-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGCAAGCCACGTTTGGTGGCCCTGAAGACAGCAGCATTATCTCTGCAGGGAGGACGGAAGGTCATGAAAAACTGTTTTTTGGCAGT	AGRTEGHEKLFF	In	VDJ	1	14	3.285282170538997E-5	4.1240393197691716E-5	36	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	21	9	1	6	10	10	45	38	54	48	64													Vb 4	AGRTEGHEKLFF+TCRBV29-01+TCRBJ01-04	TCRBV29-01*01	TCRBD02-01*02	TCRBJ01-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTCGGTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CSVRSGANVLTF	In	VDJ	1	15	3.519945182720355E-5	4.418613556895541E-5	36	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	5	8	5	1	0	0	25	-1	-1	34	37						01,02							Vb 4	CSVRSGANVLTF+TCRBV29-01+TCRBJ02-06	TCRBV29-01*01	TCRBD02-01	TCRBJ02-06*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAGGAACTTTCTCACTATGGCTACACCTTCGGTTCG	CSVEELSHYGYTF	In	VDJ	1	15	3.519945182720355E-5	4.418613556895541E-5	39	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-02	01	3	1	8	3	0	8	25	-1	39	36	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVEELSHYGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01		TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGATGGGCGGGAGTTCCCAGATACGCAGTATTTTGGCCCA	CSVDGREFPDTQYF	In	VDJ	1	15	3.519945182720355E-5	4.418613556895541E-5	42	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	7	2	4	3	4	25	36	46	39	50													Vb 4	CSVDGREFPDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCCTAATTGTCCAGGGGGCCACTGAAGCTTTCTTTGGACAA	CSLIVQGATEAFF	In	VDJ	1	16	3.7546081949017114E-5	4.7131877940219106E-5	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	8	4	0	4	9	0	25	31	-1	40	48													Vb 4	CSLIVQGATEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCCTCACTTATGAACACTGAAGCTTTCTTTGGACAA	CSASLMNTEAFF	In	VDJ	1	16	3.7546081949017114E-5	4.7131877940219106E-5	36	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	7	3	10	0	4	2	25	32	39	36	41						01,02							Vb 4	CSASLMNTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD02-01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTAGCTACCGGACAGGGCGGCTATGGCTACACCTTCGGTTCG	CSVATGQGGYGYTF	In	VDJ	1	16	3.7546081949017114E-5	4.7131877940219106E-5	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	1	3	4	7	3	25	33	48	40	51													Vb 4	CSVATGQGGYGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGGCTAATCAGGGACTAGCGGGGAGGATTTAACGTTGAGCAGTTCTTCGGGCCA		Out	VDJ	1	16	3.7546081949017114E-5		59	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	1	0	3	9	8	12	22	35	56	43	68													Vb 4	X+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCTGAAGACAGCAGCATATATCTCTGCARCGCCGAGGTCGGAGAGGGCTACGAGCAGTACTTCGGGCCG	CXAEVGEGYEQYF	In	VDJ	1	17	3.989271207083068E-5	5.00776203114828E-5	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	10	11	0	3	14	0	25	29	-1	43	48													Vb 4	CXAEVGEGYEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCCCCAGACGGACAAACCGGGGAGCTGTTTTTTGGAGAA	CSAPDGQTGELFF	In	VDJ	1	17	3.989271207083068E-5	5.00776203114828E-5	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	7	1	6	5	8	1	25	32	45	40	46													Vb 4	CSAPDGQTGELFF+TCRBV29-01+TCRBJ02-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAACTGGCCTCTACGAGCAGTACTTCGGGCCG	CSVETGLYEQYF	In	VDJ	1	17	3.989271207083068E-5	5.00776203114828E-5	36	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-07	01	2	9	0	3	3	2	25	37	43	40	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVETGLYEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01		TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGCAAGCCACGTTTGGTGGCCCTGAAGACAGCAGCWATATCTCTGCAGGGAGGACGGAAGGTCATGAAAAACTGTTTTTTGGCAGT	AGRTEGHEKLFF	In	VDJ	1	17	3.989271207083068E-5	5.00776203114828E-5	36	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	22	9	1	6	11	10	45	37	54	48	64													Vb 4	AGRTEGHEKLFF+TCRBV29-01+TCRBJ01-04	TCRBV29-01*01	TCRBD02-01*02	TCRBJ01-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCCCGTAGGGGGGGCGGTGGAAGAGCAAGCACTGAAGCTTTCTTTGGACAA	CSARRGGGGRASTEAFF	In	VDJ	1	18	4.2239342192644256E-5	5.302336268274649E-5	51	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	7	9	0	4	6	15	25	32	45	38	60													Vb 4	CSARRGGGGRASTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD02-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGGGGGGACAGGGAGCACAGATACGCAGTATTTTGGCCCA	CSVEGGTGSTDTQYF	In	VDJ	1	18	4.2239342192644256E-5	5.302336268274649E-5	45	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	1	0	3	0	2	0	25	38	-1	40	49													Vb 4	CSVEGGTGSTDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAGGGGAGGGGACAGAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CSVEGRGQSSYNEQFF	In	VDJ	1	18	4.2239342192644256E-5	5.302336268274649E-5	48	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-01	01	3	0	5	0	6	2	25	36	49	42	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVEGRGQSSYNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01		TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGCCCAAACAGGGGGGGAGACCCAGTACTTCGGGCCA	CSVAQTGGETQYF	In	VDJ	1	19	4.4585972314457824E-5	5.596910505401019E-5	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	3	1	5	5	1	25	35	48	40	49													Vb 4	CSVAQTGGETQYF+TCRBV29-01+TCRBJ02-05	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGATCTGTCCCTTGGAGTCTATGAGCAGTTCTTCGGGCCA	CSVEDLSLGVYEQFF	In	VDJ	1	20	4.693260243627139E-5	5.891484742527388E-5	45	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	10	2	8	10	3	25	39	53	49	56													Vb 4	CSVEDLSLGVYEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGGATTGACAGGCTGGGCTGAAGCTTTCTTTGGACAA	CSGLTGWAEAFF	In	VDJ	1	21	4.927923255808496E-5	6.186058979653757E-5	36	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	2	4	6	4	5	25	32	42	36	47													Vb 4	CSGLTGWAEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGGAGTTCAGGGGGCACCTTCTACGAGCAGTACTTCGGGCCG	CSVGSSGGTFYEQYF	In	VDJ	1	21	4.927923255808496E-5	6.186058979653757E-5	45	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	4	0	3	6	5	25	35	49	41	54													Vb 4	CSVGSSGGTFYEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTAGACTAGCGGGAGGCTACAATGAGCAGTTCTTCGGGCCA	CSVRLAGGYNEQFF	In	VDJ	1	27	6.335901328896638E-5	7.953504402411973E-5	42	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	2	1	3	1	0	25	34	-1	35	48													Vb 4	CSVRLAGGYNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGTTATCGTACTAGCGGGGGGGGCATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	28	6.570564341077994E-5		46	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	3	0	8	7	2	25	35	55	42	57													Vb 4	X+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGATCTGGGGGGTTTAAGCGGGAGGGCCGGGGATACGCAGTATTTTGGCCCA	CSVEDLGGLSGRAGDTQYF	In	VDJ	1	30	7.03989036544071E-5	8.837227113791082E-5	57	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	0	6	0	6	13	5	24	38	61	51	66													Vb 4	CSVEDLGGLSGRAGDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTCGACAGGGGGCAACCACAGATACGCAGTATTTTGGCCCA	CSVRQGATTDTQYF	In	VDJ	1	31	7.274553377622066E-5	9.131801350917451E-5	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	2	0	2	1	3	25	34	45	35	48													Vb 4	CSVRQGATTDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGGGTCGAAGGGTACCGGGGGCACTGAAGCTTTCTTTGGACAA	CSGSKGTGGTEAFF	In	VDJ	1	36	8.447868438528851E-5	1.0604672536549298E-4	42	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	7	8	2	4	13	0	25	32	-1	45	51													Vb 4	CSGSKGTGGTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD02-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGCGACAGGGGGGGCCAACGTCCTGACTTTCGGGGCC	CSVATGGANVLTF	In	VDJ	1	36	8.447868438528851E-5	1.0604672536549298E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	4	2	3	4	1	0	25	35	-1	36	43													Vb 4	CSVATGGANVLTF+TCRBV29-01+TCRBJ02-06	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-06*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGGTCCTGCAGGGGAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	40	9.386520487254278E-5		41	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	4	2	2	7	0	25	35	-1	42	48													Vb 4	X+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAGAAGGGGGCTGGGGCCAACGTCCTGACTTTCGGGGCC	CSVEKGAGANVLTF	In	VDJ	1	41	9.621183499435635E-5	1.2077543722181146E-4	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	3	5	1	2	2	0	25	36	-1	38	44													Vb 4	CSVEKGAGANVLTF+TCRBV29-01+TCRBJ02-06	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-06*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCGCGTGGGGCCCAAGAGACCCAGTACTTCGGGCCA	CSARGAQETQYF	In	VDJ	1	42	9.855846511616992E-5	1.2372117959307514E-4	36	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	7	7	0	1	5	0	25	32	-1	37	42													Vb 4	CSARGAQETQYF+TCRBV29-01+TCRBJ02-05	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTTCGGTGGGGACCCCGAATGGGTCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	47	1.1029161572523777E-4		49	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-05	01	5	0	7	2	6	11	25	34	45	40	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	X+TCRBV29-01+TCRBJ02-05	TCRBV29-01*01		TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCTTCCCGGACAGACTCTAACTATGGCTACACCTTCGGTTCG	CSASRTDSNYGYTF	In	VDJ	1	54	1.2671802657793275E-4	1.5907008804823947E-4	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	1	5	0	6	3	25	32	44	38	47													Vb 4	CSASRTDSNYGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAACCGTGGACAGGGGGAACACCGGGGAGCTGTTTTTTGGAGAA	CSVETVDRGNTGELFF	In	VDJ	1	55	1.2906465669974634E-4	1.6201583041950318E-4	48	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	2	1	2	1	5	0	25	37	-1	42	51													Vb 4	CSVETVDRGNTGELFF+TCRBV29-01+TCRBJ02-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTGACCCCACAGGGTTTTGGCGAGCAGTACTTCGGGCCG	CSVTPQGFGEQYF	In	VDJ	1	56	1.314112868215599E-4	1.6496157279076687E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	3	3	6	6	6	25	33	45	39	51													Vb 4	CSVTPQGFGEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGTTACGAAAGACTAGCGGGGGTCTACACAGATACGCAGTATTTTGGCCCA	CSYERLAGVYTDTQYF	In	VDJ	1	58	1.3610454706518703E-4	1.7085305753329426E-4	48	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	9	2	2	2	8	4	25	30	50	38	54													Vb 4	CSYERLAGVYTDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD02-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGGCGGTCGGGGTACGTACAATGAGCAGTTCTTCGGGCCA	CSVEGGRGTYNEQFF	In	VDJ	1	75	1.7599725913601771E-4	2.2093067784477704E-4	45	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	1	8	3	4	5	4	25	38	48	43	52													Vb 4	CSVEGGRGTYNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAGAGGGGTCGCCGGATGGCCCAGTACTTCGGGCCA	CSVERGRRMAQYF	In	VDJ	2	79	1.85383779623272E-4	2.3271364732983183E-4	39	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-05	01	3	5	2	9	1	11	25	36	42	37	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVERGRRMAQYF+TCRBV29-01+TCRBJ02-05	TCRBV29-01*01		TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTATGGCAGGGGAAGAGACCCAGTACTTCGGGCCA	CSVMAGEETQYF	In	VDJ	2	88	2.0650345071959413E-4	2.592253286712051E-4	36	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	4	2	3	4	0	25	34	-1	38	44													Vb 4	CSVMAGEETQYF+TCRBV29-01+TCRBJ02-05	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAACGAGGACTAGCGGGGTTTGTCGGGCCG		Out	VDJ	2	100	2.3466301218135697E-4		34	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	2	1	3	17	4	4	25	37	53	41	57													Vb 4	X+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD02-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTCTCATTCACGGCAATCAGCCCCAGCATTTTGGTGAT	CSVLIHGNQPQHF	In	VDJ	2	107	2.5108942303405193E-4	3.151944337252153E-4	39	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-05	01	5	3	7	2	7	1	25	34	43	41	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVLIHGNQPQHF+TCRBV29-01+TCRBJ01-05	TCRBV29-01*01		TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAGATAGCGAACCCCCTCCAAGGCTACACCTTCGGTTCG	CSVEIANPLQGYTF	In	VDJ	2	117	2.7455572425218763E-4	3.446518574378522E-4	42	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	3	5	6	8	2	12	25	36	43	38	55						01,02							Vb 4	CSVEIANPLQGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD02-01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCTTCACTAGCGGGGGCTCCTCCTACAATGAGCAGTTCTTCGGGCCA	CSFTSGGSSYNEQFF	In	VDJ	2	118	2.769023543740012E-4	3.475975998091159E-4	45	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	8	3	2	0	3	3	25	31	45	34	48													Vb 4	CSFTSGGSSYNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCCAAGGACAGTATGAACACTGAAGCTTTCTTTGGACAA	CSAKDSMNTEAFF	In	VDJ	2	125	2.933287652266962E-4	3.6821779640796177E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	1	5	0	4	2	25	32	42	36	44													Vb 4	CSAKDSMNTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGTGGGAACAGGGGGCGCCGGTTTCTTCGGGCCA	CSVVGTGGAGFF	In	VDJ	3	130	3.050619158357641E-4	3.829465082642802E-4	36	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	3	0	16	5	6	25	35	49	40	55													Vb 4	CSVVGTGGAGFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTTATGCCGGCGGAGGGCGAGGGACCCAGTACTTCGGGCCA	CSVYAGGGRGTQYF	In	VDJ	3	134	3.1444843632301835E-4	3.94729477749335E-4	42	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	5	10	0	7	9	5	25	34	49	43	54													Vb 4	CSVYAGGGRGTQYF+TCRBV29-01+TCRBJ02-05	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAATATGGAGAAGGGACCGGGGAGCTGTTTTTTGGAGAA	CSVEYGEGTGELFF	In	VDJ	3	138	3.238349568102726E-4	4.0651244723438975E-4	42	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-02	01	2	5	3	5	8	0	25	37	-1	45	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVEYGEGTGELFF+TCRBV29-01+TCRBJ02-02	TCRBV29-01*01		TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGAAGGGGCCGGAGAGACCCAGTACTTCGGGCCA	CSVEEGAGETQYF	In	VDJ	3	153	3.5903440863747617E-4	4.5069858280334516E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	0	5	2	4	0	4	25	-1	44	39	48													Vb 4	CSVEEGAGETQYF+TCRBV29-01+TCRBJ02-05	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGATCTGGGGAGTACAGATACGCAGTATTTTGGCCCA	CSVEDLGSTDTQYF	In	VDJ	3	160	3.7546081949017113E-4	4.7131877940219104E-4	42	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	0	9	2	3	4	1	25	39	48	43	49													Vb 4	CSVEDLGSTDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGATAAAGGGTGGGACACTGAAGCTTTCTTTGGACAA	CSVEDKGWDTEAFF	In	VDJ	3	168	3.9423386046467967E-4	4.948847183723006E-4	42	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-01	01	0	5	3	3	3	4	25	39	46	42	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVEDKGWDTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01		TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGGGGGCAGACAGGATAGTGGGGCCAGCTGAAGATGAGCAGTTCTTCGGGCCA		Out	VDJ	3	175	4.106602713173747E-4		52	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	7	2	4	8	6	19	25	32	44	38	63													Vb 4	X+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGACAGGGGACTAAAAATGAACACTGAAGCTTTCTTTGGACAA	CSVDRGLKMNTEAFF	In	VDJ	4	176	4.1300690143918826E-4	5.184506573424102E-4	45	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	3	0	9	0	3	4	25	36	46	39	50						01,02							Vb 4	CSVDRGLKMNTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD02-01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGATAGGTGGCCAAGGGCTTTCTTTGGACAA	CSVEDRWPRAFF	In	VDJ	4	177	4.1535353156100185E-4	5.213963997136739E-4	36	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-01	01	0	5	4	11	1	9	25	39	43	40	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVEDRWPRAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01		TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCTCAGCGGGAGGGTGGGCCTACAATGAGCAGTTCTTCGGGCCA	CSSAGGWAYNEQFF	In	VDJ	4	206	4.834058050935953E-4	6.06822928480321E-4	42	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	8	6	0	2	2	4	25	31	43	33	47													Vb 4	CSSAGGWAYNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTCATGGAACCTCGGGAAACACCATATATTTTGGAGAG	CSVHGTSGNTIYF	In	VDJ	4	216	5.06872106311731E-4	6.362803521929579E-4	39	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-03	01	5	1	8	4	3	6	25	34	40	37	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVHGTSGNTIYF+TCRBV29-01+TCRBJ01-03	TCRBV29-01*01		TCRBJ01-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGGGGACGGCGGTTCACCCCTCCACTTTGGGAAC	CSVEGDGGSPLHF	In	VDJ	5	226	5.303384075298667E-4	6.657377759055949E-4	39	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-06	01	1	0	7	9	0	5	25	-1	43	38	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVEGDGGSPLHF+TCRBV29-01+TCRBJ01-06	TCRBV29-01*01		TCRBJ01-06*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGTAAAGGGGTGGATTAGCACAGATACGCAGTATTTTGGCCCA	CSVVKGWISTDTQYF	In	VDJ	5	235	5.514580786261889E-4	6.922494572469681E-4	45	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	5	2	0	3	6	25	35	43	38	49													Vb 4	CSVVKGWISTDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCAAAAAAGGGAGGCTAGCGGACTAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	5	240	5.631912292352567E-4		49	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	8	4	5	0	12	3	25	31	50	43	53						01,02							Vb 4	X+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD02-01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAGACTAGCGGGAGAACGGAGACCCAGTACTTCGGGCCA	CSVETSGRTETQYF	In	VDJ	5	246	5.772710099661381E-4	7.246526233308687E-4	42	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	3	2	2	5	0	4	25	-1	48	36	52													Vb 4	CSVETSGRTETQYF+TCRBV29-01+TCRBJ02-05	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCAAACCGGACAGCCTTCGGCCTAAGGCTACACCTTCGGTTCG		Out	VDJ	5	273	6.406300232551045E-4		41	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	8	1	5	8	5	12	25	31	42	36	54													Vb 4	X+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTCGGTCCCGGGGGCCCTACAATGAGCAGTTCTTCGGGCCA	CSVRSRGPYNEQFF	In	VDJ	6	282	6.617496943514266E-4	8.306993486963617E-4	42	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-01	01	5	6	0	2	7	0	25	34	-1	41	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVRSRGPYNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01		TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTCAGGTCGATATTAGCACAGATACGCAGTATTTTGGCCCA	CSVQVDISTDTQYF	In	VDJ	6	284	6.664429545950538E-4	8.365908334388891E-4	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	4	4	0	0	8	25	-1	38	34	46													Vb 4	CSVQVDISTDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGTCAAAGCGGGGGGCATATACAATGAGCAGTTCTTCGGGCCA	CSVVKAGGIYNEQFF	In	VDJ	6	306	7.180688172749523E-4	9.013971656066903E-4	45	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	6	1	4	4	4	25	35	48	39	52													Vb 4	CSVVKAGGIYNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCTTCCGTCAGGGACAACGAACCGGGGAGCTGTTTTTTGGAGAA	CSFRQGQRTGELFF	In	VDJ	8	390	9.151857475072922E-4	0.0011488395247928407	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	8	0	6	5	8	4	25	31	45	39	49													Vb 4	CSFRQGQRTGELFF+TCRBV29-01+TCRBJ02-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGATCGGGGCACAGATACGCAGTATTTTGGCCCA	CSVEDRGTDTQYF	In	VDJ	9	465	0.00109118300664331	0.0013697702026376178	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	8	4	1	1	0	25	39	-1	40	44						01,02							Vb 4	CSVEDRGTDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD02-01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCCGGAAGGATACACCTACGAGCAGTACGTCGGGCCG		Out	VDJ	10	486	0.0011404622392013949		37	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-07	01	7	1	8	17	2	23	25	32	37	34	60				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	X+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01		TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCTTGGCTGGGACAGGGGAAAGATACGCAGTATTTTGGCCCA	CSAWLGQGKDTQYF	In	VDJ	15	743	0.0017435461805074821	0.0021886865818489245	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	7	0	2	5	7	2	25	32	49	39	51													Vb 4	CSAWLGQGKDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTCAGGGGTGACGCGGGGGCTCGGGCTTTCCTACGAGCAGTACGTCGGGCCG		Out	VDJ	25	1258	0.0029520606932414706		52	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	6	7	2	17	10	25	25	33	50	43	75													Vb 4	X+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD02-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGGGAGGACGGAAGGTCATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	49	2471	0.005798523031001331		37	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	9	10	1	6	0	10	25	-1	35	30	45													Vb 4	X+TCRBV29-01+TCRBJ01-04	TCRBV29-01*01	TCRBD02-01*02	TCRBJ01-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCACGGGACTCATAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	13	3.0506191583576405E-5		38	TCRBV10	unresolved		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	10	0	10	0	1	2	26	33	40	34	42		TCRBV10-01,TCRBV10-02				01,02								X+TCRBV10-X+TCRBJ01-05	unresolved	TCRBD02-01	TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGGSGACTCRGCTGTGTATCTCTGTGCCAGCAGTCCCTACAGGGAACCCAACGGGGAGCTGTTTTTTGGAGAA	CASSPYREPNGELFF	In	VDJ	1	14	3.285282170538997E-5	4.1240393197691716E-5	45	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	3	3	7	5	7	22	33	44	38	51		TCRBV07-04,TCRBV07-05												CASSPYREPNGELFF+TCRBV07-X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGYWCCCTCTCAGACWTCTGTKTACTTCTGTGCCAGCGGCACAGGGGGGAATCAGCCCCAGCATTTTGGTGAT	CASGTGGNQPQHF	In	VDJ	1	14	3.285282170538997E-5	4.1240393197691716E-5	39	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	8	3	1	4	3	1	28	37	48	40	49		TCRBV06-04,TCRBV06-07												CASGTGGNQPQHF+TCRBV06-X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CGACTCGGCYRTGTATCKCTGTGCTAGCAGCTGGGGGAGAGGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSWGRGSYNEQFF	In	VDJ	1	16	3.7546081949017114E-5	4.7131877940219106E-5	45	TCRBV07	unresolved					TCRBJ02	TCRBJ02-01	01	4	6	1	0	0	5	18	-1	36	31	41		TCRBV07-05,TCRBV07-06		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSWGRGSYNEQFF+TCRBV07-X+TCRBJ02-01	unresolved		TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTTACTCAGAGAGGGGCTACGAGCAGTACTTCGGGCCG	CASSYSERGYEQYF	In	VDJ	1	18	4.2239342192644256E-5	5.302336268274649E-5	42	TCRBV06	unresolved					TCRBJ02	TCRBJ02-07	01	0	5	2	3	4	0	24	41	-1	45	50		TCRBV06-05,TCRBV06-06,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSERGYEQYF+TCRBV06-X+TCRBJ02-07	unresolved		TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTAACGGACAGGTTTCAATTCAGTACTTCGGCGCC	CASSNGQVSIQYF	In	VDJ	1	18	4.2239342192644256E-5	5.302336268274649E-5	39	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	5	1	4	10	3	5	23	35	45	38	50		TCRBV06-07,TCRBV06-08												CASSNGQVSIQYF+TCRBV06-X+TCRBJ02-04	unresolved	TCRBD01-01*01	TCRBJ02-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCRTGTATSTCTGTGCCAGCAGCTTGGGCAGGGGTACAGATACGCAGTATTTTGGCCCA	CASSLGRGTDTQYF	In	VDJ	1	18	4.2239342192644256E-5	5.302336268274649E-5	42	TCRBV11	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	4	2	3	3	1	19	33	42	36	43		TCRBV11-01,TCRBV11-03												CASSLGRGTDTQYF+TCRBV11-X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGGGGACTCRGCYGTGTATCTCTGTGCCAGCGTCGACCCCACTAGAGATACGCAGTATTTTGGCCCA	CASVDPTRDTQYF	In	VDJ	1	19	4.4585972314457824E-5	5.596910505401019E-5	39	TCRBV07	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	8	3	8	5	9	0	22	31	-1	40	45		TCRBV07-02,TCRBV07-04				01,02								CASVDPTRDTQYF+TCRBV07-X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTTACGGACAGAGTAGCGGCGGCTACACCTTCGGTTCG	CASSYGQSSGGYTF	In	VDJ	1	20	4.693260243627139E-5	5.891484742527388E-5	42	TCRBV06	unresolved					TCRBJ01	TCRBJ01-02	01	2	1	5	8	0	9	23	-1	44	38	53		TCRBV06-07,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYGQSSGGYTF+TCRBV06-X+TCRBJ01-02	unresolved		TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGYWCCCTCTCAGACWTCTGTKTACTTCTGTGCCAGCAGTTACTCTCCAGGCCGGGGCTACGAGCAGTACTTCGGGCCG	CASSYSPGRGYEQYF	In	VDJ	1	22	5.162586267989853E-5	6.480633216780127E-5	45	TCRBV06	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	0	8	3	3	7	0	28	45	-1	52	57		TCRBV06-04,TCRBV06-07												CASSYSPGRGYEQYF+TCRBV06-X+TCRBJ02-07	unresolved	TCRBD02-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTTATGTAGCGGAGCCCCCCTACAATGAGCAGTTCTTCGGGCCA	CASSYVAEPPYNEQFF	In	VDJ	1	23	5.39724928017121E-5	6.775207453906497E-5	48	TCRBV06	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	5	5	2	2	6	23	37	45	39	51		TCRBV06-07,TCRBV06-08				01,02								CASSYVAEPPYNEQFF+TCRBV06-X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGGGGACTYGGCYGTGTATCTCTGTGCCAGCAGCCCGGAGGGGAACACTGAAGCTTTCTTTGGACAA	CASSPEGNTEAFF	In	VDJ	1	23	5.39724928017121E-5	6.775207453906497E-5	39	TCRBV07	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	5	10	0	1	2	0	22	34	-1	36	42		TCRBV07-01,TCRBV07-02												CASSPEGNTEAFF+TCRBV07-X+TCRBJ01-01	unresolved	TCRBD02-01*02	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGATCCGGGACAGGGGGCTATGGCTACAYCTTCGGTTCG	CASRSGTGGYGYXF	In	VDJ	1	25	5.866575304533924E-5	7.364355928159235E-5	42	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	0	0	16	4	11	26	37	53	41	64		TCRBV06-07,TCRBV06-08												CASRSGTGGYGYXF+TCRBV06-X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGRGGACTCMGCYGTGTATCTCTGTGCCAGCAGCTTAGGAACAGGTTGGAACTATGGCTACACCTTCGGTTCG	CASSLGTGWNYGYTF	In	VDJ	1	26	6.101238316715281E-5	7.658930165285605E-5	45	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	3	4	2	2	4	22	38	45	40	49		TCRBV07-04,TCRBV07-08												CASSLGTGWNYGYTF+TCRBV07-X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGGACTCSGCCGTGTATCTCTGTGCCAGCAGCTTCTCTGGCAACGGGGAGCTGTTTTTTGGAGAA	CASSFSGNGELFF	In	VDJ	1	29	6.805227353259351E-5	8.542652876664713E-5	39	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	9	0	7	4	2	18	32	39	36	41		TCRBV07-02,TCRBV07-08												CASSFSGNGELFF+TCRBV07-X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCAAGAGAGGGTCTACTAATGAAAAACTGTTTTTTGGCAGT	CASKRGSTNEKLFF	In	VDJ	1	29	6.805227353259351E-5	8.542652876664713E-5	42	TCRBV06	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	7	11	0	2	3	3	28	38	46	41	49		TCRBV06-04,TCRBV06-08												CASKRGSTNEKLFF+TCRBV06-X+TCRBJ01-04	unresolved	TCRBD02-01*02	TCRBJ01-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTTACGGGGGTACCTCCTATGGYTACACCTTCGGTTCG	CASSYGGTSYGYTF	In	VDJ	1	31	7.274553377622066E-5	9.131801350917451E-5	42	TCRBV06	unresolved					TCRBJ01	TCRBJ01-02	01	2	6	1	11	0	13	24	-1	44	39	57		TCRBV06-05,TCRBV06-06,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYGGTSYGYTF+TCRBV06-X+TCRBJ01-02	unresolved		TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCCTSTATCTCTGTGCCAGACCTTGGGACCGGGGCAATCAGCCCCAGCATTTTGGTGAT	CARPWDRGNQPQHF	In	VDJ	1	33	7.74387940198478E-5	9.72094982517019E-5	42	TCRBV05	unresolved					TCRBJ01	TCRBJ01-05	01	7	0	7	2	4	4	19	28	37	32	41		TCRBV05-03,TCRBV05-06,TCRBV05-07		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CARPWDRGNQPQHF+TCRBV05-X+TCRBJ01-05	unresolved		TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGGACTCMGCCRTGTATCKCTGTGCCAGCAGCTTGGCGGGCAGGGGTATGGCCTTGAGCAATGAGCAGTTCTTCGGGCCA	CASSLAGRGMALSNEQFF	In	VDJ	1	34	7.978542414166136E-5	1.001552406229656E-4	54	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	4	2	6	6	12	20	34	46	40	58		TCRBV07-07,TCRBV07-08												CASSLAGRGMALSNEQFF+TCRBV07-X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGGGGACTYRGCTGTGTATCTCTGTGCCAGCAGCTTAGTTCAGGGCTATGAGCAGTTCTTCGGGCCA	CASSLVQGYEQFF	In	VDJ	1	34	7.978542414166136E-5	1.001552406229656E-4	39	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	4	3	8	5	2	22	35	45	40	47		TCRBV07-01,TCRBV07-04												CASSLVQGYEQFF+TCRBV07-X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGGSGACTYGGCTGTGTATCTCTGTGCCAGCAGCCCGGGACAGCAAAGCACGGAAGCTTTCTTTGGACAA	CASSPGQQSTEAFF	In	VDJ	1	35	8.213205426347493E-5	1.031009829942293E-4	42	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	5	8	2	9	22	34	43	36	52		TCRBV07-01,TCRBV07-05												CASSPGQQSTEAFF+TCRBV07-X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCAGTGACTCGGGACAGCCCTCGGGTGAGCAGTTCTTCGGGCCA	CASSDSGQPSGEQFF	In	VDJ	1	35	8.213205426347493E-5	1.031009829942293E-4	45	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	0	5	9	0	8	28	-1	52	45	60		TCRBV06-04,TCRBV06-08												CASSDSGQPSGEQFF+TCRBV06-X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
SGACTCRGCYRTGTATCKCTGTGCCAGCAGTTGCGGGATAAAATGACCCACCAGACTGGGACCCAGTACTTCGGGCCA		Out	VDJ	1	36	8.447868438528851E-5		53	TCRBV07	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	6	7	3	7	2	21	19	30	38	32	59		TCRBV07-05,TCRBV07-07												X+TCRBV07-X+TCRBJ02-05	unresolved	TCRBD02-01*02	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGGGGACTYRGCTGTGTATCTCTGTGCCCCAGCTTACTTCGGGCTTATGGCTACACCTTCGGTTCG		Out	VDJ	1	36	8.447868438528851E-5		38	TCRBV07	unresolved					TCRBJ01	TCRBJ01-02	01	11	8	0	5	12	1	22	28	44	40	45		TCRBV07-01,TCRBV07-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV07-X+TCRBJ01-02	unresolved		TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCAGTGACCCCTAGTTACAGCTCTGAAGCTTTCTTTGGACAA		Out	VDJ	1	36	8.447868438528851E-5		43	TCRBV06	unresolved					TCRBJ01	TCRBJ01-01	01	2	3	5	6	8	2	28	43	55	51	57		TCRBV06-04,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-X+TCRBJ01-01	unresolved		TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCRTGTATCKCTGTGCCAGCAGCTTAGGCGGGGGAGCCACCGGGGAGCTGTTTTTTGGAGAA	CASSLGGGATGELFF	In	VDJ	1	37	8.682531450710208E-5	1.0899246773675668E-4	45	TCRBV07	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	1	7	2	4	0	3	18	-1	41	34	44		TCRBV07-02,TCRBV07-06												CASSLGGGATGELFF+TCRBV07-X+TCRBJ02-02	unresolved	TCRBD02-01*01	TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTGAACCGGGACAGAACTACGAGCAGTACTTCGGGCCG	CASSEPGQNYEQYF	In	VDJ	1	38	8.917194462891565E-5	1.1193821010802038E-4	42	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	5	3	5	2	26	38	50	43	52		TCRBV06-01,TCRBV06-07,TCRBV06-08												CASSEPGQNYEQYF+TCRBV06-X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGGGGACTYRGCTGTGTATCTCTGTGCCAGCAGCCATAAGGGGTAGCGGGGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	43	1.009050952379835E-4		43	TCRBV07	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	5	4	5	9	0	22	34	-1	43	50		TCRBV07-01,TCRBV07-04				01,02								X+TCRBV07-X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGYWCCCTCTCAGACWTCTGTKTACTTCTGTGCCAGCAGTCTCCGGGACGAGCAGTACTTCGGGCCG	CASSLRDEQYF	In	VDJ	1	49	1.1498487596886492E-4	1.4434137619192102E-4	33	TCRBV06	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	8	4	5	3	0	26	38	-1	41	45		TCRBV06-04,TCRBV06-07				01,02								CASSLRDEQYF+TCRBV06-X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCACCCCCCATAACCCGGACAGGGGGCAATATCAGCCCCAGCATTTTGGTGAT	CATPHNPDRGQYQPQHF	In	VDJ	1	51	1.1967813621249205E-4	1.502328609344484E-4	51	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	10	1	0	5	13	3	28	35	59	48	62		TCRBV06-04,TCRBV06-08												CATPHNPDRGQYQPQHF+TCRBV06-X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTTACAGGGGACAGGGTACCGGGGAGCTGTTTTTTGGAGAA	CASSYRGQGTGELFF	In	VDJ	1	56	1.314112868215599E-4	1.6496157279076687E-4	45	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	2	0	3	5	2	1	26	41	52	43	53		TCRBV06-07,TCRBV06-08												CASSYRGQGTGELFF+TCRBV06-X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGAGTCCGGTCCCAGCACTCCTACGAGCAGTACGTCGGGCCG		Out	VDJ	1	60	1.407978073088142E-4		47	TCRBV10	unresolved					TCRBJ02	TCRBJ02-07	01	0	4	5	17	6	19	26	43	52	49	71		TCRBV10-01,TCRBV10-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV10-X+TCRBJ02-07	unresolved		TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGGGGACTCRGCYGTGTATCTCTGTGCCAGCAGCTGGGGACAGCTCCCTGAAGCTTTCTTTGGACAA	CASSWGQLPEAFF	In	VDJ	1	60	1.407978073088142E-4	1.7674454227582163E-4	39	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	0	5	6	1	4	22	35	43	36	47		TCRBV07-02,TCRBV07-04												CASSWGQLPEAFF+TCRBV07-X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCRGCCATGTATCGCTGTGCCAGCAGTCCGCGGACAGGTACCAACTATGGCTACACCTTCGGTTCG	CASSPRTGTNYGYTF	In	VDJ	1	66	1.548775880396956E-4	1.944189965034038E-4	45	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	1	4	2	5	4	19	30	42	35	46		TCRBV07-06,TCRBV07-07												CASSPRTGTNYGYTF+TCRBV07-X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCAGTGGCGAACAGGGGGCTCTTTCCTGAAGCTTTCTTTGGACAA		Out	VDJ	2	76	1.783438892578313E-4		46	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	3	0	6	5	6	23	35	49	40	55		TCRBV06-04,TCRBV06-08												X+TCRBV06-X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGGGGACTYGGCYGTGTATCTCTGTGCCAGCAGCTACCGACAGGGGGCTATGGCTTTCTTTGGACAA	CASSYRQGAMAFF	In	VDJ	2	87	2.0415682059778055E-4	2.5627958629994137E-4	39	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	2	0	11	3	4	22	35	48	38	52		TCRBV07-01,TCRBV07-02												CASSYRQGAMAFF+TCRBV07-X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGYWCCCTCTCAGACWTCTGTKTACTTCTGTGCCAGCAGTTATGGAGATACGCAGTATTTTGGCCCA	CASSYGDTQYF	In	VDJ	2	92	2.158899712068484E-4	2.7100829815625987E-4	33	TCRBV06	unresolved					TCRBJ02	TCRBJ02-03	01	3	0	10	5	1	0	26	40	-1	41	43		TCRBV06-04,TCRBV06-07		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYGDTQYF+TCRBV06-X+TCRBJ02-03	unresolved		TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCRGCCATGTATCGCTGTGCCAGCAGCCGGGGGGCTGGGTTGGGGACAGATACGCAGTATTTTGGCCCA	CASSRGAGLGTDTQYF	In	VDJ	2	92	2.158899712068484E-4	2.7100829815625987E-4	48	TCRBV07	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	8	1	3	0	11	19	-1	38	31	49		TCRBV07-06,TCRBV07-07												CASSRGAGLGTDTQYF+TCRBV07-X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGGGGACTYRGCTGTGTATCTCTGTGCCAGCAGCTTCGTCCCTGGAGAGACCCAGTACTTCGGGCCA	CASSFVPGETQYF	In	VDJ	2	95	2.2292986157228912E-4	2.7984552527005095E-4	39	TCRBV07	unresolved					TCRBJ02	TCRBJ02-05	01	3	0	10	4	7	0	22	36	-1	43	45		TCRBV07-01,TCRBV07-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFVPGETQYF+TCRBV07-X+TCRBJ02-05	unresolved		TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCRGCCATGTATCGCTGTGCCAGCAGCTTAGGGTTGGACTCCTACGAGCAGTACTTCGGGCCG	CASSLGLDSYEQYF	In	VDJ	2	100	2.3466301218135697E-4	2.945742371263694E-4	42	TCRBV07	unresolved					TCRBJ02	TCRBJ02-07	01	1	1	8	0	4	0	19	35	-1	39	42		TCRBV07-06,TCRBV07-07		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGLDSYEQYF+TCRBV07-X+TCRBJ02-07	unresolved		TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTTACGCGACAGGGGGGAGCGTCGGCTACACCTTCGGTTCG	CASSYATGGSVGYTF	In	VDJ	2	102	2.393562724249841E-4	3.004657218688968E-4	45	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	2	1	8	2	7	23	38	49	40	56		TCRBV06-07,TCRBV06-08												CASSYATGGSVGYTF+TCRBV06-X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGGGGACTYRGCTGTGTATCTCTGTGCCAGCAGCTTGGACGGACCCGTTTTCCACCGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	2	104	2.4404953266861124E-4		53	TCRBV07	unresolved					TCRBJ01	TCRBJ01-01	01	3	1	7	1	0	16	22	-1	40	36	56		TCRBV07-01,TCRBV07-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV07-X+TCRBJ01-01	unresolved		TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CGACTCGGCYGTGTATCTCTGTGCCAGCAGCTAGATGGGGCTGGAATGAAGCTTTCTTTGGACAA		Out	VDJ	2	105	2.463961627904248E-4		40	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	7	0	7	4	5	19	32	41	36	46		TCRBV07-02,TCRBV07-05												X+TCRBV07-X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGGGGACTYGGCYGTGTATCTCTGTGCCAGCAGCTTAGGACTAGCGGGAGGAGGGTATTTTGGCCCA	CASSLGLAGGGYF	In	VDJ	3	130	3.050619158357641E-4	3.829465082642802E-4	39	TCRBV07	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	1	2	1	14	0	3	18	-1	47	34	50		TCRBV07-01,TCRBV07-02												CASSLGLAGGGYF+TCRBV07-X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCATGGAGCGGGGGGGGGCCACAGATACGCAGTATTTTGGCCCA	CASMERGGATDTQYF	In	VDJ	3	159	3.7311418936835755E-4	4.683730370309273E-4	45	TCRBV10	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	7	6	0	2	3	3	26	36	49	39	52		TCRBV10-01,TCRBV10-02												CASMERGGATDTQYF+TCRBV10-X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGGGGACTYRGCTGTGTATCTCTGTGCCAGCAGCTTAATAATGGGCAATGAGCAGTTCTTCGGGCCA	CASSLIMGNEQFF	In	VDJ	3	164	3.848473399774254E-4	4.8310174888724583E-4	39	TCRBV07	unresolved					TCRBJ02	TCRBJ02-01	01	4	0	9	6	7	0	22	35	-1	42	45		TCRBV07-01,TCRBV07-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLIMGNEQFF+TCRBV07-X+TCRBJ02-01	unresolved		TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGGACTCSGCCGTGTATCTCTGTGCCAGCCAGAGCTCCTATAATTCACCCCTCCACTTTGGGAAC	CASQSSYNSPLHF	In	VDJ	3	172	4.03620380951934E-4	5.066676878573554E-4	39	TCRBV07	unresolved					TCRBJ01	TCRBJ01-06	01	8	4	5	0	0	2	18	-1	30	27	32		TCRBV07-02,TCRBV07-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASQSSYNSPLHF+TCRBV07-X+TCRBJ01-06	unresolved		TCRBJ01-06*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGGCCCGGACAGGGGGAACTCTACGAGCAGTACGTCGGGCCG	CASRPGQGELYEQYV	In	VDJ	4	176	4.1300690143918826E-4	5.184506573424102E-4	45	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	1	1	17	4	18	23	34	48	38	66		TCRBV06-07,TCRBV06-08												CASRPGQGELYEQYV+TCRBV06-X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGTGCTAAAAGTACTGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	4	192	4.5055298338820534E-4		47	TCRBV06	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	9	3	10	0	10	1	28	36	49	46	50		TCRBV06-04,TCRBV06-08				01,02								X+TCRBV06-X+TCRBJ02-06	unresolved	TCRBD02-01	TCRBJ02-06*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGGGGACTYRGCTGTGTATCTCTGTGCCAGCAGCCCGTATAAGCGGGAGGTAAATCTGGGAGAGCAGTTCTTCGGGCCA	CASSPYKREVNLGEQFF	In	VDJ	4	197	4.622861339972732E-4	5.803112471389477E-4	51	TCRBV07	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	6	1	10	7	11	22	34	50	41	61		TCRBV07-01,TCRBV07-04												CASSPYKREVNLGEQFF+TCRBV07-X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAAGCCGGAGCGCTACTACAATGAGCAGTTCTTCGGGCCA	CASKPERYYNEQFF	In	VDJ	4	202	4.7401928460634105E-4	5.950399589952662E-4	42	TCRBV06	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	7	6	6	3	6	3	26	36	46	42	49		TCRBV06-07,TCRBV06-08				01,02								CASKPERYYNEQFF+TCRBV06-X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGGGGACTYRGCTGTGTATCTCTGTGCCAGCAGCTTAACGCTCCACAATGAGCAGTTCTTCGGGCCA	CASSLTLHNEQFF	In	VDJ	5	238	5.584979689916296E-4	7.010866843607592E-4	39	TCRBV07	unresolved					TCRBJ02	TCRBJ02-01	01	2	3	7	5	0	5	22	-1	39	37	44		TCRBV07-01,TCRBV07-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLTLHNEQFF+TCRBV07-X+TCRBJ02-01	unresolved		TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGGGGACTYRGCTGTGTATCTCTGTGCCAGCAGCCCCGGGGACCCGAATGAGCAGTTCTTCGGGCCA	CASSPGDPNEQFF	In	VDJ	5	253	5.936974208188331E-4	7.452728199297146E-4	39	TCRBV07	unresolved					TCRBJ02	TCRBJ02-01	01	5	0	7	7	4	3	22	34	43	38	46		TCRBV07-01,TCRBV07-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPGDPNEQFF+TCRBV07-X+TCRBJ02-01	unresolved		TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGGGGACTYRGCTGTGTATCTCTGTGCCAGCAGCTCCCAGGGAGGCGAGGGCTATGGCTACACCTTCGGTTCG	CASSSQGGEGYGYTF	In	VDJ	5	261	6.124704617933417E-4	7.688387588998242E-4	45	TCRBV07	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	3	9	1	4	3	6	22	36	45	39	51		TCRBV07-01,TCRBV07-04												CASSSQGGEGYGYTF+TCRBV07-X+TCRBJ01-02	unresolved	TCRBD02-01*02	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCAGAGGGACTAGCATCTACGAGCAGTACTTCGGGCCG	CASRGTSIYEQYF	In	VDJ	12	577	0.0013540055802864297	0.0016996933482191514	39	TCRBV06	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	0	7	3	1	2	23	34	44	35	46		TCRBV06-04,TCRBV06-08				01,02								CASRGTSIYEQYF+TCRBV06-X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCAGTGTCACGGTAAACACTGAAGCTTTCTTTGGACAA	CASSVTVNTEAFF	In	VDJ	12	592	0.0013892050321136333	0.0017438794837881068	39	TCRBV06	unresolved		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	5	8	5	2	4	2	23	35	42	39	44		TCRBV06-04,TCRBV06-08				01,02								CASSVTVNTEAFF+TCRBV06-X+TCRBJ01-01	unresolved	TCRBD02-01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGGGTTCTTTCCAGGGAGAGGCCTTACGTCGGGCCG	CARVLSRERPYV	In	VDJ	12	619	0.0014525640454025996	0.0018234145278122266	36	TCRBV06	unresolved					TCRBJ02	TCRBJ02-07	01	9	4	3	17	9	12	23	31	45	40	57		TCRBV06-04,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CARVLSRERPYV+TCRBV06-X+TCRBJ02-07	unresolved		TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCAGTGAATCCCTAGCGGGGGATCAATGAGCAGTTCTTCGGGCCA		Out	VDJ	16	778	0.001825678234770957		46	TCRBV06	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	2	4	2	6	3	2	23	38	51	41	53		TCRBV06-01,TCRBV06-04,TCRBV06-08												X+TCRBV06-X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCRGCCATGTATCGCTGTGCTAGCGGATCCCGGGACGTCCACGGGGAAGAGACCCAGTACTTCGGGCCA	CASGSRDVHGEETQYF	In	VDJ	58	2884	0.006767681271310335	0.008495520998724493	48	TCRBV07	unresolved					TCRBJ02	TCRBJ02-05	01	8	0	7	3	7	10	18	27	39	34	49		TCRBV07-06,TCRBV07-07		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASGSRDVHGEETQYF+TCRBV07-X+TCRBJ02-05	unresolved		TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGGACTCGGCCCTGTATCTCTGTGCCAGCAGCCTCGATATGGGCGAGACCCAGTACTTCGGGCCA	CASSLDMGETQYF	In	VDJ	1	20	4.693260243627139E-5	5.891484742527388E-5	39	TCRBV05	TCRBV05-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	8	0	5	8	0	20	32	-1	40	44														CASSLDMGETQYF+TCRBV05-08+TCRBJ02-05	TCRBV05-08*01	TCRBD01-01*01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGGGGACTTGGCTGTGTATCTCTGTGCCAGCAGCCCTCCTAGCACAGATACGCAGTATTTTGGCCCA	CASSPPSTDTQYF	In	VDJ	1	13	3.0506191583576405E-5	3.8294650826428025E-5	39	TCRBV07	TCRBV07-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	4	10	0	1	3	22	34	37	35	40						01,02								CASSPPSTDTQYF+TCRBV07-01+TCRBJ02-03	TCRBV07-01*01	TCRBD02-01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGGGGACTTGGCTGTGTATCTCTGTGTCAGCAGCCCTTAGGGGACAGGGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	13	3.0506191583576405E-5		52	TCRBV07	TCRBV07-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	0	3	0	6	0	22	34	-1	40	49														X+TCRBV07-01+TCRBJ02-06	TCRBV07-01*01	TCRBD01-01*01	TCRBJ02-06*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGGGGACTTGGCTGTGTATCTCTGTGCCAGCAGCTCAACAGGGTACGATACGCAGTATTTTGGCCCA	CASSSTGYDTQYF	In	VDJ	1	17	3.989271207083068E-5	5.00776203114828E-5	39	TCRBV07	TCRBV07-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	3	3	6	0	3	22	-1	43	37	46														CASSSTGYDTQYF+TCRBV07-01+TCRBJ02-03	TCRBV07-01*01	TCRBD01-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGGGGACTTGGCTGTGTATCTCTGTGCCAGCAGCCAGGAAGACAGGGCTGGCTACACCTTCGGTTCG	CASSQEDRAGYTF	In	VDJ	1	18	4.2239342192644256E-5	5.302336268274649E-5	39	TCRBV07	TCRBV07-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	2	3	7	6	1	22	34	47	40	48														CASSQEDRAGYTF+TCRBV07-01+TCRBJ01-02	TCRBV07-01*01	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGGGGACTTGGCTGTGTATCTCTGTGCCAGCAGCTTAAGTGCTGGCCAAGGCTACACCTTCGGTTCG	CASSLSAGQGYTF	In	VDJ	1	19	4.4585972314457824E-5	5.596910505401019E-5	39	TCRBV07	TCRBV07-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	9	0	8	8	3	22	35	46	43	49														CASSLSAGQGYTF+TCRBV07-01+TCRBJ01-02	TCRBV07-01*01	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGGGGACTTGGCTGTGTATCTCTGTGCCAGCAGTCGGGCGTCGGGTTGGGGCTACACCTTCGGTTCG	CASSRASGWGYTF	In	VDJ	1	19	4.4585972314457824E-5	5.596910505401019E-5	39	TCRBV07	TCRBV07-01	01				TCRBJ01	TCRBJ01-02	01	6	8	0	8	2	10	22	33	39	35	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRASGWGYTF+TCRBV07-01+TCRBJ01-02	TCRBV07-01*01		TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGGGGACTTGGCTGTGTATCTCTGTGCCAGCAGCTTAACCCCCAACCGTGGAGATACGCAGTATTTTGGCCCA	CASSLTPNRGDTQYF	In	VDJ	1	27	6.335901328896638E-5	7.953504402411973E-5	45	TCRBV07	TCRBV07-01	01				TCRBJ02	TCRBJ02-03	01	4	0	10	5	14	0	22	35	-1	49	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLTPNRGDTQYF+TCRBV07-01+TCRBJ02-03	TCRBV07-01*01		TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGGGGACTTGGCTGTGTATCTCTGTGCCAGCAGCCCACTAGCGGGAGGGCCATTTTCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSPLAGGPFSNTGELFF	In	VDJ	1	63	1.4783769767425488E-4	1.8558176938961271E-4	57	TCRBV07	TCRBV07-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	5	3	0	0	2	7	22	34	49	36	56														CASSPLAGGPFSNTGELFF+TCRBV07-01+TCRBJ02-02	TCRBV07-01*01	TCRBD02-01*02	TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGGGGACTTGGCTGTGTATCTCTGTGCCAGCAGCGAACATTGTTCCAGCTCGAAAGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	63	1.4783769767425488E-4		52	TCRBV07	TCRBV07-01	01				TCRBJ01	TCRBJ01-02	01	5	2	7	4	21	0	22	34	-1	55	58				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV07-01+TCRBJ01-02	TCRBV07-01*01		TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGGGGACTTGGCTGTGTATCTCTGTGCCAGCAGCGAACCGGGACAGCACAATGAGCAGTTCTTCGGGCCA	CASSEPGQHNEQFF	In	VDJ	4	192	4.5055298338820534E-4	5.655825352826292E-4	42	TCRBV07	TCRBV07-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	0	5	5	5	1	22	34	46	39	47														CASSEPGQHNEQFF+TCRBV07-01+TCRBJ02-01	TCRBV07-01*01	TCRBD01-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGGACTCCGCCGTGTATCTCTGTGCTAGCAGCCAGGGACCGAACACTGAAGCTTTCTTTGGACAA	CASSQGPNTEAFF	In	VDJ	1	16	3.7546081949017114E-5	4.7131877940219106E-5	39	TCRBV07	TCRBV07-08					TCRBJ01	TCRBJ01-01	01	5	0	7	1	2	1	20	32	39	34	40			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQGPNTEAFF+TCRBV07-08+TCRBJ01-01	TCRBV07-08		TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGGACTCCGCCGTGTATCTCTGTGCCAGCAGCTTATGGGGGGTGGAGACCCAGTACTTCGGGCCA	CASSLWGVETQYF	In	VDJ	1	21	4.927923255808496E-5	6.186058979653757E-5	39	TCRBV07	TCRBV07-08		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	2	9	1	5	1	2	20	35	42	36	44			01,02											CASSLWGVETQYF+TCRBV07-08+TCRBJ02-05	TCRBV07-08	TCRBD02-01*01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGGTGGGACTGCCCTATCGGCAGTTCTTCGGGCCA	CASSEVGLPYRQFF	In	VDJ	1	15	3.519945182720355E-5	4.418613556895541E-5	42	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	0	10	12	2	9	23	38	46	40	55						01,02							Vb 12	CASSEVGLPYRQFF+TCRBV10-02+TCRBJ02-01	TCRBV10-02*01	TCRBD02-01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCACTAGCGGGGGGAGCACAGATACGCAGTATTTTGGCCCA	CASTSGGSTDTQYF	In	VDJ	1	17	3.989271207083068E-5	5.00776203114828E-5	42	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	7	4	1	0	0	0	23	-1	-1	33	44													Vb 12	CASTSGGSTDTQYF+TCRBV10-02+TCRBJ02-03	TCRBV10-02*01	TCRBD02-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGACAGGGTCCCGAACGGGCCCCCAGCATTTTGGTGAT		Out	VDJ	1	17	3.989271207083068E-5		43	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	4	3	10	0	12	23	-1	42	37	54													Vb 12	X+TCRBV10-02+TCRBJ01-05	TCRBV10-02*01	TCRBD01-01*01	TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTCAAACCCACAGGGGACCGGGGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	18	4.2239342192644256E-5		47	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	3	2	5	7	6	23	35	49	42	55													Vb 12	X+TCRBV10-02+TCRBJ02-05	TCRBV10-02*01	TCRBD01-01*01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAGCCACGTTTGGTGCGCTCCCAGACATCTGTGTATTCTGCGCCAGCAGTGAGGGCAGGGATGTCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	31	7.274553377622066E-5		41	TCRBV10	TCRBV10-02	01				TCRBJ02	TCRBJ02-07	01	19	4	3	3	18	4	40	38	61	56	65				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	X+TCRBV10-02+TCRBJ02-07	TCRBV10-02*01		TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCACACGGGGGGGACAGGGGAATCAGCCCCAGCATTTTGGTGAT	CASTRGGQGNQPQHF	In	VDJ	1	36	8.447868438528851E-5	1.0604672536549298E-4	45	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	7	0	2	4	7	0	23	33	-1	40	50													Vb 12	CASTRGGQGNQPQHF+TCRBV10-02+TCRBJ01-05	TCRBV10-02*01	TCRBD01-01*01	TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGATCAGGACAGGGGGCGCGAGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	43	1.009050952379835E-4		47	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	1	0	8	3	4	23	37	51	40	55													Vb 12	X+TCRBV10-02+TCRBJ01-04	TCRBV10-02*01	TCRBD01-01*01	TCRBJ01-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCATGGAGCGGGGGGGGCCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	65	1.5253095791788204E-4		44	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	7	6	0	2	3	2	23	33	46	36	48													Vb 12	X+TCRBV10-02+TCRBJ02-03	TCRBV10-02*01	TCRBD02-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCCTATCCAGAGCGGGTAGTGGGAATGAGCAGTTCTTCGGGCCA	CASLSRAGSGNEQFF	In	VDJ	2	98	2.2996975193772983E-4	2.8868275238384204E-4	45	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	8	6	4	7	8	7	23	32	46	40	53						01,02							Vb 12	CASLSRAGSGNEQFF+TCRBV10-02+TCRBJ02-01	TCRBV10-02*01	TCRBD02-01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCTTGACCAGGGGGGGCGACACCGGGGAGCTGTTTTTTGGAGAA	CASLTRGGDTGELFF	In	VDJ	3	141	3.308748471757133E-4	4.1534967434818084E-4	45	TCRBV10	TCRBV10-02	01				TCRBJ02	TCRBJ02-02	01	8	4	1	3	5	4	23	32	44	37	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASLTRGGDTGELFF+TCRBV10-02+TCRBJ02-02	TCRBV10-02*01		TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGCTGCCACAGGAGACCCAGTACTTCGGGCCA	CASSELPQETQYF	In	VDJ	3	169	3.9658049058649325E-4	4.978304607435643E-4	39	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	3	5	5	5	0	23	38	-1	43	47													Vb 12	CASSELPQETQYF+TCRBV10-02+TCRBJ02-05	TCRBV10-02*01	TCRBD01-01*01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGCCTCGACAGACTCTGGAAACACCATATATTTTGGAGAG	CASSASTDSGNTIYF	In	VDJ	4	212	4.974855858244768E-4	6.244973827079031E-4	45	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	4	2	5	0	4	1	23	36	45	40	46													Vb 12	CASSASTDSGNTIYF+TCRBV10-02+TCRBJ01-03	TCRBV10-02*01	TCRBD01-01*01	TCRBJ01-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGGGACAGGGGTTTGGATGAGCAGTTCTTCGGGCCA	CASRDRGLDEQFF	In	VDJ	8	404	9.480385692126821E-4	0.0011900799179905325	39	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	1	2	8	0	5	23	-1	43	34	48													Vb 12	CASRDRGLDEQFF+TCRBV10-02+TCRBJ02-01	TCRBV10-02*01	TCRBD01-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGGGCAGGGATGTCTACGAGCAGTACTTCGGGCCG	CASSEGRDVYEQYF	In	VDJ	80	4021	0.009435799719812364	0.011844830074851313	42	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	4	3	3	2	4	23	38	45	40	49													Vb 12	CASSEGRDVYEQYF+TCRBV10-02+TCRBJ02-07	TCRBV10-02*01	TCRBD01-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCATCAGTGAGGGTGGGGACGGATTCTACGAGCAGTACGTCGGGCCG	CAISEGGDGFYEQYV	In	VDJ	1	16	3.7546081949017114E-5	4.7131877940219106E-5	45	TCRBV10	TCRBV10-03	01				TCRBJ02	TCRBJ02-07	01	2	0	7	17	4	19	24	39	48	43	67				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CAISEGGDGFYEQYV+TCRBV10-03+TCRBJ02-07	TCRBV10-03*01		TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGCCGGGACTAGCGGGCCAAGAGACCCAGTACTTCGGGCCA	CAISEPGLAGQETQYF	In	VDJ	1	56	1.314112868215599E-4	1.6496157279076687E-4	48	TCRBV10	TCRBV10-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	2	0	4	1	2	0	23	38	-1	40	52						01,02							Vb 12	CAISEPGLAGQETQYF+TCRBV10-03+TCRBJ02-05	TCRBV10-03*01	TCRBD02-01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGTCGATGGGTTACGGCTACACCTTCGGTTCG	CAISESMGYGYTF	In	VDJ	2	99	2.323163820595434E-4	2.916284947551057E-4	39	TCRBV10	TCRBV10-03	01				TCRBJ01	TCRBJ01-02	01	0	0	9	8	3	4	23	40	46	43	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CAISESMGYGYTF+TCRBV10-03+TCRBJ01-02	TCRBV10-03*01		TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGTCGGGACTTAAGGGGACCCAGTACTTCGGGCCA	CAISESGLKGTQYF	In	VDJ	3	128	3.003686555921369E-4	3.7705502352175285E-4	42	TCRBV10	TCRBV10-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	0	0	10	7	0	6	23	-1	46	40	52						01,02							Vb 12	CAISESGLKGTQYF+TCRBV10-03+TCRBJ02-05	TCRBV10-03*01	TCRBD02-01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGTCGGACCTACACTGAAGCTTTCTTTGGACAA		Out	VDJ	3	149	3.496478881502219E-4		40	TCRBV10	TCRBV10-03	01				TCRBJ01	TCRBJ01-01	01	0	1	7	3	0	2	23	-1	44	40	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	X+TCRBV10-03+TCRBJ01-01	TCRBV10-03*01		TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCGAACTTTCGGATACGCAGTATTTTGGCCCA	CASSIELSDTQYF	In	VDJ	1	13	3.0506191583576405E-5	3.8294650826428025E-5	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	3	10	6	3	4	27	41	47	44	51			01,02			01,02							Vb 17	CASSIELSDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTGAAAACAGGGAGAACACTGAAGCTTTCTTTGGACAA	CASENRENTEAFF	In	VDJ	1	13	3.0506191583576405E-5	3.8294650826428025E-5	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	8	3	3	1	4	1	27	36	46	40	47			01,02										Vb 17	CASENRENTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTGGGGGGACAAGGACTAATGAAAAACTGTTTTTTGGCAGT	CASGGTRTNEKLFF	In	VDJ	1	13	3.0506191583576405E-5	3.8294650826428025E-5	42	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-04	01	8	0	6	2	3	3	27	36	45	39	48			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASGGTRTNEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01		TCRBJ01-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACAATGGGGACCGGGGAGCTGTTTTTTGGAGAA	CASTMGTGELFF	In	VDJ	1	14	3.285282170538997E-5	4.1240393197691716E-5	36	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-02	01	7	6	2	5	4	0	27	37	-1	41	45			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASTMGTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01		TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCAGGGACGTACCGAACACTGAAGCTTTCTTTGGACAA	CASTRDVPNTEAFF	In	VDJ	1	14	3.285282170538997E-5	4.1240393197691716E-5	42	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	7	0	7	1	3	5	27	37	45	40	50			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASTRDVPNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCGACTCCTTGAACACTGAAGCTTTCTTTGGACAA	CASSDSLNTEAFF	In	VDJ	1	14	3.285282170538997E-5	4.1240393197691716E-5	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	6	2	10	0	1	3	27	38	43	39	46			01,02			01,02							Vb 17	CASSDSLNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGGCCGACAGGGACCCGGGGAGCTGTTTTTTGGAGAA	CASSGRQGPGELFF	In	VDJ	1	14	3.285282170538997E-5	4.1240393197691716E-5	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	2	3	6	4	2	27	39	50	43	52			01,02										Vb 17	CASSGRQGPGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD01-01*01	TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTGGAGATTATCGGACACTGAAGCTTTCTTTGGACAA	CASSWRLSDTEAFF	In	VDJ	1	14	3.285282170538997E-5	4.1240393197691716E-5	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	5	10	2	3	1	8	27	39	44	40	52			01,02										Vb 17	CASSWRLSDTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01*02	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCTTCGGGACAGGGGGGAATCAGCCCCAGCATTTTGGTGAT	CASSFGTGGNQPQHF	In	VDJ	1	15	3.519945182720355E-5	4.418613556895541E-5	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	0	1	4	4	1	27	38	53	42	54			01,02										Vb 17	CASSFGTGGNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACGTTGTTAGCGGGAGGGCCGGGGCAGTATTTTGGCCCA	CASSTLLAGGPGQYF	In	VDJ	1	15	3.519945182720355E-5	4.418613556895541E-5	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	4	5	0	11	6	5	27	40	57	46	62			01,02										Vb 17	CASSTLLAGGPGQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*02	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGGAGGGATACCCCTACAATGAGCAGTTCTTCGGGCCA	CASSMEGYPYNEQFF	In	VDJ	1	15	3.519945182720355E-5	4.418613556895541E-5	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	10	0	2	0	5	27	-1	47	41	52			01,02										Vb 17	CASSMEGYPYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*02	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATACCCAGGAGTGGAGAGCAGTACTTCGGGCCG	CASSIPRSGEQYF	In	VDJ	1	16	3.7546081949017114E-5	4.7131877940219106E-5	39	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-07	01	2	4	4	7	2	6	27	42	48	44	54			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIPRSGEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01		TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCCTCCCGGGGACAGGACCAGGAAACACCATATATTTTGGAGAG	CASSILPGTGPGNTIYF	In	VDJ	1	16	3.7546081949017114E-5	4.7131877940219106E-5	51	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	3	0	4	4	7	4	27	41	56	48	60			01,02										Vb 17	CASSILPGTGPGNTIYF+TCRBV19-01+TCRBJ01-03	TCRBV19-01	TCRBD01-01*01	TCRBJ01-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGATACGGGCTGATGGCTACACCTTCGGTTCG		Out	VDJ	1	17	3.989271207083068E-5		40	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-02	01	0	8	0	6	3	2	27	44	51	47	53			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	X+TCRBV19-01+TCRBJ01-02	TCRBV19-01		TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGGAAAGGGGACTAGCGGGAGTAATGAGCAGTTCTTCGGGCCA	CASSGKGTSGSNEQFF	In	VDJ	1	17	3.989271207083068E-5	5.00776203114828E-5	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	0	2	7	6	1	27	39	59	45	60			01,02										Vb 17	CASSGKGTSGSNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*02	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AAGCCACGTTTGGTGCCAAAAGAACCCGAAGCTTTCTATCTCTGTGCCAGTAGTATCCTCGGGACAGGAGAGCAGTACTTCGGGCCG	CASSILGTGEQYF	In	VDJ	1	18	4.2239342192644256E-5	5.302336268274649E-5	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	0	4	7	4	1	42	56	68	60	69			01,02										Vb 17	CASSILGTGEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAAACGAGCTGAACAGATGAACACTGAAGCTTTCTTTGGACAA	CASKRAEQMNTEAFF	In	VDJ	1	19	4.4585972314457824E-5	5.596910505401019E-5	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	3	5	0	10	1	27	37	51	47	52			01,02										Vb 17	CASKRAEQMNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGTGCCGGGGTACACTGAAGCTTTCTTTGGACAA	CASSIVPGYTEAFF	In	VDJ	1	20	4.693260243627139E-5	5.891484742527388E-5	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	1	8	3	3	3	1	27	43	51	46	52			01,02										Vb 17	CASSIVPGYTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTCGGGCGCCCTACGAGCAGTACTTCGGGCCG	CASSIRAPYEQYF	In	VDJ	1	20	4.693260243627139E-5	5.891484742527388E-5	39	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-07	01	3	8	0	2	2	2	27	41	47	43	49			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIRAPYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01		TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGCAGGGGTCGCGGGCACTGAAGCTTTCTTTGGACAA	CASSAGVAGTEAFF	In	VDJ	1	20	4.693260243627139E-5	5.891484742527388E-5	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	4	2	4	1	7	27	39	46	40	53			01,02										Vb 17	CASSAGVAGTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGGAACGGGACAGTTAACCGGGGGCAAAAACATTCAGTACTTCGGCGCC	CASSGTGQLTGGKNIQYF	In	VDJ	1	20	4.693260243627139E-5	5.891484742527388E-5	54	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	5	0	5	3	5	11	27	39	51	44	62			01,02										Vb 17	CASSGTGQLTGGKNIQYF+TCRBV19-01+TCRBJ02-04	TCRBV19-01	TCRBD01-01*01	TCRBJ02-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTCAGAACCGGGGGTTTACAATGAGCAGTTCTTCGGGCCA	CASSSEPGVYNEQFF	In	VDJ	1	20	4.693260243627139E-5	5.891484742527388E-5	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	8	2	4	7	2	27	39	52	46	54			01,02										Vb 17	CASSSEPGVYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTGAGACAGGTTATAGCAATCAGCCCCAGCATTTTGGTGAT	CASETGYSNQPQHF	In	VDJ	1	20	4.693260243627139E-5	5.891484742527388E-5	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	8	2	4	0	2	3	27	36	44	38	47			01,02										Vb 17	CASETGYSNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGGGGACAGGGAAACTGTTTTTTGGCAGT	CASRGTGKLFF	In	VDJ	1	21	4.927923255808496E-5	6.186058979653757E-5	33	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	0	3	11	1	0	27	38	-1	39	48			01,02										Vb 17	CASRGTGKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD01-01*01	TCRBJ01-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTATCCAAAGCCGGGGCCTGCTAGAAGCTTTCTTTGGACAA	CASIQSRGLLEAFF	In	VDJ	1	21	4.927923255808496E-5	6.186058979653757E-5	42	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	7	7	0	8	9	6	27	37	51	46	57			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASIQSRGLLEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAGTCGGGAAGGCCCACCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	22	5.162586267989853E-5		44	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	8	3	2	2	7	27	40	47	42	54			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01*02	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTGGGGCCATAGCGGGAGACGAGCAGTTCTTCGGGCCA	CASGAIAGDEQFF	In	VDJ	1	22	5.162586267989853E-5	6.480633216780127E-5	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	8	5	2	10	7	2	27	36	52	43	54			01,02										Vb 17	CASGAIAGDEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*02	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGAGGGGGCCGGCTATGGCTACACCTTCGGTTCG	CASSIEGAGYGYTF	In	VDJ	1	25	5.866575304533924E-5	7.364355928159235E-5	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	6	0	4	0	3	27	-1	50	44	53			01,02										Vb 17	CASSIEGAGYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTTGGGAGAACACTGAAGCTTTCTTTGGACAA	CASSIWENTEAFF	In	VDJ	1	25	5.866575304533924E-5	7.364355928159235E-5	39	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	3	0	8	1	2	0	27	41	-1	43	47			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIWENTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGTACCGGGACAGCAGCAATTAGCTTTCTTTGGACAA	CASSVPGQQQLAFF	In	VDJ	1	25	5.866575304533924E-5	7.364355928159235E-5	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	5	10	5	8	27	39	51	44	59			01,02										Vb 17	CASSVPGQQQLAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTTCCAGGGATTTAGTCAGCCCCAGCATTTTGGTGAT	CASSFQGFSQPQHF	In	VDJ	1	26	6.101238316715281E-5	7.658930165285605E-5	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	4	3	6	3	6	27	39	47	42	53			01,02										Vb 17	CASSFQGFSQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AAGCCACGTTTGGTGCCAAAAGAACCCGACAGCTTTCTACTCTGTGCCAGTAGTATCCTCGGGACAGGAGAGCAGTACTTCGGGCCG		Out	VDJ	1	29	6.805227353259351E-5		38	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	21	0	4	7	21	1	43	39	68	60	69			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCGTCGGGAGCACAGATACGCAGTATTTTGGCCCA	CASSIVGSTDTQYF	In	VDJ	1	29	6.805227353259351E-5	8.542652876664713E-5	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	8	4	0	3	0	27	41	-1	44	48			01,02			01,02							Vb 17	CASSIVGSTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTTTTCTGCCAGATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSIFLPDSNQPQHF	In	VDJ	1	29	6.805227353259351E-5	8.542652876664713E-5	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	4	5	0	8	1	27	41	52	49	53			01,02										Vb 17	CASSIFLPDSNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAGTCGGTTCAAGGAAAAACTGTTTTTTGGCAGT	CASSSRFKEKLFF	In	VDJ	1	30	7.03989036544071E-5	8.837227113791082E-5	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	4	8	5	8	2	6	27	40	45	42	51			01,02			01,02							Vb 17	CASSSRFKEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD02-01	TCRBJ01-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGCGGGACGGCCGGGAGCAATCAGCCCCAGCATTTTGGTGAT	CASGTAGSNQPQHF	In	VDJ	1	31	7.274553377622066E-5	9.131801350917451E-5	42	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-05	01	9	0	7	1	1	7	27	35	41	36	48			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASGTAGSNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01		TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGTAGGGACAAGTTCCTACGAGCAGTACTTCGGGCCG	CASSIVGTSSYEQYF	In	VDJ	1	31	7.274553377622066E-5	9.131801350917451E-5	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	0	6	1	2	3	27	43	51	45	54			01,02										Vb 17	CASSIVGTSSYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCTCCCCCCGGGAGTGGGCAATCAGCCCCAGCATTTTGGTGAT	CASSLPPGVGNQPQHF	In	VDJ	1	31	7.274553377622066E-5	9.131801350917451E-5	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	5	8	2	2	7	3	27	39	52	46	55			01,02										Vb 17	CASSLPPGVGNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD02-01*02	TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTCAAGAACTACAGGGGGCAAGCACCGGGGAGCTGTTTTTTGGAGAA	CASQELQGASTGELFF	In	VDJ	1	31	7.274553377622066E-5	9.131801350917451E-5	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	8	3	0	4	8	3	27	36	53	44	56			01,02										Vb 17	CASQELQGASTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD01-01*01	TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGACGGGGATGGCTACACCTTCGGTTCG	CASSIDGDGYTF	In	VDJ	1	32	7.509216389803423E-5	9.426375588043821E-5	36	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	0	8	3	6	0	0	27	-1	-1	44	49			01,02										Vb 17	CASSIDGDGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD02-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGGCTGGGCCTGATTCAAGAGACCCAGTACTTCGGGCCA	CASSIGLGLIQETQYF	In	VDJ	1	32	7.509216389803423E-5	9.426375588043821E-5	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	1	8	0	2	4	6	27	43	51	47	57			01,02										Vb 17	CASSIGLGLIQETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD01-01*01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCGGGACAGGGTATCAGCCCCAGCATTTTGGTGAT	CASTGTGYQPQHF	In	VDJ	1	33	7.74387940198478E-5	9.72094982517019E-5	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	7	0	3	5	2	1	27	37	48	39	49			01,02										Vb 17	CASTGTGYQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGGACAGGGTACGGAGAGACCCAGTACTTCGGGCCA	CASSIGTGYGETQYF	In	VDJ	1	33	7.74387940198478E-5	9.72094982517019E-5	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	1	1	3	4	0	5	27	-1	51	43	56			01,02										Vb 17	CASSIGTGYGETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD01-01*01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCCCCTGACTGGCAGGCACTGAACACTGAAGCTTTCTTTGGACAA	CASSPPDWQALNTEAFF	In	VDJ	1	33	7.74387940198478E-5	9.72094982517019E-5	51	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	5	4	4	0	12	3	27	39	55	51	58			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSPPDWQALNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTCAGGACTAGCGGGAGCTTTCGATACGCAGTATTTTGGCCCA	CASSSGLAGAFDTQYF	In	VDJ	1	33	7.74387940198478E-5	9.72094982517019E-5	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	1	2	6	3	5	27	39	55	42	60			01,02										Vb 17	CASSSGLAGAFDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*02	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCTCGGGGGTAGCGGGAGGGCAGGTGAGCAGTTCTTCGGGCCA	CASSLGGSGRAGEQFF	In	VDJ	1	34	7.978542414166136E-5	1.001552406229656E-4	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	5	0	9	8	4	27	39	58	47	62			01,02										Vb 17	CASSLGGSGRAGEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*02	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGACTAGCGGGGGAGCCTTGGGATACGCAGTATTTTGGCCCA	CASSIGLAGEPWDTQYF	In	VDJ	1	36	8.447868438528851E-5	1.0604672536549298E-4	51	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	1	2	2	6	0	8	27	-1	55	43	63			01,02										Vb 17	CASSIGLAGEPWDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTCAGGGGGCCCCTGGAAACACCATATATTTTGGAGAG	CASSIQGAPGNTIYF	In	VDJ	1	36	8.447868438528851E-5	1.0604672536549298E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	3	4	0	2	1	2	27	41	50	42	52			01,02										Vb 17	CASSIQGAPGNTIYF+TCRBV19-01+TCRBJ01-03	TCRBV19-01	TCRBD01-01*01	TCRBJ01-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAGCTTTCTATCTCTGTGCCAGTAGTTTCGTTTCCGGGACAGGGGCTTCCCATCGTGGAAACACCATATATTTTGGAGAG	CASSFVSGTGASHRGNTIYF	In	VDJ	1	36	8.447868438528851E-5	1.0604672536549298E-4	60	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	0	2	3	9	10	14	26	45	35	55			01,02										Vb 17	CASSFVSGTGASHRGNTIYF+TCRBV19-01+TCRBJ01-03	TCRBV19-01	TCRBD01-01*01	TCRBJ01-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGACATGGGGTAGCTAATTCACCCCTCCACTTTGGGAAC	CASRHGVANSPLHF	In	VDJ	1	37	8.682531450710208E-5	1.0899246773675668E-4	42	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-06	01	6	6	2	6	4	4	27	38	46	42	50			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASRHGVANSPLHF+TCRBV19-01+TCRBJ01-06	TCRBV19-01		TCRBJ01-06*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AAGCCACGTTTGGTGCCAAAAGACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCCTCGGGACAGGAGAGCAGTACTTCGGGCCG	CASSILGTGEQYF	In	VDJ	1	38	8.917194462891565E-5	1.1193821010802038E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	0	4	7	4	1	42	56	68	60	69			01,02										Vb 17	CASSILGTGEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAAGACTAGCGGGGGGCTGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	38	8.917194462891565E-5		44	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	4	2	1	5	1	2	27	40	54	41	56			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD02-01*01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTCATTGGGGCAGCCACACTGAAGCTTTCTTTGGACAA	CASHWGSHTEAFF	In	VDJ	1	39	9.151857475072921E-5	1.1488395247928406E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	8	7	0	3	4	4	27	36	45	40	49			01,02										Vb 17	CASHWGSHTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCCCAACAGGGAGCAATCAGCCCCAGCATTTTGGTGAT	CASSPTGSNQPQHF	In	VDJ	1	42	9.855846511616992E-5	1.2372117959307514E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	3	3	1	4	0	27	38	-1	42	48			01,02										Vb 17	CASSPTGSNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGTGATCTTATACACCGGGGAGCTGTTTTTTGGAGAA	CASSVILYTGELFF	In	VDJ	1	42	9.855846511616992E-5	1.2372117959307514E-4	42	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-02	01	5	2	8	3	2	6	27	39	43	41	49			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSVILYTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01		TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCAGTCTTGAGACCCAGTACTTCGGGCCA	CASSSLETQYF	In	VDJ	1	43	1.009050952379835E-4	1.2666692196433885E-4	33	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	4	5	5	0	4	27	-1	41	38	45			01,02										Vb 17	CASSSLETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD01-01*01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAAGGGAACTAGCGGGTTCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSKGTSGFSGANVLTF	In	VDJ	1	43	1.009050952379835E-4	1.2666692196433885E-4	54	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	4	3	4	0	5	2	27	40	54	45	56			01,02			01,02							Vb 17	CASSKGTSGFSGANVLTF+TCRBV19-01+TCRBJ02-06	TCRBV19-01	TCRBD02-01	TCRBJ02-06*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTGGAAAGTTAGGTGAGCAGTTCTTCGGGCCA	CASGKLGEQFF	In	VDJ	1	43	1.009050952379835E-4	1.2666692196433885E-4	33	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-01	01	8	1	8	9	0	8	27	-1	39	36	47			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASGKLGEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01		TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGGACAGCCATATCAATCAGCCCCAGCATTTTGGTGAT	CASRDSHINQPQHF	In	VDJ	1	45	1.0559835548161063E-4	1.3255840670686622E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	1	5	3	0	6	27	-1	44	38	50			01,02										Vb 17	CASRDSHINQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACCCCGACCCGCTCGCCCTACGAGCAGTACTTCGGGCCG	CASSTPTRSPYEQYF	In	VDJ	1	45	1.0559835548161063E-4	1.3255840670686622E-4	45	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-07	01	4	2	7	2	4	8	27	40	47	44	55			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSTPTRSPYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01		TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACAGGGGTCGGTCAGCCCCAGCATTTTGGTGAT	CASSTGVGQPQHF	In	VDJ	1	47	1.1029161572523777E-4	1.3844989144939362E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	4	2	6	0	4	27	-1	46	40	50			01,02										Vb 17	CASSTGVGQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAATGAGTTTCCGGGTTTTCGAGCAGTTCTTCGGGCCA		Out	VDJ	1	48	1.1263824584705134E-4		40	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	7	8	4	10	9	5	27	37	50	46	55			01,02			01,02							Vb 17	X+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCTGGGGCGGGGGTCAGCCCCAGCATTTTGGTGAT	CASTWGGGQPQHF	In	VDJ	1	49	1.1498487596886492E-4	1.4434137619192102E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	7	7	2	6	6	0	27	37	-1	43	50			01,02										Vb 17	CASTWGGGQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD02-01*01	TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGACTTTGGGGATCAGCCCCAGCATTTTGGTGAT	CASSIDFGDQPQHF	In	VDJ	1	49	1.1498487596886492E-4	1.4434137619192102E-4	42	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-05	01	0	6	2	5	4	0	27	44	-1	48	52			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIDFGDQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01		TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGCCCAAACAGGGATCTATGGCTACACCTTCGGTTCG	CASSAQTGIYGYTF	In	VDJ	1	52	1.2202476633430562E-4	1.531786033057121E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	3	3	4	6	2	27	39	51	45	53			01,02										Vb 17	CASSAQTGIYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAATAAATTGGGACAGCAAGGGGAGACCCAGTACTTCGGGCCA	CASNKLGQQGETQYF	In	VDJ	1	54	1.2671802657793275E-4	1.5907008804823947E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	7	0	5	5	7	6	27	37	51	44	57			01,02										Vb 17	CASNKLGQQGETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD01-01*01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGGACAGAGAATCGCCCTCACCTTCGGTTCG	CASSGQRIALTF	In	VDJ	1	54	1.2671802657793275E-4	1.5907008804823947E-4	36	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	1	5	13	0	11	27	-1	45	39	56			01,02										Vb 17	CASSGQRIALTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGCGGGACAGGGTTGTCGAATGAGCAGTTCTTCGGGCCA	CASGTGLSNEQFF	In	VDJ	1	59	1.384511771870006E-4	1.7379879990455795E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	9	0	3	7	1	6	27	35	45	36	51			01,02										Vb 17	CASGTGLSNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD01-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCTCACCTCAGGGGGCGAGAGGAGCTTTCTTTGGACAA	CASTSPQGARGAFF	In	VDJ	1	62	1.4549106755244132E-4	1.8263602701834903E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	4	0	10	8	6	27	37	53	45	59			01,02										Vb 17	CASTSPQGARGAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AAGCCACGTTTGGTGCCAAAAGAACCCGACAGYTTCTATCTCTGTGCCAGTAGTATCCTCGGGACAGGAGAGCAGTACTTCGGGCCG	CASSILGTGEQYF	In	VDJ	1	66	1.548775880396956E-4	1.944189965034038E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	0	4	7	4	1	42	56	68	60	69			01,02										Vb 17	CASSILGTGEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGAGGGTCCCATACGCAGTATTTTGGCCCA	CASSIGGSHTQYF	In	VDJ	1	67	1.5722421816150917E-4	1.973647388746675E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	1	11	0	7	0	4	27	-1	48	43	52			01,02										Vb 17	CASSIGGSHTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*02	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTTGGAGTCGGACGAGCAGTACGTCGGGCCG		Out	VDJ	1	67	1.5722421816150917E-4		32	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-07	01	8	1	7	17	7	10	27	36	47	43	57			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	X+TCRBV19-01+TCRBJ02-07	TCRBV19-01		TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCGGGACGGTTCCTTCCCGGAACACTGAAGCTTTCTTTGGACAA	CASSIGTVPSRNTEAFF	In	VDJ	1	69	1.619174784051363E-4	2.0325622361719488E-4	51	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	3	0	7	1	1	12	27	41	47	42	59			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIGTVPSRNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCTGGGGTATGAGCAGTTCTTCGGGCCA	CASSLGYEQFF	In	VDJ	1	69	1.619174784051363E-4	2.0325622361719488E-4	33	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-01	01	5	6	2	8	2	1	27	39	45	41	46			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSLGYEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01		TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGTCCAGGACAGATGGGATTCACCCCTCCACTTTGGGAAC	CASSVQDRWDSPLHF	In	VDJ	1	70	1.6426410852694986E-4	2.062019659884586E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	1	5	8	5	5	27	39	50	44	55			01,02										Vb 17	CASSVQDRWDSPLHF+TCRBV19-01+TCRBJ01-06	TCRBV19-01	TCRBD01-01*01	TCRBJ01-06*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCCCAACCAGAAACTACGAGCAGTACTTCGGGCCG	CASSPTRNYEQYF	In	VDJ	1	71	1.6661073864876344E-4	2.0914770835972227E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	4	5	3	6	3	27	38	47	44	50			01,02										Vb 17	CASSPTRNYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTTTAAGGGGACTAGCGGGGGGGCGAGGAATGAGCAGTTCTTCGGGCCA	CASSFKGTSGGARNEQFF	In	VDJ	1	71	1.6661073864876344E-4	2.0914770835972227E-4	54	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	0	0	7	6	5	27	39	61	45	66			01,02										Vb 17	CASSFKGTSGGARNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGCAACTACCCGAGATACGCAGTATTTTGGCCCA	CASSIATTRDTQYF	In	VDJ	1	72	1.6895736877057702E-4	2.1209345073098596E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	1	3	9	5	2	4	27	43	49	45	53			01,02			01,02							Vb 17	CASSIATTRDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGTCAGTAGTATAAAGGTAGTTTCTCCTGAAGCTTTCTTTGGACAA	CVSSIKVVSPEAFF	In	VDJ	1	73	1.7130399889239058E-4	2.1503919310224967E-4	42	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	2	5	4	6	1	9	27	42	46	43	55			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CVSSIKVVSPEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACGGTGGGCAGGTTCAATGAAAAACTGTTTTTTGGCAGT	CASTVGRFNEKLFF	In	VDJ	1	74	1.7365062901420416E-4	2.1798493547351336E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	7	4	4	5	7	3	27	37	48	44	51			01,02										Vb 17	CASTVGRFNEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD01-01*01	TCRBJ01-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTCGACAGGGGGCAATCAGCCCCAGCATTTTGGTGAT	CASSSTGGNQPQHF	In	VDJ	2	77	1.8069051937964485E-4	2.2682216258730444E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	2	2	2	2	0	27	39	-1	41	49			01,02										Vb 17	CASSSTGGNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTGGTAGGGGCCCCCCGGAGACCCAGTACTTCGGGCCA	CASGRGPPETQYF	In	VDJ	2	80	1.8773040974508556E-4	2.3565938970109552E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	7	0	5	0	6	27	-1	45	40	51			01,02										Vb 17	CASGRGPPETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD01-01*01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCACCACACCGGGGAGCTGTTTTTTGGAGAA	CASSHHTGELFF	In	VDJ	2	82	1.924236699887127E-4	2.4155087444362292E-4	36	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-02	01	5	3	7	3	1	1	27	39	42	40	43			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSHHTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01		TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AAGCCACGTTTGGTGCCAAAAGAACCCGACAGCTTTTATCTCTGTGCCAGTAGTATCCTCGGGACAGGAGAGCAGTACTTCGGGCCG		Out	VDJ	2	83	1.9477030011052628E-4		38	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	24	0	4	7	24	1	43	36	68	60	69			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGGCAACATCGGGACTGAAGCTTTCTTTGGACAA	CASSGNIGTEAFF	In	VDJ	2	84	1.9711693023233983E-4	2.474423591861503E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	5	8	4	5	8	0	27	39	-1	47	51			01,02			01,02							Vb 17	CASSGNIGTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGACAGGGGGCCAAGAGACCCAGTACTTCGGGCCA	CASRTGGQETQYF	In	VDJ	2	87	2.0415682059778055E-4	2.5627958629994137E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	2	1	1	0	0	27	-1	-1	38	47			01,02										Vb 17	CASRTGGQETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD01-01*01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCCCGTAGAGGGGGGACAGATACGCAGTATTTTGGCCCA	CASSPRRGGTDTQYF	In	VDJ	2	88	2.0650345071959413E-4	2.592253286712051E-4	45	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-03	01	5	5	1	3	8	1	27	39	53	47	54			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSPRRGGTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01		TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGGCGGGGGGCCCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASRAGGPNTGELFF	In	VDJ	2	90	2.1119671096322127E-4	2.6511681341373245E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	6	7	1	0	1	2	27	38	47	39	49			01,02										Vb 17	CASRAGGPNTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD02-01*01	TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGCGCTAGCGGGAGCCCATGAGCAGTTCTTCGGGCCA	CASSIALAGAHEQFF	In	VDJ	2	94	2.2058323145047554E-4	2.7689978289878724E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	1	4	2	8	2	3	27	43	55	45	58			01,02										Vb 17	CASSIALAGAHEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*02	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGTTAGGGCAACTACGAGCAGTACGTCGGGCCG	CASSIG*GNYEQYV	Stop	VDJ	2	101	2.3700964230317052E-4		42	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-07	01	1	5	3	17	3	17	27	43	50	46	67			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIG*GNYEQYV+TCRBV19-01+TCRBJ02-07	TCRBV19-01		TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGGCTAGCGGGAGTTTTGAGACCCAGTACTTCGGGCCA	CASRASGSFETQYF	In	VDJ	2	103	2.4170290254679766E-4	3.034114642401605E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	6	4	2	5	2	4	27	38	50	40	54			01,02										Vb 17	CASRASGSFETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD02-01*02	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGAGGGTAGGACTGAAGCTTTCTTTGGACAA	CASSIEGRTEAFF	In	VDJ	2	109	2.557826832776791E-4	3.2108591846774265E-4	39	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	0	0	9	5	0	4	27	-1	47	44	51			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIEGRTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTCGCGCGTTGAACACTGAAGCTTTCTTTGGACAA	CASSIRALNTEAFF	In	VDJ	2	112	2.628225736431198E-4	3.2992314558153373E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	3	7	6	0	2	3	27	41	46	43	49			01,02			01,02							Vb 17	CASSIRALNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTATCCCTCCTCCAATGAGCAGTTCTTCGGGCCA	CASSYPSSNEQFF	In	VDJ	2	116	2.7220909413037405E-4	3.417061150665885E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	4	10	6	5	4	27	39	46	44	50			01,02			01,02							Vb 17	CASSYPSSNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCAATGGCGGGGGGGAGCACAGATACGCAGTATTTTGGCCCA	CASSPMAGGSTDTQYF	In	VDJ	3	127	2.9802202547032333E-4	3.7410928115048914E-4	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	7	0	0	6	0	27	39	-1	45	54			01,02										Vb 17	CASSPMAGGSTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAGGATAGAGAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSRIESSYNEQFF	In	VDJ	3	141	3.308748471757133E-4	4.1534967434818084E-4	45	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-01	01	4	1	8	0	0	7	27	-1	43	40	50			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSRIESSYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01		TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TCTGTGCCAGTAGTAAAAACCATAGACGAGCGACAGACGTAGTCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSKNHRRATDVVSGANVLTF	In	VDJ	3	141	3.308748471757133E-4	4.1534967434818084E-4	66	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	4	2	5	0	16	7	2	15	36	31	43			01,02										Vb 17	CASSKNHRRATDVVSGANVLTF+TCRBV19-01+TCRBJ02-06	TCRBV19-01	TCRBD01-01*01	TCRBJ02-06*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCACCCGGAGGGGGAATGAGCAGTTCTTCGGGCCA	CATRRGNEQFF	In	VDJ	3	146	3.4260799778478116E-4	4.3007838620449934E-4	33	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-01	01	10	5	1	7	5	0	27	34	-1	39	45			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CATRRGNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01		TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCGGGTCTGGAAACACCATATATTTTGGAGAG	CASSIGSGNTIYF	In	VDJ	3	147	3.4495462790659474E-4	4.33024128575763E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	3	8	4	1	0	0	27	-1	-1	41	45			01,02			01,02							Vb 17	CASSIGSGNTIYF+TCRBV19-01+TCRBJ01-03	TCRBV19-01	TCRBD02-01	TCRBJ01-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTTTCGACAGGGGGGCAATCAGCCCCAGCATTTTGGTGAT	CASSFRQGGNQPQHF	In	VDJ	3	148	3.473012580284083E-4	4.359698709470267E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	2	1	2	4	0	27	39	-1	43	52			01,02										Vb 17	CASSFRQGGNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCTGGACAGTCGGGGATCGGCCCCAGCATTTTGGTGAT	CASSWTVGDRPQHF	In	VDJ	3	152	3.566877785156626E-4	4.477528404320815E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	1	5	9	2	10	27	38	46	40	56			01,02										Vb 17	CASSWTVGDRPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACTCTCCCAGCGGGGGGACAGATACGCAGTATTTTGGCCCA		Out	VDJ	3	162	3.801540797337983E-4		44	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	7	6	1	3	7	0	27	37	-1	44	53			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGGGGACAGGTAGTGTGCGCGGCTACACCTTCGGTTCG	CASSMGTGSVRGYTF	In	VDJ	3	172	4.03620380951934E-4	5.066676878573554E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	0	4	8	1	10	27	41	50	42	60			01,02										Vb 17	CASSMGTGSVRGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTGCTGCGAGACAAAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC	CASSCCETKSRANVLTF	In	VDJ	3	173	4.059670110737475E-4	5.09613430228619E-4	51	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	2	6	5	8	7	27	39	51	47	58			01,02										Vb 17	CASSCCETKSRANVLTF+TCRBV19-01+TCRBJ02-06	TCRBV19-01	TCRBD01-01*01	TCRBJ02-06*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCACTAGGGCTGGAAACATTCAGTACTTCGGCGCC	CATRAGNIQYF	In	VDJ	3	174	4.083136411955611E-4	5.125591725998827E-4	33	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	6	9	0	6	0	3	27	-1	41	38	44			01,02										Vb 17	CATRAGNIQYF+TCRBV19-01+TCRBJ02-04	TCRBV19-01	TCRBD01-01*01	TCRBJ02-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTTTGGGCTTAGGCAGTACTTCGGGCCG	CASSFGLRQYF	In	VDJ	4	180	4.2239342192644253E-4	5.302336268274649E-4	33	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	8	0	9	3	4	27	39	46	42	50			01,02										Vb 17	CASSFGLRQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTACGGAAAGGGGGACTGAAGCTTTCTTTGGACAA	CASSITERGTEAFF	In	VDJ	4	181	4.247400520482561E-4	5.331793691987286E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	5	1	5	7	0	27	41	-1	48	54			01,02										Vb 17	CASSITERGTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGAACAGGGGGCAAGAGCTGGCTACACCTTCGGTTCG	CASSEQGARAGYTF	In	VDJ	4	183	4.294333122918832E-4	5.39070853941256E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	3	0	7	2	6	27	39	50	41	56			01,02										Vb 17	CASSEQGARAGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGTGGGTAACGGGGAGACCCAGTACTTCGGGCCA	CASSVGNGETQYF	In	VDJ	4	187	4.388198327791375E-4	5.508538234263108E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	8	4	5	8	0	27	39	-1	47	51			01,02			01,02							Vb 17	CASSVGNGETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD02-01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAATCTGAAACCGAGGCCCCAACTATGGCTACACCTTCGGTTCG		Out	VDJ	4	189	4.4351309302276466E-4		46	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	7	11	1	2	10	4	27	37	51	47	55			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD02-01*02	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTCATGGCCCTCTGGGGGCCAACGTCCTGACTTTCGGGGCC	CASHGPLGANVLTF	In	VDJ	4	190	4.4585972314457824E-4	5.596910505401019E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	8	9	0	4	3	6	27	36	42	39	48			01,02										Vb 17	CASHGPLGANVLTF+TCRBV19-01+TCRBJ02-06	TCRBV19-01	TCRBD01-01*01	TCRBJ02-06*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCACTTACGACTGGGATCAAGAGACCCAGTACTTCGGGCCA	CATYDWDQETQYF	In	VDJ	4	192	4.5055298338820534E-4	5.655825352826292E-4	39	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-05	01	10	0	8	2	9	1	27	34	47	43	48			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CATYDWDQETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01		TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGAATCCCAGGGCTCGAGGGCTACACCTTCGGTTCG	CASRIPGLEGYTF	In	VDJ	4	198	4.646327641190868E-4	5.832569895102114E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	4	3	8	5	6	27	38	48	43	54			01,02										Vb 17	CASRIPGLEGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTCCGGACTAGCGATCACCTACGAGCAGTACTTCGGGCCG	CASSSGLAITYEQYF	In	VDJ	4	208	4.880990653372225E-4	6.127144132228484E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	1	6	2	3	4	27	39	51	42	55			01,02			01,02							Vb 17	CASSSGLAITYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTATACAGACCAACACTGAAGCTTTCTTTGGACAA	CASSIIQTNTEAFF	In	VDJ	4	211	4.951389557026632E-4	6.215516403366394E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	3	5	2	3	3	27	41	48	44	51			01,02										Vb 17	CASSIIQTNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCGACAGGGGTTATGGCTACACCTTCGGTTCG	CASSDRGYGYTF	In	VDJ	5	228	5.350316677734939E-4	6.716292606481222E-4	36	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	2	2	5	1	1	27	38	47	39	48			01,02										Vb 17	CASSDRGYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTGGCAGGGTGCTAACTATGGCTACACCTTCGGTTCG	CASSWQGANYGYTF	In	VDJ	5	233	5.467648183825617E-4	6.863579725044407E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	4	3	0	3	2	27	39	47	42	49			01,02										Vb 17	CASSWQGANYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGCCTTGACGAGGGCGAACACTGAAGCTTTCTTTGGACAA	CASSALTRANTEAFF	In	VDJ	5	236	5.538047087480024E-4	6.951951996182318E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	5	11	0	1	8	1	27	39	52	47	53			01,02										Vb 17	CASSALTRANTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01*02	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCTCGGACAGGGTGGAGCGAAAAACTGTTTTTTGGCAGT	CASSPRTGWSEKLFF	In	VDJ	5	250	5.866575304533925E-4	7.364355928159235E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	1	3	8	4	6	27	39	51	43	57			01,02										Vb 17	CASSPRTGWSEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD01-01*01	TCRBJ01-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGAGACAGACACAGATACGCAGTATTTTGGCCCA	CASSIETDTDTQYF	In	VDJ	5	268	6.288968726460367E-4	7.8945895549867E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	2	5	2	0	1	27	-1	49	44	50			01,02										Vb 17	CASSIETDTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD01-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTCGCAGCATAGCGGCCCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	5	271	6.359367630114774E-4		47	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	5	5	0	8	2	27	39	53	47	55			01,02			01,02							Vb 17	X+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAACCCTCGACAGGGTGGAGAGACCCAGTACTTCGGGCCA	CASSNPRQGGETQYF	In	VDJ	6	280	6.570564341077994E-4	8.248078639538344E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	2	3	4	6	3	27	40	53	46	56			01,02										Vb 17	CASSNPRQGGETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD01-01*01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAGGGGACAGGTCGGGATGACCGGGGAGCTGTTTTTTGGAGAA	CASSRGQVGMTGELFF	In	VDJ	6	283	6.640963244732402E-4	8.336450910676254E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	0	4	5	1	8	27	40	49	41	57			01,02										Vb 17	CASSRGQVGMTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD01-01*01	TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTTCTCTCGGACAGGGCTCTCGGTACTTCGGGCCG	CASSLGQGSRYF	In	VDJ	6	292	6.852159955695623E-4	8.601567724089987E-4	36	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	8	1	3	12	6	6	27	36	50	42	56			01,02										Vb 17	CASSLGQGSRYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGGTCGGGACAGGGGTTTCTGGCTACACCTTCGGTTCG	CASSMVGTGVSGYTF	In	VDJ	6	297	6.969491461786302E-4	8.748854842653171E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	0	2	7	4	4	27	41	55	45	59			01,02										Vb 17	CASSMVGTGVSGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTCCAGGGGCGGTAGCTATGGCTACACCTTCGGTTCG	CASSSRGGSYGYTF	In	VDJ	6	312	7.321485980058337E-4	9.190716198342725E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	4	2	4	2	6	27	39	47	41	53			01,02										Vb 17	CASSSRGGSYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTATGTGCGGGGACAGGTGCGGGAAGAGACCTAGTACTTCGGGCCA		Out	VDJ	6	315	7.391884883712744E-4		41	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	14	0	4	12	7	15	27	30	45	37	60			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD01-01*01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTCCCAAAACAATGAGCAGTTCTTCGGGCCA	CASSSQNNEQFF	In	VDJ	8	383	8.987593366545972E-4	0.0011282193281939947	36	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	4	6	5	3	2	27	39	44	42	46			01,02										Vb 17	CASSSQNNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD01-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTAAGGGGTCTCTTATAACAAGGGCTTTCTTTGGACAA	CASSIKGSLITRAFF	In	VDJ	8	384	9.011059667764107E-4	0.0011311650705652584	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	5	2	11	2	15	27	41	48	43	63			01,02										Vb 17	CASSIKGSLITRAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCAGTCCGGGACTAGACCGTTCCACAACATTCAGTACTTCGGCGCC	CASSQSGTRPFHNIQYF	In	VDJ	8	398	9.339587884818007E-4	0.0011724054637629502	51	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	5	0	8	7	6	10	27	39	53	45	63			01,02			01,02							Vb 17	CASSQSGTRPFHNIQYF+TCRBV19-01+TCRBJ02-04	TCRBV19-01	TCRBD02-01	TCRBJ02-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCCCTCCATTGGACAGTTACTATGGCTACACCTTCGGTTCG	CASSIPPLDSYYGYTF	In	VDJ	8	399	9.363054186036142E-4	0.001175351206134214	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	1	5	3	9	2	27	41	56	50	58			01,02										Vb 17	CASSIPPLDSYYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGCCCGTGGGGGGGACACTGAAGCTTTCTTTGGACAA	CASSARGGDTEAFF	In	VDJ	8	401	9.409986788472414E-4	0.0011812426908767413	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	5	9	0	3	6	0	27	39	-1	45	52			01,02										Vb 17	CASSARGGDTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACCCGGGTGACTAGGACAGAGACCCAGTACTTCGGGCCA	CASSTRVTRTETQYF	In	VDJ	9	444	0.001041903774085225	0.00130790961284108	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	4	2	8	4	7	3	27	40	53	47	56			01,02			01,02							Vb 17	CASSTRVTRTETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD02-01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCCTACAGGGGGGGAATAATTCACCCCTCCACTTTGGGAAC	CASSLQGGNNSPLHF	In	VDJ	10	485	0.0011381156090795813	0.0014286850500628916	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	6	3	1	5	3	3	27	38	49	41	52			01,02										Vb 17	CASSLQGGNNSPLHF+TCRBV19-01+TCRBJ01-06	TCRBV19-01	TCRBD01-01*01	TCRBJ01-06*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGACCGGGTCGCGAACACTGAAGCTTTCTTTGGACAA	CASSIDRVANTEAFF	In	VDJ	11	554	0.0013000330874847175	0.0016319412736800864	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	0	8	4	1	1	4	27	44	49	45	53			01,02			01,02							Vb 17	CASSIDRVANTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTTGTCCCAGTAACTATGGCTACACCTTCGGTTCG	CASCPSNYGYTF	In	VDJ	12	607	0.0014244044839408368	0.0017880656193570623	36	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	8	4	5	1	5	0	27	36	-1	41	44			01,02										Vb 17	CASCPSNYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAGGGCATCGACGAATCAGCCCCAGCATTTTGGTGAT	CASSRASTNQPQHF	In	VDJ	12	622	0.0014596039357680404	0.0018322517549260178	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	8	0	4	0	7	27	-1	44	40	51			01,02										Vb 17	CASSRASTNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCGTCCGGGTCATCCGGCCTACAATGAGCAGTTCTTCGGGCCA	CASSRPGHPAYNEQFF	In	VDJ	13	636	0.0014924567574734302	0.0018734921481237093	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	8	4	2	4	8	27	39	47	43	55			01,02			01,02							Vb 17	CASSRPGHPAYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGCGGGAGGGCAGGGGCCTACGAGCAGTACTTCGGGCCG	CASGRAGAYEQYF	In	VDJ	14	686	0.0016097882635641087	0.0020207792666868942	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	9	8	0	2	0	6	27	-1	43	35	49			01,02										Vb 17	CASGRAGAYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01*02	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCTCTAGCGGGAGGGCCCGCGAGCAGTACTTCGGGCCG	CASSSSGRAREQYF	In	VDJ	14	693	0.0016262146744168038	0.00204139946328574	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	4	0	6	2	4	27	38	52	40	56			01,02										Vb 17	CASSSSGRAREQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01*02	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTTGGGGCCAGCGGGAACGTTTGCTAATGAGCAGTTCTTCGGGCCA	CASSLGPAGTFANEQFF	In	VDJ	14	712	0.0016708006467312615	0.0020973685683397503	51	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	6	3	7	8	9	27	39	54	47	63			01,02										Vb 17	CASSLGPAGTFANEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*02	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCGATCCTAGCGAGCGAGCAGTACTTCGGGCCG	CASSPILASEQYF	In	VDJ	15	757	0.0017763990022128721	0.0022299269750466165	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	4	6	6	6	2	27	39	51	45	53			01,02			01,02							Vb 17	CASSPILASEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTATGGGGAATGAGCAGTTCTTCGGGCCA	CASSIMGNEQFF	In	VDJ	16	812	0.0019054636589126185	0.0023919428054661193	36	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-01	01	3	6	2	7	3	0	27	41	-1	44	48			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIMGNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01		TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTAACACCGGGGAGCTGTTTTTTGGAGAA	CASSINTGELFF	In	VJ	16	820	0.0019242366998871272	0.002415508744436229	36	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-02	01	3	0	0	2	0	1	27	-1	41	-1	42			01,02										Vb 17	CASSINTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01		TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCTGGGACAGGGCAATCGCTACGAGCAGTACTTCGGGCCG	CASSLGQGNRYEQYF	In	VDJ	17	868	0.0020368749457341786	0.0025569043782568864	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	3	3	2	6	27	39	50	41	56			01,02										Vb 17	CASSLGQGNRYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGTCGGAGAGACCCAGTACTTCGGGCCA	CASSIVGETQYF	In	VDJ	18	878	0.0020603412469523143	0.0025863618019695235	36	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	1	8	5	4	1	0	27	43	-1	44	47			01,02			01,02							Vb 17	CASSIVGETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD02-01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTTATAGGGCAGGCACAGATACGCAGTATTTTGGCCCA	CASSIYRAGTDTQYF	In	VDJ	18	879	0.002062687877074128	0.002589307544340787	45	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-03	01	3	5	3	1	4	3	27	41	49	45	52			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIYRAGTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01		TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTTCGCAGTCGGGCGATATTTTGAGCAGTTCTTCGGGCCA	CASSFAVGRYFEQFF	In	VDJ	22	1090	0.0025578268327767907	0.0032108591846774265	45	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-01	01	5	8	0	9	9	7	27	39	52	48	59			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSFAVGRYFEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01		TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTGGGCGAGTAACACCGGGGAGCTGTTTTTTGGAGAA	CASSWASNTGELFF	In	VDJ	23	1140	0.002675158338867469	0.0033581463032406112	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	8	0	2	1	4	27	39	44	40	48			01,02										Vb 17	CASSWASNTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD01-01*01	TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGGAGGACAAGCTCCCTACGAGCAGTACTTCGGGCCG	CASSGGQAPYEQYF	In	VDJ	31	1562	0.0036654362502727958	0.00460124958391389	42	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-07	01	5	1	6	2	3	5	27	39	47	42	52			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSGGQAPYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01		TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCGCGGTGGGCTATGGCTACACCTTCGGTTCG	CASSIAVGYGYTF	In	VDJ	33	1639	0.003846126769652441	0.004828071746501195	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	3	7	5	4	1	4	27	41	46	42	50			01,02			01,02							Vb 17	CASSIAVGYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD02-01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCCTCGGGACAGGAGAGCAGTACTTCGGGCCG	CASSILGTGEQYF	In	VDJ	259	12968	0.03043109941967837	0.038200387070547584	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	0	4	7	4	1	27	41	53	45	54			01,02										Vb 17	CASSILGTGEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAATATGCGGGAAGCACCATATATTTTGGAGAG	CASSEYAGSTIYF	In	VDJ	1	14	3.285282170538997E-5	4.1240393197691716E-5	39	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	0	7	3	9	1	2	23	40	47	41	49													Vb 11	CASSEYAGSTIYF+TCRBV25-01+TCRBJ01-03	TCRBV25-01*01	TCRBD02-01*02	TCRBJ01-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAATATGGGGCGCTTGGGTACGAGCAGTACTTCGGGCCG	CASSEYGALGYEQYF	In	VDJ	1	15	3.519945182720355E-5	4.418613556895541E-5	45	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	7	0	4	1	7	23	40	46	41	53													Vb 11	CASSEYGALGYEQYF+TCRBV25-01+TCRBJ02-07	TCRBV25-01*01	TCRBD01-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAGGGAGGGGGACACTCACCCCTCCACTTTGGGAAC	CASSEGGGHSPLHF	In	VDJ	1	17	3.989271207083068E-5	5.00776203114828E-5	42	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-06	01	3	9	0	10	0	6	23	-1	44	37	50													Vb 11	CASSEGGGHSPLHF+TCRBV25-01+TCRBJ01-06	TCRBV25-01*01	TCRBD02-01*02	TCRBJ01-06*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGGGGGCGCGGCTAGCGGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	23	5.39724928017121E-5		46	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	4	6	1	9	0	23	34	-1	43	49						01,02							Vb 11	X+TCRBV25-01+TCRBJ02-03	TCRBV25-01*01	TCRBD02-01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGTTGACTGGAGCGGGAGCGAGCAGTTCTTCGGGCCA	CASSVDWSGSEQFF	In	VDJ	1	29	6.805227353259351E-5	8.542652876664713E-5	42	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	6	2	10	8	1	23	36	52	44	53													Vb 11	CASSVDWSGSEQFF+TCRBV25-01+TCRBJ02-01	TCRBV25-01*01	TCRBD02-01*02	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCACGGAGCGGCACACAGATACGCAGTATTTTGGCCCA	CASTERHTDTQYF	In	VDJ	1	35	8.213205426347493E-5	1.031009829942293E-4	39	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	7	6	5	2	3	2	23	33	41	36	43						01,02							Vb 11	CASTERHTDTQYF+TCRBV25-01+TCRBJ02-03	TCRBV25-01*01	TCRBD02-01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGATATTGAACGGTCTTCGGGTCCCTGAAGCTTTCTTTGGACAA		Out	VDJ	1	35	8.213205426347493E-5		49	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	3	8	4	6	14	3	23	37	55	51	58						01,02							Vb 11	X+TCRBV25-01+TCRBJ01-01	TCRBV25-01*01	TCRBD02-01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTAAAAATGACGGGGTGTGACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	36	8.447868438528851E-5		46	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	5	8	3	3	8	4	23	35	48	43	52													Vb 11	X+TCRBV25-01+TCRBJ01-01	TCRBV25-01*01	TCRBD02-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAATGGAGGCAGGGAAGAGCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	36	8.447868438528851E-5		47	TCRBV25	TCRBV25-01	01				TCRBJ02	TCRBJ02-07	01	1	4	3	3	5	5	23	39	49	44	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 11	X+TCRBV25-01+TCRBJ02-07	TCRBV25-01*01		TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGCCAAGACAGGGAATCGAGCAGTTCTTCGGGCCA		Out	VDJ	1	38	8.917194462891565E-5		40	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	2	3	10	4	4	23	36	47	40	51													Vb 11	X+TCRBV25-01+TCRBJ02-01	TCRBV25-01*01	TCRBD01-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGGTCGGCAGGGTATCCACAATGAGCAGTTCTTCGGGCCA	CASSGRQGIHNEQFF	In	VDJ	1	42	9.855846511616992E-5	1.2372117959307514E-4	45	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	4	3	5	5	5	23	36	46	41	51													Vb 11	CASSGRQGIHNEQFF+TCRBV25-01+TCRBJ02-01	TCRBV25-01*01	TCRBD01-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGTCGACCACTAGCGGGGGGTCCGGATACGCAGTATTTTGGCCCA	CASRPLAGGPDTQYF	In	VDJ	1	68	1.5957084828332273E-4	2.003104812459312E-4	45	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	9	3	1	6	6	4	23	31	49	37	53													Vb 11	CASRPLAGGPDTQYF+TCRBV25-01+TCRBJ02-03	TCRBV25-01*01	TCRBD02-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAATCGGCCGCCAGGCGAGGCTACACCTTCGGTTCG	CASSESAARRGYTF	In	VDJ	2	82	1.924236699887127E-4	2.4155087444362292E-4	42	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	4	4	8	7	3	23	39	50	46	53													Vb 11	CASSESAARRGYTF+TCRBV25-01+TCRBJ01-02	TCRBV25-01*01	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGCAAGGGGGGGAGGGAAGGTTTGGGTAATGAGCAGTTCTTCGGGCCA	CASSKGGREGLGNEQFF	In	VDJ	2	100	2.3466301218135697E-4	2.945742371263694E-4	51	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	9	0	7	3	15	23	34	44	37	59						01,02							Vb 11	CASSKGGREGLGNEQFF+TCRBV25-01+TCRBJ02-01	TCRBV25-01*01	TCRBD02-01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAAGCCAGGTTAGTAATYTCAATGAGCAGTTCTTCGGGCCA		Out	VDJ	2	108	2.534360531558655E-4		47	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	4	4	6	2	10	23	38	44	40	54													Vb 11	X+TCRBV25-01+TCRBJ02-01	TCRBV25-01*01	TCRBD01-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAATATGTAGGGGGGGAGCAGTACTTCGGGCCG	CASSEYVGGEQYF	In	VDJ	4	195	4.575928737536461E-4	5.744197623964204E-4	39	TCRBV25	TCRBV25-01	01				TCRBJ02	TCRBJ02-07	01	0	5	1	7	3	1	23	40	49	43	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 11	CASSEYVGGEQYF+TCRBV25-01+TCRBJ02-07	TCRBV25-01*01		TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGCCAACTCGGGGACTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSQLGDSGANVLTF	In	VDJ	4	221	5.186052569207989E-4	6.510090640492763E-4	48	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-06	01	6	8	3	0	6	1	23	34	45	40	46													Vb 11	CASSQLGDSGANVLTF+TCRBV25-01+TCRBJ02-06	TCRBV25-01*01	TCRBD02-01*01	TCRBJ02-06*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTCACCAACCCCCTAACCCGGACAGGCGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	6	281	6.594030642296131E-4		56	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	1	4	1	17	1	23	35	59	52	60													Vb 11	X+TCRBV25-01+TCRBJ01-01	TCRBV25-01*01	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGCCCCTCCCTAGCGGGGGGCACGATACGCAGTATTTTGGCCCA		Out	VDJ	10	506	0.0011873948416376663		47	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	4	1	6	7	3	23	34	52	41	55													Vb 11	X+TCRBV25-01+TCRBJ02-03	TCRBV25-01*01	TCRBD02-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGGTCTAGCGGCTTCTCTAGCACAGATACGCAGTATTTTGGCCCA	CASRSSGFSSTDTQYF	In	VDJ	14	678	0.0015910152225896003	0.0019972133277167846	48	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	4	5	0	2	7	23	34	43	36	50						01,02							Vb 11	CASRSSGFSSTDTQYF+TCRBV25-01+TCRBJ02-03	TCRBV25-01*01	TCRBD02-01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAGGTGGGGTCGGACTATGGCTACACCTTCGGTTCG	CASSEVGSDYGYTF	In	VDJ	28	1413	0.0033157883621225737	0.004162333970595599	42	TCRBV25	TCRBV25-01	01				TCRBJ01	TCRBJ01-02	01	3	6	2	3	3	4	23	37	44	40	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 11	CASSEVGSDYGYTF+TCRBV25-01+TCRBJ01-02	TCRBV25-01*01		TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTTGCGTTTGAACAGGAGCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	31	1575	0.003695942441856372		47	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	3	4	0	9	2	23	35	49	44	51													Vb 11	X+TCRBV25-01+TCRBJ02-07	TCRBV25-01*01	TCRBD01-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGACCTCTAGCGGGAAGGGGCAATGAGCAGTTCTTCGGGCCA	CASRPLAGRGNEQFF	In	VDJ	1	13	3.0506191583576405E-5	3.8294650826428025E-5	45	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	4	3	6	4	5	23	34	47	38	52													Vb 22	CASRPLAGRGNEQFF+TCRBV02-01+TCRBJ02-01	TCRBV02-01*01	TCRBD02-01*02	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGCATTAGGGGGCAGACCGGGGAGCTGTTTTTTGGAGAA	CASSIRGQTGELFF	In	VDJ	1	14	3.285282170538997E-5	4.1240393197691716E-5	42	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	5	0	5	4	2	23	34	45	38	47													Vb 22	CASSIRGQTGELFF+TCRBV02-01+TCRBJ02-02	TCRBV02-01*01	TCRBD01-01*01	TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGAAACCTGGATCGGGGGAGAGCAGTACGTCGGGCCG	CASSETWIGGEQYV	In	VDJ	1	14	3.285282170538997E-5	4.1240393197691716E-5	42	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	2	8	2	17	8	11	23	38	52	46	63													Vb 22	CASSETWIGGEQYV+TCRBV02-01+TCRBJ02-07	TCRBV02-01*01	TCRBD02-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGACGTTAGGTCCTACGAGCAGTACGTCGGGCCG	CASSDVRSYEQYV	In	VDJ	1	14	3.285282170538997E-5	4.1240393197691716E-5	39	TCRBV02	TCRBV02-01	01				TCRBJ02	TCRBJ02-07	01	3	4	5	17	16	4	23	37	56	53	60				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 22	CASSDVRSYEQYV+TCRBV02-01+TCRBJ02-07	TCRBV02-01*01		TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGGACAGGGGAGACTGGAGACCCAGTACTTCGGGCCA	CASSGQGRLETQYF	In	VDJ	1	15	3.519945182720355E-5	4.418613556895541E-5	42	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	2	2	5	0	6	23	-1	44	36	50													Vb 22	CASSGQGRLETQYF+TCRBV02-01+TCRBJ02-05	TCRBV02-01*01	TCRBD01-01*01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAAAGGACAGGGGAGCTATGGCTACACCTTCGGTTCG	CASKGQGSYGYTF	In	VDJ	1	16	3.7546081949017114E-5	4.7131877940219106E-5	39	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	1	2	4	2	2	23	33	44	35	46													Vb 22	CASKGQGSYGYTF+TCRBV02-01+TCRBJ01-02	TCRBV02-01*01	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTCCCCGGGGCGGGAGGGTAGTCACAGATACGCAGTATTTTGGCCCA	CASSPRGGRVVTDTQYF	In	VDJ	1	16	3.7546081949017114E-5	4.7131877940219106E-5	51	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	7	0	2	7	4	23	35	51	42	55													Vb 22	CASSPRGGRVVTDTQYF+TCRBV02-01+TCRBJ02-03	TCRBV02-01*01	TCRBD02-01*02	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTTTCGACAGCCTCTACGAGCAGTACGTCGGGCCG	CASSFDSLYEQYV	In	VDJ	1	16	3.7546081949017114E-5	4.7131877940219106E-5	39	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	2	5	17	3	17	23	35	43	38	60													Vb 22	CASSFDSLYEQYV+TCRBV02-01+TCRBJ02-07	TCRBV02-01*01	TCRBD01-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGAACAGGGGGCAGGTGAAAAACTGTTTTTTGGCAGT	CASSEQGAGEKLFF	In	VDJ	1	17	3.989271207083068E-5	5.00776203114828E-5	42	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	2	4	0	7	0	3	23	-1	46	38	49													Vb 22	CASSEQGAGEKLFF+TCRBV02-01+TCRBJ01-04	TCRBV02-01*01	TCRBD01-01*01	TCRBJ01-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCACCCAGACAGGGACTGGGGCCAACGTCCTGACTTTCGGGGCC	CASTQTGTGANVLTF	In	VDJ	1	18	4.2239342192644256E-5	5.302336268274649E-5	45	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	7	2	3	2	4	1	23	33	44	37	45													Vb 22	CASTQTGTGANVLTF+TCRBV02-01+TCRBJ02-06	TCRBV02-01*01	TCRBD01-01*01	TCRBJ02-06*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTCTCGACGGGACTATAGCTGAGACCCAGTACTTCGGGCCA	CASSLDGTIAETQYF	In	VDJ	1	18	4.2239342192644256E-5	5.302336268274649E-5	45	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	0	9	5	6	5	23	35	48	41	53						01,02							Vb 22	CASSLDGTIAETQYF+TCRBV02-01+TCRBJ02-05	TCRBV02-01*01	TCRBD02-01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCACCAACCGAGACAGGGGTCAGCCCCAGCATTTTGGTGAT	CATNRDRGQPQHF	In	VDJ	1	21	4.927923255808496E-5	6.186058979653757E-5	39	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	10	2	2	6	8	0	23	30	-1	38	46													Vb 22	CATNRDRGQPQHF+TCRBV02-01+TCRBJ01-05	TCRBV02-01*01	TCRBD01-01*01	TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGGGGACAGGGGGCGGGTGAGCAGTTCTTCGGGCCA	CASRGQGAGEQFF	In	VDJ	1	21	4.927923255808496E-5	6.186058979653757E-5	39	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	0	0	9	0	3	23	-1	46	34	49													Vb 22	CASRGQGAGEQFF+TCRBV02-01+TCRBJ02-01	TCRBV02-01*01	TCRBD01-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGAATAGCGGGCTCACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	21	4.927923255808496E-5		43	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	2	5	4	4	0	2	23	-1	45	38	47						01,02							Vb 22	X+TCRBV02-01+TCRBJ02-02	TCRBV02-01*01	TCRBD02-01	TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGGTTCCGGGATCCATGAGCAGTTCTTCGGGCCA	CASSGSGIHEQFF	In	VDJ	1	21	4.927923255808496E-5	6.186058979653757E-5	39	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	8	3	8	4	3	23	36	45	40	48													Vb 22	CASSGSGIHEQFF+TCRBV02-01+TCRBJ02-01	TCRBV02-01*01	TCRBD02-01*02	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGGGGGCTCGGGACTAGCGGGACCAAGTCCTACAATGAGCAGTTCTTCGGGCCA	CARGLGTSGTKSYNEQFF	In	VDJ	1	22	5.162586267989853E-5	6.480633216780127E-5	54	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	9	0	3	1	7	5	23	31	51	38	56													Vb 22	CARGLGTSGTKSYNEQFF+TCRBV02-01+TCRBJ02-01	TCRBV02-01*01	TCRBD02-01*02	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAATATCAACCCTGGGACACAGAAAGAGACCCAGTACTTCGGGCCA	CASNINPGTQKETQYF	In	VDJ	1	23	5.39724928017121E-5	6.775207453906497E-5	48	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	7	0	6	3	11	4	23	33	50	44	54													Vb 22	CASNINPGTQKETQYF+TCRBV02-01+TCRBJ02-05	TCRBV02-01*01	TCRBD01-01*01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGTCAGGGGAATAGCGGGGGGCGCCTACGAGCAGTACGTCGGGCCG	CASSVRGIAGGAYEQYV	In	VDJ	1	24	5.631912292352567E-5	7.069781691032865E-5	51	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	4	5	1	17	9	17	23	36	55	45	72													Vb 22	CASSVRGIAGGAYEQYV+TCRBV02-01+TCRBJ02-07	TCRBV02-01*01	TCRBD02-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTCAGCAGGGGGTGAACACTGAAGCTTTCTTTGGACAA	CASSQQGVNTEAFF	In	VDJ	1	32	7.509216389803423E-5	9.426375588043821E-5	42	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	4	1	0	3	0	23	35	-1	38	45													Vb 22	CASSQQGVNTEAFF+TCRBV02-01+TCRBJ01-01	TCRBV02-01*01	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCGGGGCTTCCCGGGACGGCAACTCCTACGAGCAGTACTTCGGGCCG	CASGASRDGNSYEQYF	In	VDJ	1	37	8.682531450710208E-5	1.0899246773675668E-4	48	TCRBV02	TCRBV02-01	01				TCRBJ02	TCRBJ02-07	01	8	0	7	0	10	5	23	32	47	42	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 22	CASGASRDGNSYEQYF+TCRBV02-01+TCRBJ02-07	TCRBV02-01*01		TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGAAGCGACTAGAGGGCAGTTCTTCGGGCCA	CASSEATRGQFF	In	VDJ	1	38	8.917194462891565E-5	1.1193821010802038E-4	36	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	2	8	12	0	3	23	-1	46	40	49						01,02							Vb 22	CASSEATRGQFF+TCRBV02-01+TCRBJ02-01	TCRBV02-01*01	TCRBD02-01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGTAGAGGGCACAGATACGCAGTATTTTGGCCCA	CASSVEGTDTQYF	In	VDJ	1	39	9.151857475072921E-5	1.1488395247928406E-4	39	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	4	11	1	1	2	0	23	36	-1	38	42													Vb 22	CASSVEGTDTQYF+TCRBV02-01+TCRBJ02-03	TCRBV02-01*01	TCRBD02-01*02	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGCCCCCCCTTAGGGGAGCAGTTCTTCGGGCCA	CASSPPLGEQFF	In	VDJ	1	41	9.621183499435635E-5	1.2077543722181146E-4	36	TCRBV02	TCRBV02-01	01				TCRBJ02	TCRBJ02-01	01	6	5	3	10	9	0	23	34	-1	43	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 22	CASSPPLGEQFF+TCRBV02-01+TCRBJ02-01	TCRBV02-01*01		TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGTTCAGCGGGAAACCTACGAGCAGTACTTCGGGCCG	CASSVQRETYEQYF	In	VDJ	1	42	9.855846511616992E-5	1.2372117959307514E-4	42	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	6	3	2	3	2	23	36	46	39	48													Vb 22	CASSVQRETYEQYF+TCRBV02-01+TCRBJ02-07	TCRBV02-01*01	TCRBD02-01*02	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAAGCGTAGGGGGGACGGGGAGCTGTTTTTTGGAGAA	CASKRRGDGELFF	In	VDJ	1	43	1.009050952379835E-4	1.2666692196433885E-4	39	TCRBV02	TCRBV02-01	01				TCRBJ02	TCRBJ02-02	01	7	5	1	7	5	2	23	33	44	38	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 22	CASKRRGDGELFF+TCRBV02-01+TCRBJ02-02	TCRBV02-01*01		TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTTTACAGGGAGTCACGGATAATGAAAAACTGTTTTTTGGCAGT	CASSLQGVTDNEKLFF	In	VDJ	1	45	1.0559835548161063E-4	1.3255840670686622E-4	48	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	3	3	4	2	9	23	35	43	37	52													Vb 22	CASSLQGVTDNEKLFF+TCRBV02-01+TCRBJ01-04	TCRBV02-01*01	TCRBD01-01*01	TCRBJ01-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAAAGGGACAGGCGGAAACACCATATATTTTGGAGAG	CASKGTGGNTIYF	In	VDJ	1	48	1.1263824584705134E-4	1.413956338206573E-4	39	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	7	0	4	4	2	1	23	33	43	35	44													Vb 22	CASKGTGGNTIYF+TCRBV02-01+TCRBJ01-03	TCRBV02-01*01	TCRBD01-01*01	TCRBJ01-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGAAGCGCTCGGACTGATCGATGGCTACACCTTCGGTTCG	CASSEALGLIDGYTF	In	VDJ	1	51	1.1967813621249205E-4	1.502328609344484E-4	45	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	0	1	10	6	4	5	23	40	49	44	54						01,02							Vb 22	CASSEALGLIDGYTF+TCRBV02-01+TCRBJ01-02	TCRBV02-01*01	TCRBD02-01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTTGGCAGGAAAATTCACCCCTCCACTTTGGGAAC	CASSWQENSPLHF	In	VDJ	1	56	1.314112868215599E-4	1.6496157279076687E-4	39	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	4	4	7	3	2	23	35	42	38	44													Vb 22	CASSWQENSPLHF+TCRBV02-01+TCRBJ01-06	TCRBV02-01*01	TCRBD01-01*01	TCRBJ01-06*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGAGCAGGTGAGCTCCTACGAGCAGTACTTCGGGCCG	CASSEQVSSYEQYF	In	VDJ	1	58	1.3610454706518703E-4	1.7085305753329426E-4	42	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	4	4	0	1	4	23	37	42	38	46													Vb 22	CASSEQVSSYEQYF+TCRBV02-01+TCRBJ02-07	TCRBV02-01*01	TCRBD01-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGTCCAGGGAGTCTATGGCTACACCTTCGGTTCG	CASSVQGVYGYTF	In	VDJ	1	61	1.4314443743062774E-4	1.7969028464708534E-4	39	TCRBV02	TCRBV02-01	01				TCRBJ01	TCRBJ01-02	01	4	4	3	4	2	3	23	36	43	38	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 22	CASSVQGVYGYTF+TCRBV02-01+TCRBJ01-02	TCRBV02-01*01		TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGAGGGACAGGGGGTGATCGGAACTATGGCTACATCTTCGGTTCG	CASRGTGGDRNYGYIF	In	VDJ	1	64	1.5018432779606846E-4	1.8852751176087643E-4	48	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	0	1	16	1	21	23	34	46	35	67													Vb 22	CASRGTGGDRNYGYIF+TCRBV02-01+TCRBJ01-02	TCRBV02-01*01	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGAGACCAGGACCTCCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSETRTSSGANVLTF	In	VDJ	1	64	1.5018432779606846E-4	1.8852751176087643E-4	51	TCRBV02	TCRBV02-01	01				TCRBJ02	TCRBJ02-06	01	3	1	7	0	5	3	23	37	46	42	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 22	CASSETRTSSGANVLTF+TCRBV02-01+TCRBJ02-06	TCRBV02-01*01		TCRBJ02-06*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGAGGGGCTTAACTATGGCTACACCTTCGGTTCG	CASSEGLNYGYTF	In	VDJ	1	70	1.6426410852694986E-4	2.062019659884586E-4	39	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	7	0	1	0	1	23	-1	42	37	43													Vb 22	CASSEGLNYGYTF+TCRBV02-01+TCRBJ01-02	TCRBV02-01*01	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGAAAAGGTCATAACATATGGCTACACCTTCGGTTCG	CASSEKVITYGYTF	In	VDJ	2	92	2.158899712068484E-4	2.7100829815625987E-4	42	TCRBV02	TCRBV02-01	01				TCRBJ01	TCRBJ01-02	01	2	3	6	5	9	0	23	38	-1	47	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 22	CASSEKVITYGYTF+TCRBV02-01+TCRBJ01-02	TCRBV02-01*01		TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGTCACTAGAAACTCCTACGAGCAGTACTTCGGGCCA	CASSVTRNSYEQYF	In	VDJ	2	96	2.2527649169410267E-4	2.827912676413146E-4	42	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	4	3	8	11	2	13	23	36	43	38	56						01,02							Vb 22	CASSVTRNSYEQYF+TCRBV02-01+TCRBJ02-05	TCRBV02-01*01	TCRBD02-01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGAGCGGGGCCAGCCCCAGCATTTTGGTGAT	CASSERGQPQHF	In	VDJ	2	100	2.3466301218135697E-4	2.945742371263694E-4	36	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	3	7	3	7	0	1	23	-1	43	37	44													Vb 22	CASSERGQPQHF+TCRBV02-01+TCRBJ01-05	TCRBV02-01*01	TCRBD02-01*01	TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCACTAACAGGGGGCATAACGAGCAGTACTTCGGGCCG	CASTNRGHNEQYF	In	VDJ	2	101	2.3700964230317052E-4	2.975199794976331E-4	39	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	3	0	5	3	3	23	33	45	36	48													Vb 22	CASTNRGHNEQYF+TCRBV02-01+TCRBJ02-07	TCRBV02-01*01	TCRBD01-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGGCACAGGGGGCAGGACTGAAGCTTTCTTTGGACAA	CASSGTGGRTEAFF	In	VDJ	3	127	2.9802202547032333E-4	3.7410928115048914E-4	42	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	3	0	5	2	3	23	36	47	38	50													Vb 22	CASSGTGGRTEAFF+TCRBV02-01+TCRBJ01-01	TCRBV02-01*01	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGGGGGGGACAGATCCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSGGDRSSGANVLTF	In	VDJ	3	130	3.050619158357641E-4	3.829465082642802E-4	51	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	4	0	5	0	3	3	23	36	46	39	49													Vb 22	CASSGGDRSSGANVLTF+TCRBV02-01+TCRBJ02-06	TCRBV02-01*01	TCRBD01-01*01	TCRBJ02-06*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCACCCTAAGGACGGAGACCCAGTACTTCGGGCCA	CASTLRTETQYF	In	VDJ	3	141	3.308748471757133E-4	4.1534967434818084E-4	36	TCRBV02	TCRBV02-01	01				TCRBJ02	TCRBJ02-05	01	7	1	7	5	6	1	23	33	43	39	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 22	CASTLRTETQYF+TCRBV02-01+TCRBJ02-05	TCRBV02-01*01		TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGATTCGGATCAGGGGCAGTCTATGGCTACACCTTCGGTTCG	CASRFGSGAVYGYTF	In	VDJ	3	148	3.473012580284083E-4	4.359698709470267E-4	45	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	4	2	4	8	4	23	34	48	42	52													Vb 22	CASRFGSGAVYGYTF+TCRBV02-01+TCRBJ01-02	TCRBV02-01*01	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCCGAGTTACACTAGCGGGGAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	3	159	3.7311418936835755E-4		44	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	8	3	3	3	8	0	23	32	-1	40	50													Vb 22	X+TCRBV02-01+TCRBJ02-05	TCRBV02-01*01	TCRBD02-01*01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGCTCTAGCTTAACCTACGAGCAGTACTTCGGGCCG	CASSSSLTYEQYF	In	VDJ	4	182	4.270866821700697E-4	5.361251115699923E-4	39	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	4	7	2	2	4	23	34	41	36	45						01,02							Vb 22	CASSSSLTYEQYF+TCRBV02-01+TCRBJ02-07	TCRBV02-01*01	TCRBD02-01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGGGCATACTGGGGCCGGGGAGAGACCCAGTACTTCGGGCCA	CASRAYWGRGETQYF	In	VDJ	4	188	4.411664629009511E-4	5.537995657975745E-4	45	TCRBV02	TCRBV02-01	01				TCRBJ02	TCRBJ02-05	01	6	7	0	4	8	5	23	34	47	42	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 22	CASRAYWGRGETQYF+TCRBV02-01+TCRBJ02-05	TCRBV02-01*01		TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGAGACCAGGGACTAGCGGGGCGTACAAGAGACCCAGTACTTCGGGCCA	CASSETRD*RGVQETQYF	Stop	VDJ	4	189	4.4351309302276466E-4		54	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	3	0	3	2	5	4	23	37	55	42	59													Vb 22	CASSETRD*RGVQETQYF+TCRBV02-01+TCRBJ02-05	TCRBV02-01*01	TCRBD02-01*01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGCCTAGACAGGGGGCGGGAGGGGACCCAGTACTTCGGGCCA	CASSLDRGREGTQYF	In	VDJ	4	204	4.787125448499682E-4	6.009314437377935E-4	45	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	2	0	7	4	7	23	34	48	38	55													Vb 22	CASSLDRGREGTQYF+TCRBV02-01+TCRBJ02-05	TCRBV02-01*01	TCRBD01-01*01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGAAAAGGAGGGGAGTGGGGCGAGCAGTACTTCGGGCCG	CASRKGGEWGEQYF	In	VDJ	5	264	6.195103521587824E-4	7.776759860136152E-4	42	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	10	0	6	4	8	23	34	44	38	52													Vb 22	CASRKGGEWGEQYF+TCRBV02-01+TCRBJ02-07	TCRBV02-01*01	TCRBD02-01*02	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGAGGACTCAGCCATGTACTTCTGTACCAGCAGCGAAGCGACAGGGGGCGGCGGCTACACCTTCGGTTCG	CTSSEATGGGGYTF	In	VDJ	7	371	8.705997751928343E-4	0.0010928704197388304	42	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	2	0	8	0	3	23	-1	50	40	53													Vb 22	CTSSEATGGGGYTF+TCRBV02-01+TCRBJ01-02	TCRBV02-01*01	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGCGGACAGGCCTACGAGCAGTACGTCGGGCCG	CASSGQAYEQYV	In	VDJ	8	382	8.964127065327836E-4	0.001125273585822731	36	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	1	4	17	1	15	23	34	42	35	57													Vb 22	CASSGQAYEQYV+TCRBV02-01+TCRBJ02-07	TCRBV02-01*01	TCRBD01-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGACCGTCAGGGACTAGCGGGCTACGAGCAGTACTTCGGGCCG	CASSDRQGLAGYEQYF	In	VDJ	8	386	9.057992270200379E-4	0.0011370565553077859	48	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	3	0	4	3	6	0	23	37	-1	43	55						01,02							Vb 22	CASSDRQGLAGYEQYF+TCRBV02-01+TCRBJ02-07	TCRBV02-01*01	TCRBD02-01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGCGCGGGCGGCAGTCTAGGCGAGCAGTACTTCGGGCCG	CASSAGGSLGEQYF	In	VDJ	8	400	9.386520487254279E-4	0.0011782969485054776	42	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	7	4	6	1	12	23	34	40	35	52						01,02							Vb 22	CASSAGGSLGEQYF+TCRBV02-01+TCRBJ02-07	TCRBV02-01*01	TCRBD02-01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGAGGGACAGGGGGCGATCGGAACTATGGCTACACCTTCGGTTCG	CASRGTGGDRNYGYTF	In	VDJ	9	450	0.0010559835548161064	0.0013255840670686623	48	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	0	0	2	1	6	23	34	47	35	53													Vb 22	CASRGTGGDRNYGYTF+TCRBV02-01+TCRBJ01-02	TCRBV02-01*01	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGAAGTAGGCAGGGGGGACGAGCAGTACTTCGGGCCG	CASSEVGRGDEQYF	In	VDJ	9	473	0.0011099560476178184	0.0013933361416077273	42	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	4	1	5	4	1	23	39	50	43	51													Vb 22	CASSEVGRGDEQYF+TCRBV02-01+TCRBJ02-07	TCRBV02-01*01	TCRBD01-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTCTAAACCGGGACCCTGATACGCAGTATTTTGGCCCA	CASSLNRDPDTQYF	In	VDJ	11	530	0.0012437139645611918	0.0015612434567697578	42	TCRBV02	TCRBV02-01	01				TCRBJ02	TCRBJ02-03	01	5	0	7	6	7	3	23	35	47	42	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 22	CASSLNRDPDTQYF+TCRBV02-01+TCRBJ02-03	TCRBV02-01*01		TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGACGGCGTCACAGATACGCAGTATTTTGGCCCA	CASSDGVTDTQYF	In	VDJ	34	1724	0.004045590330006594	0.005078459848058608	39	TCRBV02	TCRBV02-01	01				TCRBJ02	TCRBJ02-03	01	3	9	0	2	1	2	23	37	41	38	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 22	CASSDGVTDTQYF+TCRBV02-01+TCRBJ02-03	TCRBV02-01*01		TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCGGCGGGACTAGCGGGAGTTACGAGCAGTACTTCGGGCCG	CAGGTSGSYEQYF	In	VDJ	51	2559	0.0060050264817209245	0.007538154728063793	39	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	11	0	2	4	3	1	23	29	46	32	47													Vb 22	CAGGTSGSYEQYF+TCRBV02-01+TCRBJ02-07	TCRBV02-01*01	TCRBD02-01*02	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGTACCCTCTCAGACATCTGTGTACTTCTGTGCCAGCAGTTACCAGGGAAAATATGGCTACACCTTCGGTTCG	CASSYQGKYGYTF	In	VDJ	1	15	3.519945182720355E-5	4.418613556895541E-5	39	TCRBV06	TCRBV06-04		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	4	3	5	3	4	28	40	48	43	52			01,02											CASSYQGKYGYTF+TCRBV06-04+TCRBJ01-02	TCRBV06-04	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGTACCCTCTCAGACATCTGTGTACTTCTGTGCCAGCAGTTACCCAGAGACCCAGTACTTCGGGCCA	CASSYPETQYF	In	VDJ	1	18	4.2239342192644256E-5	5.302336268274649E-5	33	TCRBV06	TCRBV06-04					TCRBJ02	TCRBJ02-05	01	5	3	7	4	1	2	28	40	43	41	45			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYPETQYF+TCRBV06-04+TCRBJ02-05	TCRBV06-04		TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGTACCCTCTCAGACATCTGTGTACTTCTGTGCCAGCAGTGATGCAGTCACCTATGGCTACACCTTCGGTTCG	CASSDAVTYGYTF	In	VDJ	1	21	4.927923255808496E-5	6.186058979653757E-5	39	TCRBV06	TCRBV06-04		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	4	5	4	2	4	28	42	47	44	51			01,02											CASSDAVTYGYTF+TCRBV06-04+TCRBJ01-02	TCRBV06-04	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGTACCCTCTCAGACATCTGTGTACTTCTGTGCCAGCAGTGACTCGACATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	27	6.335901328896638E-5		37	TCRBV06	TCRBV06-04					TCRBJ01	TCRBJ01-05	01	0	2	7	5	0	0	28	-1	-1	45	48			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-04+TCRBJ01-05	TCRBV06-04		TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGTACCCTCTCAGACATCTGTGTACTTCTGTGCCAGCAGTGAATTTGGGGCTCAAGGAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	34	7.978542414166136E-5		50	TCRBV06	TCRBV06-04		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	7	0	1	4	6	28	42	51	46	57			01,02											X+TCRBV06-04+TCRBJ01-05	TCRBV06-04	TCRBD01-01*01	TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGTACCCTCTCAGACATCTGTGTACTTCTGTGCCAGCACTCCGGGAAGAGGCTACACCTTCGGTTCG	CASTPGRGYTF	In	VDJ	1	62	1.4549106755244132E-4	1.8263602701834903E-4	33	TCRBV06	TCRBV06-04		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	7	8	3	8	3	3	28	38	46	41	49			01,02											CASTPGRGYTF+TCRBV06-04+TCRBJ01-02	TCRBV06-04	TCRBD02-01*02	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTGAAAGCAGCTACGAGCAGTACGTCGGGCCG	CASSESSYEQYV	In	VDJ	1	15	3.519945182720355E-5	4.418613556895541E-5	36	TCRBV06	TCRBV06-07	01				TCRBJ02	TCRBJ02-07	01	5	4	5	17	5	14	26	38	46	43	60				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSESSYEQYV+TCRBV06-07+TCRBJ02-07	TCRBV06-07*01		TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTTAATGGCCAGGACAGGCCTTGAGTGCCTTCGGTTCG	CASS*WPGQALSAF	Stop	VDJ	1	16	3.7546081949017114E-5		42	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	1	4	15	7	9	26	40	54	47	63														CASS*WPGQALSAF+TCRBV06-07+TCRBJ01-02	TCRBV06-07*01	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCATCCCACATCGGGACTTGAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASIPHRDLSSYNEQFF	In	VDJ	1	20	4.693260243627139E-5	5.891484742527388E-5	51	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	7	0	10	0	9	4	26	36	51	45	55						01,02								CASIPHRDLSSYNEQFF+TCRBV06-07+TCRBJ02-01	TCRBV06-07*01	TCRBD02-01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCATTCCCTCGTCGGGACTCACACTCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASIPSSGLTLSGANVLTF	In	VDJ	1	22	5.162586267989853E-5	6.480633216780127E-5	57	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	7	0	10	0	10	6	24	34	50	44	56						01,02								CASIPSSGLTLSGANVLTF+TCRBV06-07+TCRBJ02-06	TCRBV06-07*01	TCRBD02-01	TCRBJ02-06*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGGCTTAAGGGTGAAGCTTTCTTTGGACAA	CASRLKGEAFF	In	VDJ	1	25	5.866575304533924E-5	7.364355928159235E-5	33	TCRBV06	TCRBV06-07	01				TCRBJ01	TCRBJ01-01	01	6	5	3	7	5	0	26	37	-1	42	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRLKGEAFF+TCRBV06-07+TCRBJ01-01	TCRBV06-07*01		TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGGAGGGGCAATGAGCAGTTCTTCGGGCCA	CASRRGNEQFF	In	VDJ	1	28	6.570564341077994E-5	8.248078639538343E-5	33	TCRBV06	TCRBV06-07	01				TCRBJ02	TCRBJ02-01	01	6	5	2	6	1	0	26	37	-1	38	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRRGNEQFF+TCRBV06-07+TCRBJ02-01	TCRBV06-07*01		TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCACAGACCGGGACAGAGTATAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	38	8.917194462891565E-5		46	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	10	0	5	0	6	4	26	33	46	39	50														X+TCRBV06-07+TCRBJ01-05	TCRBV06-07*01	TCRBD01-01*01	TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTCTCGGGTACGAGCAGTACTTCGGGCCG	CASSLGYEQYF	In	VDJ	1	43	1.009050952379835E-4	1.2666692196433885E-4	33	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	8	4	4	2	0	26	38	-1	40	44						01,02								CASSLGYEQYF+TCRBV06-07+TCRBJ02-07	TCRBV06-07*01	TCRBD02-01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGCCGCACAGGGTACGACGAGCAGTACGTCGGGCCG	CASSRTGYDEQYV	In	VDJ	1	75	1.7599725913601771E-4	2.2093067784477704E-4	39	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	3	3	17	4	16	26	37	47	41	63														CASSRTGYDEQYV+TCRBV06-07+TCRBJ02-07	TCRBV06-07*01	TCRBD01-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTCCGAACATGGTCGACCCTACGAGCAGTACGTCGGGCCG		Out	VDJ	35	1731	0.004062016740859289		44	TCRBV06	TCRBV06-07	01				TCRBJ02	TCRBJ02-07	01	5	2	7	17	12	15	26	38	53	50	68				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-07+TCRBJ02-07	TCRBV06-07*01		TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAGCTTAGCGACTAGCAGGATAGATGAACAGTTCTTCGGGCCA	CASSLATSRIDEQFF	In	VDJ	1	13	3.0506191583576405E-5	3.8294650826428025E-5	45	TCRBV07	TCRBV07-07	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	2	7	13	0	12	19	-1	43	36	55						01,02								CASSLATSRIDEQFF+TCRBV07-07+TCRBJ02-01	TCRBV07-07*01	TCRBD02-01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAGCTTTATTCAGGCTCAAGGCATTCAGTACTTCGGCGCC	CASSFIQAQGIQYF	In	VDJ	1	15	3.519945182720355E-5	4.418613556895541E-5	42	TCRBV07	TCRBV07-07	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	3	4	4	9	4	7	19	33	41	37	48														CASSFIQAQGIQYF+TCRBV07-07+TCRBJ02-04	TCRBV07-07*01	TCRBD01-01*01	TCRBJ02-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCAGCCATGTATCGCTGTGCCAACAGCCTAGGGACGAGGACCCAAGAGACCCAGTACTTCGGGCCA	CANSLGTRTQETQYF	In	VDJ	1	18	4.2239342192644256E-5	5.302336268274649E-5	45	TCRBV07	TCRBV07-07	01				TCRBJ02	TCRBJ02-05	01	1	1	7	1	0	6	19	-1	39	35	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CANSLGTRTQETQYF+TCRBV07-07+TCRBJ02-05	TCRBV07-07*01		TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAGCCCCAGAGGGGAAGGGGTTCATCAGCCCCAGCATTTTGGTGAT	CASSPRGEGVHQPQHF	In	VDJ	1	19	4.4585972314457824E-5	5.596910505401019E-5	48	TCRBV07	TCRBV07-07	01				TCRBJ01	TCRBJ01-05	01	5	5	2	5	5	9	19	31	41	36	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPRGEGVHQPQHF+TCRBV07-07+TCRBJ01-05	TCRBV07-07*01		TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCAGCCATGTATCGCTGTGCTAGCAGCCCGGGGACTAGCGGGTATCGAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	21	4.927923255808496E-5		53	TCRBV07	TCRBV07-07	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	0	4	0	3	3	19	31	46	34	49						01,02								X+TCRBV07-07+TCRBJ02-02	TCRBV07-07*01	TCRBD02-01	TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAGCACCGGACAGGGCACCTGGGAGACCCAGTACTTCGGGCCA	CASSTGQGTWETQYF	In	VDJ	1	25	5.866575304533924E-5	7.364355928159235E-5	45	TCRBV07	TCRBV07-07	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	1	3	5	3	7	19	31	42	34	49														CASSTGQGTWETQYF+TCRBV07-07+TCRBJ02-05	TCRBV07-07*01	TCRBD01-01*01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAGCTTAGAGTCTGGAAGGCCTAACTATGGCTACACCTTCGGTTCG	CASSLESGRPNYGYTF	In	VDJ	1	31	7.274553377622066E-5	9.131801350917451E-5	48	TCRBV07	TCRBV07-07	01				TCRBJ01	TCRBJ01-02	01	1	1	8	0	5	4	19	35	43	40	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLESGRPNYGYTF+TCRBV07-07+TCRBJ01-02	TCRBV07-07*01		TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAGCTTGGTCCCCTGCTATTCACCCCTCCACTTTGGGAAC	CASSLVPCYSPLHF	In	VDJ	1	37	8.682531450710208E-5	1.0899246773675668E-4	42	TCRBV07	TCRBV07-07	01				TCRBJ01	TCRBJ01-06	01	3	0	10	8	0	9	19	-1	35	33	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLVPCYSPLHF+TCRBV07-07+TCRBJ01-06	TCRBV07-07*01		TCRBJ01-06*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCAGCCATGTATCGCTGTGCTAGCAGCTTAGGCGGGGCAGGGGAGACCCAGTACTTCGGGCCA	CASSLGGAGETQYF	In	VDJ	1	48	1.1263824584705134E-4	1.413956338206573E-4	42	TCRBV07	TCRBV07-07	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	1	7	3	5	0	5	19	-1	41	35	46														CASSLGGAGETQYF+TCRBV07-07+TCRBJ02-05	TCRBV07-07*01	TCRBD02-01*01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CGAAGCTTGAGGATTCAGCAGTGTATTTTTGTGCCAGCAGCCCTCCAACCGGGGAGCTGTTTTTTGGAGAA	CASSPPTGELFF	In	VDJ	2	83	1.9477030011052628E-4	2.4449661681488663E-4	36	TCRBV16	TCRBV16-01					TCRBJ02	TCRBJ02-02	01	4	4	6	5	3	0	29	42	-1	45	47			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPPTGELFF+TCRBV16-01+TCRBJ02-02	TCRBV16-01		TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CGAAGCTTGAGGATTCAGCAGTGTATTTTTGTGCCAGCAGCCAATTTGATCCCACCGGGGAGCTGTTTTTTGGAGAA	CASSQFDPTGELFF	In	VDJ	6	285	6.687895847168673E-4	8.395365758101528E-4	42	TCRBV16	TCRBV16-01					TCRBJ02	TCRBJ02-02	01	1	2	8	4	2	3	29	45	49	47	52			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQFDPTGELFF+TCRBV16-01+TCRBJ02-02	TCRBV16-01		TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAGCCACGTTTGGTGCTGGGGGACTCAGCTTGTATTTCTGTGCCAGCAGCAAAGGACCGGCGGACACTGAAGCTTTCTTTGGACAA	CASSKGPADTEAFF	In	VDJ	1	13	3.0506191583576405E-5	3.8294650826428025E-5	42	TCRBV21	TCRBV21-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	1	7	5	3	5	0	39	55	-1	60	64						01,02								CASSKGPADTEAFF+TCRBV21-01+TCRBJ01-01	TCRBV21-01*01	TCRBD02-01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CACCAGCCAAACAGCTTTGTACTTCTGTGCCAGCGGCAGACAGGGCTGGGAAAAACTGTTTTTTGGCAGT	CASGRQGWEKLFF	In	VDJ	1	18	4.2239342192644256E-5	5.302336268274649E-5	39	TCRBV22	TCRBV22-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	13	2	3	8	10	4	25	28	45	38	49														CASGRQGWEKLFF+TCRBV22-01+TCRBJ01-04	TCRBV22-01*01	TCRBD01-01*01	TCRBJ01-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CACCAGCCAAACAGCTTTGTACTTCTGTGCCATCAGGGCCTCCGTCCGGAACACTGAAGCTTTCTTTGGACAA	CAIRASVRNTEAFF	In	VDJ	1	50	1.1733150609067848E-4	1.472871185631847E-4	42	TCRBV22	TCRBV22-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	13	4	3	1	5	10	25	28	38	33	48														CAIRASVRNTEAFF+TCRBV22-01+TCRBJ01-01	TCRBV22-01*01	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CACCAGCCAAACAGCTTTGTACTTCTGTCCTGGGAGGGCAAATCGCGAACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC	CPGRANREQSRANVLTF	In	VDJ	4	215	5.045254761899175E-4	6.333346098216942E-4	51	TCRBV22	TCRBV22-01	01				TCRBJ02	TCRBJ02-06	01	1	3	6	5	8	5	25	40	51	48	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CPGRANREQSRANVLTF+TCRBV22-01+TCRBJ02-06	TCRBV22-01*01		TCRBJ02-06*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGACAGGGGGCGCTTACCCTATGGCTACACCTTCGGTTCG	CASSQDRGRLPYGYTF	In	VDJ	1	13	3.0506191583576405E-5	3.8294650826428025E-5	48	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	4	0	4	0	7	23	-1	48	40	55													Vb 7.1	CASSQDRGRLPYGYTF+TCRBV04-01+TCRBJ01-02	TCRBV04-01*01	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGTAGGGCTGAACACTGAAGCTTTCTTTGGACAA	CASSQVGLNTEAFF	In	VDJ	1	14	3.285282170538997E-5	4.1240393197691716E-5	42	TCRBV04	TCRBV04-01	01				TCRBJ01	TCRBJ01-01	01	1	5	3	0	1	1	23	39	44	40	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 7.1	CASSQVGLNTEAFF+TCRBV04-01+TCRBJ01-01	TCRBV04-01*01		TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGTGATGTCAGGGGGTGGCTACACCTTCGGTTCG	CASSQVMSGGGYTF	In	VDJ	1	14	3.285282170538997E-5	4.1240393197691716E-5	42	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	4	1	7	6	0	23	39	-1	45	52													Vb 7.1	CASSQVMSGGGYTF+TCRBV04-01+TCRBJ01-02	TCRBV04-01*01	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCCTTACGCCGGGCAGGCGGTACCAGATACGCAGTATTTTGGCCCA	CASSPYAGQAVPDTQYF	In	VDJ	1	14	3.285282170538997E-5	4.1240393197691716E-5	51	TCRBV04	TCRBV04-01	01				TCRBJ02	TCRBJ02-03	01	4	4	4	4	11	6	23	36	51	47	57				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 7.1	CASSPYAGQAVPDTQYF+TCRBV04-01+TCRBJ02-03	TCRBV04-01*01		TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGAGGATGCGGTAAGCTCCTACGAGCAGTACTTCGGGCCG	CASSQEDAVSSYEQYF	In	VDJ	1	17	3.989271207083068E-5	5.00776203114828E-5	48	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	7	5	0	4	4	23	40	48	44	52						01,02							Vb 7.1	CASSQEDAVSSYEQYF+TCRBV04-01+TCRBJ02-07	TCRBV04-01*01	TCRBD02-01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAATACACAGGGGTTGAGCAGTACTTCGGGCCG	CASSQYTGVEQYF	In	VDJ	1	19	4.4585972314457824E-5	5.596910505401019E-5	39	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	3	2	7	3	2	23	38	48	41	50													Vb 7.1	CASSQYTGVEQYF+TCRBV04-01+TCRBJ02-07	TCRBV04-01*01	TCRBD01-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCCACGGACAGACAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	19	4.4585972314457824E-5		37	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	8	1	5	2	3	1	23	32	41	35	42													Vb 7.1	X+TCRBV04-01+TCRBJ02-05	TCRBV04-01*01	TCRBD01-01*01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGAGCCTAGCCGGGGGAAAGAGACCCAGTACTTCGGGCCA	CASSQEPSRGKETQYF	In	VDJ	1	20	4.693260243627139E-5	5.891484742527388E-5	48	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	0	8	2	3	7	1	23	40	53	47	54													Vb 7.1	CASSQEPSRGKETQYF+TCRBV04-01+TCRBJ02-05	TCRBV04-01*01	TCRBD02-01*01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGGGGGTGTTTACACTGAAGCTTTCTTTGGACAA	CASSQGGVYTEAFF	In	VDJ	1	22	5.162586267989853E-5	6.480633216780127E-5	42	TCRBV04	TCRBV04-01	01				TCRBJ01	TCRBJ01-01	01	1	6	2	3	0	5	23	-1	43	39	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 7.1	CASSQGGVYTEAFF+TCRBV04-01+TCRBJ01-01	TCRBV04-01*01		TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGATTCGAAAGGGGTTTGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	24	5.631912292352567E-5		41	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	5	2	7	7	2	23	34	46	41	48													Vb 7.1	X+TCRBV04-01+TCRBJ01-04	TCRBV04-01*01	TCRBD01-01*01	TCRBJ01-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAGGGGACCGAGAAGGTAGCGGGCTACACCTTCGGTTCG	CASSQGTEKVAGYTF	In	VDJ	1	25	5.866575304533924E-5	7.364355928159235E-5	45	TCRBV04	TCRBV04-01	01				TCRBJ01	TCRBJ01-02	01	3	0	7	8	1	13	23	37	43	38	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 7.1	CASSQGTEKVAGYTF+TCRBV04-01+TCRBJ01-02	TCRBV04-01*01		TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGCGAGGGGAACAGATACGCAGTATTTTGGCCCA	CASSQARGTDTQYF	In	VDJ	1	26	6.101238316715281E-5	7.658930165285605E-5	42	TCRBV04	TCRBV04-01	01				TCRBJ02	TCRBJ02-03	01	1	5	2	3	2	1	23	39	46	41	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 7.1	CASSQARGTDTQYF+TCRBV04-01+TCRBJ02-03	TCRBV04-01*01		TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCGCTGGCTGGGAGCCTCCGGGGAGCTGTTTTTTGGAGAA	CASSRWLGASGELFF	In	VDJ	1	34	7.978542414166136E-5	1.001552406229656E-4	45	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	4	9	2	6	7	3	23	36	48	43	51													Vb 7.1	CASSRWLGASGELFF+TCRBV04-01+TCRBJ02-02	TCRBV04-01*01	TCRBD02-01*02	TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CRRRRGACTCAGCCSTGTATCTCTRCGCCAGCAGCCAAGATAAGGGAGTGTGGACTGAAGCTTTCTTTGGACAA	XASSQDKGVWTEAFF	In	VDJ	1	35	8.213205426347493E-5	1.031009829942293E-4	45	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	0	9	2	5	3	5	22	39	47	42	52													Vb 7.1	XASSQDKGVWTEAFF+TCRBV04-01+TCRBJ01-01	TCRBV04-01*01	TCRBD02-01*02	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAGACCGAGGGAGGGGGCGAGGAGCTGTTTTTTGGAGAA	CASSQTEGGGEELFF	In	VDJ	1	43	1.009050952379835E-4	1.2666692196433885E-4	45	TCRBV04	TCRBV04-01	01				TCRBJ02	TCRBJ02-02	01	3	5	0	10	9	2	23	37	53	46	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 7.1	CASSQTEGGGEELFF+TCRBV04-01+TCRBJ02-02	TCRBV04-01*01		TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCTTACTAGCGGGGACAATGAGCAGTTCTTCGGGCCA	CASSLTSGDNEQFF	In	VDJ	1	53	1.243713964561192E-4	1.5612434567697578E-4	42	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	3	3	5	2	0	23	36	-1	38	48													Vb 7.1	CASSLTSGDNEQFF+TCRBV04-01+TCRBJ02-01	TCRBV04-01*01	TCRBD02-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCCTAACCGGGGGCTTGAAGCTTTCTTTGGACAA	CASSPNRGLEAFF	In	VDJ	1	68	1.5957084828332273E-4	2.003104812459312E-4	39	TCRBV04	TCRBV04-01	01				TCRBJ01	TCRBJ01-01	01	4	6	0	7	6	1	23	36	48	42	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 7.1	CASSPNRGLEAFF+TCRBV04-01+TCRBJ01-01	TCRBV04-01*01		TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAATCTAGGGGACAGGGGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSQSRGQGNTGELFF	In	VDJ	1	69	1.619174784051363E-4	2.0325622361719488E-4	51	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	2	0	3	1	5	0	23	38	-1	43	52													Vb 7.1	CASSQSRGQGNTGELFF+TCRBV04-01+TCRBJ02-02	TCRBV04-01*01	TCRBD01-01*01	TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGAGGATAGCGGGGCTAGCACAGATACGCAGTATTTTGGCCCA	CASSQEDSGASTDTQYF	In	VDJ	2	85	1.9946356035415342E-4	2.50388101557414E-4	51	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	5	3	0	3	2	23	40	51	43	53													Vb 7.1	CASSQEDSGASTDTQYF+TCRBV04-01+TCRBJ02-03	TCRBV04-01*01	TCRBD02-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGGTGACTCTGGAAACACCATATATTTTGGAGAG	CASSQGDSGNTIYF	In	VDJ	2	87	2.0415682059778055E-4	2.5627958629994137E-4	42	TCRBV04	TCRBV04-01	01				TCRBJ01	TCRBJ01-03	01	1	2	8	0	2	0	23	39	-1	41	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 7.1	CASSQGDSGNTIYF+TCRBV04-01+TCRBJ01-03	TCRBV04-01*01		TCRBJ01-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGATGAGCGGGCACGAGCTGGGGCCAACGTCCYGACTTTCGGGGCC	CASSQDERARAGANVXTF	In	VDJ	4	206	4.834058050935953E-4	6.06822928480321E-4	54	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	0	6	4	2	2	6	23	40	48	42	54						01,02							Vb 7.1	CASSQDERARAGANVXTF+TCRBV04-01+TCRBJ02-06	TCRBV04-01*01	TCRBD02-01	TCRBJ02-06*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CTCCCTCCCAGACATCTGTATACTTCTGTGCCAGCAGTTCTCGAGCTAAGGTGAACACTGAAGCTTTCTTTGGACAA	CASSSRAKVNTEAFF	In	VDJ	1	14	3.285282170538997E-5	4.1240393197691716E-5	45	TCRBV06	TCRBV06-09	01				TCRBJ01	TCRBJ01-01	01	4	5	4	0	9	0	26	39	-1	48	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 13.1	CASSSRAKVNTEAFF+TCRBV06-09+TCRBJ01-01	TCRBV06-09*01		TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CTCCCTCCCAGACATCTGTATACTTCTGTGCCAGCACTGGACAGGGTCTCAATGAGCAGTTCTTCGGGCCA	CASTGQGLNEQFF	In	VDJ	1	33	7.74387940198478E-5	9.72094982517019E-5	39	TCRBV06	TCRBV06-09	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	7	1	3	6	2	3	26	36	46	38	49													Vb 13.1	CASTGQGLNEQFF+TCRBV06-09+TCRBJ02-01	TCRBV06-09*01	TCRBD01-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGCACATTGGGTCGGGTTAATCAGCCCCAGCATTTTGGTGAT	CASTLGRVNQPQHF	In	VDJ	1	17	3.989271207083068E-5	5.00776203114828E-5	42	TCRBV10	TCRBV10-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	7	8	4	4	8	2	26	36	48	44	50			01,02			01,02							Vb 12	CASTLGRVNQPQHF+TCRBV10-01+TCRBJ01-05	TCRBV10-01	TCRBD02-01	TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGCAGTGTGGGGGGTCGGCTTCTCCTACGAGCAGTACGTCGGGCCG		Out	VDJ	1	21	4.927923255808496E-5		46	TCRBV10	TCRBV10-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	4	9	1	17	1	24	26	39	46	40	70			01,02										Vb 12	X+TCRBV10-01+TCRBJ02-07	TCRBV10-01	TCRBD02-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGCAGTGTGGGCCTTCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	23	5.39724928017121E-5		40	TCRBV10	TCRBV10-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	8	0	2	1	3	26	39	44	40	47			01,02										Vb 12	X+TCRBV10-01+TCRBJ02-03	TCRBV10-01	TCRBD01-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGCATCCTTTACAGGGAGGCCCCTACGAGCAGTACGTCGGGCCG		Out	VDJ	1	34	7.978542414166136E-5		44	TCRBV10	TCRBV10-01					TCRBJ02	TCRBJ02-07	01	7	3	3	17	6	20	26	36	48	42	68			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	X+TCRBV10-01+TCRBJ02-07	TCRBV10-01		TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGCAGTGCGGGGTACGAGCAGTACTTCGGGCCG	CASSAGYEQYF	In	VDJ	1	43	1.009050952379835E-4	1.2666692196433885E-4	33	TCRBV10	TCRBV10-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	4	8	3	4	0	0	26	-1	-1	39	44			01,02										Vb 12	CASSAGYEQYF+TCRBV10-01+TCRBJ02-07	TCRBV10-01	TCRBD02-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGCAGTGAGGGTCAGGGGGCGCAGTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	45	1.0559835548161063E-4		49	TCRBV10	TCRBV10-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	2	4	0	4	3	4	26	41	52	44	56			01,02										Vb 12	X+TCRBV10-01+TCRBJ01-04	TCRBV10-01	TCRBD01-01*01	TCRBJ01-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGCAGAAACAGGGAGGGAGCCTACAATGAGCAGTTCTTCGGGCCA	CASRNREGAYNEQFF	In	VDJ	1	71	1.6661073864876344E-4	2.0914770835972227E-4	45	TCRBV10	TCRBV10-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	9	0	2	5	2	26	37	49	42	51			01,02										Vb 12	CASRNREGAYNEQFF+TCRBV10-01+TCRBJ02-01	TCRBV10-01	TCRBD02-01*02	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGCAGTGAGTCGAAGTCAAGAGCAGTACGTCGGGCCG		Out	VDJ	2	87	2.0415682059778055E-4		37	TCRBV10	TCRBV10-01					TCRBJ02	TCRBJ02-07	01	0	4	5	17	11	4	26	43	57	54	61			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	X+TCRBV10-01+TCRBJ02-07	TCRBV10-01		TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGCAGTGAGTCGGGGCTGAAAGCGCAGTATTTTGGCCCA	CASSESGLKAQYF	In	VDJ	2	103	2.4170290254679766E-4	3.034114642401605E-4	39	TCRBV10	TCRBV10-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	7	0	10	0	6	26	-1	48	43	54			01,02										Vb 12	CASSESGLKAQYF+TCRBV10-01+TCRBJ02-03	TCRBV10-01	TCRBD01-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGCAGTATACGACAGGGGGCCGAGAGACCCAGTACTTCGGGCCA		Out	VDJ	3	163	3.825007098556119E-4		44	TCRBV10	TCRBV10-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	2	0	4	4	2	26	38	52	42	54			01,02										Vb 12	X+TCRBV10-01+TCRBJ02-05	TCRBV10-01	TCRBD01-01*01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCACCGTAGCGGGAGGGCCTGTTAGGCAATGAGCAGTTCTTCGGGCCA		Out	VDJ	11	537	0.001260140375413887		46	TCRBV10	TCRBV10-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	10	5	0	6	3	9	26	33	47	36	56			01,02										Vb 12	X+TCRBV10-01+TCRBJ02-01	TCRBV10-01	TCRBD02-01*02	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAGGGACTTGGGCCTATATTTCTGTGCCAGCAGCCTCCTCAGGGGGCTCTACGAGCAGTACGTCGGGCCG	CASSLLRGLYEQYV	In	VDJ	1	16	3.7546081949017114E-5	4.7131877940219106E-5	42	TCRBV12	TCRBV12-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	4	0	17	5	15	22	34	47	39	62														CASSLLRGLYEQYV+TCRBV12-01+TCRBJ02-07	TCRBV12-01*01	TCRBD01-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAGGGACTTGGGCCTATATTTCTGTGCCAGCAGCTTCCCGGGACAGGGGGCTGAGCAGTTCTTCGGGCCA	CASSFPGQGAEQFF	In	VDJ	1	43	1.009050952379835E-4	1.2666692196433885E-4	42	TCRBV12	TCRBV12-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	0	0	9	3	0	22	36	-1	39	51														CASSFPGQGAEQFF+TCRBV12-01+TCRBJ02-01	TCRBV12-01*01	TCRBD01-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAGGGACTTGGGCCTATATTTCTGTGCCAGCAGCCTGCGGGTGGACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	3	159	3.7311418936835755E-4		40	TCRBV12	TCRBV12-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	7	4	5	2	3	22	34	41	36	44						01,02								X+TCRBV12-01+TCRBJ02-02	TCRBV12-01*01	TCRBD02-01	TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GCAAGCCACGTTTGGTGGGACGCAGCCATGTACTGTGTGCCACCAGCAGACCCAGACAGGACGAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	13	3.0506191583576405E-5		46	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	2	2	4	5	4	3	35	50	60	54	63														X+TCRBV15-01+TCRBJ01-04	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGGCCTATCGGGGGCCAACGTCCTGACTTTCGGGGCC	CATSRGLSGANVLTF	In	VDJ	1	16	3.7546081949017114E-5	4.7131877940219106E-5	45	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	1	4	9	4	2	3	18	34	39	36	42						01,02								CATSRGLSGANVLTF+TCRBV15-01+TCRBJ02-06	TCRBV15-01*01	TCRBD02-01	TCRBJ02-06*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGCGAAAACCATCAGCCCCAGCATTTTGGTGAT	CATSSENHQPQHF	In	VDJ	1	18	4.2239342192644256E-5	5.302336268274649E-5	39	TCRBV15	TCRBV15-01	01				TCRBJ01	TCRBJ01-05	01	3	2	8	5	1	5	18	32	35	33	40				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSSENHQPQHF+TCRBV15-01+TCRBJ01-05	TCRBV15-01*01		TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GCAAGCCACGTTTGGTGGGACGAGCCATGTACCTGTGTGCCACCAGCAGACCCAGACAGGACGAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	19	4.4585972314457824E-5		46	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	2	2	4	5	4	3	35	50	60	54	63														X+TCRBV15-01+TCRBJ01-04	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGGCACAGGGGGGGAAATCAGCCCCAGCATTTTGGTGAT	CATSRHRGGNQPQHF	In	VDJ	1	21	4.927923255808496E-5	6.186058979653757E-5	45	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	3	1	4	2	3	18	32	42	34	45														CATSRHRGGNQPQHF+TCRBV15-01+TCRBJ01-05	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGGCCGACAGCTTTCAATGAGCAGTTCTTCGGGCCA	CATSRPTAFNEQFF	In	VDJ	1	22	5.162586267989853E-5	6.480633216780127E-5	42	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	2	5	6	3	4	18	32	40	35	44														CATSRPTAFNEQFF+TCRBV15-01+TCRBJ02-01	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GCAAGCCACGTTTGGTGGGACGCAGCATGTACCTGTGTGCCACCAGCAGACCCAGACAGGACGAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	22	5.162586267989853E-5		46	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	2	2	4	5	4	3	35	50	60	54	63														X+TCRBV15-01+TCRBJ01-04	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAAGGCAGGGATCGGGCACTGAAGCTTTCTTTGGACAA	CATSRRQGSGTEAFF	In	VDJ	1	27	6.335901328896638E-5	7.953504402411973E-5	45	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	4	3	4	3	6	18	33	41	36	47														CATSRRQGSGTEAFF+TCRBV15-01+TCRBJ01-01	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGTGGACGGGGTGGCAATCAGCCCCAGCATTTTGGTGAT	CATSSGRGGNQPQHF	In	VDJ	1	30	7.03989036544071E-5	8.837227113791082E-5	45	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	3	8	3	2	4	2	18	32	41	36	43														CATSSGRGGNQPQHF+TCRBV15-01+TCRBJ01-05	TCRBV15-01*01	TCRBD02-01*01	TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGGGGAAGTGACAGGGAGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CATSRGEVTGSSGANVLTF	In	VDJ	1	32	7.509216389803423E-5	9.426375588043821E-5	57	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	1	2	3	0	7	2	18	34	48	41	50														CATSRGEVTGSSGANVLTF+TCRBV15-01+TCRBJ02-06	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-06*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATTATGAAAGGGGGCTCTACGAGCAGTACTTCGGGCCG	CATSRDYERGLYEQYF	In	VDJ	1	33	7.74387940198478E-5	9.72094982517019E-5	48	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	5	0	3	7	1	18	35	49	42	50														CATSRDYERGLYEQYF+TCRBV15-01+TCRBJ02-07	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGGAGGGGATTCCTACGAGCAGTACTTCGGGCCG	CATSRGGDSYEQYF	In	VDJ	1	33	7.74387940198478E-5	9.72094982517019E-5	42	TCRBV15	TCRBV15-01	01				TCRBJ02	TCRBJ02-07	01	1	5	2	1	1	2	18	34	40	35	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSRGGDSYEQYF+TCRBV15-01+TCRBJ02-07	TCRBV15-01*01		TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATAAGAAGGCGTCAGAAGAGACCCAGTACTTCGGGCCA	CATSRDKKASEETQYF	In	VDJ	1	35	8.213205426347493E-5	1.031009829942293E-4	48	TCRBV15	TCRBV15-01	01				TCRBJ02	TCRBJ02-05	01	0	4	5	3	11	0	18	35	-1	46	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSRDKKASEETQYF+TCRBV15-01+TCRBJ02-05	TCRBV15-01*01		TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGGGAAGTGGGGGAAAATGAAAAACTGTTTTTTGGCAGT	CATSREVGENEKLFF	In	VDJ	1	35	8.213205426347493E-5	1.031009829942293E-4	45	TCRBV15	TCRBV15-01	01				TCRBJ01	TCRBJ01-04	01	3	6	1	5	6	2	18	32	43	38	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSREVGENEKLFF+TCRBV15-01+TCRBJ01-04	TCRBV15-01*01		TCRBJ01-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACGCAGCCATGTACCTGTGTGCCACCAGGGACAGGGGGAGCAGCAATCAGCCCCAGCATTTTGGTGAT	CATRDRGSSNQPQHF	In	VDJ	1	35	8.213205426347493E-5	1.031009829942293E-4	45	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	1	1	1	0	3	18	-1	39	29	42														CATRDRGSSNQPQHF+TCRBV15-01+TCRBJ01-05	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACGCAGCCATGTACCTGTGTGTCACCAGCAGAGGGGACGGCAGGTCACCCCTCCACTTTGGGAAC	CVTSRGDGRSPLHF	In	VDJ	1	38	8.917194462891565E-5	1.1193821010802038E-4	42	TCRBV15	TCRBV15-01	01				TCRBJ01	TCRBJ01-06	01	1	0	7	10	0	6	18	-1	39	34	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CVTSRGDGRSPLHF+TCRBV15-01+TCRBJ01-06	TCRBV15-01*01		TCRBJ01-06*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACGCAGCCATGTACCTGTGTGCAACCTTGGGGAATTGGGAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	39	9.151857475072921E-5		43	TCRBV15	TCRBV15-01	01				TCRBJ01	TCRBJ01-05	01	8	0	8	1	3	6	18	27	34	30	40				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV15-01+TCRBJ01-05	TCRBV15-01*01		TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGAAATTTTGGGAGGGTATGAGCAGTTCTTCGGGCCA	CATSREILGGYEQFF	In	VDJ	1	40	9.386520487254278E-5	1.1782969485054776E-4	45	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	9	0	8	6	1	18	35	48	41	49														CATSREILGGYEQFF+TCRBV15-01+TCRBJ02-01	TCRBV15-01*01	TCRBD02-01*02	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAACACCTTTAACAGGGGGCTCGTTCAGCCCCAGCATTTTGGTGAT	CATSNTFNRGLVQPQHF	In	VDJ	1	42	9.855846511616992E-5	1.2372117959307514E-4	51	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	3	0	6	9	4	18	31	49	40	53														CATSNTFNRGLVQPQHF+TCRBV15-01+TCRBJ01-05	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGAACTAGGAACCTACGAGCAGTACTTCGGGCCG	CATSRELGTYEQYF	In	VDJ	1	44	1.0325172535979707E-4	1.2961266433560254E-4	42	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	3	8	2	0	3	18	-1	40	35	43						01,02								CATSRELGTYEQYF+TCRBV15-01+TCRBJ02-07	TCRBV15-01*01	TCRBD02-01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGAGAACAGTTTGGAGCTGGCCGCCCACGGGCAGTTCTTCGGGCCA	CATSRENSLELAAHGQFF	In	VDJ	1	45	1.0559835548161063E-4	1.3255840670686622E-4	54	TCRBV15	TCRBV15-01	01				TCRBJ02	TCRBJ02-01	01	0	3	5	12	2	21	18	35	41	37	62				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSRENSLELAAHGQFF+TCRBV15-01+TCRBJ02-01	TCRBV15-01*01		TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGAGTCGGTGGATATTGAAAAACTGTTTTTTGGCAGT	CATSRESVDIEKLFF	In	VDJ	1	52	1.2202476633430562E-4	1.531786033057121E-4	45	TCRBV15	TCRBV15-01	01				TCRBJ01	TCRBJ01-04	01	0	1	8	7	6	3	18	35	44	41	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSRESVDIEKLFF+TCRBV15-01+TCRBJ01-04	TCRBV15-01*01		TCRBJ01-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCGGGGACAGGCCGCGCGATGAGCAGTTCTTCGGGCCA	CATSGDRPRDEQFF	In	VDJ	1	54	1.2671802657793275E-4	1.5907008804823947E-4	42	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	0	4	8	1	7	18	30	39	31	46														CATSGDRPRDEQFF+TCRBV15-01+TCRBJ02-01	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATCGACAGGGGGGGTACGAGCAGTACTTCGGGCCG	CATSRDRQGGYEQYF	In	VDJ	1	57	1.3375791694337347E-4	1.6790731516203055E-4	45	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	2	1	4	2	2	18	35	46	37	48														CATSRDRQGGYEQYF+TCRBV15-01+TCRBJ02-07	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATGGGACTAGAGCCTACAATGAGCAGTTCTTCGGGCCA	CATSRDGTRAYNEQFF	In	VDJ	2	97	2.2762312181591625E-4	2.857370100125783E-4	48	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	0	8	2	1	2	18	35	44	36	46						01,02								CATSRDGTRAYNEQFF+TCRBV15-01+TCRBJ02-01	TCRBV15-01*01	TCRBD02-01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCTACGGGGTGAACGGGTGGTCGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	2	102	2.393562724249841E-4		52	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	5	8	3	2	2	13	18	30	37	32	50														X+TCRBV15-01+TCRBJ01-05	TCRBV15-01*01	TCRBD02-01*01	TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGCGGGGCGGGAGGGCGACGAGCAGTACTTCGGGCCG	CATSRAGREGDEQYF	In	VDJ	2	110	2.5812931339949267E-4	3.2403166083900636E-4	45	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	1	7	0	5	4	2	18	34	47	38	49														CATSRAGREGDEQYF+TCRBV15-01+TCRBJ02-07	TCRBV15-01*01	TCRBD02-01*02	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATGGGGGGGCGCAGAGATTCGATGGCTACACCTTCGGTTCG	CATSRDGGAQRFDGYTF	In	VDJ	2	113	2.6516920376493336E-4	3.3286888795279744E-4	51	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	0	9	0	6	1	12	18	35	43	36	55														CATSRDGGAQRFDGYTF+TCRBV15-01+TCRBJ01-02	TCRBV15-01*01	TCRBD02-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGAGTCAGACAGATCCAATCAGCCCCAGCATTTTGGTGAT	CATSRESDRSNQPQHF	In	VDJ	3	134	3.1444843632301835E-4	3.94729477749335E-4	48	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	2	5	3	4	3	18	35	44	39	47														CATSRESDRSNQPQHF+TCRBV15-01+TCRBJ01-05	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGGAATAATGGCGGTGAAAAACTGTTTTTTGGCAGT	CATSRNNGGEKLFF	In	VDJ	4	178	4.1770016168281537E-4	5.243421420849376E-4	42	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	3	7	5	7	8	0	18	32	-1	40	44						01,02								CATSRNNGGEKLFF+TCRBV15-01+TCRBJ01-04	TCRBV15-01*01	TCRBD02-01	TCRBJ01-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGGTATACAGGACGTGCGGACTGAAGCTTTCTTTGGACAA	CATSRGIQDVRTEAFF	In	VDJ	4	193	4.528996135100189E-4	5.685282776538929E-4	48	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	3	4	5	4	8	18	34	43	38	51														CATSRGIQDVRTEAFF+TCRBV15-01+TCRBJ01-01	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGTTAGGGGACAGGCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	5	235	5.514580786261889E-4		47	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	1	0	4	3	4	0	18	34	-1	38	46														X+TCRBV15-01+TCRBJ02-01	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGGACAGGGGGAGAACATTCAGTACTTCGGCGCC	CATSRGQGENIQYF	In	VDJ	6	279	6.547098039859859E-4	8.218621215825706E-4	42	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	1	2	1	7	0	2	18	-1	43	34	45														CATSRGQGENIQYF+TCRBV15-01+TCRBJ02-04	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGCCAGAGGAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CATSSQRSSYNEQFF	In	VDJ	6	281	6.594030642296131E-4	8.277536063250981E-4	45	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	10	2	0	5	0	18	32	-1	37	41														CATSSQRSSYNEQFF+TCRBV15-01+TCRBJ02-01	TCRBV15-01*01	TCRBD02-01*02	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCCGGGGGACAGGGGACAATGAGCAGTTCTTCGGGCCA	CATSRGTGDNEQFF	In	VDJ	6	313	7.344952281276472E-4	9.220173622055362E-4	42	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	0	2	5	3	0	18	30	-1	33	43														CATSRGTGDNEQFF+TCRBV15-01+TCRBJ02-01	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCATGGGACAGACCAGCAATCAGCCCCAGCATTTTGGTGAT	CATSMGQTSNQPQHF	In	VDJ	6	321	7.532682691021559E-4	9.455833011756458E-4	45	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	0	5	1	1	3	18	31	39	32	42														CATSMGQTSNQPQHF+TCRBV15-01+TCRBJ01-05	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGTTATCAGCCTCGATATGGCTACACCTTCGGTTCG	CATSSYQPRYGYTF	In	VDJ	7	339	7.955076112948001E-4	9.986066638583923E-4	42	TCRBV15	TCRBV15-01	01				TCRBJ01	TCRBJ01-02	01	3	4	5	5	4	6	18	32	39	36	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSSYQPRYGYTF+TCRBV15-01+TCRBJ01-02	TCRBV15-01*01		TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGTACGGGAGAGGGATCAGATACGCAGTATTTTGGCCCA	CATSSTGEGSDTQYF	In	VDJ	8	405	9.503851993344957E-4	0.0011930256603617962	45	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	8	2	4	2	6	18	32	40	34	46														CATSSTGEGSDTQYF+TCRBV15-01+TCRBJ02-03	TCRBV15-01*01	TCRBD02-01*02	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATCATCCCACAGGTAATGGGGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	8	413	9.691582403090043E-4		56	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	3	4	2	7	7	18	35	47	42	54														X+TCRBV15-01+TCRBJ01-05	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGACCGACAGGGGTGAACACTGAAGCTTTCTTTGGACAA	CATSRPTGVNTEAFF	In	VDJ	9	466	0.0010935296367651235	0.0013727159450088813	45	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	2	2	0	2	0	18	33	-1	35	43														CATSRPTGVNTEAFF+TCRBV15-01+TCRBJ01-01	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGTCGGACAGGGGGCGCAGTCCAAGAGACCCAGTACTTCGGGCCA	CATSSRTGGAVQETQYF	In	VDJ	11	564	0.0013234993887028532	0.0016613986973927233	51	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	1	0	1	2	5	18	32	45	34	50														CATSSRTGGAVQETQYF+TCRBV15-01+TCRBJ02-05	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATAGGAGCAAGTCGAACACCGGGGAGCTGTTTTTTGGAGAA	CATSRDRSKSNTGELFF	In	VDJ	18	902	0.00211666036987584	0.002657059618879852	51	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	0	10	2	0	2	5	18	35	41	37	46														CATSRDRSKSNTGELFF+TCRBV15-01+TCRBJ02-02	TCRBV15-01*01	TCRBD02-01*02	TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGGATACAGGGTTGAGCCCCAGCATTTTGGTGAT	CATSRGYRVEPQHF	In	VDJ	21	1041	0.002442841956807926	0.0030665178084855055	42	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	1	3	3	8	3	3	18	34	43	37	46														CATSRGYRVEPQHF+TCRBV15-01+TCRBJ01-05	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCGGAGGAGCGACTAGCGGGAGAGCCACATTTGGCTACGAGCAGTACTTCGGGCCG	CATSGGATSGRATFGYEQYF	In	VDJ	21	1059	0.00248508129900057	0.003119541171168252	60	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	1	2	2	3	4	12	18	34	50	38	62														CATSGGATSGRATFGYEQYF+TCRBV15-01+TCRBJ02-07	TCRBV15-01*01	TCRBD02-01*02	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGCGGGAACAGGGTTGGGTACGAGCAGTACTTCGGGCCG	CATSSGNRVGYEQYF	In	VDJ	24	1194	0.0028018763654454023	0.003517216391288851	45	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	3	3	4	5	5	18	32	43	37	48														CATSSGNRVGYEQYF+TCRBV15-01+TCRBJ02-07	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACGCAGCCATGTACCTGTGTGCCACGCAAACGGGGGACAAAGACACTGAAGCTTTCTTTGGACAA	CATQTGDKDTEAFF	In	VDJ	26	1289	0.003024806227017691	0.0037970619165589017	42	TCRBV15	TCRBV15-01	01				TCRBJ01	TCRBJ01-01	01	9	0	6	3	8	3	18	26	40	34	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATQTGDKDTEAFF+TCRBV15-01+TCRBJ01-01	TCRBV15-01*01		TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACGCAGCCATGTACCTGTGTGCCACCAGTCCCGTCGGGTACCAAGAGACCCAGTACTTCGGGCCA	CATSPVGYQETQYF	In	VDJ	49	2479	0.005817296071975839	0.007302495338362697	42	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	6	8	4	0	6	1	18	29	39	35	40						01,02								CATSPVGYQETQYF+TCRBV15-01+TCRBJ02-05	TCRBV15-01*01	TCRBD02-01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGACCCAGACAGGACGAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	99	4972	0.011667444965657069		46	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	2	2	4	5	4	3	18	33	43	37	46														X+TCRBV15-01+TCRBJ01-04	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ACGTTTGGTGGAGCTTGGTGACTCTGCTGTGTTTTCTGTGCCAGCAGCCCAAGGGCAGGTTCTGGAGGTAAACTGTTTTTTGGCAGT		Out	VDJ	1	13	3.0506191583576405E-5		44	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	22	10	1	11	31	1	37	32	68	63	69		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ01-04	TCRBV03	TCRBD02-01*02	TCRBJ01-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCACCGGGGGTTTGGGAAGCAATCAGCCCCAGCATTTTGGTGAT	CASTGGLGSNQPQHF	In	VDJ	1	13	3.0506191583576405E-5	3.8294650826428025E-5	45				TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	7	8	2	1	1	7	24	34	41	35	48	TCRBV06,TCRBV10	TCRBV06-01,TCRBV06-05,TCRBV06-06,TCRBV10-03												CASTGGLGSNQPQHF+X+TCRBJ01-05		TCRBD02-01*01	TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGTTACGCCGGACAGCTCACAGATACGCAGTATTTTGGCCCA	CASSYAGQLTDTQYF	In	VDJ	1	13	3.0506191583576405E-5	3.8294650826428025E-5	45	TCRBV06			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	1	5	2	3	2	24	39	48	42	50		TCRBV06-05,TCRBV06-06												CASSYAGQLTDTQYF+TCRBV06-X+TCRBJ02-03	TCRBV06	TCRBD01-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGCGTACAGATCCTACGAGCAGTACTTCGGGCCG	CASSQAYRSYEQYF	In	VDJ	1	13	3.0506191583576405E-5	3.8294650826428025E-5	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	3	5	1	3	1	26	42	49	45	50		TCRBV03-01,TCRBV03-02												CASSQAYRSYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD01-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGTGGGTGGCGGGGGGGCTCGTACTGAGCAGTTCTTCGGGCCA	CASSQVGGGGARTEQFF	In	VDJ	1	13	3.0506191583576405E-5	3.8294650826428025E-5	51	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	1	7	0	9	6	7	26	42	57	48	64		TCRBV03-01,TCRBV03-02												CASSQVGGGGARTEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCAAGGGCAGGTTCTGGAGGTAAACTGTTTTTGGCAGT		Out	VDJ	1	13	3.0506191583576405E-5		44	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	4	10	1	18	14	7	26	39	58	53	65		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ01-04	TCRBV03	TCRBD02-01*02	TCRBJ01-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCTAATGCAGGACTCGACTATGGCTACACCTTCGGTTCG	CASSPNAGLDYGYTF	In	VDJ	1	13	3.0506191583576405E-5	3.8294650826428025E-5	45	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	4	1	10	3	8	2	26	39	52	47	54		TCRBV03-01,TCRBV03-02				01,02								CASSPNAGLDYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD02-01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCGCACCGGGACTAGCGGGAAAGGAGCAGTACTTCGGGCCG	CASSAPGLAGKEQYF	In	VDJ	1	13	3.0506191583576405E-5	3.8294650826428025E-5	45	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	0	3	7	5	3	26	38	56	43	59		TCRBV03-01,TCRBV03-02												CASSAPGLAGKEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01*02	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTTAGATTCCGGGTTTGAAGCTTTCTTTGGACAA	CASSLDSGFEAFF	In	VDJ	1	13	3.0506191583576405E-5	3.8294650826428025E-5	39	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	5	8	4	7	8	2	26	38	50	46	52		TCRBV03-01,TCRBV03-02				01,02								CASSLDSGFEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD02-01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATTTTGGATCCCTTGGCACTGAAGCTTTCTTTGGACAA	CSARDFGSLGTEAFF	In	VDJ	1	13	3.0506191583576405E-5	3.8294650826428025E-5	45	TCRBV20						TCRBJ01	TCRBJ01-01	01	0	1	8	4	4	8	26	40	47	44	55		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDFGSLGTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTATCGGGACAGAGGCAGGGACCCAGTACTTCGGGCCA	CASSIGTEAGTQYF	In	VDJ	1	13	3.0506191583576405E-5	3.8294650826428025E-5	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	0	5	7	3	7	22	34	44	37	51		TCRBV12-03,TCRBV12-04												CASSIGTEAGTQYF+TCRBV12-X+TCRBJ02-05	TCRBV12	TCRBD01-01*01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CACCAACCAGACMTCTMTGTACYTCTGTGCCAGCAGTTTCGGCAGGGGTTTACGCGGGGAGCTGTTTTTTGGAGAA	CASSFGRGLRGELFF	In	VDJ	1	13	3.0506191583576405E-5	3.8294650826428025E-5	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	4	2	7	3	6	23	37	46	40	52	TCRBV27,TCRBV28													CASSFGRGLRGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGCCCCCGACAGGAGATCGCTGAAGCTTTCTTTGGACAA		Out	VDJ	1	13	3.0506191583576405E-5		44	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	2	4	6	5	6	24	37	48	42	54		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGCTCAAGTCGACTAGCGGAAGGGAGGAGAGACCCAGTACTTCGGGCCA	CATSAQVD*RKGGETQYF	Stop	VDJ	1	13	3.0506191583576405E-5		54	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	2	5	4	8	8	24	37	54	45	62		TCRBV24-01,TCRBV24-or09_02				01,02								CATSAQVD*RKGGETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD02-01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGCCATAAGATGGGTTTCATGAACACTGAAGCTTTCTTTGGACAA	CASSHKMGFMNTEAFF	In	VDJ	1	13	3.0506191583576405E-5	3.8294650826428025E-5	48	TCRBV24						TCRBJ01	TCRBJ01-01	01	7	0	9	0	9	5	24	35	47	44	52		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSHKMGFMNTEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24		TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCATCAGTGAAGGGCAGCACCCCTACGAGCAGTACTTCGGGCCG	CAISEGQHPYEQYF	In	VDJ	1	13	3.0506191583576405E-5	3.8294650826428025E-5	42	unresolved						TCRBJ02	TCRBJ02-07	01	1	4	5	2	2	4	23	39	44	41	48	TCRBV06,TCRBV10			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CAISEGQHPYEQYF+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCCCCGGACTAGCGGGAGTTTACAATGAGCAGTTCTTCGGGCCA	CASSPGLAGVYNEQFF	In	VDJ	1	13	3.0506191583576405E-5	3.8294650826428025E-5	48	TCRBV05			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	1	2	4	3	2	19	31	47	34	49		TCRBV05-06,TCRBV05-07												CASSPGLAGVYNEQFF+TCRBV05-X+TCRBJ02-01	TCRBV05	TCRBD02-01*02	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTTGGGTCGCCTAGCGGGGCTACCAGATACGCAGTATTTTGGCCCA	CASSLGRLAGLPDTQYF	In	VDJ	1	13	3.0506191583576405E-5	3.8294650826428025E-5	51	TCRBV05			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	4	3	4	5	4	19	35	49	40	53		TCRBV05-06,TCRBV05-07												CASSLGRLAGLPDTQYF+TCRBV05-X+TCRBJ02-03	TCRBV05	TCRBD02-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AACCAGACAGCTCTTTACTTCTGTGCCACCAGTGAGGCCCCGGGACAGTATCCCCCCCGAGGCAAAAACATTCAGTACTTCGGCGCC	CATSEAPGQYPPRGKNIQYF	In	VDJ	1	14	3.285282170538997E-5	4.1240393197691716E-5	60	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	4	0	5	3	6	14	21	35	48	41	62		TCRBV24-01,TCRBV24-or09_02												CATSEAPGQYPPRGKNIQYF+TCRBV24-X+TCRBJ02-04	TCRBV24	TCRBD01-01*01	TCRBJ02-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGTTTAGGGAGGGACGTCTACGAGCAGTACTTCGGGCCG	CASSLGRDVYEQYF	In	VDJ	1	14	3.285282170538997E-5	4.1240393197691716E-5	42	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	1	10	0	3	0	4	26	-1	48	42	52		TCRBV12-03,TCRBV12-04												CASSLGRDVYEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD02-01*02	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AAGCCACGTTTGGTGCCAGCCAGACCTCTGTACCTCTGTGCCAGCAGTCGGACTAGCGCAAAGATGGGTGAGCAGTTCTTCGGGCCA	CASSRTSAKMGEQFF	In	VDJ	1	14	3.285282170538997E-5	4.1240393197691716E-5	45				TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	1	6	9	1	10	36	48	58	49	68	TCRBV25,TCRBV27,TCRBV28	TCRBV25-01,TCRBV25-or09_02,TCRBV27-01,TCRBV28-01				01,02								CASSRTSAKMGEQFF+X+TCRBJ02-01		TCRBD02-01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ACGACTCGGCCMTGTATCKCTGTGCCAGCAGCTTAGCGGCGGGGGGGGGCACAGATACGCAGTATTTTGGCCCA	CASSLAAGGGTDTQYF	In	VDJ	1	14	3.285282170538997E-5	4.1240393197691716E-5	48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	2	7	0	1	4	1	20	34	47	38	48	TCRBV05,TCRBV07													CASSLAAGGGTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTGGGACAGGTCTATGGCTACACCTTCGGTTCG	CASSLGQVYGYTF	In	VDJ	1	14	3.285282170538997E-5	4.1240393197691716E-5	39	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	0	4	4	1	1	26	39	48	40	49		TCRBV03-01,TCRBV03-02												CASSLGQVYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTTAGGAAGGTCACCCCTCCACTTTGGGAAC	CASSLGRSPLHF	In	VDJ	1	14	3.285282170538997E-5	4.1240393197691716E-5	36	TCRBV03						TCRBJ01	TCRBJ01-06	01	5	1	8	10	3	3	26	38	44	41	47		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGRSPLHF+TCRBV03-X+TCRBJ01-06	TCRBV03		TCRBJ01-06*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGTGAGATAGCCAAAAACATTCAGTACTTCGGCGCC	CASSEIAKNIQYF	In	VDJ	1	14	3.285282170538997E-5	4.1240393197691716E-5	39	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	6	11	2	0	1	2	26	37	41	38	43		TCRBV03-01,TCRBV03-02												CASSEIAKNIQYF+TCRBV03-X+TCRBJ02-04	TCRBV03	TCRBD02-01*02	TCRBJ02-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGCTTACCCCCGGGGGCACTGAAGCTTTCTTTGGACAA	CSALTPGGTEAFF	In	VDJ	1	14	3.285282170538997E-5	4.1240393197691716E-5	39	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	6	8	2	4	9	0	26	34	-1	43	49		TCRBV20-01,TCRBV20-or09_02												CSALTPGGTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGACGACTACGGATGGGGCACTGAAGCTTTCTTTGGACAA	CSARDDYGWGTEAFF	In	VDJ	1	14	3.285282170538997E-5	4.1240393197691716E-5	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	0	2	9	4	1	9	26	40	46	41	55		TCRBV20-01,TCRBV20-or09_02				01,02								CSARDDYGWGTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGATACGGGACGACAGGGGGCCTTGCCTACGAGCAGTACTTCGGGCCG	CSARYGTTGGLAYEQYF	In	VDJ	1	14	3.285282170538997E-5	4.1240393197691716E-5	51	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	2	0	2	8	4	26	38	56	46	60		TCRBV20-01,TCRBV20-or09_02												CSARYGTTGGLAYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTGGGGGAACCGGGGAGCTGTTTTTTGGAGAA	CSASGGTGELFF	In	VDJ	1	14	3.285282170538997E-5	4.1240393197691716E-5	36	TCRBV20						TCRBJ02	TCRBJ02-02	01	3	6	1	5	1	1	26	37	43	38	44		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSASGGTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20		TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTGTTCCCGGGACAGGGTACAATGAGCAGTTCTTCGGGCCA	CASSVPGTGYNEQFF	In	VDJ	1	14	3.285282170538997E-5	4.1240393197691716E-5	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	0	3	4	6	0	22	34	-1	40	49		TCRBV12-03,TCRBV12-04												CASSVPGTGYNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD01-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTTGGGAGGGCCGGCCACGAGCAGTACTTCGGGCCG	CASSFGRAGHEQYF	In	VDJ	1	14	3.285282170538997E-5	4.1240393197691716E-5	42	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	9	0	5	3	6	24	36	46	39	52		TCRBV24-01,TCRBV24-or09_02												CASSFGRAGHEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01*02	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCATTTTGGACAGGTCCTACCGGGGACGAGCAGTACTTCGGGCCG		Out	VDJ	1	14	3.285282170538997E-5		46	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	1	4	5	4	11	23	33	44	37	55	TCRBV06,TCRBV10													X+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGAAGCTCCCAGAACGGACAGGGGGCCCCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	14	3.285282170538997E-5		50				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	1	0	4	8	2	18	31	50	39	52	TCRBV05,TCRBV11	TCRBV05-03,TCRBV11-03												X+X+TCRBJ01-02		TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATSTCTGTGCCAGCACCCCCGACAGGGGGATCACCGGGGAGCTGTTTTTTGGAGAA	CASTPDRGITGELFF	In	VDJ	1	14	3.285282170538997E-5	4.1240393197691716E-5	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	7	2	1	4	5	2	18	28	42	33	44	TCRBV07,TCRBV11													CASTPDRGITGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCCACGGACTAGCGGGAGGTTCAGATACGCAGTATTTTGGCCCA	CASSHGLAGGSDTQYF	In	VDJ	1	14	3.285282170538997E-5	4.1240393197691716E-5	48	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	1	1	4	3	2	18	30	47	33	49	TCRBV07,TCRBV11													CASSHGLAGGSDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCGGGACTAGCGGACAATGAGCAGTTCTTCGGGCCA	CASSLAGLADNEQFF	In	VDJ	1	14	3.285282170538997E-5	4.1240393197691716E-5	45				TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	0	5	5	0	0	18	-1	-1	35	46	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03				01,02								CASSLAGLADNEQFF+X+TCRBJ02-01		TCRBD02-01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
SGACTCGGCYRTGTATCTCTGTGCCAGCAGCTTAAGGGGATCTTACTCCTACAATGAGCAGTTCTTCGGGCCA	CASSLRGSYSYNEQFF	In	VDJ	1	14	3.285282170538997E-5	4.1240393197691716E-5	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	5	2	0	0	6	19	-1	39	34	45	TCRBV07,TCRBV11													CASSLRGSYSYNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCRGCCATGTATCKCTGTGCCAGCAGCTTAGACGGGGGTGGGGAGACCCAGTACTTCGGGCCA	CASSLDGGGETQYF	In	VDJ	1	14	3.285282170538997E-5	4.1240393197691716E-5	42	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	1	8	2	5	1	4	19	35	42	36	46	TCRBV07,TCRBV11													CASSLDGGGETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCRGCCATGTATCKCTGTGCCAGCAGCTTGGGACTAGCGGGAGGGCGGGAGACCCAGTACTTCGGGCCA	CASSLGLAGGRETQYF	In	VDJ	1	14	3.285282170538997E-5	4.1240393197691716E-5	48	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	3	0	0	5	0	3	19	-1	49	33	52	TCRBV07,TCRBV11													CASSLGLAGGRETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*02	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCMTSTATCTCTGTGCCAGCAGCCGGCAGGGAATTACCCCTCTCATCTTAGGCGGTTCG	CASSRQGITPLILG	In	VDJ	1	14	3.285282170538997E-5	4.1240393197691716E-5	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	4	3	19	3	21	19	31	39	34	60	TCRBV05,TCRBV11													CASSRQGITPLILG+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCMTGTATCTCTGTGCCAGCAGCCGAAGGGGAGCAGACTATGGCTACACCTTCGGTTCG	CASSRRGADYGYTF	In	VDJ	1	14	3.285282170538997E-5	4.1240393197691716E-5	42	unresolved						TCRBJ01	TCRBJ01-02	01	4	5	2	3	3	5	19	31	39	34	44	TCRBV05,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRRGADYGYTF+X+TCRBJ01-02	unresolved		TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCCTSTATCTCTGTGCCAGCAGCTTAGCGGGCGGCCAAGAGACCCAGTACTTCGGGCCA	CASSLAGGQETQYF	In	VDJ	1	14	3.285282170538997E-5	4.1240393197691716E-5	42	unresolved			unresolved			TCRBJ02	TCRBJ02-05	01	0	8	0	1	0	2	19	-1	40	36	42	TCRBV05,TCRBV11			TCRBD01,TCRBD02										CASSLAGGQETQYF+X+TCRBJ02-05	unresolved	unresolved	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGRGGACTCRGCYSTGTATCTCTGTGCCAGCAGCTTCGGTCCTAACACTGAAGCTTTCTTTGGACAA	CASSFGPNTEAFF	In	VDJ	1	14	3.285282170538997E-5	4.1240393197691716E-5	39	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	3	8	5	2	0	4	22	-1	39	36	43	TCRBV05,TCRBV07					01,02								CASSFGPNTEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCACAATGGTAGCGGGGGCGATAAACACCGGGGAGCTGTTTTTTGGAGAA	CATMVAGAINTGELFF	In	VDJ	1	14	3.285282170538997E-5	4.1240393197691716E-5	48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	10	5	2	2	6	5	23	30	45	36	50	TCRBV02,TCRBV12													CATMVAGAINTGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01*01	TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TYRGRRGACWCAGCMMKGTAYTTCTGTGCCAGCGAATCCAAAGCCAGGGGGTCCTATAATTCACCCCTCCACTTTGGGAAC	CASESKARGSYNSPLHF	In	VDJ	1	14	3.285282170538997E-5	4.1240393197691716E-5	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	8	4	1	1	11	0	23	32	-1	43	50	TCRBV02,TCRBV21													CASESKARGSYNSPLHF+X+TCRBJ01-06	unresolved	TCRBD01-01*01	TCRBJ01-06*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TTTGGTGCATCCTGAAGACAGCAGTTCTACATCTGCAGTGCTAGAGATTCCGACTCACTTCTCACAGATACGCAGTATTTTGGCCCA	CSARDSDSLLTDTQYF	In	VDJ	1	14	3.285282170538997E-5	4.1240393197691716E-5	48	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	2	10	2	4	7	33	47	55	51	62		TCRBV20-01,TCRBV20-or09_02				01,02								CSARDSDSLLTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGTAAGATAGGGGCAGGTACCGGGGAGCTGTTTTTTGGAGAA	CASSKIGAGTGELFF	In	VDJ	1	15	3.519945182720355E-5	4.418613556895541E-5	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	5	2	5	5	5	26	38	48	43	53		TCRBV12-03,TCRBV12-04												CASSKIGAGTGELFF+TCRBV12-X+TCRBJ02-02	TCRBV12	TCRBD01-01*01	TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAAGTACAGATACGCAGTATTTTGGCCCA	CASSLSTDTQYF	In	VDJ	1	15	3.519945182720355E-5	4.418613556895541E-5	36	TCRBV12						TCRBJ02	TCRBJ02-03	01	2	5	5	3	0	1	26	-1	43	41	44		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLSTDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12		TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AAGCCACGTTTGGTGGTCAGGAGAMCAGCACGGTATTTCTGTGCCAGCAGCAAAGGACCGGCGGACACTGAAGCTTTCTTTGGACAA	CASSKGPADTEAFF	In	VDJ	1	15	3.519945182720355E-5	4.418613556895541E-5	42	TCRBV21			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	1	7	5	3	5	0	39	55	-1	60	64		TCRBV21-or09_02,TCRBV21-01				01,02								CASSKGPADTEAFF+TCRBV21-X+TCRBJ01-01	TCRBV21	TCRBD02-01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGTGACCGGGACCTCACCGGGGAGCTGTTTTTTGGAGAA	CASSDRDLTGELFF	In	VDJ	1	15	3.519945182720355E-5	4.418613556895541E-5	42							TCRBJ02	TCRBJ02-02	01	3	0	7	4	2	2	24	38	45	40	47	TCRBV06,TCRBV10	TCRBV06-01,TCRBV10-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSDRDLTGELFF+X+TCRBJ02-02			TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAACAGCCAAGATATCTCAGGGGGGGATGAGCAGTTCTTCGGGCCA	CANSQDISGGDEQFF	In	VDJ	1	15	3.519945182720355E-5	4.418613556895541E-5	45	TCRBV03						TCRBJ02	TCRBJ02-01	01	0	4	1	8	5	2	26	43	55	48	57		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CANSQDISGGDEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03		TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAGGGCACTGGAGCACGAGATACGCAGTATTTTGGCCCA	CASSQEGTGARDTQYF	In	VDJ	1	15	3.519945182720355E-5	4.418613556895541E-5	48	TCRBV03						TCRBJ02	TCRBJ02-03	01	0	8	0	5	0	11	26	-1	47	43	58		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQEGTGARDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03		TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGACGGGACAGGGGAGGGGAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	15	3.519945182720355E-5		50	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	1	0	2	4	3	5	26	42	55	45	60		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD01-01*01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGCAATACAGATACGCAGTATTTTGGCCCA	CASSQGNTDTQYF	In	VDJ	1	15	3.519945182720355E-5	4.418613556895541E-5	39	TCRBV03						TCRBJ02	TCRBJ02-03	01	1	4	6	3	1	2	26	42	45	43	47		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQGNTDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03		TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGGGCTGGGAATCCCTCACAGATACGCAGTATTTTGGCCCA	CSAGWESLTDTQYF	In	VDJ	1	15	3.519945182720355E-5	4.418613556895541E-5	42	TCRBV20						TCRBJ02	TCRBJ02-03	01	6	0	8	2	5	6	26	34	43	39	49		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAGWESLTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGGGGGCGAACAATGAGCAGTTCTTCGGGCCA	CSAGANNEQFF	In	VDJ	1	15	3.519945182720355E-5	4.418613556895541E-5	33	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	6	0	5	0	2	26	-1	40	34	42		TCRBV20-01,TCRBV20-or09_02												CSAGANNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATATAGCGGTAATCTATGAGCAGTTCTTCGGGCCA	CSARDIAVIYEQFF	In	VDJ	1	15	3.519945182720355E-5	4.418613556895541E-5	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	5	5	8	2	6	26	40	48	42	54		TCRBV20-01,TCRBV20-or09_02				01,02								CSARDIAVIYEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCGGGAGCGGCCCGTATAGCAATCAGCCCCAGCATTTTGGTGAT	CSASGSGPYSNQPQHF	In	VDJ	1	15	3.519945182720355E-5	4.418613556895541E-5	48	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	3	8	2	0	0	9	26	-1	43	37	52		TCRBV20-01,TCRBV20-or09_02												CSASGSGPYSNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD02-01*02	TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTCCCGAGCGGAGGAGGGGGAGACCCAGTACTTCGGGCCA	CSASRAEEGETQYF	In	VDJ	1	15	3.519945182720355E-5	4.418613556895541E-5	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	5	10	0	5	11	1	26	35	52	46	53		TCRBV20-01,TCRBV20-or09_02												CSASRAEEGETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*02	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TCMRGRGACWCAGCWSKGTAYTTCTGTGCCAGCAGAATTATAGCGGAAGAGACCCAGTACTTCGGGCCA	CASRIIAEETQYF	In	VDJ	1	15	3.519945182720355E-5	4.418613556895541E-5	39	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	6	5	5	3	5	0	22	33	-1	38	44	TCRBV12,TCRBV21					01,02								CASRIIAEETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTAACACAGGAACCCAGCCCCAGCATTTTGGTGAT	CASSNTGTQPQHF	In	VDJ	1	15	3.519945182720355E-5	4.418613556895541E-5	39	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	3	4	7	3	4	22	34	42	37	46		TCRBV12-03,TCRBV12-04												CASSNTGTQPQHF+TCRBV12-X+TCRBJ01-05	TCRBV12	TCRBD01-01*01	TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTGGGGCCTAGACAGATACAATGAGCAGTTCTTCGGGCCA	CATSDWGLDRYNEQFF	In	VDJ	1	15	3.519945182720355E-5	4.418613556895541E-5	48	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	2	5	4	8	1	24	40	53	48	54		TCRBV24-01,TCRBV24-or09_02												CATSDWGLDRYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD01-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGGTGGGGGGCTGAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CATSGGGLSSYNEQFF	In	VDJ	1	15	3.519945182720355E-5	4.418613556895541E-5	48	TCRBV24						TCRBJ02	TCRBJ02-01	01	5	6	0	0	3	4	24	37	46	40	50		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSGGGLSSYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24		TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTGTTCTAGGAAATGAGCAGTTCTTCGGGCCA	CASSVLGNEQFF	In	VDJ	1	15	3.519945182720355E-5	4.418613556895541E-5	36	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	4	8	7	2	2	24	37	43	39	45	TCRBV24,TCRBV27					01,02								CASSVLGNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCATGTATCKCTGTGCCAGCAGCATCAGCGGGGGCGGGACCGGGGAGCTGTTTTTTGGAGAA	CASSISGGGTGELFF	In	VDJ	1	15	3.519945182720355E-5	4.418613556895541E-5	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	5	6	2	5	3	4	18	30	41	33	45	TCRBV07,TCRBV11													CASSISGGGTGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01*01	TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTACAAGACAGGGTACAATGAGCAGTTCTTCGGGCCA	CASSYKTGYNEQFF	In	VDJ	1	15	3.519945182720355E-5	4.418613556895541E-5	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	2	3	4	4	0	18	31	-1	35	42	TCRBV07,TCRBV11													CASSYKTGYNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGCCCCACTAGCGGGAAGGCCAAAAACATTCAGTACTTCGGCGCC	CASSPTSGKAKNIQYF	In	VDJ	1	15	3.519945182720355E-5	4.418613556895541E-5	48	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	5	3	3	1	3	2	19	31	44	34	46	TCRBV07,TCRBV11													CASSPTSGKAKNIQYF+X+TCRBJ02-04	unresolved	TCRBD02-01*02	TCRBJ02-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTTAGAGGGGGCGTGGGTAGTGGGGAATTCACCCCTCCACTTTGGGAAC	CASSLEGAWVVGNSPLHF	In	VDJ	1	15	3.519945182720355E-5	4.418613556895541E-5	54	TCRBV05			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	2	5	0	7	2	13	19	33	42	35	55		TCRBV05-06,TCRBV05-07												CASSLEGAWVVGNSPLHF+TCRBV05-X+TCRBJ01-06	TCRBV05	TCRBD01-01*01	TCRBJ01-06*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCCGACAGGGGTAGTTTTGGCACCGGGGAGCTGTTTTTTGGAGAA	CASSPDRGSFGTGELFF	In	VDJ	1	16	3.7546081949017114E-5	4.7131877940219106E-5	51	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	2	2	4	2	9	26	39	49	41	58		TCRBV03-01,TCRBV03-02												CASSPDRGSFGTGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD01-01*01	TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ARCYYRGKGACTCWGCTGTGTATTTYTGTGCCAGCAGCGTAGTGGGGGGGTACACTGAAGCTTTCTTTGGACAA	CASSVVGGYTEAFF	In	VDJ	1	16	3.7546081949017114E-5	4.7131877940219106E-5	42	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	5	9	0	3	5	1	26	38	50	43	51	TCRBV03,TCRBV12													CASSVVGGYTEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCCCCTATGAGGACAGGGGATAAGGCTACACCTTCGGTTCG	CASPYEDRG*GYTF	Stop	VDJ	1	16	3.7546081949017114E-5		42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	8	1	2	8	8	4	26	35	52	43	56		TCRBV03-01,TCRBV03-02												CASPYEDRG*GYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGAAACGCCAGGTGAGAGGGAACACTGAAGCTTTCTTTGGACAA	CSAKRQVRGNTEAFF	In	VDJ	1	16	3.7546081949017114E-5	4.7131877940219106E-5	45	TCRBV20						TCRBJ01	TCRBJ01-01	01	6	4	4	1	7	7	26	34	45	41	52		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAKRQVRGNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAAGGGGGGGCTCTACGAGCAGTACTTCGGGCCG	CSAKGGLYEQYF	In	VDJ	1	16	3.7546081949017114E-5	4.7131877940219106E-5	36	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	4	9	0	3	1	2	26	36	44	37	46		TCRBV20-01,TCRBV20-or09_02												CSAKGGLYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACCCAGGGGTGGAGAGACCCAGTACTTCGGGCCA	CSARPRGGETQYF	In	VDJ	1	16	3.7546081949017114E-5	4.7131877940219106E-5	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	4	2	4	2	3	26	38	46	40	49		TCRBV20-01,TCRBV20-or09_02												CSARPRGGETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGACAGGGACTACCTAGGGACCCAGTACTTCGGGCCA	CSARDRDYLGTQYF	In	VDJ	1	16	3.7546081949017114E-5	4.7131877940219106E-5	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	0	0	9	7	2	6	26	40	49	42	55		TCRBV20-01,TCRBV20-or09_02				01,02								CSARDRDYLGTQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGACCTTCTCGAAAAACTGTTTTTTGGCAGT	CSARDLLEKLFF	In	VDJ	1	16	3.7546081949017114E-5	4.7131877940219106E-5	36	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	0	4	10	8	1	4	26	40	43	41	47		TCRBV20-01,TCRBV20-or09_02				01,02								CSARDLLEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD02-01	TCRBJ01-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTTCTCGACACAGATACGCAGTATTTTGGCCCA	CSARVLDTDTQYF	In	VDJ	1	16	3.7546081949017114E-5	4.7131877940219106E-5	39	TCRBV20						TCRBJ02	TCRBJ02-03	01	1	2	8	2	5	0	26	39	-1	44	46		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARVLDTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTGTGCAGGTCCAAGAGACCCAGTACTTCGGGCCA	CSASVQVQETQYF	In	VDJ	1	16	3.7546081949017114E-5	4.7131877940219106E-5	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	4	4	1	4	1	26	37	45	41	46		TCRBV20-01,TCRBV20-or09_02												CSASVQVQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAACGGGGGACTAGCGGGGGGCCCCGGGGAGCTGTTTTTTGGAGAA	CANGGLAGGPGELFF	In	VDJ	1	16	3.7546081949017114E-5	4.7131877940219106E-5	45	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	10	0	1	6	4	2	22	29	48	33	50		TCRBV12-03,TCRBV12-04												CANGGLAGGPGELFF+TCRBV12-X+TCRBJ02-02	TCRBV12	TCRBD02-01*01	TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTTTCCTAACTAGCGAGACTGAGCAGTTCTTCGGGCCA	CASSFLTSETEQFF	In	VDJ	1	16	3.7546081949017114E-5	4.7131877940219106E-5	42	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	3	6	9	4	4	22	36	47	40	51		TCRBV12-03,TCRBV12-04				01,02								CASSFLTSETEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD02-01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGCTCGGACAGAGCTAATGAAAAACTGTTTTTTGGCAGT	CASSSDRANEKLFF	In	VDJ	1	16	3.7546081949017114E-5	4.7131877940219106E-5	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	7	1	5	3	3	2	24	35	44	38	46		TCRBV24-01,TCRBV24-or09_02												CASSSDRANEKLFF+TCRBV24-X+TCRBJ01-04	TCRBV24	TCRBD01-01*01	TCRBJ01-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGGGAGGACAGGGCTGGACAGCCCCAGCATTTTGGTGAT	CASREDRAGQPQHF	In	VDJ	1	16	3.7546081949017114E-5	4.7131877940219106E-5	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	7	1	3	7	3	5	24	35	46	38	51		TCRBV24-01,TCRBV24-or09_02												CASREDRAGQPQHF+TCRBV24-X+TCRBJ01-05	TCRBV24	TCRBD01-01*01	TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCATTGCCGGGACTAGTGAGACCCAGTACTTCGGGCCA	CASSIAGTSETQYF	In	VDJ	1	16	3.7546081949017114E-5	4.7131877940219106E-5	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	4	0	8	5	6	1	19	31	45	37	46	TCRBV07,TCRBV11					01,02								CASSIAGTSETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CTGGCAAGCCACGTTTGGTGCCAGCCAGACCTCTGTACCTCTGTGCCAGCACCGTCTAGCGGGACCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	16	3.7546081949017114E-5		40				TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	7	4	3	2	4	0	41	51	-1	55	64	TCRBV25,TCRBV27,TCRBV28	TCRBV25-01,TCRBV25-or09_02,TCRBV27-01,TCRBV28-01												X+X+TCRBJ02-07		TCRBD02-01*02	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTGGCGACCCCAGGGGACACTGAAGCTTTCTTTGGACAA	CASSLATPGDTEAFF	In	VDJ	1	16	3.7546081949017114E-5	4.7131877940219106E-5	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	4	2	3	8	0	18	32	-1	40	46	TCRBV05,TCRBV11													CASSLATPGDTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCRGCCATGTATCKCTGTGCCAGCAGCTTGGGAGCGTCAACAGGGGGCACTGAAGYTTTCTTTGGACAA	CASSLGASTGGTEXFF	In	VDJ	1	16	3.7546081949017114E-5	4.7131877940219106E-5	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	3	0	13	10	8	19	33	52	43	60	TCRBV07,TCRBV11													CASSLGASTGGTEXFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
SGACTCGGCYSTSTATCTCTGTGCCAGCAGCTCTCCGGGACGCTCGGCTGAAGCTTTCTTTGGACAA	CASSSPGRSAEAFF	In	VDJ	1	16	3.7546081949017114E-5	4.7131877940219106E-5	42	unresolved						TCRBJ01	TCRBJ01-01	01	3	0	7	6	4	6	19	32	41	36	47	TCRBV05,TCRBV07			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSPGRSAEAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGCAAGCCACGTTTGGTGCATCCTGAAGACAGCAGTTCTACATCTGCAGTGCTAGATGGGAGGGTTGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	16	3.7546081949017114E-5		37	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	2	9	0	7	1	1	44	56	64	57	65		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD02-01*02	TCRBJ01-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGGGGACTYGGCYGTGTATSTCTGTGCCAGCAGCTTAGCAGGGGCTTCGGGAAACACCATATATTTTGGAGAG	CASSLAGASGNTIYF	In	VDJ	1	16	3.7546081949017114E-5	4.7131877940219106E-5	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	0	5	2	4	0	5	22	-1	44	39	49	TCRBV07,TCRBV11													CASSLAGASGNTIYF+X+TCRBJ01-03	unresolved	TCRBD01-01*01	TCRBJ01-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTAGATGGGCAGACATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	16	3.7546081949017114E-5		43	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	8	0	5	6	4	24	36	46	42	50	TCRBV09,TCRBV21													X+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTGAAGGGCGATACGCAGTATTTTGGCCCA		Out	VDJ	1	17	3.989271207083068E-5		34	TCRBV12						TCRBJ02	TCRBJ02-03	01	5	5	3	6	2	1	26	38	44	40	45		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV12-X+TCRBJ02-03	TCRBV12		TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGTTACTAAGGGACGAGCAGTACTTCGGGCCG		Out	VDJ	1	17	3.989271207083068E-5		35	TCRBV06						TCRBJ02	TCRBJ02-07	01	1	5	3	5	1	0	24	40	-1	41	45		TCRBV06-05,TCRBV06-06		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-X+TCRBJ02-07	TCRBV06		TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCAAATTCGAATACCAAGAGACCCAGTACTTCGGGCCA	CASSKFEYQETQYF	In	VDJ	1	17	3.989271207083068E-5	5.00776203114828E-5	42	TCRBV03						TCRBJ02	TCRBJ02-05	01	5	2	8	0	6	2	26	38	46	44	48		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSKFEYQETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03		TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCAATAAGACTCCATTTACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	17	3.989271207083068E-5		55	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	5	2	10	5	5	14	26	38	47	43	61		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ02-06	TCRBV03	TCRBD02-01	TCRBJ02-06*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAACTCCACCGAATTCTTGCAGGGCCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	17	3.989271207083068E-5		46	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	10	4	3	3	17	1	26	30	52	47	53		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCAAACCTAGCGGCCCGAAACAATGAGCAGTTCTTCGGGCCA	CSANLAARNNEQFF	In	VDJ	1	17	3.989271207083068E-5	5.00776203114828E-5	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	4	5	5	4	6	26	34	45	38	51		TCRBV20-01,TCRBV20-or09_02				01,02								CSANLAARNNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACTGAGCGGGAGCCTCTACGAGCAGTACTTCGGGCCG	CSARLSGSLYEQYF	In	VDJ	1	17	3.989271207083068E-5	5.00776203114828E-5	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	6	2	3	3	3	26	38	49	41	52		TCRBV20-01,TCRBV20-or09_02												CSARLSGSLYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAAAGAACAGGGGGCAATGAGCAGTTCTTCGGGCCA	CSARERTGGNEQFF	In	VDJ	1	17	3.989271207083068E-5	5.00776203114828E-5	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	3	1	6	4	0	26	40	-1	44	52		TCRBV20-01,TCRBV20-or09_02												CSARERTGGNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCCAGCAAGACAGGGCTATGGCTACACCTTCGGTTCG	CSARDPARQGYGYTF	In	VDJ	1	17	3.989271207083068E-5	5.00776203114828E-5	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	2	3	4	8	0	26	40	-1	48	55		TCRBV20-01,TCRBV20-or09_02												CSARDPARQGYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATGTCGGGCCCACGGGACTAGCGGGGGAGCAGTACTTCGGGCCG	CSARDVGPTGLAGEQYF	In	VDJ	1	17	3.989271207083068E-5	5.00776203114828E-5	51	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	0	0	3	7	12	0	26	40	-1	52	65		TCRBV20-01,TCRBV20-or09_02												CSARDVGPTGLAGEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGGTCCCTCTTATAGCGGGGGGGCGGGATACGCAGTATTTTGGCCCA		Out	VDJ	1	17	3.989271207083068E-5		53	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	1	5	0	6	11	3	26	39	61	50	64		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTAGGGCAACAGGGGCGAGTGGCAATCAGCCCCAGCATTTTGGTGAT	CSASRATGASGNQPQHF	In	VDJ	1	17	3.989271207083068E-5	5.00776203114828E-5	51	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	3	2	2	7	6	26	37	51	44	57		TCRBV20-01,TCRBV20-or09_02												CSASRATGASGNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGGTGAGCCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	17	3.989271207083068E-5		35	TCRBV20						TCRBJ02	TCRBJ02-04	01	5	0	10	0	0	2	26	-1	37	35	39		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV20-X+TCRBJ02-04	TCRBV20		TCRBJ02-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTCGACTAGCGGGAGTATCAACGAGCAGTACTTCGGGCCG	CSASTSGSINEQYF	In	VDJ	1	17	3.989271207083068E-5	5.00776203114828E-5	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	2	2	5	2	5	26	35	49	37	54		TCRBV20-01,TCRBV20-or09_02												CSASTSGSINEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGATCTAGGGGCCAACTACGAGCAGTACGTCGGGCCG	CASSQDLGANYEQYV	In	VDJ	1	17	3.989271207083068E-5	5.00776203114828E-5	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	5	2	17	3	18	23	40	48	43	66	TCRBV01,TCRBV04													CASSQDLGANYEQYV+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGCCACAGGGACAGGGGGTTCGATGGCTACACCTTCGGTTCG	CATSHRDRGFDGYTF	In	VDJ	1	17	3.989271207083068E-5	5.00776203114828E-5	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	0	1	6	5	4	24	35	51	40	55		TCRBV24-01,TCRBV24-or09_02												CATSHRDRGFDGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAACACAGGAGCCCCCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	17	3.989271207083068E-5		43	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	11	3	4	2	5	6	24	31	41	36	47	TCRBV24,TCRBV27													X+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ARRRRGACTCAGCYGYGTATCTCTRCGCCAGCAGCTAAGGACAGGGACTCAATCAGCCCTAGCATTTTGGTGAT	XASS*GQGLNQP*HF	Stop	VDJ	1	17	3.989271207083068E-5		45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	1	3	14	2	14	22	35	45	37	59	TCRBV01,TCRBV07													XASS*GQGLNQP*HF+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAATCGCGGGAGCGAAAAACATTCAGTACTTCGGCGCC	CASSQIAGAKNIQYF	In	VDJ	1	18	4.2239342192644256E-5	5.302336268274649E-5	45	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	2	7	2	4	3	2	26	41	51	44	53		TCRBV03-01,TCRBV03-02												CASSQIAGAKNIQYF+TCRBV03-X+TCRBJ02-04	TCRBV03	TCRBD02-01*02	TCRBJ02-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAAGACAGAAGGGGCTACACCTTCGGTTCG	CASSQEDRRGYTF	In	VDJ	1	18	4.2239342192644256E-5	5.302336268274649E-5	39	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	2	5	8	1	4	26	43	49	44	53		TCRBV03-01,TCRBV03-02												CASSQEDRRGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCATCCACAGTGGGGGGTATGGCTACACCTTCGGTTCG	CASIHSGGYGYTF	In	VDJ	1	18	4.2239342192644256E-5	5.302336268274649E-5	39	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	3	9	1	5	4	0	26	40	-1	44	50		TCRBV03-01,TCRBV03-02												CASIHSGGYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD02-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAAGGGATTTGAACACTGAAGCTTTCTTTGGACAA	CSARRDLNTEAFF	In	VDJ	1	18	4.2239342192644256E-5	5.302336268274649E-5	39	TCRBV20						TCRBJ01	TCRBJ01-01	01	2	0	8	0	1	2	26	38	43	39	45		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARRDLNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGCCGGACAGGTTTGGGAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	18	4.2239342192644256E-5		44	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	1	1	4	6	2	6	26	39	48	41	54		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-04	TCRBV20	TCRBD01-01*01	TCRBJ02-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCGGCGCAAGGGCGGGGGAGCCCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	18	4.2239342192644256E-5		50	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	3	7	2	1	10	3	26	37	54	47	57		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGATTCAGGGGACACCCTTGGCTACGAGCAGTACTTCGGGCCG	CASSQDSGDTLGYEQYF	In	VDJ	1	18	4.2239342192644256E-5	5.302336268274649E-5	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	0	6	3	5	7	23	40	51	45	58	TCRBV01,TCRBV04													CASSQDSGDTLGYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTTTCGGGGGCGCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSFGGAGANVLTF	In	VDJ	1	18	4.2239342192644256E-5	5.302336268274649E-5	45	TCRBV12						TCRBJ02	TCRBJ02-06	01	3	6	0	2	1	1	22	36	43	37	44		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFGGAGANVLTF+TCRBV12-X+TCRBJ02-06	TCRBV12		TCRBJ02-06*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCCCTCACTAGCGGGCAGATCCTACGAGCAGTACTTCGGGCCG	CASSPSLAGRSYEQYF	In	VDJ	1	18	4.2239342192644256E-5	5.302336268274649E-5	48	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	3	4	1	5	4	24	36	50	41	54		TCRBV24-01,TCRBV24-or09_02				01,02								CASSPSLAGRSYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTCCGAACAGGGATTCGACTAATGAAAAACTGTTTTTTGGCAGT	CASSPNRDSTNEKLFF	In	VDJ	1	18	4.2239342192644256E-5	5.302336268274649E-5	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	3	3	2	4	5	24	36	46	40	51	TCRBV24,TCRBV27													CASSPNRDSTNEKLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATCGGGGTACAGCTATGGCTACACCTTCGGTTCG	CASSLSGYSYGYTF	In	VDJ	1	18	4.2239342192644256E-5	5.302336268274649E-5	42				TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	6	8	3	4	4	5	24	36	45	40	50	TCRBV24,TCRBV27	TCRBV24-01,TCRBV24-or09_02,TCRBV27-01												CASSLSGYSYGYTF+X+TCRBJ01-02		TCRBD02-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAACAAGGGGGAAGAGGGGTGTATGGGGCCAACGTCCTGACTTTCGGGGCC	CSAREQGGRGVYGANVLTF	In	VDJ	1	18	4.2239342192644256E-5	5.302336268274649E-5	57	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	0	5	1	3	3	12	24	38	47	41	59		TCRBV20-01,TCRBV20-or09_02												CSAREQGGRGVYGANVLTF+TCRBV20-X+TCRBJ02-06	TCRBV20	TCRBD01-01*01	TCRBJ02-06*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCCCGGGACCGCATGCGGATACGCAGTATTTTGGCCCA	CASSPGPHADTQYF	In	VDJ	1	18	4.2239342192644256E-5	5.302336268274649E-5	42	unresolved						TCRBJ02	TCRBJ02-03	01	5	0	7	6	2	8	18	30	37	32	45	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPGPHADTQYF+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGGGGACTCRGCYKTGTATKTCTGTGCCAGCAGCTTAACGTTCCAGGGAGGTATGGCTACACCTTCGGTTCG		Out	VDJ	1	18	4.2239342192644256E-5		44	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	2	9	1	5	8	0	18	33	-1	41	47	TCRBV09,TCRBV11													X+X+TCRBJ01-02	unresolved	TCRBD02-01*02	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCSTGTATSTCTGTGCCAGCAGCTTAGCCTTCAGTTTACAAGAGACCCAGTACTTCGGGCCA	CASSLAFSLQETQYF	In	VDJ	1	18	4.2239342192644256E-5	5.302336268274649E-5	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	0	4	5	2	3	4	18	35	41	38	45	TCRBV07,TCRBV11													CASSLAFSLQETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCRTGTATSKCTGTGCCAGCATCGTAACCCAGTACGGGACCACTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	18	4.2239342192644256E-5		50	unresolved						TCRBJ02	TCRBJ02-07	01	7	0	7	0	14	2	18	28	47	42	49	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCRTGTATCTCTGTGCCAGCAGCTTATTGGGCGCGAAACCGAACACTGAAGCTTTCTTTGGACAA	CASSLLGAKPNTEAFF	In	VDJ	1	18	4.2239342192644256E-5	5.302336268274649E-5	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	8	0	1	2	8	19	34	40	36	48	TCRBV07,TCRBV11													CASSLLGAKPNTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCMTSTATCTCTGTGCCAGCAGCCCAGGTGTTCTCACCGGGGAGCTGTTTTTTGGAGAA	CASSPGVLTGELFF	In	VDJ	1	18	4.2239342192644256E-5	5.302336268274649E-5	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	4	4	4	1	6	19	31	36	32	42	TCRBV05,TCRBV11													CASSPGVLTGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCCGACAAGGTTCGAGGGAGGTATCGTACGTCGGGCCG	CASSRQGSREVSYV	In	VDJ	1	18	4.2239342192644256E-5	5.302336268274649E-5	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	9	1	17	13	9	19	31	50	44	59	TCRBV05,TCRBV11													CASSRQGSREVSYV+X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GARGACTCGGCCCTSTATCTCTGTGCCAGCAGCTTGGGAGGGATCACCGGGGAGCTGTTTTTTGGAGAA	CASSLGGITGELFF	In	VDJ	1	18	4.2239342192644256E-5	5.302336268274649E-5	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	0	11	0	4	0	2	19	-1	40	35	42	TCRBV04,TCRBV05													CASSLGGITGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01*02	TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGTCAGACAGGGCGGGAACCTGAAGCTTTCTTTGGACAA	CASSQTGREPEAFF	In	VDJ	1	18	4.2239342192644256E-5	5.302336268274649E-5	42	TCRBV05			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	2	3	6	3	7	19	30	40	33	47		TCRBV05-06,TCRBV05-07												CASSQTGREPEAFF+TCRBV05-X+TCRBJ01-01	TCRBV05	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ACGTTTGGTGGAGCTTGGTRMTCTGCTGTGTATTTCTGTGCCAGCAGCCCAAGGGCAGGTTCTGGAGGTAAACTGTTTTTTGGCAGT	CASSPRAGSGGKLFF	In	VDJ	1	19	4.4585972314457824E-5	5.596910505401019E-5	45	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	4	10	1	11	14	1	36	49	68	63	69		TCRBV03-01,TCRBV03-02												CASSPRAGSGGKLFF+TCRBV03-X+TCRBJ01-04	TCRBV03	TCRBD02-01*02	TCRBJ01-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TRKMMCCWMYCAGACATCTGTGTAYYTCTRTGCCAGCAGACAGGGTTACGAGCAGTTCTTCGGGCCA	XASRQGYEQFF	In	VDJ	1	19	4.4585972314457824E-5	5.596910505401019E-5	33	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	3	3	10	0	4	27	-1	44	38	48	TCRBV06,TCRBV26													XASRQGYEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGACAGGGGGGAAACGCAGTATTTTGGCCCA	CASSQDRGETQYF	In	VDJ	1	19	4.4585972314457824E-5	5.596910505401019E-5	39	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	4	1	9	0	3	26	-1	50	43	53		TCRBV03-01,TCRBV03-02												CASSQDRGETQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD01-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGCGGTAGGTCCGAATGAAAAACTGTTTTTTGGCAGT	CASSQAVGPNEKLFF	In	VDJ	1	19	4.4585972314457824E-5	5.596910505401019E-5	45	TCRBV03						TCRBJ01	TCRBJ01-04	01	1	5	4	5	4	4	26	42	49	46	53		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQAVGPNEKLFF+TCRBV03-X+TCRBJ01-04	TCRBV03		TCRBJ01-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTCAACTAGCGGGGGGGGCCAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	19	4.4585972314457824E-5		47	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	3	0	4	3	2	26	38	54	41	56		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ARCYYRGKGACTCWGCTGTGTATTTYTGTGCCAGCAGGACCCGGGGGATCACGTATGGCTACACCTTCGGTTCG	CASRTRGITYGYTF	In	VDJ	1	19	4.4585972314457824E-5	5.596910505401019E-5	42	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	6	8	2	5	4	6	26	37	47	41	53	TCRBV03,TCRBV12													CASRTRGITYGYTF+X+TCRBJ01-02	unresolved	TCRBD02-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGGCCTCAGCGGGAGAGGTACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	19	4.4585972314457824E-5		40	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	9	6	2	3	5	4	26	31	44	36	48		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCAAGCGGGGGTCGGGCTCCTACAATGAGCAGTTCTTCGGGCCA	CSAKRGSGSYNEQFF	In	VDJ	1	19	4.4585972314457824E-5	5.596910505401019E-5	45	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	6	2	0	2	5	26	34	44	36	49		TCRBV20-01,TCRBV20-or09_02												CSAKRGSGSYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACGGGACCCCTTCGCCCTTATAGCAATCAGCCCCAGCATTTTGGTGAT	CSATGPLRPYSNQPQHF	In	VDJ	1	19	4.4585972314457824E-5	5.596910505401019E-5	51	TCRBV20						TCRBJ01	TCRBJ01-05	01	4	0	7	0	1	13	26	36	42	37	55		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSATGPLRPYSNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20		TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCGGGCCATCCTACGAGCAGTACTTCGGGCCG	CSASGPSYEQYF	In	VDJ	1	19	4.4585972314457824E-5	5.596910505401019E-5	36	TCRBV20						TCRBJ02	TCRBJ02-07	01	3	8	0	1	1	2	26	37	42	38	44		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSASGPSYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCAAGACTGGAACTACAATGAGCAGTTCTTCGGGCCA	CSAQDWNYNEQFF	In	VDJ	1	19	4.4585972314457824E-5	5.596910505401019E-5	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	2	10	3	3	4	26	35	42	38	46		TCRBV20-01,TCRBV20-or09_02				01,02								CSAQDWNYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAGCCACGTTTGGTGCATCCTGAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATACGGAAGCCGGGGAGCTGTTTTTTGGAGAA	CSARDTEAGELFF	In	VDJ	1	19	4.4585972314457824E-5	5.596910505401019E-5	39	TCRBV20						TCRBJ02	TCRBJ02-02	01	0	1	8	6	3	2	42	56	62	59	64		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDTEAGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20		TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCACTTCCAGTGGAAGACAGGGGGCGATGAACACCGGGGAGCTGTTTTTTGGAGAA	CASTSSGRQGAMNTGELFF	In	VDJ	1	19	4.4585972314457824E-5	5.596910505401019E-5	57	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	7	2	0	1	12	3	22	32	54	44	57		TCRBV12-03,TCRBV12-04												CASTSSGRQGAMNTGELFF+TCRBV12-X+TCRBJ02-02	TCRBV12	TCRBD01-01*01	TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGTCCCCGCGGGGAGAGCACCGGGGAGCTGTTTTTTGGAGAA	CASSPRGESTGELFF	In	VDJ	1	19	4.4585972314457824E-5	5.596910505401019E-5	45	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	5	7	3	4	4	4	22	34	44	38	48		TCRBV12-03,TCRBV12-04												CASSPRGESTGELFF+TCRBV12-X+TCRBJ02-02	TCRBV12	TCRBD02-01*01	TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTACGTTTGCGGGAGGCAGAGACCCAGTACTTCGGGCCA	CASSLRLREAETQYF	In	VDJ	1	19	4.4585972314457824E-5	5.596910505401019E-5	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	2	7	1	4	5	1	18	33	46	38	47	TCRBV07,TCRBV11													CASSLRLREAETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*02	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGGGGACTYRGCTKTGTATYTCTGTGCCAGCAGCTCGGGCCTGGAGACTGAAGCTTTCTTTGGACAA	CASSSGLETEAFF	In	VDJ	1	19	4.4585972314457824E-5	5.596910505401019E-5	39	unresolved						TCRBJ01	TCRBJ01-01	01	3	8	0	5	0	6	22	-1	40	36	46	TCRBV07,TCRBV09			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSGLETEAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCAGCGTAGGGAACTACAATGAGCAGTTCTTCGGGCCA	CASSVGNYNEQFF	In	VDJ	1	19	4.4585972314457824E-5	5.596910505401019E-5	39	unresolved						TCRBJ02	TCRBJ02-01	01	0	1	8	3	0	1	23	-1	42	39	43	TCRBV09,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVGNYNEQFF+X+TCRBJ02-01	unresolved		TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCAACCCGGGACAGACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	20	4.693260243627139E-5		37	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	0	5	3	5	0	26	34	-1	39	46		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATGTGCAGGGTGGCACTGAAGCTTTCTTTGGACAA	CSARDVQGGTEAFF	In	VDJ	1	20	4.693260243627139E-5	5.891484742527388E-5	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	4	3	4	4	3	26	40	49	44	52		TCRBV20-01,TCRBV20-or09_02												CSARDVQGGTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGGTACTAGGACTAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	20	4.693260243627139E-5		46	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	1	1	10	0	7	0	26	39	-1	46	51		TCRBV20-01,TCRBV20-or09_02				01,02								X+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCCAAACAAGAAATGAGCAGTTCTTCGGGCCA	CSASQTRNEQFF	In	VDJ	1	20	4.693260243627139E-5	5.891484742527388E-5	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	3	6	7	4	3	26	37	44	41	47		TCRBV20-01,TCRBV20-or09_02												CSASQTRNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTAGGCTCCAGGGGAATGAAAAACTGTTTTTTGGCAGT	CSASRLQGNEKLFF	In	VDJ	1	20	4.693260243627139E-5	5.891484742527388E-5	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	4	2	5	7	0	26	37	-1	44	50		TCRBV20-01,TCRBV20-or09_02												CSASRLQGNEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD01-01*01	TCRBJ01-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCAGGGGGGGGGTCTAGCACAGATACGCAGTATTTTGGCCCA	CSAPGGGSSTDTQYF	In	VDJ	1	20	4.693260243627139E-5	5.891484742527388E-5	45	TCRBV20						TCRBJ02	TCRBJ02-03	01	5	4	1	0	1	7	26	35	43	36	50		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAPGGGSSTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTGGGACAGGGGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	20	4.693260243627139E-5		38	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	2	4	1	2	26	35	46	36	48		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGGCCCCTCGAACGGCCTTCTGGAAACACCATATATTTTGGAGAG	CASRPLERPSGNTIYF	In	VDJ	1	20	4.693260243627139E-5	5.891484742527388E-5	48	TCRBV12						TCRBJ01	TCRBJ01-03	01	6	9	0	1	11	2	22	33	47	44	49		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRPLERPSGNTIYF+TCRBV12-X+TCRBJ01-03	TCRBV12		TCRBJ01-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGTGAGGGAGCCCAAGAGACCCAGTACTTCGGGCCA	CASSEGAQETQYF	In	VDJ	1	20	4.693260243627139E-5	5.891484742527388E-5	39	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	5	9	2	1	2	1	22	34	41	36	42	TCRBV02,TCRBV12													CASSEGAQETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*02	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGCTCGACTAGCGGGAGATGGTACGAGCAGTACTTCGGGCCG	CASSSTSGRWYEQYF	In	VDJ	1	20	4.693260243627139E-5	5.891484742527388E-5	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	2	2	4	3	4	23	34	49	37	53	TCRBV24,TCRBV27													CASSSTSGRWYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCTCCAGAGCAGGCGGGGAGCTGTTTTTTGGAGAA	CATSRAGGELFF	In	VDJ	1	20	4.693260243627139E-5	5.891484742527388E-5	36	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	9	4	4	7	7	0	24	33	-1	40	44		TCRBV24-01,TCRBV24-or09_02												CATSRAGGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD01-01*01	TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCATCAGTGACTATTTCGCGGGACTAGCGATTTCCCCTGCTTGGCCCA		Out	VDJ	1	20	4.693260243627139E-5		46	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	1	0	6	19	7	11	23	39	56	46	67	TCRBV06,TCRBV10					01,02								X+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCRTGTATCKCTGTGCCAGCAGCGCCCGACAGGGGGGAGGGGCCAACGTCCTGACTTTCGGGGCC	CASSARQGGGANVLTF	In	VDJ	1	20	4.693260243627139E-5	5.891484742527388E-5	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	2	1	4	4	2	18	30	43	34	45	TCRBV07,TCRBV11													CASSARQGGGANVLTF+X+TCRBJ02-06	unresolved	TCRBD01-01*01	TCRBJ02-06*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCRTGTATCKCTGTGCTAGCAGCCTGACAGGGGAGGATTTCCTAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	20	4.693260243627139E-5		50	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	2	2	0	2	8	18	30	40	32	48	TCRBV07,TCRBV11													X+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTGACCCGCCGGGACAGGGTTGGTGAGAGGCTGAAGCTTTCTTTGGACAA		Out	VDJ	1	20	4.693260243627139E-5		56	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	0	3	6	8	11	18	32	49	40	60	TCRBV05,TCRBV11													X+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCRGCCMTGTATCKCTGTGCCAGCAGCTTAGAGTGGGGGAACACTGAAGCTTTCTTTGGACAA	CASSLEWGNTEAFF	In	VDJ	1	20	4.693260243627139E-5	5.891484742527388E-5	42	unresolved						TCRBJ01	TCRBJ01-01	01	0	6	2	1	2	0	19	36	-1	38	42	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLEWGNTEAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGGGGACTCRGCYKTGTATYTCTGTGCCAGCAGCTGGGACCGTTCCTACGAGCAGTACGTCGGGCCG	CASSWDRSYEQYV	In	VDJ	1	20	4.693260243627139E-5	5.891484742527388E-5	39	unresolved						TCRBJ02	TCRBJ02-07	01	4	0	7	17	1	19	23	35	41	36	60	TCRBV07,TCRBV09			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSWDRSYEQYV+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAATTCAGAGATACGCAGTATTTTGGCCCA	CASSQFRDTQYF	In	VDJ	1	21	4.927923255808496E-5	6.186058979653757E-5	36	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	4	5	5	2	0	26	41	-1	43	46		TCRBV03-01,TCRBV03-02												CASSQFRDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD01-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTCGGAGAGACTGAAGCTTTCTTTGGACAA	CASSLGETEAFF	In	VDJ	1	21	4.927923255808496E-5	6.186058979653757E-5	36	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	4	10	2	5	2	2	26	39	45	41	47		TCRBV03-01,TCRBV03-02												CASSLGETEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD02-01*02	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACCGAGCGGGAGGCACAAATAAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CSATEREAQISSYNEQFF	In	VDJ	1	21	4.927923255808496E-5	6.186058979653757E-5	54	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	6	1	0	3	10	26	36	48	39	58		TCRBV20-01,TCRBV20-or09_02												CSATEREAQISSYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCGGTGGGGGACTAGGGACTTCTTCGGGCCA	CSARDRWGTRDFF	In	VDJ	1	21	4.927923255808496E-5	6.186058979653757E-5	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	0	8	16	7	4	26	40	55	47	59		TCRBV20-01,TCRBV20-or09_02				01,02								CSARDRWGTRDFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTAGTAGGGGCGGAACAGCCCCAGCATTTTGGTGAT	CSARVVGAEQPQHF	In	VDJ	1	21	4.927923255808496E-5	6.186058979653757E-5	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	1	5	2	7	4	5	26	39	48	43	53		TCRBV20-01,TCRBV20-or09_02												CSARVVGAEQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCTAGGGGGGCTACAACCGTATACAATGAGCAGTTCTTCGGGCCA	CSAPRGATTVYNEQFF	In	VDJ	1	21	4.927923255808496E-5	6.186058979653757E-5	48	TCRBV20						TCRBJ02	TCRBJ02-01	01	5	5	1	4	3	12	26	35	44	38	56		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAPRGATTVYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20		TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCACGTTTGGTGCCAGCCAGACCTCTGTACCTCTGTGCCAGCCAACTTGACACCACCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASQLDTTSGANVLTF	In	VDJ	1	21	4.927923255808496E-5	6.186058979653757E-5	48				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	8	2	6	0	6	4	33	42	52	48	56	TCRBV25,TCRBV27,TCRBV28	TCRBV25-01,TCRBV25-or09_02,TCRBV27-01,TCRBV28-01												CASQLDTTSGANVLTF+X+TCRBJ02-06		TCRBD01-01*01	TCRBJ02-06*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGGACTCGGCCSTGTATCTCTGTGCCAGCAGCGGCAGGGTTGGCAATGAGCAGTTCTTCGGGCCA	CASSGRVGNEQFF	In	VDJ	1	21	4.927923255808496E-5	6.186058979653757E-5	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	4	3	6	2	4	18	30	37	32	41	TCRBV05,TCRBV07													CASSGRVGNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCTCTGTCGGACACCACCTACGAGCAGTACTTCGGGCCG	CASSLALSDTTYEQYF	In	VDJ	1	21	4.927923255808496E-5	6.186058979653757E-5	48				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	1	6	2	6	3	18	35	46	41	49	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03												CASSLALSDTTYEQYF+X+TCRBJ02-07		TCRBD01-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCMTSTATCTCTGTGCCAGCAGCTTAGAGTTTAACACCGGGGAGCTGTTTTTTGGAGAA	CASSLEFNTGELFF	In	VDJ	1	21	4.927923255808496E-5	6.186058979653757E-5	42	unresolved			unresolved			TCRBJ02	TCRBJ02-02	01	2	11	2	2	1	3	19	33	37	34	40	TCRBV05,TCRBV11			TCRBD01,TCRBD02										CASSLEFNTGELFF+X+TCRBJ02-02	unresolved	unresolved	TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCTTGGCCCCGTTACAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	21	4.927923255808496E-5		40	TCRBV05			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	7	9	0	3	2	7	19	28	33	30	40		TCRBV05-06,TCRBV05-07												X+TCRBV05-X+TCRBJ01-05	TCRBV05	TCRBD01-01*01	TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGAGCTTGGTGACTCTGCTGTGTWTTCTGTGCCAGCAGCCAAAAATCCGGGACTAGCGGGCCGCCTACGAGCAGTACGTCGGGCCG		Out	VDJ	1	21	4.927923255808496E-5		52	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	19	0	4	17	22	18	29	27	61	49	79		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCGGGGACAGGGGGTGCCATCGGTGGCTACACCTTCGGTTCG	CASSPGTGGAIGGYTF	In	VDJ	1	22	5.162586267989853E-5	6.480633216780127E-5	48	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	0	1	7	2	9	26	39	52	41	61		TCRBV03-01,TCRBV03-02												CASSPGTGGAIGGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ARCYYRGKGACTCWGCTGTGTATTTYTGTGCCAGCAGGTTCATAGGGCAGCCCCAGCATTTTGGTGAT	CASRFIGQPQHF	In	VDJ	1	22	5.162586267989853E-5	6.480633216780127E-5	36	unresolved						TCRBJ01	TCRBJ01-05	01	6	5	3	7	6	0	26	37	-1	43	47	TCRBV03,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRFIGQPQHF+X+TCRBJ01-05	unresolved		TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAAGGACACCCAGATACGCAGTATTTTGGCCCA	CSAREGHPDTQYF	In	VDJ	1	22	5.162586267989853E-5	6.480633216780127E-5	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	1	6	4	1	2	26	40	46	41	48		TCRBV20-01,TCRBV20-or09_02												CSAREGHPDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATTTAGGACTTCGTGGCTATACCTTCGGTTCG	CSARDLGLRGYTF	In	VDJ	1	22	5.162586267989853E-5	6.480633216780127E-5	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	0	1	10	14	4	10	26	40	49	44	59		TCRBV20-01,TCRBV20-or09_02				01,02								CSARDLGLRGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD02-01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGGGCTAGCGGGGTCAGAGTCTCACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	22	5.162586267989853E-5		52	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	1	4	3	5	3	10	26	39	51	42	61		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGATCGAATGAGGGAAATAACTTACGAGCAGTACTTCGGGCCG	CASSQDRMREITYEQYF	In	VDJ	1	22	5.162586267989853E-5	6.480633216780127E-5	51	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	11	0	4	6	8	23	40	51	46	59	TCRBV01,TCRBV04													CASSQDRMREITYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTCCCCAGGGGGCCATTAATGGCTACACCTTCGGTTCG	CASSPQGAINGYTF	In	VDJ	1	22	5.162586267989853E-5	6.480633216780127E-5	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	4	0	6	3	5	22	34	45	37	50		TCRBV12-03,TCRBV12-04												CASSPQGAINGYTF+TCRBV12-X+TCRBJ01-02	TCRBV12	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCAGTGAAGAGGTCATAACATATGGCTACACCTTCGGTTCG	CASSEEVITYGYTF	In	VDJ	1	22	5.162586267989853E-5	6.480633216780127E-5	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	5	11	1	5	3	8	22	34	41	37	49	TCRBV09,TCRBV12													CASSEEVITYGYTF+X+TCRBJ01-02	unresolved	TCRBD02-01*02	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTCATCCTACGAGCAGTACTTCGGGCCG	CATSDSSYEQYF	In	VDJ	1	22	5.162586267989853E-5	6.480633216780127E-5	36	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	4	6	1	0	0	24	-1	-1	40	42		TCRBV24-01,TCRBV24-or09_02												CATSDSSYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGCCCTCGGGACCACAGATACGCAGTATTTTGGCCCA	CATSALGTTDTQYF	In	VDJ	1	22	5.162586267989853E-5	6.480633216780127E-5	42	TCRBV24						TCRBJ02	TCRBJ02-03	01	5	0	7	2	5	0	24	37	-1	42	47		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSALGTTDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24		TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTTAGGGCCAATCAGCCCCAGCATTTTGGTGAT	CASSFRANQPQHF	In	VDJ	1	22	5.162586267989853E-5	6.480633216780127E-5	39	TCRBV24						TCRBJ01	TCRBJ01-05	01	6	5	3	3	3	1	24	36	43	39	44		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFRANQPQHF+TCRBV24-X+TCRBJ01-05	TCRBV24		TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGATCCGAGCAAGGTGGCAATCAGCCCCAGCATTTTGGTGAT	CASRSEQGGNQPQHF	In	VDJ	1	22	5.162586267989853E-5	6.480633216780127E-5	45	unresolved						TCRBJ01	TCRBJ01-05	01	6	5	4	2	9	2	23	34	46	43	48	TCRBV06,TCRBV10			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRSEQGGNQPQHF+X+TCRBJ01-05	unresolved		TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTTAGCTCCAGGACAGGGGGTTACGAGCAATACTTCGGGCCG		Out	VDJ	1	22	5.162586267989853E-5		47	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	1	1	13	5	10	19	35	50	40	60	TCRBV07,TCRBV11													X+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCCTAGCGGTAGAAACCTACAATGAGCAGTTCTTCGGGCCA	CASSLAVETYNEQFF	In	VDJ	1	22	5.162586267989853E-5	6.480633216780127E-5	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	5	8	2	2	3	18	35	40	37	43	TCRBV07,TCRBV11					01,02								CASSLAVETYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGGGGACTCRGCYRTGTATCTCTGTGCCAGCAGCTTGGTTCCTTGGGTGGGGCAGGGTTGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	22	5.162586267989853E-5		56	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	4	3	0	16	1	19	33	54	49	55	TCRBV07,TCRBV11													X+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTTTTCGCCCGGGGGGAATTCACCCCTCCACTTTGGGAAC	CASSFSPGGNSPLHF	In	VDJ	1	22	5.162586267989853E-5	6.480633216780127E-5	45	TCRBV05			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-06	01	2	8	1	7	6	0	19	33	-1	39	46		TCRBV05-06,TCRBV05-07												CASSFSPGGNSPLHF+TCRBV05-X+TCRBJ01-06	TCRBV05	TCRBD02-01*01	TCRBJ01-06*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCGACCCGGGGCTCCTACATTTTGGTGAT	CASSDPGLLHF	In	VDJ	1	23	5.39724928017121E-5	6.775207453906497E-5	33	TCRBV12						TCRBJ01	TCRBJ01-05	01	6	7	0	16	6	5	26	37	48	43	53		TCRBV12-03,TCRBV12-04,TCRBV12-05		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSDPGLLHF+TCRBV12-X+TCRBJ01-05	TCRBV12		TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCGTGGGGACCAGGAGGTAGTGAGCAGTTCTTTGGGCCA	CASSPWGPGGSEQFF	In	VDJ	1	23	5.39724928017121E-5	6.775207453906497E-5	45	TCRBV03						TCRBJ02			4	0	7	22	4	23	26	39	48	43	71		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01			TCRBJ02-01,TCRBJ02-05						CASSPWGPGGSEQFF+TCRBV03-X+TCRBJ02-X	TCRBV03		TCRBJ02	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAATGATCCCGTGGGAGACCCAGTACTTCGGGCCA	CSARMIPWETQYF	In	VDJ	1	23	5.39724928017121E-5	6.775207453906497E-5	39	TCRBV20						TCRBJ02	TCRBJ02-05	01	2	0	10	5	10	0	26	38	-1	48	50		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARMIPWETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20		TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTACCAGGGGGCGGACAGATACGCAGTATTTTGGCCCA	CASSTRGRTDTQYF	In	VDJ	1	23	5.39724928017121E-5	6.775207453906497E-5	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	4	0	3	2	2	24	36	46	38	48		TCRBV24-01,TCRBV24-or09_02												CASSTRGRTDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD01-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATTTCCAATACTCTGAAGCGGGGACCAAAGAGACCCAGTACTTCGGGCCA	CSARDFQYSEAGTKETQYF	In	VDJ	1	23	5.39724928017121E-5	6.775207453906497E-5	57	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	0	6	3	3	15	4	24	38	60	53	64		TCRBV20-01,TCRBV20-or09_02												CSARDFQYSEAGTKETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGGACTCGGCCSTGTATCTCTGTGCCAGCAGCTTAGATGGCAGGTATGAGCAGTTCTTCGGGCCA	CASSLDGRYEQFF	In	VDJ	1	23	5.39724928017121E-5	6.775207453906497E-5	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	1	4	4	8	4	1	18	34	42	38	43	TCRBV05,TCRBV07,TCRBV11													CASSLDGRYEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCRTGTATCTCTGTGCCAGCAGAAACGGGGCAGCGAGACCTATAGGCTACACCTTCGGTTCG	CASRNGAARPIGYTF	In	VDJ	1	23	5.39724928017121E-5	6.775207453906497E-5	45	unresolved						TCRBJ01	TCRBJ01-02	01	6	7	0	8	4	13	19	30	39	34	52	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRNGAARPIGYTF+X+TCRBJ01-02	unresolved		TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AAGRAGACWCRGCWSYGTATCTCTGCGTCAGCAGCCAAGGACAGGGACTCAATCAGCCCCAGCATTTTGGTGAT	CVSSQGQGLNQPQHF	In	VDJ	1	24	5.631912292352567E-5	7.069781691032865E-5	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	1	2	3	3	0	3	23	-1	46	39	49	TCRBV01,TCRBV23													CVSSQGQGLNQPQHF+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCCAAGCGGGAGGAACACAGATACGCAGTATTTTGGCCCA	CSAPSGRNTDTQYF	In	VDJ	1	24	5.631912292352567E-5	7.069781691032865E-5	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	6	1	2	4	2	26	34	47	38	49		TCRBV20-01,TCRBV20-or09_02												CSAPSGRNTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAAAGATTCCCTAGCACGCACAGATACGCAGTATTTTGGCCCA	CSAKDSLARTDTQYF	In	VDJ	1	24	5.631912292352567E-5	7.069781691032865E-5	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	4	7	1	4	2	26	40	49	44	51		TCRBV20-01,TCRBV20-or09_02				01,02								CSAKDSLARTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGAAAGGGGGCGTGTACGAGCAGTACTTCGGGCCG	CSARKGGVYEQYF	In	VDJ	1	24	5.631912292352567E-5	7.069781691032865E-5	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	5	0	4	3	3	26	37	47	40	50		TCRBV20-01,TCRBV20-or09_02												CSARKGGVYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGGGCAACGGGGGGGGCCGAAAGATACGCAGTATTTTGGCCCA	CSAGQRGGPKDTQYF	In	VDJ	1	24	5.631912292352567E-5	7.069781691032865E-5	45	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	8	0	5	6	6	26	35	49	41	55		TCRBV20-01,TCRBV20-or09_02												CSAGQRGGPKDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACGAACCGGGACTAACGAATGAGCAGTTCTTCGGGCCA	CATSDEPGLTNEQFF	In	VDJ	1	24	5.631912292352567E-5	7.069781691032865E-5	45	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	0	9	7	6	3	24	38	51	44	54		TCRBV24-01,TCRBV24-or09_02				01,02								CATSDEPGLTNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CTMSCTCYCAGACWTCTGTKTACTTCTGTGCCAGCAGGAGAGCGGCATACACAGATACGCAGTATTTTGGCCCA	CASRRAAYTDTQYF	In	VDJ	1	24	5.631912292352567E-5	7.069781691032865E-5	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	6	5	2	3	4	26	37	45	40	49	TCRBV06,TCRBV10					01,02								CASRRAAYTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ACGACTCGGCCSTGTATCTCTGTGCCAGCAGCTTACTTCAGGGCAAATGGGGAAATTCACCCCTCCACTTTGGGAAC	CASSLLQGKWGNSPLHF	In	VDJ	1	24	5.631912292352567E-5	7.069781691032865E-5	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	2	4	3	7	3	10	18	33	41	36	51	TCRBV05,TCRBV07													CASSLLQGKWGNSPLHF+X+TCRBJ01-06	unresolved	TCRBD01-01*01	TCRBJ01-06*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCGGAAACAGGGGGATTAATGAAAAACTGTTTTTTGGCAGT	CASSGNRGINEKLFF	In	VDJ	1	24	5.631912292352567E-5	7.069781691032865E-5	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	3	1	4	4	2	18	30	42	34	44	TCRBV07,TCRBV11													CASSGNRGINEKLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCACCGGGACGCTTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	24	5.631912292352567E-5		46							TCRBJ02	TCRBJ02-01	01	0	0	7	4	3	3	18	35	43	38	46	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ02-01			TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCTTTCCTGGACCCAGGACGGACCCTCCTTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	24	5.631912292352567E-5		56	TCRBV03						TCRBJ02	TCRBJ02-07	01	4	1	7	4	7	17	25	38	49	45	66		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ02-07	TCRBV03		TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTGAGCGGGGGGGTCCCGAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	24	5.631912292352567E-5		50	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	3	6	0	0	1	3	19	32	43	33	46	TCRBV05,TCRBV07,TCRBV11													X+X+TCRBJ02-02	unresolved	TCRBD02-01*01	TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AACYSRRGGACTCAGCYRTGTAYTTYTGTGCCAGCTCAGGGTATAACTATGGCTACACCTTCGGTTCG	CASSGYNYGYTF	In	VDJ	1	25	5.866575304533924E-5	7.364355928159235E-5	36	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	12	4	3	1	5	2	26	31	41	36	43	TCRBV02,TCRBV12													CASSGYNYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTCCCAGAGGGACAGTATCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	25	5.866575304533924E-5		41	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	1	1	5	2	0	3	26	-1	45	39	48		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACAGATCGGACAGGGGGTTATTTGAATACGCAGTATTTTGGCCCA	CSATDRTGGYLNTQYF	In	VDJ	1	25	5.866575304533924E-5	7.364355928159235E-5	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	1	1	7	2	8	26	40	52	42	60		TCRBV20-01,TCRBV20-or09_02												CSATDRTGGYLNTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCCTGCCCGGGGGCGGAATTAACTATGGCTACACCTTCGGTTCG	CSASLPGGGINYGYTF	In	VDJ	1	25	5.866575304533924E-5	7.364355928159235E-5	48	TCRBV20						TCRBJ01	TCRBJ01-02	01	3	6	0	1	7	5	26	37	50	44	55		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSASLPGGGINYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20		TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCGTTCGGGACAGGGGGCAACAGCCCCAGCATTTTGGTGAT	CSASVRDRGQQPQHF	In	VDJ	1	25	5.866575304533924E-5	7.364355928159235E-5	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	0	0	7	5	2	26	37	54	42	56		TCRBV20-01,TCRBV20-or09_02												CSASVRDRGQQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGTGGAGCGGGCGGGGGGTATTGTCGGCAATGAGCAGTTCTTCGGGCCA	CSVERAGGIVGNEQFF	In	VDJ	1	25	5.866575304533924E-5	7.364355928159235E-5	48	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	7	7	1	6	8	9	26	33	49	41	58		TCRBV20-01,TCRBV20-or09_02												CSVERAGGIVGNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTGCGACAGACACCGGGGAGCTGTTTTTTGGAGAA	CASSATDTGELFF	In	VDJ	1	25	5.866575304533924E-5	7.364355928159235E-5	39	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	2	5	3	2	0	22	34	-1	36	41		TCRBV12-03,TCRBV12-04												CASSATDTGELFF+TCRBV12-X+TCRBJ02-02	TCRBV12	TCRBD01-01*01	TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGATGTGGGGAGTTTGGGCACCGGGGAGCTGTTTTTTGGAGAA	CASSQDVGSLGTGELFF	In	VDJ	1	25	5.866575304533924E-5	7.364355928159235E-5	51				TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	0	9	2	4	4	6	18	35	44	39	50	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03												CASSQDVGSLGTGELFF+X+TCRBJ02-02		TCRBD02-01*02	TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAACACACAGGGGTGGGAGACCCAGTACTTCGGGCCA	CASNTQGWETQYF	In	VDJ	1	26	6.101238316715281E-5	7.658930165285605E-5	39	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	7	3	2	5	4	3	26	36	47	40	50		TCRBV03-01,TCRBV03-02												CASNTQGWETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD01-01*01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTTGCAAATCCCTTCCGACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	26	6.101238316715281E-5		46	TCRBV03						TCRBJ02	TCRBJ02-01	01	4	4	6	5	3	11	26	39	44	42	55		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ02-01	TCRBV03		TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCATCCAAAAAGGGACAGGGGAAGGAACAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	26	6.101238316715281E-5		53	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	0	2	3	3	6	26	41	54	44	60		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ01-05	TCRBV03	TCRBD01-01*01	TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGCCGACTAGCGGATTGTACGAGCAGTACTTCGGGCCG	CSAPTSGLYEQYF	In	VDJ	1	26	6.101238316715281E-5	7.658930165285605E-5	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	2	5	4	3	4	26	34	46	37	50		TCRBV20-01,TCRBV20-or09_02				01,02								CSAPTSGLYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACGACTAGCGGGAGCCCCTACAATGAGCAGTTCTTCGGGCCA	CSATTSGSPYNEQFF	In	VDJ	1	26	6.101238316715281E-5	7.658930165285605E-5	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	2	2	2	1	2	26	36	49	37	51		TCRBV20-01,TCRBV20-or09_02												CSATTSGSPYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATAGCGGTACAGATACGCAGTATTTTGGCCCA	CSARDSGTDTQYF	In	VDJ	1	26	6.101238316715281E-5	7.658930165285605E-5	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	5	5	3	0	1	26	-1	46	40	47		TCRBV20-01,TCRBV20-or09_02				01,02								CSARDSGTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGTGCATCCTGAAGACAGCAGCTTTACATCTGCAGTGCTAGAGATGCGGGACTAAATTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	26	6.101238316715281E-5		41	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	21	0	9	4	23	3	32	25	55	48	58		TCRBV20-01,TCRBV20-or09_02				01,02								X+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCCTATAGTGGGGTAGGCGAGCAGTTCTTCGGGCCA	CASSPYSGVGEQFF	In	VDJ	1	27	6.335901328896638E-5	7.953504402411973E-5	42	TCRBV03						TCRBJ02	TCRBJ02-01	01	4	6	2	10	8	5	26	39	51	47	56		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPYSGVGEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03		TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCGAAGGATGTTCCATTTGCAAAGAAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	27	6.335901328896638E-5		53	TCRBV03						TCRBJ02	TCRBJ02-04	01	1	2	8	4	0	17	26	-1	44	42	61		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ02-04	TCRBV03		TCRBJ02-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGTCGACAGGGGTCGCAGCAGTACGTCGGGCCG	CASSRQGSQQYV	In	VDJ	1	27	6.335901328896638E-5	7.953504402411973E-5	36	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	2	2	17	2	13	26	37	47	39	60		TCRBV03-01,TCRBV03-02												CASSRQGSQQYV+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD01-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAAACGACAGGGCCGCCACAGATACGCAGTATTTTGGCCCA	CSARNDRAATDTQYF	In	VDJ	1	27	6.335901328896638E-5	7.953504402411973E-5	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	2	3	2	3	4	26	38	48	41	52		TCRBV20-01,TCRBV20-or09_02												CSARNDRAATDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATTTGGAGGGGGACAACTATGGCTACACCTTCGGTTCG	CSARDLEGDNYGYTF	In	VDJ	1	27	6.335901328896638E-5	7.953504402411973E-5	45	TCRBV20						TCRBJ01	TCRBJ01-02	01	0	5	1	2	5	2	26	40	51	45	53		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDLEGDNYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20		TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGCGACCGGGATCTCCTATGGCTACACCTTCGGTTCG	CSARATGISYGYTF	In	VDJ	1	27	6.335901328896638E-5	7.953504402411973E-5	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	1	8	3	4	4	4	26	39	48	43	52		TCRBV20-01,TCRBV20-or09_02												CSARATGISYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD02-01*02	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGGCGGTGGGAGGGATACGCAGTATTTTGGCCCA	CSARGGGRDTQYF	In	VDJ	1	27	6.335901328896638E-5	7.953504402411973E-5	39	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	9	1	6	7	0	26	37	-1	44	50		TCRBV20-01,TCRBV20-or09_02												CSARGGGRDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTCGCTCCGGGATACGCAGTATTTTGGCCCA	CATSDSLRDTQYF	In	VDJ	1	27	6.335901328896638E-5	7.953504402411973E-5	39	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	8	5	6	5	0	24	40	-1	45	48		TCRBV24-01,TCRBV24-or09_02				01,02								CATSDSLRDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCGGCCGAAGGGGGGGTAATGAAAAACTGTTTTTTGGCAGT	CASGRRGGNEKLFF	In	VDJ	1	27	6.335901328896638E-5	7.953504402411973E-5	42	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	11	9	0	4	9	0	24	31	-1	40	47	TCRBV24,TCRBV27													CASGRRGGNEKLFF+X+TCRBJ01-04	unresolved	TCRBD02-01*01	TCRBJ01-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTGGGGACCATAATTCACCCCTCCACTTTGGGAAC	CASSGDHNSPLHF	In	VDJ	1	27	6.335901328896638E-5	7.953504402411973E-5	39	unresolved						TCRBJ01	TCRBJ01-06	01	5	0	7	5	1	1	23	35	41	36	42	TCRBV06,TCRBV10			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSGDHNSPLHF+X+TCRBJ01-06	unresolved		TCRBJ01-06*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCCATCGTCCGCAGACGGGGGCCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSHRPQTGASYNEQFF	In	VDJ	1	27	6.335901328896638E-5	7.953504402411973E-5	54	unresolved						TCRBJ02	TCRBJ02-01	01	5	6	0	0	14	0	18	30	-1	44	50	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSHRPQTGASYNEQFF+X+TCRBJ02-01	unresolved		TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTTGGCACAGAGGGAAACTGAAGCTTTCTTTGGACAA	CASSLAQRETEAFF	In	VDJ	1	27	6.335901328896638E-5	7.953504402411973E-5	42	TCRBV05			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	0	11	0	5	4	2	19	35	44	39	46		TCRBV05-06,TCRBV05-07												CASSLAQRETEAFF+TCRBV05-X+TCRBJ01-01	TCRBV05	TCRBD02-01*02	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTAGGGGGAAGCACTGAAGCTTTCTTTGGACAA	CASSVGGSTEAFF	In	VDJ	1	27	6.335901328896638E-5	7.953504402411973E-5	39	unresolved			unresolved			TCRBJ01	TCRBJ01-01	01	5	5	1	4	2	3	24	36	44	38	47	TCRBV09,TCRBV21			TCRBD01,TCRBD02										CASSVGGSTEAFF+X+TCRBJ01-01	unresolved	unresolved	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTCGGGACTAGCTTCAGATACGCAGTATTTTGGCCCA	CASSSGLASDTQYF	In	VDJ	1	28	6.570564341077994E-5	8.248078639538343E-5	42	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	0	7	4	1	2	26	39	49	40	51		TCRBV12-03,TCRBV12-04				01,02								CASSSGLASDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCACGGAAACCTGGGGGAATGAGCAGTTCTTCGGGCCA	CATETWGNEQFF	In	VDJ	1	28	6.570564341077994E-5	8.248078639538343E-5	36	TCRBV03						TCRBJ02	TCRBJ02-01	01	10	6	1	7	9	0	26	33	-1	42	47		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATETWGNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03		TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGTTGGGGGGTTCGCGTACAATGAGCAGTTCTTCGGGCCA	CASSQVGGFAYNEQFF	In	VDJ	1	28	6.570564341077994E-5	8.248078639538343E-5	48	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	1	9	1	4	2	6	26	42	50	44	56		TCRBV03-01,TCRBV03-02												CASSQVGGFAYNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCACAGGGCCTCACAGATACGCAGTATTTTGGCCCA	CASSPQGLTDTQYF	In	VDJ	1	28	6.570564341077994E-5	8.248078639538343E-5	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	3	3	2	1	3	26	39	46	40	49		TCRBV03-01,TCRBV03-02												CASSPQGLTDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD01-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCGACAAAGACACCTACAATGAGCAGTTCTTCGGGCCA	CSADKDTYNEQFF	In	VDJ	1	28	6.570564341077994E-5	8.248078639538343E-5	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	2	6	2	1	6	26	34	39	35	45		TCRBV20-01,TCRBV20-or09_02												CSADKDTYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAGGGTACTGGCTACACCTTCGGTTCG	CSAREGTGYTF	In	VDJ	1	28	6.570564341077994E-5	8.248078639538343E-5	33	TCRBV20						TCRBJ01	TCRBJ01-02	01	0	0	9	7	0	3	26	-1	43	40	46		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAREGTGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20		TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGCCATGAAGGGGCCCGTTACAATGAGCAGTTCTTCGGGCCA	CSARGHEGARYNEQFF	In	VDJ	1	28	6.570564341077994E-5	8.248078639538343E-5	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	1	5	2	4	7	5	26	39	51	46	56		TCRBV20-01,TCRBV20-or09_02												CSARGHEGARYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTATTCCGGGGGGCACTGAAGCTTTCTTTGGACAA	CSAIPGGTEAFF	In	VDJ	1	28	6.570564341077994E-5	8.248078639538343E-5	36	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	4	8	1	4	3	0	26	36	-1	39	46		TCRBV20-01,TCRBV20-or09_02												CSAIPGGTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTCAGGGACGAGCAGTACTTCGGGCCG	CATSDFRDEQYF	In	VDJ	1	28	6.570564341077994E-5	8.248078639538343E-5	36	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	4	3	5	0	0	24	-1	-1	41	46		TCRBV24-01,TCRBV24-or09_02												CATSDFRDEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTCAGGTTTGGGCCCCTACGAGCAGTACTTCGGGCCG	CASSSGLGPYEQYF	In	VDJ	1	28	6.570564341077994E-5	8.248078639538343E-5	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	4	4	2	1	8	24	36	41	37	49		TCRBV24-01,TCRBV24-or09_02												CASSSGLGPYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTAAGGTTATGAACACTGAAGCTTTCTTTGGACAA	CASSKVMNTEAFF	In	VDJ	1	28	6.570564341077994E-5	8.248078639538343E-5	39	unresolved						TCRBJ01	TCRBJ01-01	01	5	5	4	0	1	3	23	35	39	36	42	TCRBV06,TCRBV10			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSKVMNTEAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCWMCCAGACAKCTSTKTACTTSTGTGCCAGCAGTTTAACGGGGGAGGGTCCAGATACGCAGTATTTTGGCCCA	CASSLTGEGPDTQYF	In	VDJ	1	28	6.570564341077994E-5	8.248078639538343E-5	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	4	9	0	4	6	2	23	36	49	42	51	TCRBV06,TCRBV24													CASSLTGEGPDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCCCTTTCAGGCACCGAAACACTGAAGCTTTCTTTGGACAA	CASSPFRHRNTEAFF	In	VDJ	1	28	6.570564341077994E-5	8.248078639538343E-5	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	4	4	2	5	6	18	30	39	35	45	TCRBV07,TCRBV11													CASSPFRHRNTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCCTCGGGACTAGCGGGGACCAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	28	6.570564341077994E-5		47	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	0	3	4	3	2	18	30	46	33	48	TCRBV07,TCRBV11													X+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
SGACTCGGCYRTGTATCTCTGTGCCAGCAGCTTTCTAGCGAGAGAAGAGACCCAGTACTTCGGGCCA	CASSFLAREETQYF	In	VDJ	1	28	6.570564341077994E-5	8.248078639538343E-5	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	3	4	6	3	1	4	19	33	40	34	44	TCRBV07,TCRBV11					01,02								CASSFLAREETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTTAAACAGGGTCGGCTATGGCTACACCTTCGGTTCG	CASSLNRVGYGYTF	In	VDJ	1	28	6.570564341077994E-5	8.248078639538343E-5	42	TCRBV05			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	3	3	4	2	4	19	33	41	35	45		TCRBV05-06,TCRBV05-07												CASSLNRVGYGYTF+TCRBV05-X+TCRBJ01-02	TCRBV05	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCMTSTATCKCTGTGCCAGCAGCTTAGCGCAGGGGCCAGATACGCAGTATTTTGGCCCA	CASSLAQGPDTQYF	In	VDJ	1	28	6.570564341077994E-5	8.248078639538343E-5	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	4	2	4	4	1	19	33	43	37	44	TCRBV05,TCRBV07													CASSLAQGPDTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGAGACCCCGGGACAGAGGTGGCTTTCTTTGGACAA	CASRDPGTEVAFF	In	VDJ	1	29	6.805227353259351E-5	8.542652876664713E-5	39	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	0	5	11	7	5	26	37	51	44	56		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASRDPGTEVAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCCCCACCGGGCATTTAGGGCGGCTACACCTTCGGTTCG	CASSPPPGI*GGYTF	Stop	VDJ	1	29	6.805227353259351E-5		45	TCRBV03						TCRBJ01	TCRBJ01-02	01	4	5	3	8	15	1	26	39	58	54	59		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPPPGI*GGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03		TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGGTCCCTCTCTGGGGAAAAACTGTTTTTTGGCAGT	CASSRSLSGEKLFF	In	VDJ	1	29	6.805227353259351E-5	8.542652876664713E-5	42	TCRBV03						TCRBJ01	TCRBJ01-04	01	4	0	9	8	11	0	26	39	-1	50	53		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRSLSGEKLFF+TCRBV03-X+TCRBJ01-04	TCRBV03		TCRBJ01-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCCCGGGACAGGGTATAGCTACACCTTCGGTTCG	CSAPGTGYSYTF	In	VDJ	1	29	6.805227353259351E-5	8.542652876664713E-5	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	0	3	9	4	4	26	34	47	38	51		TCRBV20-01,TCRBV20-or09_02												CSAPGTGYSYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCGGGGCGGGGCACACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	29	6.805227353259351E-5		46	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	7	3	2	5	2	26	40	51	45	53		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTTGGGCAGGCCCACACCTTCGGTTCG	CSARVGQAHTF	In	VDJ	1	29	6.805227353259351E-5	8.542652876664713E-5	33	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	4	4	12	5	3	26	39	48	44	51		TCRBV20-01,TCRBV20-or09_02												CSARVGQAHTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCCCATATTGGGGTAGCGGGAGGGTACGACGAGCAGTACTTCGGGCCG		Out	VDJ	1	29	6.805227353259351E-5		53	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	5	0	5	11	4	23	36	58	47	62	TCRBV01,TCRBV04													X+X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCATGAATTCAGAAAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASMNSESSYNEQFF	In	VDJ	1	29	6.805227353259351E-5	8.542652876664713E-5	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	7	4	5	0	6	4	22	32	41	38	45		TCRBV12-03,TCRBV12-04												CASMNSESSYNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD01-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCTACAGGGGGCATGGGAGCAGTACTTCGGGCCG	CASSLQGAWEQYF	In	VDJ	1	29	6.805227353259351E-5	8.542652876664713E-5	39	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	3	0	7	2	4	24	36	47	38	51		TCRBV24-01,TCRBV24-or09_02												CASSLQGAWEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGCTTGACAGGGGGCGAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	29	6.805227353259351E-5		46	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	2	0	1	0	1	18	-1	42	32	43	TCRBV07,TCRBV11													X+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATCGGGGTGAGACAGTTGAGCAGTTCTTCGGGCCA	CASSQDRGETVEQFF	In	VDJ	1	30	7.03989036544071E-5	8.837227113791082E-5	45	TCRBV03						TCRBJ02	TCRBJ02-01	01	0	2	5	9	9	1	26	43	57	52	58		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDRGETVEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03		TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGTGGGGGGCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	30	7.03989036544071E-5		44	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	1	9	1	2	2	0	26	42	-1	44	50		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGCTATCGGGGGAACACTGAAGCTTTCTTTGGACAA	CSYRGNTEAFF	In	VDJ	1	30	7.03989036544071E-5	8.837227113791082E-5	33	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	9	8	3	1	4	0	26	31	-1	35	40		TCRBV20-01,TCRBV20-or09_02												CSYRGNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGGGCTGGGGAGGGGTATGATGGCACCCCTCCACTTTGGGAAC		Out	VDJ	1	30	7.03989036544071E-5		40	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-06	01	5	9	0	11	1	9	26	35	43	36	52		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-06	TCRBV20	TCRBD02-01*02	TCRBJ01-06*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCAAAGGGTTCCTATGGCTACACCTTCGGTTCG	CSAKGSYGYTF	In	VDJ	1	30	7.03989036544071E-5	8.837227113791082E-5	33	TCRBV20						TCRBJ01	TCRBJ01-02	01	6	5	3	4	2	3	26	34	40	36	43		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAKGSYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20		TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATAACGCCCATTTGTTCGACGGCTACGAGCAGTACTTCGGGCCG	CSARDNAHLFDGYEQYF	In	VDJ	1	30	7.03989036544071E-5	8.837227113791082E-5	51	TCRBV20						TCRBJ02	TCRBJ02-07	01	0	2	7	3	16	2	26	40	59	56	61		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDNAHLFDGYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTATGACAGGGGGCGCGCCGAATGGCAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	30	7.03989036544071E-5		49	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	2	0	4	1	11	26	36	47	37	58		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTCGCCGGGACAACCGGTGGTGAAAACTGTTTTTTGGCAGT		Out	VDJ	1	30	7.03989036544071E-5		43	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	0	6	10	5	10	26	35	46	40	56		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD01-01*01	TCRBJ01-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGGAGGACTAGCGGGACCGGAGATACGCAGTATTTTGGCCCA	CASRRTSGTGDTQYF	In	VDJ	1	30	7.03989036544071E-5	8.837227113791082E-5	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	1	3	5	2	4	23	34	48	36	52	TCRBV06,TCRBV10													CASRRTSGTGDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCAGGGGGTCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	30	7.03989036544071E-5		43				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	5	1	2	0	1	18	-1	41	35	42	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03												X+X+TCRBJ02-03		TCRBD01-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGCTCCCGGACAGGGCTTTATACCGGGGAGCTGTTTTTTGGAGAA	CASSSRTGLYTGELFF	In	VDJ	1	30	7.03989036544071E-5	8.837227113791082E-5	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	1	3	5	3	6	19	32	43	35	49	TCRBV07,TCRBV11													CASSSRTGLYTGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCRGCCATGTATCKCTGTGCCAGCAGCCCACGACCCGATCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	30	7.03989036544071E-5		43	unresolved						TCRBJ01	TCRBJ01-05	01	5	2	7	3	4	5	19	31	38	35	43	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ01-05	unresolved		TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCRGCCMTSTATCKCTGTGCCAGCAGCCCAGCCGCCGACAGCAAACTACAGCATTTTGGTGAT	CASSPAADSKLQHF	In	VDJ	1	30	7.03989036544071E-5	8.837227113791082E-5	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	2	5	13	9	7	19	31	45	40	52	TCRBV05,TCRBV07													CASSPAADSKLQHF+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCGCAGTTCAGGTAGCGGGACCAGGCAATGAGCAGTTCTTCGGGCCA	CASSAVQVAGPGNEQFF	In	VDJ	1	30	7.03989036544071E-5	8.837227113791082E-5	51	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	5	3	6	10	5	19	31	49	41	54	TCRBV05,TCRBV11													CASSAVQVAGPGNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCACCCGGACTAGCGGGAGGTACCAAGAGACCCAGTACTTCGGGCCA	CASSTRTSGRYQETQYF	In	VDJ	1	31	7.274553377622066E-5	9.131801350917451E-5	51	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	5	1	1	0	4	1	26	38	56	42	57		TCRBV03-01,TCRBV03-02												CASSTRTSGRYQETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01*02	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTCCGGGACAGCTGAAGCTTTCTTTGGACAA	CASSSGTAEAFF	In	VDJ	1	31	7.274553377622066E-5	9.131801350917451E-5	36	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	5	6	3	0	26	38	-1	41	48		TCRBV03-01,TCRBV03-02												CASSSGTAEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCGGGCTAGCGGTCGTAAACCCTACGAGCAGTACTTCGGGCCG	CSARDRASGRKPYEQYF	In	VDJ	1	31	7.274553377622066E-5	9.131801350917451E-5	51	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	4	5	2	5	8	26	40	52	45	60		TCRBV20-01,TCRBV20-or09_02				01,02								CSARDRASGRKPYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATGATTTCCGGGGCGGGATGCAAGAAAAACTGTTTTTTGGCAGT	CSARDDFRGGMQEKLFF	In	VDJ	1	31	7.274553377622066E-5	9.131801350917451E-5	51	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	0	7	3	8	11	5	26	40	57	51	62		TCRBV20-01,TCRBV20-or09_02												CSARDDFRGGMQEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD02-01*02	TCRBJ01-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATGGTTTGGATTCTGGTGAGCAGTTCTTCGGGCCA	CSARDGLDSGEQFF	In	VDJ	1	31	7.274553377622066E-5	9.131801350917451E-5	42	TCRBV20						TCRBJ02	TCRBJ02-01	01	0	1	8	9	6	6	26	40	49	46	55		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDGLDSGEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20		TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCTAAGCGGGACAGGGGCTCCTACAATGAGCAGTTCTTCGGGCCA	CSAPKRDRGSYNEQFF	In	VDJ	1	31	7.274553377622066E-5	9.131801350917451E-5	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	0	2	0	7	0	26	35	-1	42	52		TCRBV20-01,TCRBV20-or09_02												CSAPKRDRGSYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTGAACTCACCAGGACCCAGAGCTCCTACGAGCAGTACGTCGGGCCG	CASSELTRTQSSYEQYV	In	VDJ	1	31	7.274553377622066E-5	9.131801350917451E-5	51	TCRBV12						TCRBJ02	TCRBJ02-07	01	5	1	7	17	10	23	22	34	48	44	71		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSELTRTQSSYEQYV+TCRBV12-X+TCRBJ02-07	TCRBV12		TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCCGCTAAAATGCCTAGGAGTGAGGGGCTCCACTTTGGGAAC		Out	VDJ	1	31	7.274553377622066E-5		43	TCRBV24						TCRBJ01	TCRBJ01-06	01	9	5	2	16	20	0	24	33	-1	53	58		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV24-X+TCRBJ01-06	TCRBV24		TCRBJ01-06*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCATGTATCKCTGTGCCAGCAGCCTTCGGACAGGGGGCGGGTATGAAAAACTGTTTTTTGGCAGT	CASSLRTGGGYEKLFF	In	VDJ	1	31	7.274553377622066E-5	9.131801350917451E-5	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	1	0	6	4	4	18	30	45	34	49	TCRBV07,TCRBV11													CASSLRTGGGYEKLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCCCTAGCGACGAGCTCCTACGAGCAGTACTTCGGGCCG	CASSLALATSSYEQYF	In	VDJ	1	31	7.274553377622066E-5	9.131801350917451E-5	48				TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	4	6	0	1	5	18	35	42	36	47	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03				01,02								CASSLALATSSYEQYF+X+TCRBJ02-07		TCRBD02-01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCCGGGACTTCGTCCTTAACAATGAGCAGTTCTTCGGGCCA	CASSRDFVLNNEQFF	In	VDJ	1	31	7.274553377622066E-5	9.131801350917451E-5	45	TCRBV05			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	0	10	5	1	9	19	31	38	32	47		TCRBV05-06,TCRBV05-07				01,02								CASSRDFVLNNEQFF+TCRBV05-X+TCRBJ02-01	TCRBV05	TCRBD02-01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGCTTGGKGACTCKGCYSTSTATYTCTGTGCCAGCAGCTTGACACAGGTTTTTCCCACAGATACGCAGTATTTTGGCCCA	CASSLTQVFPTDTQYF	In	VDJ	1	32	7.509216389803423E-5	9.426375588043821E-5	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	3	4	2	5	7	26	38	48	43	55	TCRBV03,TCRBV05													CASSLTQVFPTDTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAAAGGGCCGCGGGTAACACTGAAGCTTTCTTTGGACAA	CSARERAAGNTEAFF	In	VDJ	1	32	7.509216389803423E-5	9.426375588043821E-5	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	0	7	4	2	7	1	26	40	52	47	53		TCRBV20-01,TCRBV20-or09_02				01,02								CSARERAAGNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCAGTTCAGGGGTAACTATGGCTACACCTTCGGTTCG	CSAQFRGNYGYTF	In	VDJ	1	32	7.509216389803423E-5	9.426375588043821E-5	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	4	2	1	5	0	26	35	-1	40	46		TCRBV20-01,TCRBV20-or09_02												CSAQFRGNYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGATTTGGGATTAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	32	7.509216389803423E-5		47	unresolved						TCRBJ02	TCRBJ02-03	01	0	0	8	0	3	2	23	40	47	43	49	TCRBV01,TCRBV04			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGCCAATACGGATACCAAGAGACCCAGTACTTCGGGCCA	CATSQYGYQETQYF	In	VDJ	1	32	7.509216389803423E-5	9.426375588043821E-5	42	TCRBV24						TCRBJ02	TCRBJ02-05	01	7	1	8	0	7	1	24	35	45	42	46		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSQYGYQETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24		TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTTCCACTAGCGGGAGCACAGATACGCAGTATTTTGGCCCA	CATSSTSGSTDTQYF	In	VDJ	1	32	7.509216389803423E-5	9.426375588043821E-5	45	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	3	4	0	3	0	24	36	-1	39	48		TCRBV24-01,TCRBV24-or09_02				01,02								CATSSTSGSTDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTAATAGGGGATACGCAGTATTTTGGCCCA	CASSLIGDTQYF	In	VDJ	1	32	7.509216389803423E-5	9.426375588043821E-5	36	TCRBV24						TCRBJ02	TCRBJ02-03	01	6	5	3	6	5	0	24	36	-1	41	45		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLIGDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24		TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCTTGGGAACGGGAGGGCTTGACGAGCAGTACTTCGGGCCG	CASSLGTGGLDEQYF	In	VDJ	1	32	7.509216389803423E-5	9.426375588043821E-5	45				TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	8	0	5	3	4	18	34	45	37	49	TCRBV05,TCRBV07	TCRBV05-08,TCRBV07-02												CASSLGTGGLDEQYF+X+TCRBJ02-07		TCRBD02-01*02	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ACGACTCGGCCSTGTATCTCTGTGCTAGCAGCTTACGGCGGACCGGGGAGCTGTTTTTTGGAGAA	CASSLRRTGELFF	In	VDJ	1	32	7.509216389803423E-5	9.426375588043821E-5	39	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	2	7	5	5	2	0	18	33	-1	35	39	TCRBV05,TCRBV07					01,02								CASSLRRTGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01	TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGATTTTCTGGGGCCGTACGAGCAGTACTTCGGGCCG	CASSQDFLGPYEQYF	In	VDJ	1	32	7.509216389803423E-5	9.426375588043821E-5	45				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	7	0	4	6	2	18	35	46	41	48	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03												CASSQDFLGPYEQYF+X+TCRBJ02-07		TCRBD01-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAACCCGGGCGGGGGGAACACTGAAGCTTTCTTTGGACAA	CASNPGGGNTEAFF	In	VDJ	1	32	7.509216389803423E-5	9.426375588043821E-5	42	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	7	7	2	1	6	0	19	29	-1	35	42	TCRBV07,TCRBV11													CASNPGGGNTEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AAGCCACGTTTGGTGCCAGCCAGACCTCTGTACCTCTGTGCCAGCAGTTTACAGGGGGGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSLQGGSYNEQFF	In	VDJ	1	33	7.74387940198478E-5	9.72094982517019E-5	45				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	4	1	0	0	1	36	-1	58	51	59	TCRBV27,TCRBV28	TCRBV27-01,TCRBV28-01												CASSLQGGSYNEQFF+X+TCRBJ02-01		TCRBD01-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAGAAGGGGGCTGGAAACACCATATATTTTGGAGAG	CASSQEKGAGNTIYF	In	VDJ	1	33	7.74387940198478E-5	9.72094982517019E-5	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	0	5	1	2	2	0	26	43	-1	45	51		TCRBV03-01,TCRBV03-02												CASSQEKGAGNTIYF+TCRBV03-X+TCRBJ01-03	TCRBV03	TCRBD01-01*01	TCRBJ01-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTACCGACAGGGGTGGTTTCTCTTCGGGCCA	CASSYRQGWFLF	In	VDJ	1	33	7.74387940198478E-5	9.72094982517019E-5	36	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	2	2	17	4	7	26	38	50	42	57		TCRBV03-01,TCRBV03-02												CASSYRQGWFLF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD01-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGACCTTCTCGGGGGCACACACACAGATACGCAGTATTTTGGCCCA	CSARDLLGGTHTDTQYF	In	VDJ	1	33	7.74387940198478E-5	9.72094982517019E-5	51	TCRBV20						TCRBJ02	TCRBJ02-03	01	0	6	0	2	7	5	26	40	53	47	58		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDLLGGTHTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTGTCGATACCGGGACAGAGAACACTGAAGCTTTCTTTGGACAA	CSASVDTGTENTEAFF	In	VDJ	1	33	7.74387940198478E-5	9.72094982517019E-5	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	0	5	1	10	1	26	37	54	47	55		TCRBV20-01,TCRBV20-or09_02												CSASVDTGTENTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGTGACCCGGGCAGCCAAGAGACCCAGTACTTCGGGCCA	CASSDPGSQETQYF	In	VDJ	1	33	7.74387940198478E-5	9.72094982517019E-5	42	unresolved						TCRBJ02	TCRBJ02-05	01	5	8	0	1	5	2	22	34	43	39	45	TCRBV02,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSDPGSQETQYF+X+TCRBJ02-05	unresolved		TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCAACCAGACAGCTCTTTACTTCTGTACCCTCCCACTAGCGGGAGTTGGGGAGACCCAGTACTTCGGGCCA	CTLPLAGVGETQYF	In	VDJ	1	33	7.74387940198478E-5	9.72094982517019E-5	42	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	15	3	2	5	8	5	24	27	46	35	51		TCRBV24-01,TCRBV24-or09_02												CTLPLAGVGETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD02-01*02	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGAGGGACATCAAGAGACCCAGTACTTCGGGCCA	CASSQEGHQETQYF	In	VDJ	1	33	7.74387940198478E-5	9.72094982517019E-5	42				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	0	0	6	2	0	1	18	-1	41	35	42	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03												CASSQEGHQETQYF+X+TCRBJ02-05		TCRBD01-01*01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGTATCTCTGTGCCAGCAGCTTAGCCGACGATAGCGGGGGGGCCGTGGACCCTGGCCGCCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	33	7.74387940198478E-5		67				TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	2	5	0	6	9	16	8	22	42	31	58	TCRBV05,TCRBV07,TCRBV11	TCRBV05-04,TCRBV05-05,TCRBV05-08,TCRBV07-02,TCRBV07-09,TCRBV11-01												X+X+TCRBJ02-02		TCRBD02-01*01	TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGAGGGCAGGGAGGTCAGGAACTATGGCTACACCTTCGGTTCG	CASSQEGREVRNYGYTF	In	VDJ	1	34	7.978542414166136E-5	1.001552406229656E-4	51	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	0	9	1	2	5	5	23	40	51	45	56	TCRBV01,TCRBV04													CASSQEGREVRNYGYTF+X+TCRBJ01-02	unresolved	TCRBD02-01*02	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGCGGGACAGGGGCTCAGCCCCAGCATTTTGGTGAT	CASSRGTGAQPQHF	In	VDJ	1	34	7.978542414166136E-5	1.001552406229656E-4	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	0	2	6	2	1	26	39	51	41	52		TCRBV03-01,TCRBV03-02												CASSRGTGAQPQHF+TCRBV03-X+TCRBJ01-05	TCRBV03	TCRBD01-01*01	TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTCCGAGGAAGCGGGGGACCGATACGCAGTATTTTGGCCCA		Out	VDJ	1	34	7.978542414166136E-5		47	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	6	2	6	8	3	26	39	55	47	58		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGCTTGGKGACTCKGCYRTGTATYTCTGTGCCAGCAGCTTGGGACTAGCGGGAACTATCTACGAGCAGTACTTCGGGCCG	CASSLGLAGTIYEQYF	In	VDJ	1	34	7.978542414166136E-5	1.001552406229656E-4	48	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	0	3	3	2	5	26	38	53	40	58	TCRBV03,TCRBV11													CASSLGLAGTIYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCCGGGGGGCTGGGCACGGGGAGCTGTTTTTTGGAGAA	CASRGAGHGELFF	In	VDJ	1	34	7.978542414166136E-5	1.001552406229656E-4	39	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	8	8	1	7	0	7	26	-1	42	35	49		TCRBV03-01,TCRBV03-02												CASRGAGHGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD02-01*01	TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCAACCCAGCTGAGGGATACGCAGTATTTTGGCCCA	CSATQLRDTQYF	In	VDJ	1	34	7.978542414166136E-5	1.001552406229656E-4	36	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	11	1	6	9	0	26	34	-1	43	47		TCRBV20-01,TCRBV20-or09_02												CSATQLRDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCCCGGGACTTTCACAGATACGCAGTATTTTGGCCCA	CSAPGTFTDTQYF	In	VDJ	1	34	7.978542414166136E-5	1.001552406229656E-4	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	0	10	2	4	2	26	34	44	38	46		TCRBV20-01,TCRBV20-or09_02				01,02								CSAPGTFTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCCGGGAGACTCCCGCGCCGGGGAGCTGTTTTTTGGAGAA	CSAPGDSRAGELFF	In	VDJ	1	34	7.978542414166136E-5	1.001552406229656E-4	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	6	8	2	6	2	9	26	34	42	36	51		TCRBV20-01,TCRBV20-or09_02												CSAPGDSRAGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD02-01*02	TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACGCGGGGCAGGGTCCTCCTACAATGAGCAGTTCTTCGGGCCA	CSARRGAGSSYNEQFF	In	VDJ	1	34	7.978542414166136E-5	1.001552406229656E-4	48	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	2	7	3	0	1	7	26	38	45	39	52		TCRBV20-01,TCRBV20-or09_02												CSARRGAGSSYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAATTGTCAGGGACGGGCACTGAAGCTTTCTTTGGACAA	CASSELSGTGTEAFF	In	VDJ	1	34	7.978542414166136E-5	1.001552406229656E-4	45	TCRBV06						TCRBJ01	TCRBJ01-01	01	2	0	7	4	6	3	23	38	49	44	52		TCRBV06-01,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSELSGTGTEAFF+TCRBV06-X+TCRBJ01-01	TCRBV06		TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAACTCAATGAAGACAGGGCTGGGCGAAAAACTGTTTTTTGGCAGT	CASNSMKTGLGEKLFF	In	VDJ	1	34	7.978542414166136E-5	1.001552406229656E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	7	2	3	8	10	6	18	28	45	38	51	TCRBV07,TCRBV11													CASNSMKTGLGEKLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTTAGCGTCAGGGGGGAGCACAGATACGCAGTATTTTGGCCCA	CASSLASGGSTDTQYF	In	VDJ	1	34	7.978542414166136E-5	1.001552406229656E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	4	1	0	2	1	18	35	44	37	45	TCRBV07,TCRBV11													CASSLASGGSTDTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGCGAAACAGGGGGCTCGGCCGGGGAGCTGTTTTTTGGAGAA	CASSETGGSAGELFF	In	VDJ	1	34	7.978542414166136E-5	1.001552406229656E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	3	0	6	3	4	19	31	43	34	47	TCRBV07,TCRBV11													CASSETGGSAGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ACTYGGCYGTGTATCTCTGTGCCAGCAGCTTCGGACAGGCGGCACTTGAGCCGGTCCGGTTTTTTTCTCGAGCAGTACGTCGGGCCG		Out	VDJ	1	34	7.978542414166136E-5		64	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	1	4	17	2	40	15	28	37	30	77	TCRBV07,TCRBV11													X+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGGACTCSGCCSTSTATCTCTGTGCCAGCTCCTTATCTTACCACAGATCGGTGCTAAAGGGCTACACCTTCGGTTCG	CASSLSYHRSVLKGYTF	In	VDJ	1	35	8.213205426347493E-5	1.031009829942293E-4	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	8	3	5	8	13	13	20	29	46	42	59	TCRBV05,TCRBV07													CASSLSYHRSVLKGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAAGGCGGAGGGGCAAGGGGGCAGAGAGACCCAGTACTTCGGGCCA	CSAKAEGQGGRETQYF	In	VDJ	1	35	8.213205426347493E-5	1.031009829942293E-4	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	5	0	4	13	2	26	36	56	49	58		TCRBV20-01,TCRBV20-or09_02												CSAKAEGQGGRETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCCGCGGGAGGTCTACGAGCAGTACTTCGGGCCG	CSARDPREVYEQYF	In	VDJ	1	35	8.213205426347493E-5	1.031009829942293E-4	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	7	1	3	3	1	26	40	51	43	52		TCRBV20-01,TCRBV20-or09_02												CSARDPREVYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGTTATCTAGAGTCGGTGAGCAGTTCTTCGGGCCA	CSARLSRVGEQFF	In	VDJ	1	35	8.213205426347493E-5	1.031009829942293E-4	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	4	8	9	5	6	26	37	46	42	52		TCRBV20-01,TCRBV20-or09_02				01,02								CSARLSRVGEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGACCCGGGACACCATAACTATGGCTACACCTTCGGTTCG	CASSQDPGHHNYGYTF	In	VDJ	1	35	8.213205426347493E-5	1.031009829942293E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	0	6	1	3	3	23	40	49	43	52	TCRBV01,TCRBV04													CASSQDPGHHNYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGACGGCTGGACCTACAATGAGCAGTTCTTCGGGCCA	CASSQDGWTYNEQFF	In	VDJ	1	35	8.213205426347493E-5	1.031009829942293E-4	45	unresolved						TCRBJ02	TCRBJ02-01	01	0	1	8	2	5	0	23	40	-1	45	48	TCRBV01,TCRBV04			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDGWTYNEQFF+X+TCRBJ02-01	unresolved		TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGCCCCCTGGCTAGCGGATCCCCCGGGGAGCTGTTTTTTGGAGAA	CASSPLASGSPGELFF	In	VDJ	1	35	8.213205426347493E-5	1.031009829942293E-4	48	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	7	4	5	6	8	5	24	35	50	43	55		TCRBV24-01,TCRBV24-or09_02				01,02								CASSPLASGSPGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD02-01	TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGGCCCGGGACGGCCTACAATGAGCAGTTCTTCGGGCCA	CASRPGTAYNEQFF	In	VDJ	1	35	8.213205426347493E-5	1.031009829942293E-4	42	TCRBV24						TCRBJ02	TCRBJ02-01	01	7	0	7	2	4	2	24	35	44	39	46		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRPGTAYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24		TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTAGGACGGCCGGGGGGTACAATGAGCAGTTCTTCGGGCCA	CASSRTAGGYNEQFF	In	VDJ	1	35	8.213205426347493E-5	1.031009829942293E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	8	1	4	8	0	24	36	-1	44	51	TCRBV24,TCRBV27													CASSRTAGGYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTTACGGATATAGCACAGATACGCAGTATTTTGGCCCA	CASSYGYSTDTQYF	In	VDJ	1	35	8.213205426347493E-5	1.031009829942293E-4	42	unresolved						TCRBJ02	TCRBJ02-03	01	6	1	8	0	3	3	24	36	42	39	45	TCRBV24,TCRBV27			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYGYSTDTQYF+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGGGGACTAGCGGGTCGAGCAGATACGCAGTATTTTGGCCCA	CASRGLAGRADTQYF	In	VDJ	1	35	8.213205426347493E-5	1.031009829942293E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	0	4	4	0	5	23	-1	46	34	51	TCRBV02,TCRBV12					01,02								CASRGLAGRADTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCACCGAGGGGGACTAACAACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	36	8.447868438528851E-5		43	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	7	0	9	5	6	3	24	34	47	40	50	TCRBV06,TCRBV10					01,02								X+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGCACCGGGACCTCGGCAGACCCAGTACTTCGGGCCA	CASSQAPGPRQTQYF	In	VDJ	1	36	8.447868438528851E-5	1.0604672536549298E-4	45	TCRBV03						TCRBJ02	TCRBJ02-05	01	1	0	7	6	4	6	26	42	51	46	57		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQAPGPRQTQYF+TCRBV03-X+TCRBJ02-05	TCRBV03		TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCGTGAACGGGACTATGTACGAGCAGTACGTCGGGCCG		Out	VDJ	1	36	8.447868438528851E-5		44	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	0	9	17	7	15	26	39	53	46	68		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAAGGGTGAACTATGGCTACACCTTCGGTTCG	CSARRVNYGYTF	In	VDJ	1	36	8.447868438528851E-5	1.0604672536549298E-4	36	TCRBV20						TCRBJ01	TCRBJ01-02	01	2	5	3	2	0	2	26	-1	42	38	44		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARRVNYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20		TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATAGAGGACAGGGCACTGAAGCTTTCTTTGGACAA	CSARDRGQGTEAFF	In	VDJ	1	36	8.447868438528851E-5	1.0604672536549298E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	1	3	4	4	0	26	40	-1	44	52		TCRBV20-01,TCRBV20-or09_02												CSARDRGQGTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATTCTAGCGGGAGGGTCACAGATACGCAGTATTTTGGCCCA	CSARDSSGRVTDTQYF	In	VDJ	1	36	8.447868438528851E-5	1.0604672536549298E-4	48	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	0	4	0	2	2	1	26	40	54	42	55		TCRBV20-01,TCRBV20-or09_02												CSARDSSGRVTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGGACTCGGCCSTGTATCTCTGTGCCAGCAGCCGACAGGGCTCCTACGAGCAGTACGTCGGGCCG	CASSRQGSYEQYV	In	VDJ	1	36	8.447868438528851E-5	1.0604672536549298E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	2	3	17	1	17	18	30	38	31	55	TCRBV05,TCRBV07													CASSRQGSYEQYV+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGATGGGCACAATAATTCACCCCTCCACTTTGGGAAC	CASSQDGHNNSPLHF	In	VDJ	1	36	8.447868438528851E-5	1.0604672536549298E-4	45				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	0	8	0	5	1	3	18	35	40	36	43	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03												CASSQDGHNNSPLHF+X+TCRBJ01-06		TCRBD01-01*01	TCRBJ01-06*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AAGRAGACWCRGCWSYGTATCTCTGCGCCAGCAGCCAATCTCGGGCGGCGAATTCACCCCTCCACTTTGGGAAC	CASSQSRAANSPLHF	In	VDJ	1	37	8.682531450710208E-5	1.0899246773675668E-4	45	unresolved						TCRBJ01	TCRBJ01-06	01	2	8	0	7	4	4	23	38	46	42	50	TCRBV01,TCRBV23			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQSRAANSPLHF+X+TCRBJ01-06	unresolved		TCRBJ01-06*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATCCTCCCCGGGACAGAACCACAGATACGCAGTATTTTGGCCCA	CASSQDPPRDRTTDTQYF	In	VDJ	1	37	8.682531450710208E-5	1.0899246773675668E-4	54	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	0	5	2	8	3	26	43	58	51	61		TCRBV03-01,TCRBV03-02												CASSQDPPRDRTTDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD01-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAATGCTGGAGGGGGCTGGAACTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CNAGGGWNSGANVLTF	In	VDJ	1	37	8.682531450710208E-5	1.0899246773675668E-4	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	1	7	0	0	0	5	26	-1	44	39	49		TCRBV20-01,TCRBV20-or09_02												CNAGGGWNSGANVLTF+TCRBV20-X+TCRBJ02-06	TCRBV20	TCRBD01-01*01	TCRBJ02-06*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGAGGGGGCTCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	37	8.682531450710208E-5		37	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	6	5	1	0	1	0	26	34	-1	35	41		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-03	TCRBV20	TCRBD01-01*01	TCRBJ01-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAATGCCTGGACAGGGGGTTCCTACAATGAGCAGTTCTTCGGGCCA	CSANAWTGGSYNEQFF	In	VDJ	1	37	8.682531450710208E-5	1.0899246773675668E-4	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	1	1	1	6	1	26	36	52	42	53		TCRBV20-01,TCRBV20-or09_02												CSANAWTGGSYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGCCCGGGACAGGGTGACAGATACGCAGTATTTTGGCCCA	CSARARDRVTDTQYF	In	VDJ	1	37	8.682531450710208E-5	1.0899246773675668E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	1	0	3	3	3	2	26	39	51	42	53		TCRBV20-01,TCRBV20-or09_02												CSARARDRVTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCCCCGGGACAGGATTTAACACCGGGGAGCTGTTTTTTGGAGAA	CSASPGTGFNTGELFF	In	VDJ	1	37	8.682531450710208E-5	1.0899246773675668E-4	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	0	4	2	4	4	26	37	49	41	53		TCRBV20-01,TCRBV20-or09_02												CSASPGTGFNTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD01-01*01	TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCTTTCCGGACAGGGAGATCTTAGCTACACCTTCGGTTCG	CSALSGQGDLSYTF	In	VDJ	1	37	8.682531450710208E-5	1.0899246773675668E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	1	3	9	6	8	26	35	49	41	57		TCRBV20-01,TCRBV20-or09_02												CSALSGQGDLSYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGTTACAGGGGAGCGGGCGGGGAAAAACTGTTTTTTGGCAGT	CASSYRGAGGEKLFF	In	VDJ	1	37	8.682531450710208E-5	1.0899246773675668E-4	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	3	2	8	0	10	22	-1	42	35	52		TCRBV12-03,TCRBV12-04												CASSYRGAGGEKLFF+TCRBV12-X+TCRBJ01-04	TCRBV12	TCRBD01-01*01	TCRBJ01-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTCCAGGGGGCTAGGGGCCAACGTCCTGACTTTCGGGGCC	CASSSRGLGANVLTF	In	VDJ	1	37	8.682531450710208E-5	1.0899246773675668E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	6	4	0	4	2	2	24	36	46	38	48		TCRBV24-01,TCRBV24-or09_02												CASSSRGLGANVLTF+TCRBV24-X+TCRBJ02-06	TCRBV24	TCRBD01-01*01	TCRBJ02-06*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATTCCCGACAGGTGTCTATGGCTACACCTTCGGTTCG	CASSLFPTGVYGYTF	In	VDJ	1	37	8.682531450710208E-5	1.0899246773675668E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	2	4	4	8	3	24	36	50	44	53		TCRBV24-01,TCRBV24-or09_02												CASSLFPTGVYGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCGGGGGACAGGGGGCCCAAAATGAGCAGTTCTTCGGGCCA	CASGGQGAQNEQFF	In	VDJ	1	37	8.682531450710208E-5	1.0899246773675668E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	8	0	0	7	2	4	18	27	41	29	45	TCRBV05,TCRBV11													CASGGQGAQNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTCCAGGGGCCCCCTGGCAATGAGCAGTTCTTCGGGCCA	CASSVQGPPGNEQFF	In	VDJ	1	37	8.682531450710208E-5	1.0899246773675668E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	4	2	6	1	8	23	37	44	38	52	TCRBV09,TCRBV21													CASSVQGPPGNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTTGCTCGGGAGACCCAGTACTTCGGGCCA	CASSFARETQYF	In	VDJ	1	38	8.917194462891565E-5	1.1193821010802038E-4	36	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	3	8	5	5	4	0	26	40	-1	44	47		TCRBV12-03,TCRBV12-04				01,02								CASSFARETQYF+TCRBV12-X+TCRBJ02-05	TCRBV12	TCRBD02-01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGATGTTGCGACTGGGCCGGTCTATGGCTACACCTTCGGTTCG	CASSQDVATGPVYGYTF	In	VDJ	1	38	8.917194462891565E-5	1.1193821010802038E-4	51	unresolved						TCRBJ01	TCRBJ01-02	01	0	8	0	4	10	4	23	40	54	50	58	TCRBV01,TCRBV04			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDVATGPVYGYTF+X+TCRBJ01-02	unresolved		TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAATGGCAAGGGGCTAGGGATCAGGAATGAGCAGTTCTTCGGGCCA	CSANGKGLGIRNEQFF	In	VDJ	1	38	8.917194462891565E-5	1.1193821010802038E-4	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	5	2	7	6	12	26	36	47	42	59		TCRBV20-01,TCRBV20-or09_02												CSANGKGLGIRNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAGRAGACWCRGCMCTGTATCTCTGCGCCAGCAGCCAAGGGACAGGGCGGCCAGGTGGCTACACCTTCGGTTCG	CASSQGTGRPGGYTF	In	VDJ	1	38	8.917194462891565E-5	1.1193821010802038E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	1	3	7	0	8	23	-1	47	39	55	TCRBV04,TCRBV23													CASSQGTGRPGGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCGGTCTCGGGACTAGCGGGAGGGTCCAAGAGACCCAGTACTTCGGGCCA	CASGLGTSGRVQETQYF	In	VDJ	1	38	8.917194462891565E-5	1.1193821010802038E-4	51	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	8	0	0	1	6	1	22	31	53	37	54		TCRBV12-03,TCRBV12-04												CASGLGTSGRVQETQYF+TCRBV12-X+TCRBJ02-05	TCRBV12	TCRBD02-01*02	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GCCACGTTTGGTGCATCCTGAAGACAGCAGCTTCTMATCTGCAGTGCTAGAGATGCGGGACTAAATTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	38	8.917194462891565E-5		41	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	18	0	9	4	20	3	40	36	63	56	66		TCRBV20-01,TCRBV20-or09_02				01,02								X+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTCGGGGGGGATACGCAGTATTTTGGCCCA	CASSFGGDTQYF	In	VDJ	1	39	9.151857475072921E-5	1.1488395247928406E-4	36	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	8	1	6	0	0	26	-1	-1	40	47		TCRBV12-03,TCRBV12-04												CASSFGGDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCTCGTACGGGCTTCTACGAGCAGTACTTCGGGCCG	CASSPRTGFYEQYF	In	VDJ	1	39	9.151857475072921E-5	1.1488395247928406E-4	42	TCRBV03						TCRBJ02	TCRBJ02-07	01	4	8	0	3	7	2	26	39	50	46	52		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPRTGFYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03		TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCGTCGCGGGACTTCAAACCGGGGCGATGAGCAGTTCTTCGGGCCA	CASSRRGTSNRGDEQFF	In	VDJ	1	39	9.151857475072921E-5	1.1488395247928406E-4	51	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	0	10	8	6	13	24	36	48	42	61		TCRBV24-01,TCRBV24-or09_02				01,02								CASSRRGTSNRGDEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTTTAATCGGGAATGAGCAGTTCTTCGGGCCA	CASSLIGNEQFF	In	VDJ	1	39	9.151857475072921E-5	1.1488395247928406E-4	36	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	8	4	7	5	0	24	36	-1	41	45	TCRBV24,TCRBV27					01,02								CASSLIGNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAATCAGTAAACACTGAAGCTTTCTTTGGACAA	CASSESVNTEAFF	In	VDJ	1	39	9.151857475072921E-5	1.1488395247928406E-4	39	TCRBV06			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	4	5	2	1	2	23	38	42	39	44		TCRBV06-01,TCRBV06-08												CASSESVNTEAFF+TCRBV06-X+TCRBJ01-01	TCRBV06	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GCCACGTTTGGTGCATCCTGAAGACAGCAGTTCTACATCTGCAGTGCTAGAGATGCGGGACTAAATTACGAGCAGTACTTCGGGCCG	CSARDAGLNYEQYF	In	VDJ	1	39	9.151857475072921E-5	1.1488395247928406E-4	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	0	9	4	3	3	39	53	63	56	66		TCRBV20-01,TCRBV20-or09_02				01,02								CSARDAGLNYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGCTATTCCGGGACAGGGCTCGATGAGCAGTTCTTCGGGCCA	CASSYSGTGLDEQFF	In	VDJ	1	39	9.151857475072921E-5	1.1488395247928406E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	0	3	8	7	4	23	34	50	41	54	TCRBV02,TCRBV09													CASSYSGTGLDEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATTTGGAGGGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSQDLEGSGANVLTF	In	VDJ	1	40	9.386520487254278E-5	1.1782969485054776E-4	51	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-06	01	0	10	0	0	3	0	26	43	-1	46	52		TCRBV03-01,TCRBV03-02												CASSQDLEGSGANVLTF+TCRBV03-X+TCRBJ02-06	TCRBV03	TCRBD02-01*02	TCRBJ02-06*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTTAGGGCGGTCACCCCTCCACTTTGGGAAC	CASSLGRSPLHF	In	VDJ	1	40	9.386520487254278E-5	1.1782969485054776E-4	36	TCRBV03						TCRBJ01	TCRBJ01-06	01	5	5	3	10	2	3	26	38	44	40	47		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGRSPLHF+TCRBV03-X+TCRBJ01-06	TCRBV03		TCRBJ01-06*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCTCAGGGGGCGGTCGGCTACACCTTCGGTTCG	CSAPQGAVGYTF	In	VDJ	1	40	9.386520487254278E-5	1.1782969485054776E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	4	0	8	3	4	26	35	46	38	50		TCRBV20-01,TCRBV20-or09_02												CSAPQGAVGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CGTTTGGTGCCAGCCAGACCTCTGTACCTCTGTGCCAGCAGTCCCACCGGGATGCTAGCGGGAGTCGATGAGCAGTTCTTCGGGCCA	CASSPTGMLAGVDEQFF	In	VDJ	1	40	9.386520487254278E-5	1.1782969485054776E-4	51				TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	4	2	8	12	3	30	42	64	54	67	TCRBV25,TCRBV27,TCRBV28	TCRBV25-01,TCRBV25-or09_02,TCRBV27-01,TCRBV28-01												CASSPTGMLAGVDEQFF+X+TCRBJ02-01		TCRBD02-01*02	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGTCCGGGACAGAGAAATGAAAAACTGTTTTTTGGCAGT	CASSPGQRNEKLFF	In	VDJ	1	41	9.621183499435635E-5	1.2077543722181146E-4	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	0	5	5	3	3	26	37	47	40	50		TCRBV03-01,TCRBV03-02												CASSPGQRNEKLFF+TCRBV03-X+TCRBJ01-04	TCRBV03	TCRBD01-01*01	TCRBJ01-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTATAGCGAGCGGGGGGACGCGCACAGATACGCAGTATTTTGGCCCA	CSAIASGGTRTDTQYF	In	VDJ	1	41	9.621183499435635E-5	1.2077543722181146E-4	48	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	6	1	1	5	4	26	36	50	41	54		TCRBV20-01,TCRBV20-or09_02												CSAIASGGTRTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGGCATCTCGCGATCAGATACGCAGTATTTTGGCCCA	CSAGISRSDTQYF	In	VDJ	1	41	9.621183499435635E-5	1.2077543722181146E-4	39	TCRBV20						TCRBJ02	TCRBJ02-03	01	5	9	0	4	0	10	26	-1	38	35	48		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAGISRSDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCCTATGACAGGGATAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	41	9.621183499435635E-5		44	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	2	3	4	5	1	24	36	48	41	49		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-04	TCRBV24	TCRBD01-01*01	TCRBJ01-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCWMCCAGACAKCTSTKTACTTSTGTGCCAGCAGTCCTCCCCCGGGGAACACTGAAGCTTTCTTTGGACAA	CASSPPPGNTEAFF	In	VDJ	1	41	9.621183499435635E-5	1.2077543722181146E-4	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	6	8	4	1	7	0	24	36	-1	43	47	TCRBV06,TCRBV24					01,02								CASSPPPGNTEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTTATTGGGGGATTCAACCGGGGAGCTGTTTTTTGGAGAA	CASSLLGDSTGELFF	In	VDJ	1	41	9.621183499435635E-5	1.2077543722181146E-4	45	TCRBV05						TCRBJ02	TCRBJ02-02	01	2	6	1	5	3	5	19	33	41	36	46		TCRBV05-06,TCRBV05-07		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLLGDSTGELFF+TCRBV05-X+TCRBJ02-02	TCRBV05		TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCCAGGGGATCCGGACAGGGACTGGGTTTCTTTGGACAA	CASSPRGSGQGLGFF	In	VDJ	1	42	9.855846511616992E-5	1.2372117959307514E-4	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	1	3	13	11	6	26	39	58	50	64		TCRBV03-01,TCRBV03-02												CASSPRGSGQGLGFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCCACCCAGGCAAAACAAGAGACCCAGTACTTCGGGCCA	CSAPTQAKQETQYF	In	VDJ	1	42	9.855846511616992E-5	1.2372117959307514E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	4	4	2	6	5	26	35	45	41	50		TCRBV20-01,TCRBV20-or09_02												CSAPTQAKQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCGGACAGGTGGTTCCGAGCAGTACTTCGGGCCG	CSARTGGSEQYF	In	VDJ	1	42	9.855846511616992E-5	1.2372117959307514E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	1	4	6	1	6	26	35	43	36	49		TCRBV20-01,TCRBV20-or09_02												CSARTGGSEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCACAACCGATATTCAGGGGGCCGCCAGCGAGACCCAGTACTTCGGGCCA	CASTTDIQGAASETQYF	In	VDJ	1	42	9.855846511616992E-5	1.2372117959307514E-4	51	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	7	4	0	5	11	7	22	32	51	43	58		TCRBV12-03,TCRBV12-04												CASTTDIQGAASETQYF+TCRBV12-X+TCRBJ02-05	TCRBV12	TCRBD01-01*01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTGTCACTAGCGGGAGTGCAGATACGCAGTATTTTGGCCCA	CASSVTSGSADTQYF	In	VDJ	1	42	9.855846511616992E-5	1.2372117959307514E-4	45	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	3	2	4	3	2	22	34	48	37	50		TCRBV12-03,TCRBV12-04												CASSVTSGSADTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01*02	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTTCAAGAGACCCAGTACTTCGGGCCA	CATSDFQETQYF	In	VJ	1	42	9.855846511616992E-5	1.2372117959307514E-4	36	TCRBV24						TCRBJ02	TCRBJ02-05	01	1	0	0	2	0	1	24	-1	41	-1	42		TCRBV24-01,TCRBV24-or09_02												CATSDFQETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24		TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTGCAACAGCTTCAAGAGACCCAGTACTTCGGGCCA	CASSLQQLQETQYF	In	VDJ	1	42	9.855846511616992E-5	1.2372117959307514E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	1	3	5	2	2	3	19	34	40	36	43	TCRBV05,TCRBV11													CASSLQQLQETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGTGACCAGCGAAGCTTTCTTTGGACAA	CASSQVTSEAFF	In	VDJ	1	43	1.009050952379835E-4	1.2666692196433885E-4	36	TCRBV03						TCRBJ01	TCRBJ01-01	01	1	2	7	8	1	4	26	42	46	43	50		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQVTSEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03		TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGACAGGGGGGTCTACACTGAAGCTTTCTTTGGACAA	CASSQDRGVYTEAFF	In	VDJ	1	43	1.009050952379835E-4	1.2666692196433885E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	4	1	3	0	4	23	-1	47	40	51	TCRBV01,TCRBV04													CASSQDRGVYTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCAACCAGACAGCTCTTTACTTCTGTACCAGCAGGCCGCAGGGGGGGATGAGACCCCAGCATTTTGGTGAT	CTSRPQGGMRPQHF	In	VDJ	1	43	1.009050952379835E-4	1.2666692196433885E-4	42	TCRBV24						TCRBJ01	TCRBJ01-05	01	7	4	1	10	4	8	24	35	46	39	54		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CTSRPQGGMRPQHF+TCRBV24-X+TCRBJ01-05	TCRBV24		TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GAAGACTCGGCCSTGTATSTCTGTGCCAGCAGCCGCGACCAAAACTCCTACAATGAGCAGTTCTTCGGGCCA	CASSRDQNSYNEQFF	In	VDJ	1	43	1.009050952379835E-4	1.2666692196433885E-4	45	unresolved						TCRBJ02	TCRBJ02-01	01	5	2	7	0	3	5	18	30	36	33	41	TCRBV04,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRDQNSYNEQFF+X+TCRBJ02-01	unresolved		TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTAGAACCGGGAGGGCCGGGAGAGCAGTACTTCGGGCCG	CASSLEPGGPGEQYF	In	VDJ	1	43	1.009050952379835E-4	1.2666692196433885E-4	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	8	0	7	2	6	18	35	45	37	51	TCRBV07,TCRBV11													CASSLEPGGPGEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAAATGGGGACAGCACAGATACGCAGTATTTTGGCCCA	CASSQNGDSTDTQYF	In	VDJ	1	44	1.0325172535979707E-4	1.2961266433560254E-4	45	unresolved						TCRBJ02	TCRBJ02-03	01	2	0	7	0	4	0	23	38	-1	42	47	TCRBV01,TCRBV04			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQNGDSTDTQYF+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCCCGACTAGCGGGCGTCTACAATGAGCAGTTCTTCGGGCCA	CASSPRLAGVYNEQFF	In	VDJ	1	44	1.0325172535979707E-4	1.2961266433560254E-4	48	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	2	4	3	3	3	26	39	52	42	55		TCRBV03-01,TCRBV03-02				01,02								CASSPRLAGVYNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAACGGGGGGGGTTAAGGACGAGCAGTACGTCGGGCCG	CSARTGGVKDEQYV	In	VDJ	1	44	1.0325172535979707E-4	1.2961266433560254E-4	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	2	8	0	17	1	19	26	38	47	39	66		TCRBV20-01,TCRBV20-or09_02												CSARTGGVKDEQYV+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCCCTGGGGACAGGGGGCCGGGAGGGAGTGGCTACACCTTCGGTTCG	CASSPGDRGPGGSGYTF	In	VDJ	1	44	1.0325172535979707E-4	1.2961266433560254E-4	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	0	0	7	4	10	19	31	47	35	57	TCRBV07,TCRBV11													CASSPGDRGPGGSGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCCAAGATCTGCGGGGGTACGAGCAGTACTTCGGGCCG	CASSQDLRGYEQYF	In	VDJ	1	44	1.0325172535979707E-4	1.2961266433560254E-4	42				TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	0	7	2	4	3	0	18	35	-1	38	45	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03												CASSQDLRGYEQYF+X+TCRBJ02-07		TCRBD02-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTCGCACAAACCTATGGCTACACCTTCGGTTCG	CSARVAQTYGYTF	In	VDJ	1	45	1.0559835548161063E-4	1.3255840670686622E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	3	6	4	4	3	26	39	46	43	49		TCRBV20-01,TCRBV20-or09_02												CSARVAQTYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGCAAGGGATGAGGGAGACCCAGTACTTCGGGCCA	CSARQGMRETQYF	In	VDJ	1	45	1.0559835548161063E-4	1.3255840670686622E-4	39	TCRBV20						TCRBJ02	TCRBJ02-05	01	3	0	8	5	4	5	26	37	45	41	50		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARQGMRETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20		TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCAGTGGAGAGATACGCAGTATTTTGGCCCA	CSAQWRDTQYF	In	VDJ	1	45	1.0559835548161063E-4	1.3255840670686622E-4	33	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	10	2	5	4	0	26	35	-1	39	43		TCRBV20-01,TCRBV20-or09_02												CSAQWRDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCCAAGTTGAGCCTAACACTGAAGCTTTCTTTGGACAA	CASSQVEPNTEAFF	In	VDJ	1	45	1.0559835548161063E-4	1.3255840670686622E-4	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	4	6	7	2	7	2	19	31	41	38	43	TCRBV05,TCRBV11					01,02								CASSQVEPNTEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGTGGGACTAGCGGGGGTAACCGTCGGACCCAGTACTTCGGGCCA	CASSGTSGGNRRTQYF	In	VDJ	1	45	1.0559835548161063E-4	1.3255840670686622E-4	48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	4	1	2	7	0	9	23	-1	49	36	58	TCRBV02,TCRBV09													CASSGTSGGNRRTQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCGACAGGAACTATGGCTACACCTTCGGTTCG	CSADRNYGYTF	In	VDJ	1	46	1.079449856034242E-4	1.3550414907812994E-4	33	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	2	4	2	1	0	26	34	-1	35	41		TCRBV20-01,TCRBV20-or09_02												CSADRNYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGGTACAGGGGTTACAATGAGCAGTTCTTCGGGCCA	CASRYRGYNEQFF	In	VDJ	1	46	1.079449856034242E-4	1.3550414907812994E-4	39	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	3	2	4	2	1	22	33	42	35	43		TCRBV12-03,TCRBV12-04												CASRYRGYNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD01-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGTTTTCTAGCGGGAGCGGAGACCCAGTACTTCGGGCCA	CASSFLAGAETQYF	In	VDJ	1	46	1.079449856034242E-4	1.3550414907812994E-4	42	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	3	4	2	5	1	2	22	36	47	37	49		TCRBV12-03,TCRBV12-04												CASSFLAGAETQYF+TCRBV12-X+TCRBJ02-05	TCRBV12	TCRBD02-01*02	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTCCGCGGCGAATTCACCCCTCCACTTTGGGAAC	CATSDSAANSPLHF	In	VDJ	1	46	1.079449856034242E-4	1.3550414907812994E-4	42	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-06	01	2	7	5	7	2	2	24	40	46	42	48		TCRBV24-01,TCRBV24-or09_02				01,02								CATSDSAANSPLHF+TCRBV24-X+TCRBJ01-06	TCRBV24	TCRBD02-01	TCRBJ01-06*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGRRGACTYGGCYSTGTATCTCTGTGCCAGCAGCTTAGCGGGGATTTCGGGAACTAACTATGGCTACACCTTCGGTTCG	CASSLAGISGTNYGYTF	In	VDJ	1	46	1.079449856034242E-4	1.3550414907812994E-4	51	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	0	8	3	0	8	1	22	39	52	47	53	TCRBV04,TCRBV07					unresolved								CASSLAGISGTNYGYTF+X+TCRBJ01-02	unresolved	TCRBD02-01*02	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTAGGCCTCGGGGCCGGGGAGCTGTTTTTTGGAGAA	CASSLGLGAGELFF	In	VDJ	1	47	1.1029161572523777E-4	1.3844989144939362E-4	42	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	4	8	3	6	7	0	26	39	-1	46	51		TCRBV03-01,TCRBV03-02												CASSLGLGAGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD02-01*01	TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACCTTCCGGGACAGGGCTAAAGATACGCAGTATTTTGGCCCA	CSATFRDRAKDTQYF	In	VDJ	1	47	1.1029161572523777E-4	1.3844989144939362E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	0	3	5	6	4	26	36	51	42	55		TCRBV20-01,TCRBV20-or09_02												CSATFRDRAKDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACTGCTCAGGGGGCCACGAGCAGTACGTCGGGCCG		Out	VDJ	1	47	1.1029161572523777E-4		40	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	4	0	17	5	13	26	38	51	43	64		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCAGGGGCATGGCCAATCAGCCCCAGCATTTTGGTGAT	CSASRGMANQPQHF	In	VDJ	1	47	1.1029161572523777E-4	1.3844989144939362E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	4	2	3	0	6	26	-1	43	37	49		TCRBV20-01,TCRBV20-or09_02												CSASRGMANQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTGGGGGGCCTCAGCACAGATACGCAGTATTTTGGCCCA	CATSDLGGLSTDTQYF	In	VDJ	1	47	1.1029161572523777E-4	1.3844989144939362E-4	48	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	6	0	0	0	3	24	-1	48	42	51		TCRBV24-01,TCRBV24-or09_02												CATSDLGGLSTDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD01-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTTACAGGGGGTTGGACACTGAAGCTTTCTTTGGACAA	CASSYRGLDTEAFF	In	VDJ	1	47	1.1029161572523777E-4	1.3844989144939362E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	3	1	3	1	4	24	36	45	37	49	TCRBV24,TCRBV27													CASSYRGLDTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTTCTGGGACAGGGGGCTACTATGGCTACACCTTCGGTTCG	CASSSGTGGYYGYTF	In	VDJ	1	47	1.1029161572523777E-4	1.3844989144939362E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	0	0	3	3	1	24	36	51	39	52	TCRBV24,TCRBV27													CASSSGTGGYYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCATCCTAAGGGGGGACTCCTACAATGAGCAGTTCTTCGGGCCA	CASILRGDSYNEQFF	In	VDJ	1	47	1.1029161572523777E-4	1.3844989144939362E-4	45	unresolved						TCRBJ02	TCRBJ02-01	01	7	5	1	0	5	2	18	28	39	33	41	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASILRGDSYNEQFF+X+TCRBJ02-01	unresolved		TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAAAACTGGGGACAATAGGGAGCAGTTCTTCGGGCCA	CSAKTGDNREQFF	In	VDJ	1	48	1.1263824584705134E-4	1.413956338206573E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	0	6	10	6	5	26	36	48	42	53		TCRBV20-01,TCRBV20-or09_02												CSAKTGDNREQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGCCCATCCACAGGGGGGTCACTGAAGCTTTCTTTGGACAA	CSARPIHRGVTEAFF	In	VDJ	1	48	1.1263824584705134E-4	1.413956338206573E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	3	1	4	8	2	26	37	53	45	55		TCRBV20-01,TCRBV20-or09_02												CSARPIHRGVTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGTCCTTACGGGGGGCGCCGGTGGCTACACCTTCGGTTCG	CSVLTGGAGGYTF	In	VDJ	1	48	1.1263824584705134E-4	1.413956338206573E-4	39	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	7	8	1	7	6	6	26	33	46	39	52		TCRBV20-01,TCRBV20-or09_02												CSVLTGGAGGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD02-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGGAGGCCCCCGTCTAGCGGGGGCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSGGPRLAGANTGELFF	In	VDJ	1	48	1.1263824584705134E-4	1.413956338206573E-4	57	TCRBV25			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	4	4	2	0	11	0	23	36	-1	47	57		TCRBV25-01,TCRBV25-or09_02												CASSGGPRLAGANTGELFF+TCRBV25-X+TCRBJ02-02	TCRBV25	TCRBD02-01*01	TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTTAGGGGTTGGAACAGGGTACGAGCAGTACTTCGGGCCG	CASSLGVGTGYEQYF	In	VDJ	1	48	1.1263824584705134E-4	1.413956338206573E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	3	3	4	8	0	18	34	-1	42	48	TCRBV07,TCRBV11													CASSLGVGTGYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
SGACTCGGCYSTSTATCTCTGTGCCAGCAGCCATCAACAGGGGTACAATGAGCAGTTCTTCGGGCCA	CASSHQQGYNEQFF	In	VDJ	1	48	1.1263824584705134E-4	1.413956338206573E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	3	2	4	5	0	19	31	-1	36	43	TCRBV05,TCRBV07													CASSHQQGYNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ACGACTCGGCCSTGTATCTCTGTGCCAGCAGCCCAACGACAGGAAACTATGGCTACACCTTCGGTTCG	CASSPTTGNYGYTF	In	VDJ	1	49	1.1498487596886492E-4	1.4434137619192102E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	2	4	2	5	1	20	32	43	37	44	TCRBV05,TCRBV11													CASSPTTGNYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATCGCTGGGGGCTGAGAGAAAAACTGTTTTTTGGCAGT	CASSQDRWGLREKLFF	In	VDJ	1	49	1.1498487596886492E-4	1.4434137619192102E-4	48	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	6	0	8	5	5	26	43	54	48	59		TCRBV03-01,TCRBV03-02												CASSQDRWGLREKLFF+TCRBV03-X+TCRBJ01-04	TCRBV03	TCRBD01-01*01	TCRBJ01-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCTGGGACACTCGAACGAATAACTATGGCTACACCTTCGGTTCG	CSAWDTRTNNYGYTF	In	VDJ	1	49	1.1498487596886492E-4	1.4434137619192102E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	0	6	1	2	10	26	34	42	36	52		TCRBV20-01,TCRBV20-or09_02												CSAWDTRTNNYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAACGGAGACATGGGCTATGGCTACACCTTCGGTTCG	CSANGDMGYGYTF	In	VDJ	1	49	1.1498487596886492E-4	1.4434137619192102E-4	39	TCRBV20						TCRBJ01	TCRBJ01-02	01	4	2	6	4	5	4	26	36	45	41	49		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSANGDMGYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20		TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTGGGGACAGGGGGCAAGCACAGATACGCAGTATTTTGGCCCA	CATSDWGQGASTDTQYF	In	VDJ	1	49	1.1498487596886492E-4	1.4434137619192102E-4	51	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	0	0	0	1	1	24	40	53	41	54		TCRBV24-01,TCRBV24-or09_02												CATSDWGQGASTDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD01-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCMTSTATCKCTGTGCCAGCAGCTTCGGGCTAGCGGGTTCTACCTACGAGCAGTACTTCGGGCCG	CASSFGLAGSTYEQYF	In	VDJ	1	49	1.1498487596886492E-4	1.4434137619192102E-4	48	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	3	4	4	2	4	5	18	32	44	36	49	TCRBV05,TCRBV07					01,02								CASSFGLAGSTYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACCACTAGGGGGAGTCGCCTACGAGCAGTACTTCGGGCCG	CSARPLGGVAYEQYF	In	VDJ	1	50	1.1733150609067848E-4	1.472871185631847E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	5	1	2	5	5	26	38	49	43	54		TCRBV20-01,TCRBV20-or09_02												CSARPLGGVAYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATACGGGGGAACCCCTCCACTTTGGGAAC	CSARDTGEPLHF	In	VDJ	1	50	1.1733150609067848E-4	1.472871185631847E-4	36	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-06	01	0	8	2	12	2	1	26	40	48	42	49		TCRBV20-01,TCRBV20-or09_02												CSARDTGEPLHF+TCRBV20-X+TCRBJ01-06	TCRBV20	TCRBD02-01*01	TCRBJ01-06*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCGTTATCCGACACAGAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	50	1.1733150609067848E-4		46	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	0	2	6	4	9	3	26	40	53	49	56		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTTTGATGGGCGTACGAAAACCCGAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	50	1.1733150609067848E-4		55	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	8	0	0	3	11	22	36	43	39	54		TCRBV12-03,TCRBV12-04												X+TCRBV12-X+TCRBJ02-02	TCRBV12	TCRBD01-01*01	TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCTTGTTAAAGGGGGCTGGCACTGAAGCTTTCTTTGGACAA	CASSLLKGAGTEAFF	In	VDJ	1	50	1.1733150609067848E-4	1.472871185631847E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	5	0	4	5	3	18	32	44	37	47	TCRBV07,TCRBV11													CASSLLKGAGTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCAACAGGGTGGAATGGCTACACCTTCGGTTCG	CASSLATGWNGYTF	In	VDJ	1	50	1.1733150609067848E-4	1.472871185631847E-4	42				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	3	3	6	1	4	18	35	42	36	46	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03												CASSLATGWNGYTF+X+TCRBJ01-02		TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ASGACTCSGCCSTGTATCTCTGTGCCAGCAGCCGCGGGTACCAAGAGACCCAGTACTTCGGGCCA	CASSRGYQETQYF	In	VDJ	1	51	1.1967813621249205E-4	1.502328609344484E-4	39	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	7	4	0	1	1	20	32	38	33	39	TCRBV05,TCRBV07					01,02								CASSRGYQETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGAAGGGTGGGAGACCCAGTACTTCGGGCCA	CASSQEGWETQYF	In	VDJ	1	52	1.2202476633430562E-4	1.531786033057121E-4	39	unresolved						TCRBJ02	TCRBJ02-05	01	0	5	3	5	0	3	23	-1	44	40	47	TCRBV01,TCRBV04			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQEGWETQYF+X+TCRBJ02-05	unresolved		TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGTCCGGAACTATGGCTACACCTTCGGTTCG	CASSQVRNYGYTF	In	VDJ	1	52	1.2202476633430562E-4	1.531786033057121E-4	39	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	1	8	5	2	2	0	26	42	-1	44	47		TCRBV03-01,TCRBV03-02				01,02								CASSQVRNYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD02-01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGGCCCCGCCAGGTACCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	52	1.2202476633430562E-4		47	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	4	4	0	8	1	26	40	52	48	53		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD01-01*01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAAGGGGGCTGGGAAGGAAAAACTGTTTTTTGGCAGT	CSAKGAGKEKLFF	In	VDJ	1	52	1.2202476633430562E-4	1.531786033057121E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	5	0	8	0	7	26	-1	43	36	50		TCRBV20-01,TCRBV20-or09_02												CSAKGAGKEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD01-01*01	TCRBJ01-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TYRGRRGACWCAGCMMKGTAYTTCTGTGCCAGCAGCCCGGGGGCAGAGGGGACCGGGGAGCTGTTTTTTGGAGAA	CASSPGAEGTGELFF	In	VDJ	1	52	1.2202476633430562E-4	1.531786033057121E-4	45	unresolved						TCRBJ02	TCRBJ02-02	01	5	6	0	5	2	7	24	36	44	38	51	TCRBV02,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPGAEGTGELFF+X+TCRBJ02-02	unresolved		TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGCCACCAGGGTTGGGTTGGACACTGAAGCTTTCTTTGGACAA	CASSQATRVGLDTEAFF	In	VDJ	1	53	1.243713964561192E-4	1.5612434567697578E-4	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	4	3	3	4	9	23	39	48	43	57	TCRBV01,TCRBV04													CASSQATRVGLDTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGTTTAGTTTGGACAGGGGGCTCACCCCTCCACTTTGGGAAC	CASSLVWTGGSPLHF	In	VDJ	1	53	1.243713964561192E-4	1.5612434567697578E-4	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	1	1	0	10	3	0	22	38	-1	41	52		TCRBV12-03,TCRBV12-04												CASSLVWTGGSPLHF+TCRBV12-X+TCRBJ01-06	TCRBV12	TCRBD01-01*01	TCRBJ01-06*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCCTGACAGGGCTAGCGGGAGTCGAGCAGTACTTCGGGCCG	CASSLTGLAGVEQYF	In	VDJ	1	53	1.243713964561192E-4	1.5612434567697578E-4	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	4	2	6	9	1	24	36	55	45	56	TCRBV09,TCRBV21													CASSLTGLAGVEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGAACCTAAGGGGACAGGCTATGGCTACACCTTCGGTTCG	CASSQEPKGTGYGYTF	In	VDJ	1	54	1.2671802657793275E-4	1.5907008804823947E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	0	4	4	7	0	23	40	-1	47	55	TCRBV01,TCRBV04													CASSQEPKGTGYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTCCCACAAAGGGACTAGCGGGGTTTTCTACGAGCAGTACGTCGGGCCG		Out	VDJ	1	54	1.2671802657793275E-4		53	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	5	0	3	17	8	18	22	34	55	42	73		TCRBV12-03,TCRBV12-04												X+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD02-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGGACTCGGCCSTGTATCTCTGTGCCAGCAGCCCCGGGACAGACTATGGCTACACCTTCGGTTCG	CASSPGTDYGYTF	In	VDJ	1	54	1.2671802657793275E-4	1.5907008804823947E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	5	3	3	0	18	30	-1	33	40	TCRBV05,TCRBV07													CASSPGTDYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTGTAAGGGGTCTAAGTAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	55	1.2906465669974634E-4		47	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	5	2	7	2	7	24	42	49	44	56		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD01-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTGAGGTCAGAACTATACACTGAAGCTTTCTTTGGACAA	CASSLRSELYTEAFF	In	VDJ	1	55	1.2906465669974634E-4	1.6201583041950318E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	3	3	9	3	9	1	18	32	45	41	46	TCRBV07,TCRBV11					01,02								CASSLRSELYTEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAGTTGGAAGGGGGCGAGAACACTGAAGCTTTCTTTGGACAA	CASSQELEGGENTEAFF	In	VDJ	1	56	1.314112868215599E-4	1.6496157279076687E-4	51	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	5	0	1	6	2	26	43	56	49	58		TCRBV03-01,TCRBV03-02												CASSQELEGGENTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATAATAATTCAGGGAGGGGCTACACCTTCGGTTCG	CASSQDNNSGRGYTF	In	VDJ	1	56	1.314112868215599E-4	1.6496157279076687E-4	45	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	0	9	1	8	10	0	26	43	-1	53	59		TCRBV03-01,TCRBV03-02												CASSQDNNSGRGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD02-01*02	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATGGGGGGACCTACGAGCAGTACTTCGGGCCG	CSARDGGTYEQYF	In	VDJ	1	57	1.3375791694337347E-4	1.6790731516203055E-4	39	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	0	9	1	2	1	1	26	40	47	41	48		TCRBV20-01,TCRBV20-or09_02												CSARDGGTYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGATTTACCCCCACCGGGGAGCTGTTTTTTGGAGAA	CASSRFTPTGELFF	In	VDJ	1	58	1.3610454706518703E-4	1.7085305753329426E-4	42	TCRBV03						TCRBJ02	TCRBJ02-02	01	4	2	8	4	0	8	26	-1	41	39	49		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRFTPTGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03		TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGCGTAAGAGAAATCGGGCAGACTAACCTTGAGGCTACACCTTCGGTTCG		Out	VDJ	1	58	1.3610454706518703E-4		47	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	9	2	9	8	18	7	26	31	54	49	61		TCRBV20-01,TCRBV20-or09_02				01,02								X+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD02-01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGGGGTCCGGTCGGCACTGAAGCTTTCTTTGGACAA	CSARGGPVGTEAFF	In	VDJ	1	58	1.3610454706518703E-4	1.7085305753329426E-4	42	TCRBV20						TCRBJ01	TCRBJ01-01	01	1	6	2	4	0	9	26	-1	43	39	52		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARGGPVGTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCGGGGGGGCCAAAGAGACCCAGTACTTCGGGCCA	CSASGGAKETQYF	In	VDJ	1	58	1.3610454706518703E-4	1.7085305753329426E-4	39	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	3	8	0	3	0	3	26	-1	45	37	48		TCRBV20-01,TCRBV20-or09_02												CSASGGAKETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGCAGGGGGGGATGAAAAACTGTTTTTTGGCAGT	CASSQAGGDEKLFF	In	VDJ	1	59	1.384511771870006E-4	1.7379879990455795E-4	42	TCRBV03						TCRBJ01	TCRBJ01-04	01	1	4	1	6	0	2	26	-1	49	42	51		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQAGGDEKLFF+TCRBV03-X+TCRBJ01-04	TCRBV03		TCRBJ01-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCTTGGAGGAGGTGAGATCCAGTACTTCGGGCCA	CSALGGGEIQYF	In	VDJ	1	59	1.384511771870006E-4	1.7379879990455795E-4	36	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	6	10	1	10	4	9	26	34	43	38	52		TCRBV20-01,TCRBV20-or09_02												CSALGGGEIQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*02	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTTTTAACGGTCGTTACCTATAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	59	1.384511771870006E-4		49	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-06	01	3	8	5	2	6	6	26	37	46	43	52		TCRBV20-01,TCRBV20-or09_02				01,02								X+TCRBV20-X+TCRBJ01-06	TCRBV20	TCRBD02-01	TCRBJ01-06*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTCGGAGGGGGCCAACGTCCTGACTTTCGGGGCC	CASSSEGANVLTF	In	VDJ	1	59	1.384511771870006E-4	1.7379879990455795E-4	39	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-06	01	6	10	2	4	2	0	24	36	-1	38	42		TCRBV24-01,TCRBV24-or09_02												CASSSEGANVLTF+TCRBV24-X+TCRBJ02-06	TCRBV24	TCRBD02-01*02	TCRBJ02-06*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCCTGGTGGGGGAGAGGATGCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	59	1.384511771870006E-4		46	TCRBV05						TCRBJ02	TCRBJ02-07	01	0	6	1	3	1	8	19	35	41	36	49		TCRBV05-06,TCRBV05-07		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV05-X+TCRBJ02-07	TCRBV05		TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGAGCCCCGCCAGGGTAAACACCGGGGAGCTGTTTTTTGGAGAA	CSASPARVNTGELFF	In	VDJ	1	60	1.407978073088142E-4	1.7674454227582163E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	4	3	2	9	2	26	34	48	43	50		TCRBV20-01,TCRBV20-or09_02												CSASPARVNTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD01-01*01	TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCCGACAGGGGGAAGGGGTTTGGCAATCAGCCCCAGCATTTTGGTGAT	CSAPDRGKGFGNQPQHF	In	VDJ	1	60	1.407978073088142E-4	1.7674454227582163E-4	51	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	2	1	2	3	10	26	35	47	38	57		TCRBV20-01,TCRBV20-or09_02												CSAPDRGKGFGNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTACCCCGGGACAGGGTGGTACGAGCAGTACTTCGGGCCG	CSAYPGTGWYEQYF	In	VDJ	1	60	1.407978073088142E-4	1.7674454227582163E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	3	4	6	3	26	35	50	41	53		TCRBV20-01,TCRBV20-or09_02												CSAYPGTGWYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTTTAGCCAGCGGGTACGAGCAGTACTTCGGGCCG	CASSLASGYEQYF	In	VDJ	1	60	1.407978073088142E-4	1.7674454227582163E-4	39	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	6	4	4	6	0	24	36	-1	42	48	TCRBV24,TCRBV27					01,02								CASSLASGYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTGGGGCGCAGATACGCAGTATTTTGGCCCA	CSAWGADTQYF	In	VDJ	1	61	1.4314443743062774E-4	1.7969028464708534E-4	33	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	7	0	4	1	1	26	35	41	36	42		TCRBV20-01,TCRBV20-or09_02												CSAWGADTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCACACGACAGGGGGATACGAGCAGTACGTCGGGCCG	CASSHTTGGYEQYV	In	VDJ	1	61	1.4314443743062774E-4	1.7969028464708534E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	2	1	17	3	14	23	37	49	40	63	TCRBV01,TCRBV04													CASSHTTGGYEQYV+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCCACGGACAGGGTGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	61	1.4314443743062774E-4		40	TCRBV05			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	1	3	0	3	0	19	28	-1	31	39		TCRBV05-06,TCRBV05-07												X+TCRBV05-X+TCRBJ01-01	TCRBV05	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCACCGGACAGGGGGTCGAGGAGACCCAGTACTTCGGGCCA	CSATGQGVEETQYF	In	VDJ	1	62	1.4549106755244132E-4	1.8263602701834903E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	1	1	5	4	5	26	34	48	38	53		TCRBV20-01,TCRBV20-or09_02												CSATGQGVEETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAAAACAGGGGTGGCTACACCTTCGGTTCG	CSARENRGGYTF	In	VDJ	1	62	1.4549106755244132E-4	1.8263602701834903E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	3	2	7	2	0	26	40	-1	42	49		TCRBV20-01,TCRBV20-or09_02												CSARENRGGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTAAGGGACAGGGTTACAATGAGCAGTTCTTCGGGCCA	CSASKGQGYNEQFF	In	VDJ	1	62	1.4549106755244132E-4	1.8263602701834903E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	0	3	4	3	1	26	37	49	40	50		TCRBV20-01,TCRBV20-or09_02												CSASKGQGYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTGTTCAGCAGTCGACAGATACGCAGTATTTTGGCCCA	CSASVQQSTDTQYF	In	VDJ	1	62	1.4549106755244132E-4	1.8263602701834903E-4	42	TCRBV20						TCRBJ02	TCRBJ02-03	01	3	4	5	3	4	6	26	37	44	41	50		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSASVQQSTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCAAATACCGGGACAGGATACAATCAGCCCCAGCATTTTGGTGAT	CASSLANTGTGYNQPQHF	In	VDJ	1	62	1.4549106755244132E-4	1.8263602701834903E-4	54				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	0	4	3	7	3	18	35	50	42	53	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03												CASSLANTGTGYNQPQHF+X+TCRBJ01-05		TCRBD01-01*01	TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCTTGGGACGAATAAATCAGCCCCAGCATTTTGGTGAT	CASSLGRINQPQHF	In	VDJ	1	64	1.5018432779606846E-4	1.8852751176087643E-4	42							TCRBJ01	TCRBJ01-05	01	0	2	7	4	0	5	18	-1	37	34	42	TCRBV05,TCRBV07	TCRBV05-08,TCRBV07-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGRINQPQHF+X+TCRBJ01-05			TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCAATAGCGGGGGGAGCAGGACAGATACGCAGTATTTTGGCCCA	CASSNSGGSRTDTQYF	In	VDJ	1	64	1.5018432779606846E-4	1.8852751176087643E-4	48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	5	1	3	2	6	18	30	42	32	48	TCRBV07,TCRBV11													CASSNSGGSRTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGCTTGGGAGTTAGCCGGCAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	64	1.5018432779606846E-4		44	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	9	2	4	0	8	18	-1	37	32	45	TCRBV07,TCRBV11													X+X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCGAGGGCCGAACTGAAGCTTTCTTTGGACAA	CSAEGRTEAFF	In	VDJ	1	65	1.5253095791788204E-4	1.914732541321401E-4	33	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	6	11	0	5	1	4	26	34	40	35	44		TCRBV20-01,TCRBV20-or09_02												CSAEGRTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01*02	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATGATAGGTTTAGAACTGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	65	1.5253095791788204E-4		49	TCRBV20						TCRBJ01	TCRBJ01-01	01	0	5	4	0	4	8	26	40	47	44	55		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCATTGACAGGGACAGCTATGGCTACACCTTCGGTTCG	CSAIDRDSYGYTF	In	VDJ	1	66	1.548775880396956E-4	1.944189965034038E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	0	5	4	8	0	26	34	-1	42	49		TCRBV20-01,TCRBV20-or09_02												CSAIDRDSYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTTTAATCGGAGAAGAGCAGTACTTCGGGCCG	CASSLIGEEQYF	In	VDJ	1	67	1.5722421816150917E-4	1.973647388746675E-4	36	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	10	2	7	3	2	23	38	45	41	47	TCRBV24,TCRBV27													CASSLIGEEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAACCTACTAGCGGGGGTGGATGAGCAGTTCTTCGGGCCA	CASNLLAGVDEQFF	In	VDJ	1	67	1.5722421816150917E-4	1.973647388746675E-4	42	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	11	3	2	8	7	3	24	31	49	38	52	TCRBV24,TCRBV27													CASNLLAGVDEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTCCGGGACTAGCGGTTCAAGATACGCAGTATTTTGGCCCA	CASSPGLAVQDTQYF	In	VDJ	1	67	1.5722421816150917E-4	1.973647388746675E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	0	5	5	2	4	24	36	49	38	53	TCRBV24,TCRBV27					01,02								CASSPGLAVQDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGATCGGGGGGAATACTATGGCTACACCTTCGGTTCG	CASSQDRGEYYGYTF	In	VDJ	1	67	1.5722421816150917E-4	1.973647388746675E-4	45				TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	0	8	1	3	1	3	18	35	43	36	46	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03												CASSQDRGEYYGYTF+X+TCRBJ01-02		TCRBD02-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTGGGAGCGGGGGGCAACAATGAGCAGTTCTTCGGGCCA	CASSLGAGGNNEQFF	In	VDJ	1	68	1.5957084828332273E-4	2.003104812459312E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	3	6	1	5	3	2	18	32	44	35	46	TCRBV07,TCRBV11													CASSLGAGGNNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGACGCAAAAGCGGGGGTCCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	69	1.619174784051363E-4		53	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	6	2	2	6	2	26	43	57	49	59		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGCCCAACTGAGGGACGGGGTGGCTACACCTTCGGTTCG	CSPTEGRGGYTF	In	VDJ	1	69	1.619174784051363E-4	2.0325622361719488E-4	36	TCRBV20						TCRBJ01	TCRBJ01-02	01	9	0	7	7	9	4	26	31	45	40	49		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSPTEGRGGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20		TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAACGAAGCGGGGGAGAACCTAGCACAGATACGCAGTATTTTGGCCCA	CASSQRSGGEPSTDTQYF	In	VDJ	1	69	1.619174784051363E-4	2.0325622361719488E-4	54	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	2	6	2	0	3	7	23	38	49	41	56	TCRBV01,TCRBV04													CASSQRSGGEPSTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGAAGCTCCTTCAATGGGACCGATCAGATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	69	1.619174784051363E-4		47							TCRBJ02	TCRBJ02-01	01	3	0	7	8	8	7	18	31	44	39	51	TCRBV05,TCRBV11	TCRBV05-03,TCRBV11-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ02-01			TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCATCGCCGGACAGGGAAACACTGAAGCTTTCTTTGGACAA	CASIAGQGNTEAFF	In	VDJ	1	69	1.619174784051363E-4	2.0325622361719488E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	1	3	2	5	1	23	33	46	38	47	TCRBV02,TCRBV12													CASIAGQGNTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGGGGGGACAGGGGTTCTTCAGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CSAGGQGFFSSGANVLTF	In	VDJ	1	70	1.6426410852694986E-4	2.062019659884586E-4	54	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	6	0	2	0	3	8	26	34	47	37	55		TCRBV20-01,TCRBV20-or09_02												CSAGGQGFFSSGANVLTF+TCRBV20-X+TCRBJ02-06	TCRBV20	TCRBD01-01*01	TCRBJ02-06*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCCGGGACAGGGGTATGGCTACACCTTCGGTTCG	CSARDPGQGYGYTF	In	VDJ	1	70	1.6426410852694986E-4	2.062019659884586E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	0	2	5	3	0	26	40	-1	43	53		TCRBV20-01,TCRBV20-or09_02												CSARDPGQGYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGAGACCTGGGGGGCTACACCTTCGGTTCG	CSARGDLGGYTF	In	VDJ	1	70	1.6426410852694986E-4	2.062019659884586E-4	36	TCRBV20						TCRBJ01	TCRBJ01-02	01	1	6	2	8	7	0	26	39	-1	46	50		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARGDLGGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20		TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGATCCCACGACGGAAAGGGCTACAATGAGCAGTTCTTCGGGCCA	CSARSHDGKGYNEQFF	In	VDJ	1	70	1.6426410852694986E-4	2.062019659884586E-4	48	TCRBV20						TCRBJ02	TCRBJ02-01	01	2	5	3	3	13	0	26	38	-1	51	55		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARSHDGKGYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20		TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTGAGTTAAGGATGAACACTGAAGCTTTCTTTGGACAA	CSASELRMNTEAFF	In	VDJ	1	70	1.6426410852694986E-4	2.062019659884586E-4	42	TCRBV20						TCRBJ01	TCRBJ01-01	01	3	1	8	0	8	0	26	37	-1	45	48		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSASELRMNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCACCCCGGGGAGAATGAACACTGAAGCTTTCTTTGGACAA	CSATPGRMNTEAFF	In	VDJ	1	71	1.6661073864876344E-4	2.0914770835972227E-4	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	6	8	3	0	5	4	26	34	44	39	48		TCRBV20-01,TCRBV20-or09_02				01,02								CSATPGRMNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCTGAGTGGGGGCGCGGGGTATGGCTACACCTTCGGTTCG	CSALSGGAGYGYTF	In	VDJ	1	71	1.6661073864876344E-4	2.0914770835972227E-4	42	TCRBV20						TCRBJ01	TCRBJ01-02	01	6	6	0	5	7	6	26	34	47	41	53		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSALSGGAGYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20		TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCMTSTATCKCTGTGCCAGCAGTTATACAGCACTGCCTAACTATGGCTACACCTTCGGTTCG	CASSYTALPNYGYTF	In	VDJ	1	71	1.6661073864876344E-4	2.0914770835972227E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	3	5	0	4	6	19	30	38	34	44	TCRBV05,TCRBV07													CASSYTALPNYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGTTCCCGATCACAAGGCTATGGCTACACCTTCGGTTCG	CASSSRSQGYGYTF	In	VDJ	1	71	1.6661073864876344E-4	2.0914770835972227E-4	42	unresolved						TCRBJ01	TCRBJ01-02	01	5	3	6	4	8	3	23	35	46	43	49	TCRBV02,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSRSQGYGYTF+X+TCRBJ01-02	unresolved		TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCACTTTTGAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	72	1.6895736877057702E-4		35	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	4	3	10	8	1	4	26	39	43	40	47		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ01-05	TCRBV03	TCRBD02-01	TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGGGGAGGGACTAGCGGGGGGCCAATACGAGCAGTACGTCGGGCCG		Out	VDJ	1	72	1.6895736877057702E-4		47	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	6	0	1	17	5	17	26	34	54	39	71		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAAGTCTCTTGGTGAACACTGAAGCTTTCTTTGGACAA	CSARSLLVNTEAFF	In	VDJ	1	72	1.6895736877057702E-4	2.1209345073098596E-4	42	TCRBV20						TCRBJ01	TCRBJ01-01	01	2	0	10	0	8	0	26	38	-1	46	48		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARSLLVNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTTATAAGACCGGGACAGGGTGGCGCTACACCTTCGGTTCG	CSYKTGTGWRYTF	In	VDJ	1	72	1.6895736877057702E-4	2.1209345073098596E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	8	0	3	9	9	4	26	32	50	41	54		TCRBV20-01,TCRBV20-or09_02												CSYKTGTGWRYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTACCAGGGACGGCGGCTCACAGATACGCAGTATTTTGGCCCA	CASSYQGRRLTDTQYF	In	VDJ	1	72	1.6895736877057702E-4	2.1209345073098596E-4	48	unresolved						TCRBJ02	TCRBJ02-03	01	4	0	7	2	4	7	18	31	40	35	47	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYQGRRLTDTQYF+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCACCGCAGGGGAGGTGAACACTGAAGCTTTCTTTGGACAA	CASTAGEVNTEAFF	In	VDJ	1	73	1.7130399889239058E-4	2.1503919310224967E-4	42	TCRBV03						TCRBJ01	TCRBJ01-01	01	7	4	2	0	3	3	26	36	45	39	48		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASTAGEVNTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03		TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCGACCCTTAGCGGCAATGAGCAGTTCTTCGGGCCA	CASSPTLSGNEQFF	In	VDJ	1	73	1.7130399889239058E-4	2.1503919310224967E-4	42	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	5	5	6	7	0	26	39	-1	46	52		TCRBV03-01,TCRBV03-02				01,02								CASSPTLSGNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTAAGCAATCCCCTAGGCATGAGCAGTTCTTCGGGCCA	CSASKQSPRHEQFF	In	VDJ	1	73	1.7130399889239058E-4	2.1503919310224967E-4	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	4	8	8	11	2	26	37	52	48	54		TCRBV20-01,TCRBV20-or09_02				01,02								CSASKQSPRHEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCACCCGGACAGGATCAGCAGATACGCAGTATTTTGGCCCA	CASTRTGSADTQYF	In	VDJ	1	74	1.7365062901420416E-4	2.1798493547351336E-4	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	7	1	4	4	3	5	26	36	46	39	51		TCRBV03-01,TCRBV03-02												CASTRTGSADTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD01-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCACGACTAGCGGGAGTGACGAGCAGTACTTCGGGCCG	CSATTSGSDEQYF	In	VDJ	1	74	1.7365062901420416E-4	2.1798493547351336E-4	39	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	2	2	5	3	2	26	34	49	37	51		TCRBV20-01,TCRBV20-or09_02												CSATTSGSDEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCRTGTATSKCTGTGCCAGAAGCCACATAGCGGGAGGGCGGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	74	1.7365062901420416E-4		49	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	4	5	0	1	4	2	18	30	45	34	47	TCRBV05,TCRBV07,TCRBV11													X+X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTAGGGGCTACGAGCAGTACTTCGGGCCG	CSASRGYEQYF	In	VDJ	1	75	1.7599725913601771E-4	2.2093067784477704E-4	33	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	5	2	3	1	0	26	37	-1	38	43		TCRBV20-01,TCRBV20-or09_02												CSASRGYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGCATGGACAGGGGGCGCAGTATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	75	1.7599725913601771E-4		44	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	7	1	0	8	3	5	24	35	49	38	54	TCRBV24,TCRBV27													X+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGTTCTGGACTAGCGGGGACAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	75	1.7599725913601771E-4		46	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	6	1	3	2	4	1	18	29	45	33	46	TCRBV07,TCRBV11													X+X+TCRBJ02-05	unresolved	TCRBD02-01*01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGTCCCCGGGTAGCGGGGGGCCCTGGCAGATACGCAGTATTTTGGCCCA		Out	VDJ	2	76	1.783438892578313E-4		52	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	5	1	4	8	6	23	34	52	42	58	TCRBV01,TCRBV04													X+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATGGGACTAGCGGCTACGAGCAGTACTTCGGGCCG	CSARDGTSGYEQYF	In	VDJ	2	76	1.783438892578313E-4	2.2387642021604075E-4	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	0	5	3	1	0	26	40	-1	41	52		TCRBV20-01,TCRBV20-or09_02				01,02								CSARDGTSGYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATGTAAGTGGGACTTCCTACTACAATGAGCAGTTCTTCGGGCCA	CSARDVSGTSYYNEQFF	In	VDJ	2	76	1.783438892578313E-4	2.2387642021604075E-4	51	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	0	10	3	7	5	26	40	53	47	58		TCRBV20-01,TCRBV20-or09_02				01,02								CSARDVSGTSYYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTTAGGGGGATAGGGCTCAGCCCCAGCATTTTGGTGAT	CASS*GDRAQPQHF	Stop	VDJ	2	76	1.783438892578313E-4		42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	5	1	6	0	7	22	-1	41	35	48		TCRBV12-03,TCRBV12-04												CASS*GDRAQPQHF+TCRBV12-X+TCRBJ01-05	TCRBV12	TCRBD01-01*01	TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTTAACGGCAGGAAGCTCACGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	2	77	1.8069051937964485E-4		46	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	4	4	7	7	7	26	38	49	45	56		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD01-01*01	TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAAGGGAAGAAACATAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	2	77	1.8069051937964485E-4		43	TCRBV20						TCRBJ01	TCRBJ01-06	01	2	0	8	5	1	6	26	38	43	39	49		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV20-X+TCRBJ01-06	TCRBV20		TCRBJ01-06*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGAATCACCGGGACAGGGGCTCGGGGAGCTTTCTTTGGACAA	CASRITGTGARGAFF	In	VDJ	2	77	1.8069051937964485E-4	2.2682216258730444E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	0	2	10	7	7	22	33	50	40	57	TCRBV02,TCRBV12													CASRITGTGARGAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGCTCACCCGAATGAGCAGTTCTTCGGGCCA	CSARAHPNEQFF	In	VDJ	2	78	1.8303714950145843E-4	2.2976790495856812E-4	36	TCRBV20						TCRBJ02	TCRBJ02-01	01	1	3	7	7	3	3	26	39	44	42	47		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARAHPNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20		TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGATCGGAGCAGGGATGTCGGCTACACCTTCGGTTCG	CASSQDRSRDVGYTF	In	VDJ	2	79	1.85383779623272E-4	2.3271364732983183E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	4	3	8	6	5	23	40	51	46	56	TCRBV01,TCRBV04													CASSQDRSRDVGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCAAAGTTCTGGGGAAATGAGCAGTTCTTCGGGCCA	CSAKFWGNEQFF	In	VDJ	2	79	1.85383779623272E-4	2.3271364732983183E-4	36	TCRBV20						TCRBJ02	TCRBJ02-01	01	6	0	8	7	9	0	26	34	-1	43	47		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAKFWGNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20		TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGCCACCTAGCGGGGGGGCCCCCTACGAGCAGTACGTCGGGCCG	CSARPPSGGAPYEQYV	In	VDJ	2	79	1.85383779623272E-4	2.3271364732983183E-4	48	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	3	4	0	17	5	18	26	37	54	42	72		TCRBV20-01,TCRBV20-or09_02												CSARPPSGGAPYEQYV+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCMTSTATCTCTGTGCCAGCAGCCCAAGGTCCCGGACGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSPRSRTNTGELFF	In	VDJ	2	79	1.85383779623272E-4	2.3271364732983183E-4	48	unresolved						TCRBJ02	TCRBJ02-02	01	4	1	8	0	10	0	19	31	-1	41	44	TCRBV05,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPRSRTNTGELFF+X+TCRBJ02-02	unresolved		TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCTGACAGGGAATGATCAGTCCCAGCATTTTGGTGAT	CSALTGNDQSQHF	In	VDJ	2	80	1.8773040974508556E-4	2.3565938970109552E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	2	3	11	3	10	26	34	44	37	54		TCRBV20-01,TCRBV20-or09_02												CSALTGNDQSQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTTGGCGGGAGCGGGAGCAGTTCTTCGGGCCA	CSASWREREQFF	In	VDJ	2	80	1.8773040974508556E-4	2.3565938970109552E-4	36	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	7	2	10	3	3	26	37	47	40	50		TCRBV20-01,TCRBV20-or09_02												CSASWREREQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACAAGGACAGGCCTCGCGAGCAGTACTTCGGGCCG	CATSDKDRPREQYF	In	VDJ	2	80	1.8773040974508556E-4	2.3565938970109552E-4	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	1	4	6	3	5	24	38	48	41	53		TCRBV24-01,TCRBV24-or09_02												CATSDKDRPREQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCCTCCAAGCGGGAGTGTGGAATGAGCAGTTCTTCGGGCCA	CASSLQAGVWNEQFF	In	VDJ	2	80	1.8773040974508556E-4	2.3565938970109552E-4	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	6	2	7	5	5	18	30	43	35	48	TCRBV07,TCRBV11													CASSLQAGVWNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCTAAGGACCCTCAACACTGAAGCTTTCTTTGGACAA	CSARDLRTLNTEAFF	In	VDJ	2	81	1.9007703986689915E-4	2.386051320723592E-4	45	TCRBV20						TCRBJ01	TCRBJ01-01	01	0	1	7	2	5	4	26	40	49	45	53		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDLRTLNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGTCTCTTACTAGCGGGAGAGGCAACGAGCAGTACTTCGGGCCG	CSARSLTSGRGNEQYF	In	VDJ	2	81	1.9007703986689915E-4	2.386051320723592E-4	48	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	3	2	5	7	5	26	37	55	44	60		TCRBV20-01,TCRBV20-or09_02												CSARSLTSGRGNEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTTCCGGGGGGCGAAGGGAAGCTTTCTTTGGACAA	CSASSGGRREAFF	In	VDJ	2	81	1.9007703986689915E-4	2.386051320723592E-4	39	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	3	8	1	8	3	6	26	37	47	40	53		TCRBV20-01,TCRBV20-or09_02												CSASSGGRREAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTCCCGGGCTCGGGGTTGGCTACACCTTCGGTTCG	CASSPGLGVGYTF	In	VDJ	2	81	1.9007703986689915E-4	2.386051320723592E-4	39	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	6	8	3	7	8	1	24	36	49	44	50	TCRBV24,TCRBV27													CASSPGLGVGYTF+X+TCRBJ01-02	unresolved	TCRBD02-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTGGGGACAGGCCTTCATTAATCAGCCCCAGCATTTTGGTGAT	CASSWGQAFINQPQHF	In	VDJ	2	82	1.924236699887127E-4	2.4155087444362292E-4	48	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	0	4	4	1	8	26	39	48	40	56		TCRBV12-03,TCRBV12-04												CASSWGQAFINQPQHF+TCRBV12-X+TCRBJ01-05	TCRBV12	TCRBD01-01*01	TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAGACTAGCGCTGCCCTCTACAATGAGCAGTTCTTCGGGCCA	CSARETSAALYNEQFF	In	VDJ	2	82	1.924236699887127E-4	2.4155087444362292E-4	48	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	2	6	3	0	7	26	-1	48	40	55		TCRBV20-01,TCRBV20-or09_02				01,02								CSARETSAALYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAAGCGCGGTGACCTACGAGCAGTACTTCGGGCCG	CSARSAVTYEQYF	In	VDJ	2	84	1.9711693023233983E-4	2.474423591861503E-4	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	2	6	6	2	0	6	26	-1	42	38	48		TCRBV20-01,TCRBV20-or09_02				01,02								CSARSAVTYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCCTATGACAGGGGATGAAAAACTGTTTTTTGGCAGT	CASSPMTGDEKLFF	In	VDJ	2	84	1.9711693023233983E-4	2.474423591861503E-4	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	2	2	6	5	0	24	36	-1	41	49		TCRBV24-01,TCRBV24-or09_02												CASSPMTGDEKLFF+TCRBV24-X+TCRBJ01-04	TCRBV24	TCRBD01-01*01	TCRBJ01-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTCACAGGGTTTTAACAATCAGCCCCAGCATTTTGGTGAT	CASSSQGFNNQPQHF	In	VDJ	2	84	1.9711693023233983E-4	2.474423591861503E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	3	3	3	1	6	18	31	38	32	44	TCRBV05,TCRBV11													CASSSQGFNNQPQHF+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAAACTAGCGCTTGCGACAGATACGCAGTATTTTGGCCCA		Out	VDJ	2	85	1.9946356035415342E-4		49	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	3	6	3	1	6	26	43	51	44	57		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTTCAGACAGGGGGCGCACCACAGATACGCAGTATTTTGGCCCA	CASSSDRGRTTDTQYF	In	VDJ	2	85	1.9946356035415342E-4	2.50388101557414E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	2	0	2	3	4	24	36	49	39	53	TCRBV24,TCRBV27													CASSSDRGRTTDTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCAGCGTAGCGACAGGCTACGAGCAGTACTTCGGGCCG	CASSVATGYEQYF	In	VDJ	2	85	1.9946356035415342E-4	2.50388101557414E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	2	4	3	1	0	23	39	-1	40	46	TCRBV09,TCRBV12													CASSVATGYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCACTTAGGTTCCGAGCAGTACTTCGGGCCG	CASSHLGSEQYF	In	VDJ	2	86	2.01810190475967E-4	2.533338439286777E-4	36	TCRBV03						TCRBJ02	TCRBJ02-07	01	3	5	4	6	3	3	26	40	46	43	49		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSHLGSEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03		TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTTCCTAGGAGGGGGGGTAAGAGGAACTGAAGCTTTCTTTGGACAA	CSAFLGGGVRGTEAFF	In	VDJ	2	86	2.01810190475967E-4	2.533338439286777E-4	48	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	5	9	0	5	9	8	26	35	51	44	59		TCRBV20-01,TCRBV20-or09_02												CSAFLGGGVRGTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAGGCCGGACAGGGGTCTAGGAATTCACCCCTCCACTTTGGGAAC	CASSQAGQGSRNSPLHF	In	VDJ	2	87	2.0415682059778055E-4	2.5627958629994137E-4	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	3	1	2	7	4	6	23	37	50	41	56	TCRBV01,TCRBV04													CASSQAGQGSRNSPLHF+X+TCRBJ01-06	unresolved	TCRBD01-01*01	TCRBJ01-06*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCCGCATGGTCATGCAAGATACGCAGTATTTTGGCCCA		Out	VDJ	2	87	2.0415682059778055E-4		44	TCRBV03						TCRBJ02	TCRBJ02-03	01	4	0	10	5	6	7	26	39	47	45	54		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ02-03	TCRBV03		TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCGTCCGTGATCTAAGCAATCAGCCCCAGCATTTTGGTGAT	CSAVRDLSNQPQHF	In	VDJ	2	87	2.0415682059778055E-4	2.5627958629994137E-4	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	6	4	9	1	10	0	26	34	-1	44	47		TCRBV20-01,TCRBV20-or09_02				01,02								CSAVRDLSNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD02-01	TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCATCAGGCCGAGCGGGGGGACGGGGGAGACCCAGTACTTCGGGCCA	CAIRPSGGTGETQYF	In	VDJ	2	88	2.0650345071959413E-4	2.592253286712051E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	6	6	1	5	4	6	24	35	48	39	54	TCRBV06,TCRBV10													CAIRPSGGTGETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGACCTACTCCAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CSATYSSSYNEQFF	In	VDJ	2	88	2.0650345071959413E-4	2.592253286712051E-4	42	TCRBV20						TCRBJ02	TCRBJ02-01	01	6	2	7	0	0	9	26	-1	37	34	46		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSATYSSSYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20		TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGGCCTAGACTAGTTTTAGGCCCAAGAGACCCAGTACTTCGGGCCA	CASSQGLD*F*AQETQYF	Stop	VDJ	2	90	2.1119671096322127E-4		54	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	1	2	8	1	5	8	23	39	50	44	58	TCRBV01,TCRBV04					01,02								CASSQGLD*F*AQETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTTCATATAGGACAGGAAGCCAGTTCTTCGGGCCA	CASSSYRTGSQFF	In	VDJ	2	90	2.1119671096322127E-4	2.6511681341373245E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	1	4	13	6	4	23	36	49	42	53	TCRBV24,TCRBV27													CASSSYRTGSQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCCCAACTCTAGCGGGGGGAGGGGAGACCCAGTACTTCGGGCCA	CASSPTLAGGGETQYF	In	VDJ	2	91	2.1354334108503485E-4	2.6806255578499616E-4	48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	5	4	1	5	6	4	18	30	47	36	51	TCRBV07,TCRBV11													CASSPTLAGGGETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCAACAGGGGAAATGAGCAGTTCTTCGGGCCA	CASSNRGNEQFF	In	VDJ	2	93	2.1823660132866198E-4	2.7395404052752353E-4	36	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	3	2	7	1	1	26	38	46	39	47		TCRBV03-01,TCRBV03-02												CASSNRGNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD01-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATTAGTCCCGACACAGATACGCAGTATTTTGGCCCA		Out	VDJ	2	93	2.1823660132866198E-4		46	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	5	8	2	1	6	26	43	47	44	53		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACCAGTGGGGATGAAAAACTGTTTTTTGGCAGT	CSATSGDEKLFF	In	VDJ	2	93	2.1823660132866198E-4	2.7395404052752353E-4	36	TCRBV20						TCRBJ01	TCRBJ01-04	01	4	6	2	6	5	0	26	36	-1	41	45		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSATSGDEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20		TCRBJ01-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTTAAATCGTAACTACAATGAGCAGTTCTTCGGGCCA	CSALNRNYNEQFF	In	VDJ	2	93	2.1823660132866198E-4	2.7395404052752353E-4	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	5	9	3	1	8	26	35	38	36	46		TCRBV20-01,TCRBV20-or09_02				01,02								CSALNRNYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCAGTGACAGATTCTATGGCTACACCTTCGGTTCG	CSASDRFYGYTF	In	VDJ	2	97	2.2762312181591625E-4	2.857370100125783E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	2	5	4	4	3	26	34	43	38	46		TCRBV20-01,TCRBV20-or09_02												CSASDRFYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGACAAGTCGACAGGGGGCAAGAAGAGCAGTTCTTCGGGCCA	CASRQVDRGQEEQFF	In	VDJ	2	99	2.323163820595434E-4	2.916284947551057E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	2	0	10	7	5	18	29	46	36	51	TCRBV07,TCRBV11													CASRQVDRGQEEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTCCTCTGGGGGGGGCCCCTACAATGAGCAGTTCTTCGGGCCA	CASSSSGGGPYNEQFF	In	VDJ	2	100	2.3466301218135697E-4	2.945742371263694E-4	48	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	9	0	2	6	3	24	36	49	42	52		TCRBV24-01,TCRBV24-or09_02												CASSSSGGGPYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTCTTGGTACAGAGCAGTTCTTCGGGCCA	CSASLGTEQFF	In	VDJ	2	101	2.3700964230317052E-4	2.975199794976331E-4	33	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	3	6	10	7	0	26	37	-1	44	47		TCRBV20-01,TCRBV20-or09_02												CSASLGTEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGAACCCTCGGGGGTAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	2	101	2.3700964230317052E-4		44	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-06	01	4	8	2	6	5	0	24	38	-1	43	49		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-06	TCRBV24	TCRBD02-01*01	TCRBJ01-06*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGTCCGGGTTGTATGGCTACACCTTCGGTTCG	CSARSGLYGYTF	In	VDJ	2	102	2.393562724249841E-4	3.004657218688968E-4	36	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	3	8	4	5	3	3	26	37	44	40	47		TCRBV20-01,TCRBV20-or09_02				01,02								CSARSGLYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD02-01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTGTCAGGGGGCGCCGTAAGGCTACACCTTCGGTTCG		Out	VDJ	2	102	2.393562724249841E-4		43	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	4	0	8	2	7	18	32	42	34	49	TCRBV05,TCRBV11													X+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAACTTCGGCGGGAGGCCTCCACAGATACGCAGTATTTTGGCCCA	CAISELRREASTDTQYF	In	VDJ	2	103	2.4170290254679766E-4	3.034114642401605E-4	51				TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	2	7	1	2	5	4	23	38	51	43	55	TCRBV06,TCRBV10	TCRBV06-01,TCRBV06-08,TCRBV10-03												CAISELRREASTDTQYF+X+TCRBJ02-03		TCRBD02-01*02	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGGRGACWYGGCWSTGTATCTCTGYGCCAGCAGCTTRCGGGTTCAGGGTGAGCAGTTCTTCGGGCCA	CASSLRVQGEQFF	In	VDJ	2	103	2.4170290254679766E-4	3.034114642401605E-4	39	unresolved			unresolved			TCRBJ02	TCRBJ02-01	01	4	4	3	9	8	0	22	35	-1	43	48	TCRBV07,TCRBV23			TCRBD01,TCRBD02										CASSLRVQGEQFF+X+TCRBJ02-01	unresolved	unresolved	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTACGATCGGGGAGCAGTACTTCGGGCCG	CASSTIGEQYF	In	VDJ	2	104	2.4404953266861124E-4	3.063572066114242E-4	33	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	8	4	7	5	0	26	38	-1	43	47		TCRBV12-03,TCRBV12-04				01,02								CASSTIGEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD02-01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCCGTGTCGAAAGACCTATGGCTACACCTTCGGTTCG	CASSPCRKTYGYTF	In	VDJ	2	104	2.4404953266861124E-4	3.063572066114242E-4	42	unresolved						TCRBJ01	TCRBJ01-02	01	4	2	7	4	10	0	23	36	-1	46	49	TCRBV01,TCRBV04			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPCRKTYGYTF+X+TCRBJ01-02	unresolved		TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTCCCGGGCGACGGAACCATATCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	2	104	2.4404953266861124E-4		50	TCRBV03						TCRBJ02	TCRBJ02-07	01	5	8	0	1	4	12	26	38	46	42	58		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ02-07	TCRBV03		TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTCACCCGGGACAGGGGATCGGGGAGCTGTTTTTTGGAGAA	CASSHPGQGIGELFF	In	VDJ	2	104	2.4404953266861124E-4	3.063572066114242E-4	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	0	2	7	5	2	22	34	49	39	51		TCRBV12-03,TCRBV12-04												CASSHPGQGIGELFF+TCRBV12-X+TCRBJ02-02	TCRBV12	TCRBD01-01*01	TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCACAACCCCACCCCGGGACAACCTCTCTACGAGCAGTACTTCGGGCCG		Out	VDJ	2	105	2.463961627904248E-4		47	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	10	0	6	3	12	6	22	29	47	41	53		TCRBV12-03,TCRBV12-04												X+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD01-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCAACCTGTACGGGGGAGCCTACGAGCAGTACTTCGGGCCG	CASSNLYGGAYEQYF	In	VDJ	2	105	2.463961627904248E-4	3.0930294898268786E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	5	8	2	2	8	2	18	30	44	38	46	TCRBV07,TCRBV11													CASSNLYGGAYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTTAGAGATAGGGAAGAATGAAAAACTGTTTTTTGGCAGT	CASSLEIGKNEKLFF	In	VDJ	2	105	2.463961627904248E-4	3.0930294898268786E-4	45	unresolved						TCRBJ01	TCRBJ01-04	01	0	0	8	5	4	2	18	35	43	39	45	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLEIGKNEKLFF+X+TCRBJ01-04	unresolved		TCRBJ01-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGCTTGGCCGGGACAGGGGAGGATGAAAAACTGTTTTTTGGCAGT	CASSLAGTGEDEKLFF	In	VDJ	2	105	2.463961627904248E-4	3.0930294898268786E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	0	2	6	4	3	18	32	46	36	49	TCRBV07,TCRBV11													CASSLAGTGEDEKLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGACCCTAGCGGGAGGCTAAACTCCTACAATGAGCAGTTCTTCGGGCCA	CSARDPSGRLNSYNEQFF	In	VDJ	2	106	2.487427929122384E-4	3.1224869135395157E-4	54	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	4	1	0	2	5	26	40	53	42	58		TCRBV20-01,TCRBV20-or09_02												CSARDPSGRLNSYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTGTCGGTTGTGGCAGGCAATGAGCAGTACGTCGGGCCG	CASSLSVVAGNEQYV	In	VDJ	2	107	2.5108942303405193E-4	3.151944337252153E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	4	4	17	11	14	18	32	47	43	61	TCRBV05,TCRBV11													CASSLSVVAGNEQYV+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTGGCCCGGGACAGGAGGTTTTGAAAAACTGTTTTTTGGCAGT	CASSWPGTGGFEKLFF	In	VDJ	2	107	2.5108942303405193E-4	3.151944337252153E-4	48	TCRBV05			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	0	4	7	5	6	19	32	45	37	51		TCRBV05-06,TCRBV05-07												CASSWPGTGGFEKLFF+TCRBV05-X+TCRBJ01-04	TCRBV05	TCRBD01-01*01	TCRBJ01-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCACCCCGGTAGCCTCCTACAATGAGCAGTTCTTCGGGCCA	CASTPVASYNEQFF	In	VDJ	2	108	2.534360531558655E-4	3.1814017609647894E-4	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	7	5	7	0	6	0	23	33	-1	39	43	TCRBV01,TCRBV04					01,02								CASTPVASYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGGGCCTGGGGGGGGCACTGAAGCTTTCTTTGGACAA		Out	VDJ	2	108	2.534360531558655E-4		40	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	7	9	0	4	5	1	24	35	47	40	48		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD02-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCAGAGACTAGTTCGAATGAGCAGTTCTTCGGGCCA	CSAETSSNEQFF	In	VDJ	2	109	2.557826832776791E-4	3.2108591846774265E-4	36	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	2	8	7	3	4	26	34	43	37	47		TCRBV20-01,TCRBV20-or09_02				01,02								CSAETSSNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGTGACCACCCCGGGACAGCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSDHPGTANTGELFF	In	VDJ	2	109	2.557826832776791E-4	3.2108591846774265E-4	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	0	5	0	9	0	22	34	-1	43	50	TCRBV02,TCRBV12													CASSDHPGTANTGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGGCCCCGGGACAGTACAATGAGCAGTTCTTCGGGCCA	CASSQAPGQYNEQFF	In	VDJ	2	110	2.5812931339949267E-4	3.2403166083900636E-4	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	0	5	4	6	0	26	40	-1	46	53		TCRBV03-01,TCRBV03-02												CASSQAPGQYNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD01-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTGGGGGGACAGGGGATGTATGGCTACACCTTCGGTTCG	CSARVGGQGMYGYTF	In	VDJ	2	110	2.5812931339949267E-4	3.2403166083900636E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	0	2	5	4	3	26	39	53	43	56		TCRBV20-01,TCRBV20-or09_02												CSARVGGQGMYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTGGGCAGGGGGCGCGGGATGGCTACACCTTCGGTTCG	CSASGQGARDGYTF	In	VDJ	2	110	2.5812931339949267E-4	3.2403166083900636E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	4	0	6	4	5	26	37	49	41	54		TCRBV20-01,TCRBV20-or09_02												CSASGQGARDGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGCGGGAGGGCCATCGGGGACCCAGTACTTCGGGCCA	CSARAGGPSGTQYF	In	VDJ	2	111	2.6047594352130625E-4	3.2697740321027E-4	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	1	8	0	7	0	8	26	-1	47	39	55		TCRBV20-01,TCRBV20-or09_02												CSARAGGPSGTQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*02	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATCGACTGAATGAGCAGTTCTTCGGGCCA	CATSDRLNEQFF	In	VDJ	2	113	2.6516920376493336E-4	3.3286888795279744E-4	36	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	2	10	7	1	1	24	39	44	40	45		TCRBV24-01,TCRBV24-or09_02				01,02								CATSDRLNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGTAGCTTAGGACCTCCCCTATACCTCCAAGAGACCCAGTACTTCGGGCCA	CASSLGPPLYLQETQYF	In	VDJ	2	113	2.6516920376493336E-4	3.3286888795279744E-4	51							TCRBJ02	TCRBJ02-05	01	1	2	7	1	0	13	18	-1	37	34	50	TCRBV11,TCRBV12	TCRBV11-03,TCRBV12-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGPPLYLQETQYF+X+TCRBJ02-05			TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGGACGACTAGCGGGAGATGGGTTAGGTTCGGGCCA	CASSQGTTSGRWVRF	In	VDJ	2	114	2.6751583388674694E-4	3.358146303240611E-4	45	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02			1	2	2	19	4	10	26	42	58	46	68		TCRBV03-01,TCRBV03-02						TCRBJ02-01,TCRBJ02-05						CASSQGTTSGRWVRF+TCRBV03-X+TCRBJ02-X	TCRBV03	TCRBD02-01*02	TCRBJ02	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAATTTGATACGCAGTATTTTGGCCCA	CASSQFDTQYF	In	VJ	2	115	2.698624640085605E-4	3.387603726953248E-4	33	TCRBV03						TCRBJ02	TCRBJ02-03	01	2	0	0	6	0	3	26	-1	41	-1	44		TCRBV03-01,TCRBV03-02												CASSQFDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03		TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTTTGGTCCTAGGCGGGGACACAGATACGCAGTATTTTGGCCCA	CASSLVLGGDTDTQYF	In	VDJ	2	115	2.698624640085605E-4	3.387603726953248E-4	48	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	7	3	2	8	1	22	36	50	44	51		TCRBV12-03,TCRBV12-04												CASSLVLGGDTDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCSTSTATCTCTGTGCCAGCAGCTTGGTTTTGCCTCCCTACGAGCAGTACGTCGGGCCG	CASSLVLPPYEQYV	In	VDJ	2	115	2.698624640085605E-4	3.387603726953248E-4	42	unresolved						TCRBJ02	TCRBJ02-07	01	0	4	5	17	17	4	18	34	54	51	58	TCRBV05,TCRBV07			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLVLPPYEQYV+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGCGCCGTCCAGGGCTACTATGGCTACACCTTCGGTTCG	CASSAVQGYYGYTF	In	VDJ	2	116	2.7220909413037405E-4	3.417061150665885E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	4	3	3	6	2	18	30	41	36	43	TCRBV07,TCRBV11													CASSAVQGYYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCRTGTATSKCTGTGCTAGCAGCTCTAAGACAGGGTTTAATTCACCCCTCCACTTTGGGAAC	CASSSKTGFNSPLHF	In	VDJ	2	116	2.7220909413037405E-4	3.417061150665885E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	4	2	3	6	4	2	18	31	42	35	44	TCRBV07,TCRBV11													CASSSKTGFNSPLHF+X+TCRBJ01-06	unresolved	TCRBD01-01*01	TCRBJ01-06*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCACGGTCGGGGGCAAGAGACCCAGTACTTCGGGCCA	CSAHGRGQETQYF	In	VDJ	2	117	2.7455572425218763E-4	3.446518574378522E-4	39	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	6	8	2	2	7	0	26	34	-1	41	47		TCRBV20-01,TCRBV20-or09_02												CSAHGRGQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTAACAGCCGGCAGGGAGACCCAGTACTTCGGGCCA	CASSLTAGRETQYF	In	VDJ	2	118	2.769023543740012E-4	3.475975998091159E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	3	5	5	0	8	18	-1	37	33	45	TCRBV07,TCRBV11													CASSLTAGRETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAAAGGGACAGGGGGTCTTGGGGCCAACGTCCTGACTTTCGGGGCC	CASKGTGGLGANVLTF	In	VDJ	2	119	2.792489844958148E-4	3.505433421803796E-4	48	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	7	0	1	3	2	3	26	36	49	38	52		TCRBV03-01,TCRBV03-02												CASKGTGGLGANVLTF+TCRBV03-X+TCRBJ02-06	TCRBV03	TCRBD01-01*01	TCRBJ02-06*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATAATGGGACTATGCCAGTACGGTGAGCAGTTCTTCGGGCCA		Out	VDJ	2	119	2.792489844958148E-4		52	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	0	9	9	4	11	26	43	54	47	65		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCCCGAAGACAGCTACTAATGAAAAACTGTTTTTTGGCAGT	CASSPKTATNEKLFF	In	VDJ	2	119	2.792489844958148E-4	3.505433421803796E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	2	5	2	5	2	18	30	40	35	42	TCRBV07,TCRBV11													CASSPKTATNEKLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGGGCCGGGGTAAACTATGGCTACACCTTCGGTTCG	CASRAGVNYGYTF	In	VDJ	2	120	2.815956146176284E-4	3.5348908455164326E-4	39	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	7	8	3	2	3	2	24	35	43	38	45	TCRBV24,TCRBV27													CASRAGVNYGYTF+X+TCRBJ01-02	unresolved	TCRBD02-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
SGACTCGGCYSTSTATCTCTGTGCCAGAAGCTTGGGAGCGGGAAGGCGAGCAGTACTTCGGGCCG		Out	VDJ	2	120	2.815956146176284E-4		40	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	6	3	6	1	3	19	35	43	36	46	TCRBV05,TCRBV07													X+X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGAGGGGCGGGGAACGGTAATGAAAAACTGTTTTTTGGCAGT	CASRGAGNGNEKLFF	In	VDJ	2	121	2.839422447394419E-4	3.56434826922907E-4	45	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	6	7	3	4	4	5	22	33	43	37	48		TCRBV12-03,TCRBV12-04												CASRGAGNGNEKLFF+TCRBV12-X+TCRBJ01-04	TCRBV12	TCRBD02-01*01	TCRBJ01-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACTCGAGCTTCAATCAGCCCCAGCATTTTGGTGAT	CATSDSSFNQPQHF	In	VDJ	2	121	2.839422447394419E-4	3.56434826922907E-4	42	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	4	6	7	3	4	2	24	38	45	42	47		TCRBV24-01,TCRBV24-or09_02				01,02								CATSDSSFNQPQHF+TCRBV24-X+TCRBJ01-05	TCRBV24	TCRBD02-01	TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTGGGTAACAGCAATCAGCCCCAGCATTTTGGTGAT	CASSLGNSNQPQHF	In	VDJ	2	121	2.839422447394419E-4	3.56434826922907E-4	42	unresolved						TCRBJ01	TCRBJ01-05	01	3	0	9	1	0	4	18	-1	35	32	39	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGNSNQPQHF+X+TCRBJ01-05	unresolved		TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCGCCCCAGAGGACAGAATACAGACAGATACGCAGTATTTTGGCCCA	CSAAPEDRIQTDTQYF	In	VDJ	2	123	2.8863550498306906E-4	3.6232631166543435E-4	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	1	5	3	9	7	26	34	49	43	56		TCRBV20-01,TCRBV20-or09_02												CSAAPEDRIQTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGATAAGGGGGTGAGGACTGAAGCTTTCTTTGGACAA	CASSQDKGVRTEAFF	In	VDJ	2	123	2.8863550498306906E-4	3.6232631166543435E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	5	1	5	2	5	23	40	48	42	53	TCRBV01,TCRBV04													CASSQDKGVRTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCAGGGACATAAACGGAAACACCATATATTTTGGAGAG	CSARDINGNTIYF	In	VDJ	2	124	2.9098213510488264E-4	3.6527205403669806E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	6	0	6	4	2	5	26	34	42	36	47		TCRBV20-01,TCRBV20-or09_02												CSARDINGNTIYF+TCRBV20-X+TCRBJ01-03	TCRBV20	TCRBD01-01*01	TCRBJ01-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGACTAGCGGGAGGTCTCTACAATGAGCAGTTCTTCGGGCCA	CSARGLAGGLYNEQFF	In	VDJ	2	124	2.9098213510488264E-4	3.6527205403669806E-4	48	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	1	2	1	3	0	3	26	-1	52	39	55		TCRBV20-01,TCRBV20-or09_02												CSARGLAGGLYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTCCACAGGGGTGGGGTACGAGCAGTACTTCGGGCCG	CSASTGVGYEQYF	In	VDJ	2	124	2.9098213510488264E-4	3.6527205403669806E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	3	2	4	3	5	26	35	45	38	50		TCRBV20-01,TCRBV20-or09_02												CSASTGVGYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCCCCGGGAGGCGGGCTTCGCACCCAGTACTTCGGGCCA	CASSPPGGGLRTQYF	In	VDJ	2	125	2.933287652266962E-4	3.6821779640796177E-4	45	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	4	8	1	8	3	10	26	39	49	42	59		TCRBV03-01,TCRBV03-02												CASSPPGGGLRTQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01*02	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGATCACCGACTAGCGGCAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	2	125	2.933287652266962E-4		46	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	6	2	5	2	7	1	26	34	50	41	51		TCRBV20-01,TCRBV20-or09_02				01,02								X+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD02-01	TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCCCCGGGCCGTTAATGGGCAATGAGCAGTTCTTCGGGCCA	CSASPGPLMGNEQFF	In	VDJ	2	125	2.933287652266962E-4	3.6821779640796177E-4	45	TCRBV20						TCRBJ02	TCRBJ02-01	01	3	8	0	6	4	10	26	37	45	41	55		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSASPGPLMGNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20		TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGGCGACAGGGTGGGCACGGCTACACCTTCGGTTCG	CASRRQGGHGYTF	In	VDJ	2	125	2.933287652266962E-4	3.6821779640796177E-4	39	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	2	3	8	2	7	22	33	42	35	49		TCRBV12-03,TCRBV12-04												CASRRQGGHGYTF+TCRBV12-X+TCRBJ01-02	TCRBV12	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCCCGGATAGCGGGGGAGCAGTACTTCGGGCCG	CASSPRIAGEQYF	In	VDJ	3	126	2.9567539534850975E-4	3.7116353877922543E-4	39	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	4	5	3	7	6	0	26	39	-1	45	53		TCRBV03-01,TCRBV03-02												CASSPRIAGEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGTCCCCGACTATACGAGCAGTACTTCGGGCCG		Out	VDJ	3	127	2.9802202547032333E-4		38	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	2	9	4	5	0	24	37	-1	42	47		TCRBV24-01,TCRBV24-or09_02				01,02								X+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGCCCTGACTAGCGGGAGGGCAGATACGCAGTATTTTGGCCCA	CATSALTSGRADTQYF	In	VDJ	3	129	3.027152857139505E-4	3.800007658930165E-4	48	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	2	0	4	4	0	24	37	-1	41	55		TCRBV24-01,TCRBV24-or09_02												CATSALTSGRADTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01*02	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATCGACGACAGTCTCCACTATGGCTACACCTTCGGTTCG		Out	VDJ	3	130	3.050619158357641E-4		46	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	2	5	3	4	5	24	39	48	43	53		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTGGCGCAGGGGATCGGGGAGACCCAGTACTTCGGGCCA	CSARVAQGIGETQYF	In	VDJ	3	131	3.074085459575776E-4	3.8589225063554393E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	1	4	2	5	5	6	26	39	50	44	56		TCRBV20-01,TCRBV20-or09_02												CSARVAQGIGETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGGGGACTYGGCYGTGTATSTCTGTGCCAGCAGCGTGGGACTAGCGGGAGAGACGGAGAGACCCAGTACTTCGGGCCA		Out	VDJ	3	132	3.097551760793912E-4		50	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	5	0	2	4	2	6	22	34	50	36	56	TCRBV07,TCRBV11													X+X+TCRBJ02-05	unresolved	TCRBD02-01*02	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAACAGGGGGCACTAATGAAAAACTGTTTTTTGGCAGT	CASSQTGGTNEKLFF	In	VDJ	3	134	3.1444843632301835E-4	3.94729477749335E-4	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	2	3	0	2	0	0	26	-1	-1	41	50		TCRBV03-01,TCRBV03-02												CASSQTGGTNEKLFF+TCRBV03-X+TCRBJ01-04	TCRBV03	TCRBD01-01*01	TCRBJ01-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTTAGGGTTGGCTAGCGGGATCTACGAGCAGTACTTCGGGCCG	CASSLGLASGIYEQYF	In	VDJ	3	134	3.1444843632301835E-4	3.94729477749335E-4	48	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	1	4	3	3	6	1	18	34	49	40	50	TCRBV07,TCRBV11													CASSLGLASGIYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAGRAGACWCRGCMCTGTATCTCTGCGCCAGCAGCCAAGATGACAGGCCCCGCCACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	3	135	3.167950664448319E-4		49	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	2	2	4	4	3	6	20	35	44	38	50	TCRBV04,TCRBV23													X+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCCGGACAGGGGGCAGGAATACGCAGTATTTTGGCCCA	CASSRTGGRNTQYF	In	VDJ	3	138	3.238349568102726E-4	4.0651244723438975E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	1	0	7	1	4	18	30	42	31	46	TCRBV05,TCRBV11													CASSRTGGRNTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAACCCGGGGGCGCCCATCTACAATGAGCAGTTCTTCGGGCCA	CSANPGAPIYNEQFF	In	VDJ	3	140	3.285282170538997E-4	4.124039319769172E-4	45	TCRBV20						TCRBJ02	TCRBJ02-01	01	4	6	0	3	4	6	26	36	46	40	52		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSANPGAPIYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20		TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTTTAGCCGGAAAACTGTTTTTTGGCAGT	CSASLAGKLFF	In	VDJ	3	140	3.285282170538997E-4	4.124039319769172E-4	33	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	3	5	7	10	2	3	26	37	43	39	46		TCRBV20-01,TCRBV20-or09_02				01,02								CSASLAGKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD02-01	TCRBJ01-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGAGGACTCTTGGGACTATGGCTACACCTTCGGTTCG	CASSQEDSWDYGYTF	In	VDJ	3	142	3.332214772975269E-4	4.1829541671944455E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	0	1	10	3	0	6	23	-1	45	40	51	TCRBV01,TCRBV04					01,02								CASSQEDSWDYGYTF+X+TCRBJ01-02	unresolved	TCRBD02-01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCTCGCAGGCAACAGATACGCAGTATTTTGGCCCA	CSASQATDTQYF	In	VDJ	3	147	3.4495462790659474E-4	4.33024128575763E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	4	4	3	4	2	26	34	42	38	44		TCRBV20-01,TCRBV20-or09_02												CSASQATDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGCCTGACTACTACGAGCAGTACTTCGGGCCG	CSAPDYYEQYF	In	VDJ	3	147	3.4495462790659474E-4	4.33024128575763E-4	33	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	2	9	3	4	0	26	34	-1	38	43		TCRBV20-01,TCRBV20-or09_02				01,02								CSAPDYYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCTAGGGGGGCAAACTTATGGCTACACCTTCGGTTCG		Out	VDJ	3	148	3.473012580284083E-4		38	TCRBV20						TCRBJ01	TCRBJ01-02	01	6	5	1	5	2	7	26	34	42	36	49		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV20-X+TCRBJ01-02	TCRBV20		TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AAGRAGACWCRGCWSYGTATCTCTGCGCCAGCAGCCAAGATGTCAGCGGGGTTTCCACTTCGCAGTTCTTCGGGCCA	CASSQDVSGVSTSQFF	In	VDJ	3	149	3.496478881502219E-4	4.389156133182904E-4	48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	6	3	12	4	10	23	40	51	44	61	TCRBV01,TCRBV23													CASSQDVSGVSTSQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATAGGGACAGGGCCCCCTACAATGAGCAGTTCTTCGGGCCA	CSARDRDRAPYNEQFF	In	VDJ	3	149	3.496478881502219E-4	4.389156133182904E-4	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	0	3	2	2	3	26	40	51	42	54		TCRBV20-01,TCRBV20-or09_02												CSARDRDRAPYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGCCCAGACAGGGGAGAGACCCAGTACTTCGGGCCA	CASSPDRGETQYF	In	VDJ	3	150	3.5199451827203543E-4	4.418613556895541E-4	39	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	2	2	4	4	0	22	33	-1	37	45		TCRBV12-03,TCRBV12-04												CASSPDRGETQYF+TCRBV12-X+TCRBJ02-05	TCRBV12	TCRBD01-01*01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCTTGGGCAGACGGAACACTGAAGCTTTCTTTGGACAA	CASSLGRRNTEAFF	In	VDJ	3	151	3.54341148393849E-4	4.448070980608178E-4	42	unresolved			unresolved			TCRBJ01	TCRBJ01-01	01	0	2	7	1	3	1	18	34	40	37	41	TCRBV05,TCRBV07,TCRBV11			TCRBD01,TCRBD02										CASSLGRRNTEAFF+X+TCRBJ01-01	unresolved	unresolved	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGCTAGACTAGCGGGAGTTCGGCCCTACGAGCAGTACTTCGGGCCG	CSARARLAGVRPYEQYF	In	VDJ	3	154	3.613810387592897E-4	4.536443251746089E-4	51	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	1	2	2	2	3	6	26	39	54	42	60		TCRBV20-01,TCRBV20-or09_02												CSARARLAGVRPYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGATGATGATCCTACGAGCAGTACTTCGGGCCG	CSARG**SYEQYF	Stop	VDJ	3	155	3.637276688811033E-4		39	TCRBV20						TCRBJ02	TCRBJ02-07	01	1	2	8	1	0	6	26	-1	41	39	47		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARG**SYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAATTGGGCGGGAACACTGAAGCTTTCTTTGGACAA	CASSELGGNTEAFF	In	VDJ	3	155	3.637276688811033E-4	4.565900675458726E-4	42	TCRBV06						TCRBJ01	TCRBJ01-01	01	2	8	0	1	2	2	23	38	44	40	46		TCRBV06-01,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSELGGNTEAFF+TCRBV06-X+TCRBJ01-01	TCRBV06		TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTTTAAGGTGGGGCCGAGCAGTACGTCGGGCCG		Out	VDJ	3	157	3.6842092912473044E-4		37	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	7	0	17	4	11	22	37	46	41	57		TCRBV12-03,TCRBV12-04												X+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD01-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGCCGGGACAGGGGTGGAACTGAAGCTTTCTTTGGACAA	CSRDRGGTEAFF	In	VDJ	3	158	3.70767559246544E-4	4.6542729465966367E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	9	0	2	5	2	4	26	31	43	33	47		TCRBV20-01,TCRBV20-or09_02												CSRDRGGTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGAGCTGACAGGGAATACGAGCAGTACTTCGGGCCG	CASRADREYEQYF	In	VDJ	3	158	3.70767559246544E-4	4.6542729465966367E-4	39	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	2	3	4	4	2	22	33	44	37	46		TCRBV12-03,TCRBV12-04												CASRADREYEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD01-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCGATTGAGGGGGTTGGTGGATGAGCAGTTCTTCGGGCCA	CSARLRGLVDEQFF	In	VDJ	3	161	3.778074496119847E-4	4.7426452177345475E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	5	1	8	7	7	26	34	47	41	54		TCRBV20-01,TCRBV20-or09_02												CSARLRGLVDEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACCGCTAACAGGGGGAGGGACACTGAAGCTTTCTTTGGACAA		Out	VDJ	3	161	3.778074496119847E-4		47	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	3	1	3	6	4	26	38	52	44	56		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGGGCGTGGGCGCACAGATACGCAGTATTTTGGCCCA	CSARGRGRTDTQYF	In	VDJ	3	161	3.778074496119847E-4	4.7426452177345475E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	7	0	1	0	6	26	-1	42	37	48		TCRBV20-01,TCRBV20-or09_02												CSARGRGRTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTTGGGCGAGGGTCCTACAATGAGCAGTTCTTCGGGCCA	CATSDFGRGSYNEQFF	In	VDJ	3	162	3.801540797337983E-4	4.772102641447184E-4	48	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	1	11	0	1	5	0	24	41	-1	46	51		TCRBV24-01,TCRBV24-or09_02												CATSDFGRGSYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*02	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCATCAGCCTGACCTCCGGGGAGTCGGGGGAGCAGTACTTCGGGCCG	CAISLTSGESGEQYF	In	VDJ	3	164	3.848473399774254E-4	4.8310174888724583E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	8	3	7	9	8	23	34	48	43	56	TCRBV06,TCRBV10					01,02								CAISLTSGESGEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCAAAGAGGAAGCGGGAGTCTCGCAGATACGCAGTATTTTGGCCCA	CSAQRGSGSLADTQYF	In	VDJ	3	166	3.8954060022105256E-4	4.889932336297733E-4	48	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	6	2	4	9	5	26	35	52	44	57		TCRBV20-01,TCRBV20-or09_02												CSAQRGSGSLADTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGACTAGCGGGGAGGGGTGAGCAGTTCTTCGGGCCA	CASSQGLAGRGEQFF	In	VDJ	3	169	3.9658049058649325E-4	4.978304607435643E-4	45	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	1	2	3	9	0	5	26	-1	53	42	58		TCRBV03-01,TCRBV03-02												CASSQGLAGRGEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGTTGTGACTAGGAATAATGAGCAGTTCTTCGGGCCA	CSVVTRNNEQFF	In	VDJ	3	169	3.9658049058649325E-4	4.978304607435643E-4	36	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	7	2	8	7	4	4	26	33	43	37	47		TCRBV20-01,TCRBV20-or09_02				01,02								CSVVTRNNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCTTAGGATCACCGGGGAGCTGTTTTTTGGAGAA	CASSLRITGELFF	In	VDJ	3	169	3.9658049058649325E-4	4.978304607435643E-4	39	unresolved						TCRBJ02	TCRBJ02-02	01	4	1	8	4	3	1	23	36	42	39	43	TCRBV01,TCRBV04			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLRITGELFF+X+TCRBJ02-02	unresolved		TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTTGGGGAATTGGAGGCAATCAGCCCCAGCATTTTGGTGAT	CSASWGIGGNQPQHF	In	VDJ	3	171	4.012737508301204E-4	5.037219454860917E-4	45	TCRBV20						TCRBJ01	TCRBJ01-05	01	3	0	8	2	3	7	26	37	44	40	51		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSASWGIGGNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20		TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTTTTTTTGTAGGGGCTGGAGAGACCCAGTACTTCGGGCCA	CASSFFVGAGETQYF	In	VDJ	3	171	4.012737508301204E-4	5.037219454860917E-4	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	5	2	4	6	4	22	36	47	42	51		TCRBV12-03,TCRBV12-04												CASSFFVGAGETQYF+TCRBV12-X+TCRBJ02-05	TCRBV12	TCRBD01-01*01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGCTTGACGGGACAGCCTACGACCAAGGCCCAGTATTTTGGCCCA	CASSLTGQPTTKAQYF	In	VDJ	3	171	4.012737508301204E-4	5.037219454860917E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	0	5	12	3	15	19	33	43	36	58	TCRBV07,TCRBV11													CASSLTGQPTTKAQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATGGGGACAGGGGATCACTGAAGCTTTCTTTGGACAA	CASSLWGQGITEAFF	In	VDJ	3	173	4.059670110737475E-4	5.09613430228619E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	0	2	4	5	2	24	36	51	41	53		TCRBV24-01,TCRBV24-or09_02												CASSLWGQGITEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCACACCAGGGGTGGCAATCAGCCCCAGCATTTTGGTGAT	CASSHTRGGNQPQHF	In	VDJ	3	174	4.083136411955611E-4	5.125591725998827E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	4	2	2	3	2	23	37	46	40	48	TCRBV01,TCRBV04													CASSHTRGGNQPQHF+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTTTTACCCCCAGAGAGACCCAGTACTTCGGGCCA	CASSFTPRETQYF	In	VDJ	3	174	4.083136411955611E-4	5.125591725998827E-4	39	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	4	5	4	6	0	22	36	-1	42	45		TCRBV12-03,TCRBV12-04												CASSFTPRETQYF+TCRBV12-X+TCRBJ02-05	TCRBV12	TCRBD01-01*01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCATCCCGACAGGGTTATAGTTGAAGCTTTCTTTGGACAA		Out	VDJ	3	174	4.083136411955611E-4		41	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	8	2	3	7	4	7	24	34	45	38	52		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGCCGGGGGCAGTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSQAGGSGANVLTF	In	VDJ	4	176	4.1300690143918826E-4	5.184506573424102E-4	48	TCRBV03						TCRBJ02	TCRBJ02-06	01	1	6	0	3	2	2	26	42	50	44	52		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQAGGSGANVLTF+TCRBV03-X+TCRBJ02-06	TCRBV03		TCRBJ02-06*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCGCGTCCGATAGTCGAACCGGGGAGCTGTTTTTTGGAGAA	CSAASDSRTGELFF	In	VDJ	4	176	4.1300690143918826E-4	5.184506573424102E-4	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	6	5	8	5	9	4	26	34	46	43	50		TCRBV20-01,TCRBV20-or09_02				01,02								CSAASDSRTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD02-01	TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGGGCAGGGACTAAATCAGCCCCAGCATTTTGGTGAT	CASSQGQGLNQPQHF	In	VDJ	4	179	4.2004679180462895E-4	5.272878844562012E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	1	0	9	4	4	0	23	39	-1	43	50	TCRBV01,TCRBV04					01,02								CASSQGQGLNQPQHF+X+TCRBJ01-05	unresolved	TCRBD02-01	TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTTTAGGGCAATACACTGAAGCTTTCTTTGGACAA	CASSLGQYTEAFF	In	VDJ	4	179	4.2004679180462895E-4	5.272878844562012E-4	39	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	9	0	3	0	3	22	-1	41	38	44		TCRBV12-03,TCRBV12-04												CASSLGQYTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGGTTGGGGGGAGATAATTCACCCCTCCACTTTGGGAAC	CASRLGGDNSPLHF	In	VDJ	4	179	4.2004679180462895E-4	5.272878844562012E-4	42	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-06	01	6	9	1	5	3	2	23	34	43	37	45	TCRBV24,TCRBV27													CASRLGGDNSPLHF+X+TCRBJ01-06	unresolved	TCRBD02-01*01	TCRBJ01-06*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGGGATACCGGGACAAGACTACGAGCAGTACTTCGGGCCG	CATSGIPGQDYEQYF	In	VDJ	4	179	4.2004679180462895E-4	5.272878844562012E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	6	3	7	3	24	37	50	44	53		TCRBV24-01,TCRBV24-or09_02												CATSGIPGQDYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCRTGTATSKCTGTGCCAGAACCGGGGACCTACTGGGCCTCAGACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	4	179	4.2004679180462895E-4		49	unresolved						TCRBJ02	TCRBJ02-01	01	9	0	7	5	5	14	18	26	36	31	50	TCRBV07,TCRBV11,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ02-01	unresolved		TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACAGGGGGCTGCGAGCAGTACGTCGGGCCG		Out	VDJ	4	180	4.2239342192644253E-4		35	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	4	0	17	0	13	26	-1	46	38	59		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTCTGGGACTAACCGGGGAGCTGTTTTTTGGAGAA	CASSLGLTGELFF	In	VDJ	4	180	4.2239342192644253E-4	5.302336268274649E-4	39	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	0	9	5	2	0	22	34	-1	36	43		TCRBV12-03,TCRBV12-04				01,02								CASSLGLTGELFF+TCRBV12-X+TCRBJ02-02	TCRBV12	TCRBD02-01	TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGCTTGGTGACTCKGCYGTGTATKTCTGTGCCAGCAGCTTAGGACTAGCGGCAAGCTCCTACGAGCAGTACTTCGGGCCG	CASSLGLAASSYEQYF	In	VDJ	4	183	4.294333122918832E-4	5.39070853941256E-4	48	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	1	5	0	3	4	26	38	51	41	55	TCRBV03,TCRBV11					01,02								CASSLGLAASSYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACTATCAGATACGCAGTATTTTGGCCCA	CSARLSDTQYF	In	VDJ	4	183	4.294333122918832E-4	5.39070853941256E-4	33	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	4	9	4	0	1	26	-1	41	38	42		TCRBV20-01,TCRBV20-or09_02				01,02								CSARLSDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTCGACTTCCGCCGGGGAGCAGTTCTTCGGGCCA	CASSSTSAGEQFF	In	VDJ	4	183	4.294333122918832E-4	5.39070853941256E-4	39	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	2	10	10	2	9	24	36	42	38	51		TCRBV24-01,TCRBV24-or09_02				01,02								CASSSTSAGEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCCGGGGGAGGGGCCACATATGGCTACACCTTCGGTTCG	CASSLAGGGATYGYTF	In	VDJ	4	183	4.294333122918832E-4	5.39070853941256E-4	48				TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	0	9	0	5	3	6	18	35	45	38	51	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03												CASSLAGGGATYGYTF+X+TCRBJ01-02		TCRBD02-01*02	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCAGCGTAGGTGGGTGGAGCGGGGGGCGGAATGAGCAGTTCTTCGGGCCA	CASSVGGWSGGRNEQFF	In	VDJ	4	185	4.341265725355104E-4	5.449623386837833E-4	51	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	6	1	7	13	3	26	37	59	50	62	TCRBV09,TCRBV12													CASSVGGWSGGRNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGGACAGGGAATGGCTACACCTTCGGTTCG	CSARGTGNGYTF	In	VDJ	4	189	4.4351309302276466E-4	5.567453081688382E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	1	3	6	0	1	26	-1	47	39	48		TCRBV20-01,TCRBV20-or09_02												CSARGTGNGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTTTAGATAGGGGGCTGGAAAAACTGTTTTTTGGCAGT	CASSLDRGLEKLFF	In	VDJ	4	190	4.4585972314457824E-4	5.596910505401019E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	2	5	0	8	3	2	23	38	48	41	50	TCRBV24,TCRBV27													CASSLDRGLEKLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCACGAGCCCCAGGGGAGTTAAGCCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	4	191	4.482063532663918E-4		58				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	0	4	2	0	8	5	18	35	49	43	54	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03												X+X+TCRBJ02-04		TCRBD01-01*01	TCRBJ02-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTTATCGGGATACGCAGTATTTTGGCCCA	CSASYRDTQYF	In	VDJ	4	195	4.575928737536461E-4	5.744197623964204E-4	33	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	8	5	6	4	0	26	37	-1	41	44		TCRBV20-01,TCRBV20-or09_02				01,02								CSASYRDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGGTGGGGAGGCGATCAGCCCCAGCATTTTGGTGAT	CSARGWGGDQPQHF	In	VDJ	4	197	4.622861339972732E-4	5.803112471389477E-4	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	1	9	1	5	4	2	26	39	49	43	51		TCRBV20-01,TCRBV20-or09_02												CSARGWGGDQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD02-01*02	TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTGGGTGGGACAGACAGGGTTTTTTCACCCCTCCACTTTGGGAAC	CASSLGGTDRVFSPLHF	In	VDJ	4	198	4.646327641190868E-4	5.832569895102114E-4	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	3	0	5	9	4	10	18	32	43	36	53	TCRBV05,TCRBV11													CASSLGGTDRVFSPLHF+X+TCRBJ01-06	unresolved	TCRBD01-01*01	TCRBJ01-06*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAGGCAGGGGATAATTCACCCCTCCACTTTGGGAAC	CASSQAGDNSPLHF	In	VDJ	4	199	4.6697939424090036E-4	5.862027318814751E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	3	4	2	5	2	0	23	37	-1	39	45	TCRBV01,TCRBV04													CASSQAGDNSPLHF+X+TCRBJ01-06	unresolved	TCRBD01-01*01	TCRBJ01-06*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCGGTATAGCGCGTTCCTACAATGAGCAGTTCTTCGGGCCA	CSAGIARSYNEQFF	In	VDJ	4	199	4.6697939424090036E-4	5.862027318814751E-4	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	5	6	1	5	3	26	34	44	39	47		TCRBV20-01,TCRBV20-or09_02				01,02								CSAGIARSYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTTTATCTCTGTGGCAGAGAAATTCACCCCTCCACTTTGGGAAC	CASSLSLWQRNSPLHF	In	VDJ	4	199	4.6697939424090036E-4	5.862027318814751E-4	48	unresolved						TCRBJ01	TCRBJ01-06	01	6	4	5	7	12	3	24	36	51	48	54	TCRBV24,TCRBV27			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLSLWQRNSPLHF+X+TCRBJ01-06	unresolved		TCRBJ01-06*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGATCTTCGACAGGGTTTCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSQDLRQGFSGANVLTF	In	VDJ	4	199	4.6697939424090036E-4	5.862027318814751E-4	57				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	0	2	3	0	5	3	18	35	47	40	50	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03												CASSQDLRQGFSGANVLTF+X+TCRBJ02-06		TCRBD01-01*01	TCRBJ02-06*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATCGCGGGCAGACCCAGTACTTCGGGCCA	CASSQDRGQTQYF	In	VDJ	4	201	4.716726544845275E-4	5.920942166240025E-4	39	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	0	7	4	6	2	1	26	43	50	45	51		TCRBV03-01,TCRBV03-02				01,02								CASSQDRGQTQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTCAACTAGCGGGGGGGGGCCAGATACGCAGTATTTTGGCCCA	CASSSTSGGGPDTQYF	In	VDJ	4	201	4.716726544845275E-4	5.920942166240025E-4	48	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	3	0	4	3	3	26	38	54	41	57		TCRBV03-01,TCRBV03-02												CASSSTSGGGPDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGTAACACAGATACGCAGTATTTTGGCCCA	CASSQGNTDTQYF	In	VDJ	4	211	4.951389557026632E-4	6.215516403366394E-4	39	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	1	5	9	2	1	1	26	42	45	43	46		TCRBV03-01,TCRBV03-02				01,02								CASSQGNTDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGTGACAGGGTTTTTCGAAGGCTACACCTTCGGTTCG	CASSQVTGFFEGYTF	In	VDJ	4	212	4.974855858244768E-4	6.244973827079031E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	2	3	8	1	9	23	39	47	40	56	TCRBV01,TCRBV04													CASSQVTGFFEGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTAGGTAGCGGCGCCTACGAGCAGTACTTCGGGCCG	CSARVGSGAYEQYF	In	VDJ	4	216	5.06872106311731E-4	6.362803521929579E-4	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	1	5	5	2	4	2	26	39	49	43	51		TCRBV20-01,TCRBV20-or09_02				01,02								CSARVGSGAYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTTAGCGGGGGCGGAGGCCTATACGCAGTATTTTGGCCCA	CSALAGAEAYTQYF	In	VDJ	4	216	5.06872106311731E-4	6.362803521929579E-4	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	5	2	7	1	9	26	35	45	36	54		TCRBV20-01,TCRBV20-or09_02												CSALAGAEAYTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCGGTATGGACTAGAATCACAGATACGCAGTATTTTGGCCCA	CASSLAVWTRITDTQYF	In	VDJ	4	216	5.06872106311731E-4	6.362803521929579E-4	51				TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	1	8	2	5	3	18	35	47	40	50	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03				01,02								CASSLAVWTRITDTQYF+X+TCRBJ02-03		TCRBD02-01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATCAGGACAGGGGGTAAACAGATACGCAGTATTTTGGCCCA	CATSDQDRG*TDTQYF	Stop	VDJ	4	218	5.115653665553582E-4		48	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	1	1	3	2	3	24	39	51	41	54		TCRBV24-01,TCRBV24-or09_02												CATSDQDRG*TDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD01-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGATACCGGGACAACCCTCACCTACGAGCAGTACTTCGGGCCG	CASSQDTGTTLTYEQYF	In	VDJ	4	218	5.115653665553582E-4	6.421718369354853E-4	51				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	0	6	2	4	7	18	35	45	39	52	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03												CASSQDTGTTLTYEQYF+X+TCRBJ02-07		TCRBD01-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTAGTAGGCGGGAGTGGTTACGAGCAGTACTTCGGGCCG	CASSLVGGSGYEQYF	In	VDJ	4	220	5.162586267989853E-4	6.480633216780127E-4	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	1	7	2	4	3	4	18	34	44	37	48	TCRBV07,TCRBV11													CASSLVGGSGYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGTTTGTCGGGGGTCAAGAGACCCAGTACTTCGGGCCA	CASSQFVGGQETQYF	In	VDJ	4	221	5.186052569207989E-4	6.510090640492763E-4	45	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	3	8	2	2	6	1	26	40	52	46	53		TCRBV03-01,TCRBV03-02												CASSQFVGGQETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01*01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGGGGACTCRGCYGTGTATSTCTGTGCCAGCAGCTTAGGGGCTAGCGGGAGCGATGAGCAGTTCTTCGGGCCA	CASSLGASGSDEQFF	In	VDJ	4	223	5.23298517164426E-4	6.569005487918038E-4	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	1	4	2	8	3	2	18	34	47	37	49	TCRBV07,TCRBV11													CASSLGASGSDEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCAGGAGCGGTGCTAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	5	226	5.303384075298667E-4		43	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	6	5	0	4	4	26	35	44	39	48		TCRBV20-01,TCRBV20-or09_02				01,02								X+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGGGGGCACTTACACTGAAGCTTTCTTTGGACAA	CASSQGGTYTEAFF	In	VDJ	5	227	5.326850376516804E-4	6.686835182768585E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	7	0	3	0	4	23	-1	44	39	48	TCRBV01,TCRBV04													CASSQGGTYTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCCCCCGGGCGTCAGCACAGATACGCAGTATTTTGGCCCA	CSAPPGVSTDTQYF	In	VDJ	5	227	5.326850376516804E-4	6.686835182768585E-4	42	TCRBV20						TCRBJ02	TCRBJ02-03	01	6	8	0	0	6	3	26	34	44	40	47		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAPPGVSTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCTCCCACACTGGACTAGCCAAAAACATTCAGTACTTCGGCGCC	CASSHTGLAKNIQYF	In	VDJ	5	228	5.350316677734939E-4	6.716292606481222E-4	45	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	8	1	10	0	9	0	22	31	-1	40	45		TCRBV12-03,TCRBV12-04				01,02								CASSHTGLAKNIQYF+TCRBV12-X+TCRBJ02-04	TCRBV12	TCRBD02-01	TCRBJ02-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTGTTAACAGCGTTCCGGCTACTACGAGCAGTACTTCGGGCCG		Out	VDJ	5	228	5.350316677734939E-4		52	TCRBV24						TCRBJ02	TCRBJ02-07	01	0	3	5	3	3	11	24	42	49	45	60		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV24-X+TCRBJ02-07	TCRBV24		TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATTACGGGACTAGCGAGTACGAGCAGTACTTCGGGCCG	CSARDYGTSEYEQYF	In	VDJ	5	230	5.39724928017121E-4	6.775207453906496E-4	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	0	6	4	4	2	26	40	54	44	56		TCRBV20-01,TCRBV20-or09_02				01,02								CSARDYGTSEYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATTGGCAGGGTCCTAATGAAAAACTGTTTTTTGGCAGT	CSARDWQGPNEKLFF	In	VDJ	5	232	5.444181882607481E-4	6.83412230133177E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	4	3	3	4	2	26	40	49	44	51		TCRBV20-01,TCRBV20-or09_02												CSARDWQGPNEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD01-01*01	TCRBJ01-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTTTGTATCCTAGCGGGAGAGCTACAATGAGCAGTTCTTCGGGCCA	CSAFVS*RESYNEQFF	Stop	VDJ	5	236	5.538047087480024E-4		48	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	4	2	3	8	2	26	35	53	43	55		TCRBV20-01,TCRBV20-or09_02												CSAFVS*RESYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCGCAGCCAGACGTTAATGAAAAACTGTTTTTTGGCAGT	CASSLAQPDVNEKLFF	In	VDJ	5	237	5.56151338869816E-4	6.981409419894955E-4	48							TCRBJ01	TCRBJ01-04	01	0	2	7	4	7	2	18	35	45	42	47	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLAQPDVNEKLFF+X+TCRBJ01-04			TCRBJ01-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGACGGGTACACTGAAGCTTTCTTTGGACAA	CAISDGYTEAFF	In	VDJ	5	239	5.608445991134431E-4	7.040324267320228E-4	36				TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	5	8	4	3	2	1	23	35	41	37	42	TCRBV06,TCRBV10	TCRBV06-08,TCRBV10-03				01,02								CAISDGYTEAFF+X+TCRBJ01-01		TCRBD02-01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGATTTCCGATGAGCCTTCCAACTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	5	241	5.655378593570703E-4		52	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	3	6	7	0	11	4	26	37	51	48	55		TCRBV20-01,TCRBV20-or09_02				01,02								X+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD02-01	TCRBJ01-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTATTATAGGCGGAGATACGCAGTATTTTGGCCCA	CSAIIGGDTQYF	In	VDJ	5	245	5.749243798443246E-4	7.217068809596051E-4	36	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	7	5	5	6	0	26	36	-1	42	46		TCRBV20-01,TCRBV20-or09_02				01,02								CSAIIGGDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAAATAGGACACCAAGGCGGAGATACGCAGTATTTTGGCCCA	CAISEIGHQGGDTQYF	In	VDJ	5	251	5.89004160575206E-4	7.393813351871873E-4	48				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	1	6	5	3	9	23	38	46	41	55	TCRBV06,TCRBV10	TCRBV06-01,TCRBV06-08,TCRBV10-03												CAISEIGHQGGDTQYF+X+TCRBJ02-03		TCRBD01-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AACCAGACMKCTCTKTACTTCTGTGCCAGCAGTTTAGATCGGACAGACCCCCGGGTGTCTGGGAAAAACATTCAGTACTTCGGCGCC	CASSLDRTDPRVSGKNIQYF	In	VDJ	5	259	6.077772015497145E-4	7.629472741572967E-4	60	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	6	1	5	4	7	17	21	33	46	40	63	TCRBV24,TCRBV27													CASSLDRTDPRVSGKNIQYF+X+TCRBJ02-04	unresolved	TCRBD01-01*01	TCRBJ02-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTTAAACACGGGACTAGTAAGGGAGACCCAGTACTTCGGGCCA		Out	VDJ	5	259	6.077772015497145E-4		49	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	1	0	8	5	8	5	26	39	55	47	60		TCRBV20-01,TCRBV20-or09_02				01,02								X+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTGCGACTAGCGGACTTTGGAGAGACCCAGTACTTCGGGCCA	CASSLRLADFGETQYF	In	VDJ	5	261	6.124704617933417E-4	7.688387588998242E-4	48	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	3	2	5	4	2	7	18	32	43	34	50	TCRBV07,TCRBV11					01,02								CASSLRLADFGETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCAATAGGGGGAGCGGGAGGGACGGCACCGGGGAGCTGTTTTTTGGAGAA	CASSNRGSGRDGTGELFF	In	VDJ	5	263	6.171637220369688E-4	7.747302436423516E-4	54	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	5	6	0	4	9	4	26	38	57	47	61		TCRBV03-01,TCRBV03-02												CASSNRGSGRDGTGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD02-01*02	TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGAGTCGAGGGGGGAGGCAGCCCCAGCATTTTGGTGAT	CSASRGGRQPQHF	In	VDJ	5	263	6.171637220369688E-4	7.747302436423516E-4	39	TCRBV20						TCRBJ01	TCRBJ01-05	01	6	5	1	7	6	4	26	34	46	40	50		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSASRGGRQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20		TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTGCTATTGGCCACCTAGCGGGGAGATTCACAGATACGCAGTATTTTGGCCCA	CASSAIGHLAGRFTDTQYF	In	VDJ	5	267	6.265502425242231E-4	7.865132131274063E-4	57	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	4	3	2	11	5	24	37	57	48	62		TCRBV24-01,TCRBV24-or09_02												CASSAIGHLAGRFTDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGCCCGGACCGAAAGAGACCCAGTACTTCGGGCCA	CSARPGPKETQYF	In	VDJ	6	279	6.547098039859859E-4	8.218621215825706E-4	39	TCRBV20						TCRBJ02	TCRBJ02-05	01	3	1	7	3	4	3	26	37	45	41	48		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARPGPKETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20		TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGAGTCGACTAGCGGATACGAGCAGTACTTCGGGCCG	CATSESTSGYEQYF	In	VDJ	6	279	6.547098039859859E-4	8.218621215825706E-4	42	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	2	5	4	3	1	24	38	50	41	51		TCRBV24-01,TCRBV24-or09_02				01,02								CATSESTSGYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCTCTACCTCTCTGGAAACACCATATATTTTGGAGAG	CSARDLYLSGNTIYF	In	VDJ	6	280	6.570564341077994E-4	8.248078639538344E-4	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	0	4	9	0	3	3	26	40	46	43	49		TCRBV20-01,TCRBV20-or09_02				01,02								CSARDLYLSGNTIYF+TCRBV20-X+TCRBJ01-03	TCRBV20	TCRBD02-01	TCRBJ01-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTCGTCAGGGGGCAACAGGTACAATGAGCAGTTCTTCGGGCCA	CASSSSGGNRYNEQFF	In	VDJ	6	281	6.594030642296131E-4	8.277536063250981E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	4	0	4	3	6	18	31	42	34	48	TCRBV07,TCRBV11													CASSSSGGNRYNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGGCTACGGGACAGATTTTGGCTACACCTTCGGTTCG	CASSQGYGTDFGYTF	In	VDJ	6	286	6.711362148386809E-4	8.424823181814165E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	0	5	7	5	4	23	39	51	44	55	TCRBV01,TCRBV04													CASSQGYGTDFGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGACGCCGGGAGGACGACAGATACGCAGTATTTTGGCCCA	CSARDAGRTTDTQYF	In	VDJ	6	287	6.734828449604945E-4	8.454280605526802E-4	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	0	8	1	3	3	3	26	40	50	43	53		TCRBV20-01,TCRBV20-or09_02												CSARDAGRTTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGATCGCCCGGGACTAGCGGGGATTCCGAGCAGTACTTCGGGCCG	CSARSPGTSGDSEQYF	In	VDJ	6	288	6.758294750823081E-4	8.483738029239438E-4	48	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	2	0	3	6	6	4	26	38	57	44	61		TCRBV20-01,TCRBV20-or09_02												CSARSPGTSGDSEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTAGAACCACGTAATTCACCCCTCCACTTTGGGAAC	CASSLEPRNSPLHF	In	VDJ	6	290	6.805227353259352E-4	8.542652876664713E-4	42	unresolved						TCRBJ01	TCRBJ01-06	01	0	3	7	6	0	4	18	-1	37	35	41	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLEPRNSPLHF+X+TCRBJ01-06	unresolved		TCRBJ01-06*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAAGAAGCGGGAGGCCGCTATCATACCCCAGTACTTCGGGCCA	CSAKKREAAIIPQYF	In	VDJ	6	294	6.899092558131895E-4	8.66048257151526E-4	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	4	6	1	9	3	12	26	36	48	39	60		TCRBV20-01,TCRBV20-or09_02												CSAKKREAAIIPQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*02	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTAGGTCCTCCCAAGGGCTACGAGCAGTACTTCGGGCCG	CASSLGPPKGYEQYF	In	VDJ	6	296	6.946025160568166E-4	8.719397418940534E-4	45	unresolved						TCRBJ02	TCRBJ02-07	01	1	5	3	3	9	0	18	34	-1	43	47	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGPPKGYEQYF+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACGACAGGGAGGGACGGGTCAGCCCCAGCATTTTGGTGAT	CSARRQGGTGQPQHF	In	VDJ	6	303	7.110289269095115E-4	8.925599384928993E-4	45	TCRBV20						TCRBJ01	TCRBJ01-05	01	2	2	3	6	1	9	26	38	46	39	55		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARRQGGTGQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20		TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCAAGCCCCCTTAACGAGCAGTTCTTCGGGCCA	CSASPLNEQFF	In	VDJ	6	304	7.133755570313252E-4	8.95505680864163E-4	33	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	6	7	10	1	9	26	34	38	35	47		TCRBV20-01,TCRBV20-or09_02				01,02								CSASPLNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCCCCCTACGGGGACCGGTATACACAGATACGCAGTATTTTGGCCCA	CASSPLRGPVYTDTQYF	In	VDJ	6	310	7.274553377622066E-4	9.131801350917452E-4	51	unresolved						TCRBJ02	TCRBJ02-03	01	5	0	7	2	8	7	18	30	43	38	50	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPLRGPVYTDTQYF+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCCGGGGTACAATGAGCAGTTCTTCGGGCCA	CASSPGYNEQFF	In	VDJ	6	311	7.298019678840202E-4	9.161258774630089E-4	36	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	8	3	4	0	0	23	-1	-1	36	41	TCRBV01,TCRBV04													CASSPGYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATCGACTAAAATTAGAGACCCAGTACTTCGGGCCA	CASSQDRLKLETQYF	In	VDJ	6	313	7.344952281276472E-4	9.220173622055362E-4	45	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	0	2	9	4	2	5	26	43	50	45	55		TCRBV03-01,TCRBV03-02				01,02								CASSQDRLKLETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTTTATCGTCCCGTGATAATTCACCCCTCCACTTTGGGAAC	CASSLSSRDNSPLHF	In	VDJ	6	314	7.368418582494609E-4	9.249631045767999E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-06	01	0	8	6	5	4	2	23	40	46	44	48	TCRBV24,TCRBV27					01,02								CASSLSSRDNSPLHF+X+TCRBJ01-06	unresolved	TCRBD02-01	TCRBJ01-06*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGGGGGAGGGATTAAGGGGCATGAGACCCAGTACTTCGGGCCA	CSGGGIKGHETQYF	In	VDJ	6	319	7.485750088585287E-4	9.396918164331184E-4	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	7	9	0	5	1	12	26	33	41	34	53		TCRBV20-01,TCRBV20-or09_02												CSGGGIKGHETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*02	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCATCAGTGAAGTGGACAAAAGCACTGAAGCTTTCTTTGGACAA	CAISEVDKSTEAFF	In	VDJ	6	325	7.626547895894101E-4	9.573662706607005E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	1	6	4	1	4	23	39	45	40	49	TCRBV06,TCRBV10													CAISEVDKSTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCCCTGGCTGGGACAACCTACGAGCAGTACTTCGGGCCG	CASSLALAGTTYEQYF	In	VDJ	7	329	7.720413100766644E-4	9.691492401457554E-4	48				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	0	6	2	7	1	18	35	48	42	49	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03												CASSLALAGTTYEQYF+X+TCRBJ02-07		TCRBD01-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCCCCTGGCCTATGGCTACACCTTCGGTTCG	CSARDPLAYGYTF	In	VDJ	7	330	7.74387940198478E-4	9.72094982517019E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	9	0	4	6	0	26	40	-1	46	49		TCRBV20-01,TCRBV20-or09_02												CSARDPLAYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTTCCGACAGGGCGGACACTGAAGCTTTCTTTGGACAA	CASSSDRADTEAFF	In	VDJ	7	349	8.189739125129358E-4	0.0010280640875710292	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	2	3	3	3	3	24	36	46	39	49	TCRBV24,TCRBV27													CASSSDRADTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTAGAGACAGGGTCTAATGAAAAACTGTTTTTTGGCAGT	CASSLETGSNEKLFF	In	VDJ	7	363	8.518267342183258E-4	0.001069304480768721	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	1	2	3	3	1	1	18	34	42	35	43	TCRBV07,TCRBV11													CASSLETGSNEKLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCGGGGACAGGGTGAGCTCCTACGAGCAGTACTTCGGGCCG	CSAGDRVSSYEQYF	In	VDJ	7	365	8.565199944619529E-4	0.0010751959655112484	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	3	0	2	4	26	34	45	36	49		TCRBV20-01,TCRBV20-or09_02												CSAGDRVSSYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTCACCCGGGGGCGGGGGAGAGACCCAGTACTTCGGGCCA	CASSSPGGGGETQYF	In	VDJ	7	368	8.635598848273936E-4	0.0010840331926250395	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	4	7	2	4	9	0	18	31	-1	40	47	TCRBV07,TCRBV11													CASSSPGGGGETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTATAGCGGGGCAAGAGACCCAGTACTTCGGGCCA	CSAIAGQETQYF	In	VDJ	7	371	8.705997751928343E-4	0.0010928704197388304	36	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	4	5	3	2	0	0	26	-1	-1	36	44		TCRBV20-01,TCRBV20-or09_02												CSAIAGQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAYCGCCTCAGGTTCCTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	7	373	8.752930354364615E-4		40	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	9	4	4	3	4	3	24	33	41	37	44		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-04	TCRBV24	TCRBD01-01*01	TCRBJ01-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCCATTGAGCCGGGAGGTTGGTGGCTACACCTTCGGTTCG	CASSPLSREVGGYTF	In	VDJ	7	375	8.799862956800886E-4	0.0011046533892238853	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	4	8	1	7	8	4	23	36	51	44	55	TCRBV01,TCRBV04													CASSPLSREVGGYTF+X+TCRBJ01-02	unresolved	TCRBD02-01*02	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGGGGGACAAGTTGAGACCCAGTACTTCGGGCCA	CSAGGQVETQYF	In	VDJ	8	377	8.846795559237158E-4	0.0011105448739664127	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	0	6	5	2	4	26	35	43	37	47		TCRBV20-01,TCRBV20-or09_02												CSAGGQVETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGGACAGGGTGGGTCAGATACGCAGTATTTTGGCCCA		Out	VDJ	8	382	8.964127065327836E-4		43	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	1	1	3	4	0	5	26	-1	47	39	52		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTTTAATTGGGGAGACCCAGTACTTCGGGCCA	CASSLIGETQYF	In	VDJ	8	385	9.034525968982243E-4	0.0011341108129365222	36	unresolved						TCRBJ02	TCRBJ02-05	01	6	0	9	5	6	0	24	36	-1	42	45	TCRBV24,TCRBV27			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLIGETQYF+X+TCRBJ02-05	unresolved		TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGCAGACTAGCGGGGGGGCGGGAGACCCAGTACTTCGGGCCA	CASSRLAGGRETQYF	In	VDJ	8	388	9.10492487263665E-4	0.0011429480400503133	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	6	2	0	5	2	3	23	34	50	36	53	TCRBV02,TCRBV12													CASSRLAGGRETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTATCAAGCGGGAGCCGTATACGAGCAGTACTTCGGGCCG	CASSYQAGAVYEQYF	In	VDJ	8	398	9.339587884818007E-4	0.0011724054637629502	45	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	6	2	4	5	5	24	36	49	41	54		TCRBV24-01,TCRBV24-or09_02												CASSYQAGAVYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01*02	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGGGGGGGGCACCTATGGCTACACCTTCGGTTCG	CASSQGGGTYGYTF	In	VDJ	8	399	9.363054186036142E-4	0.001175351206134214	42	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	1	9	0	4	0	3	23	-1	46	39	49	TCRBV01,TCRBV04													CASSQGGGTYGYTF+X+TCRBJ01-02	unresolved	TCRBD02-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAAGGGAGGGGAGGCTACACCTTCGGTTCG	CASSQEGRGGYTF	In	VDJ	8	400	9.386520487254279E-4	0.0011782969485054776	39	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	0	9	0	8	1	2	26	43	51	44	53		TCRBV03-01,TCRBV03-02												CASSQEGRGGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD02-01*02	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTCGTCCAACCAGGGACTAGAGGGTATACGCAGTATTTTGGCCCA	CASSFVQPGTRGYTQYF	In	VDJ	8	406	9.527318294563093E-4	0.0011959714027330597	51	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	0	8	7	12	5	24	36	56	48	61		TCRBV24-01,TCRBV24-or09_02				01,02								CASSFVQPGTRGYTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCACCGTCTAGCGGGACCTACGAGCAGTACTTCGGGCCG		Out	VDJ	8	411	9.644649800653771E-4		40	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	11	4	3	2	7	0	24	31	-1	38	47		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01*02	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCGGGGGGGCCGGGAGACCCAGTACTTCGGGCCA	CSARGGRETQYF	In	VDJ	8	416	9.76198130674445E-4	0.0012254288264456968	36	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	6	8	0	5	1	4	26	34	43	35	47		TCRBV20-01,TCRBV20-or09_02												CSARGGRETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCACGCCGGACATCCCCAGGGGTGATGAAGGCTACACCTTCGGTTCG	CSATPDIPRGDEGYTF	In	VDJ	8	417	9.785447607962585E-4	0.0012283745688169605	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	4	2	8	15	7	26	34	55	49	62		TCRBV20-01,TCRBV20-or09_02												CSATPDIPRGDEGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGCCGGACAGTCGGGCTGAAGCTTTCTTTGGACAA	CSARPDSRAEAFF	In	VDJ	8	422	9.902779114053263E-4	0.0012431032806732788	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	1	5	6	3	5	26	37	46	40	51		TCRBV20-01,TCRBV20-or09_02												CSARPDSRAEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCGGGGGGCAACAAATTCACCCCTCCACTTTGGGAAC	CSARGATNSPLHF	In	VDJ	9	426	9.996644318925807E-4	0.0012548862501583337	39	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-06	01	5	8	1	7	0	5	26	-1	42	35	47		TCRBV20-01,TCRBV20-or09_02												CSARGATNSPLHF+TCRBV20-X+TCRBJ01-06	TCRBV20	TCRBD02-01*01	TCRBJ01-06*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACGTTATCTAGCGGGCGCTACGAGCAGTACTTCGGGCCG	CSATLSSGRYEQYF	In	VDJ	9	436	0.0010231307331107164	0.0012843436738709706	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	4	4	3	6	2	26	36	50	42	52		TCRBV20-01,TCRBV20-or09_02				01,02								CSATLSSGRYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTGCTAGCGGGAGGACCGGGGAGCTGTTTTTTGGAGAA	CASSASGRTGELFF	In	VDJ	9	438	0.0010278239933543434	0.001290235158613498	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	5	4	1	5	1	0	23	35	-1	36	47	TCRBV24,TCRBV27													CASSASGRTGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01*02	TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGGTACAGGGGCCCACAGATACGCAGTATTTTGGCCCA	CSAVQGPTDTQYF	In	VDJ	9	439	0.0010301706234761572	0.0012931809009847617	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	3	2	2	3	2	26	34	44	37	46		TCRBV20-01,TCRBV20-or09_02												CSAVQGPTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGGGGCTTTCAAGGGCGCCCCGAGCAGTTCTTCGGGCCA	CASRGFQGRPEQFF	In	VDJ	9	443	0.0010395571439634113	0.0013049638704698164	42	TCRBV03						TCRBJ02	TCRBJ02-01	01	6	5	3	10	9	6	26	37	50	46	56		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRGFQGRPEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03		TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGGTTGGAAAGACTACGAGCAGTACTTCGGGCCG	CSGWKDYEQYF	In	VDJ	9	446	0.001046597034328852	0.0013138010975836075	33	TCRBV20						TCRBJ02	TCRBJ02-07	01	7	1	8	3	3	4	26	33	39	36	43		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSGWKDYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCRTGTATSKCTGTGCCAGCACCCGGCACGAGCGGCCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASTRHERPNTGELFF	In	VDJ	9	449	0.0010536369246942929	0.0013226383246973986	48	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	7	6	5	0	9	1	18	28	42	37	43	TCRBV07,TCRBV11					01,02								CASTRHERPNTGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01	TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGTTCAGGGGCCTAGCGGAGATACGCAGTATTTTGGCCCA	CSVQGPSGDTQYF	In	VDJ	9	451	0.00105833018493792	0.001328529809439926	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	7	4	5	5	9	0	26	33	-1	42	49		TCRBV20-01,TCRBV20-or09_02				01,02								CSVQGPSGDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACCAGCGACTAGCGGGTATCTACAATGAGCAGTTCTTCGGGCCA	CATSDQRLAGIYNEQFF	In	VDJ	9	452	0.0010606768150597334	0.0013314755518111898	51	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	2	4	3	5	3	24	38	53	43	56		TCRBV24-01,TCRBV24-or09_02				01,02								CATSDQRLAGIYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGTTTCGGGGAGCGGGACCCAGTACTTCGGGCCA	CATSVSGSGTQYF	In	VDJ	9	452	0.0010606768150597334	0.0013314755518111898	39	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	6	5	7	8	0	24	37	-1	45	50		TCRBV24-01,TCRBV24-or09_02				01,02								CATSVSGSGTQYF+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD02-01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCAGGCGGGACATATCCACCGGGGAGCTGTTTTTTGGAGAA	CSARRDISTGELFF	In	VDJ	9	461	0.0010817964861560556	0.001357987233152563	42	TCRBV20						TCRBJ02	TCRBJ02-02	01	6	0	6	4	5	4	26	34	45	39	49		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARRDISTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20		TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACCCCGGACTAGCGGGGGGCGCGGACTACGAGCAGTACGTCGGGCCG	CATSDPGLAGGADYEQYV	In	VDJ	9	464	0.0010888363765214962	0.001366824460266354	54	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	4	1	1	17	4	20	24	38	56	42	76		TCRBV24-01,TCRBV24-or09_02												CATSDPGLAGGADYEQYV+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCATGAGAACCGGGCTTCTACGCAGTATTTTGGCCCA	CASSHENRASTQYF	In	VDJ	9	467	0.001095876266886937	0.001375661687380145	42	TCRBV03						TCRBJ02	TCRBJ02-03	01	3	8	0	8	8	3	26	40	52	48	55		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSHENRASTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03		TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTCCATCCCCAGACGACCAGAGAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	10	479	0.0011240358283486998		53	TCRBV20						TCRBJ02	TCRBJ02-03	01	3	2	7	0	10	8	26	37	50	47	58		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCAACACTAGCGGGAGTCCTGAATGAGCAGTTCTTCGGGCCA	CSATLAGVLNEQFF	In	VDJ	10	487	0.0011428088693232084	0.001434576534805419	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	3	2	7	3	5	26	34	48	37	53		TCRBV20-01,TCRBV20-or09_02												CSATLAGVLNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGGGACCGGACTAGCGGGAAAGAGACCCAATACTTCGGGCCA	CASRDRTSGKETQYF	In	VDJ	10	497	0.001166275170541344	0.001464033958518056	45	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	6	1	3	14	5	11	26	37	54	42	65		TCRBV03-01,TCRBV03-02												CASRDRTSGKETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01*02	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACTCAGAGATAGACCCGGGACAGTCAATCACTGAAGCTTTCTTTGGACAA		Out	VDJ	10	498	0.0011686218006631576		55	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	0	5	4	15	5	26	38	60	53	65		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGATCTCCGGGGTCCGTTGGGGTGAAGCTTTCTTTGGACAA	CASSQISGVRWGEAFF	In	VDJ	10	499	0.0011709684307849712	0.0014699254432605834	48	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	3	8	3	7	6	10	26	40	51	46	61		TCRBV03-01,TCRBV03-02												CASSQISGVRWGEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD02-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAATGCTCAGGGGCGGTGCTAGCACAGATACACAGTATTTTGGCCCA		Out	VDJ	10	499	0.0011709684307849712		43	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	4	2	12	0	19	26	-1	41	35	60		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGCAGCTTCTACATCTGCAGTGCTAGAGATAGGGGGAACTAGCGGGAGGGCTGGTTGGAAAACATTCAGTACTTCGGCGCC	CSARDRGN*REGWLENIQYF	Stop	VDJ	10	504	0.001182701581394039		60	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	0	3	0	5	8	8	15	29	50	37	58		TCRBV20-01,TCRBV20-or09_02												CSARDRGN*REGWLENIQYF+TCRBV20-X+TCRBJ02-04	TCRBV20	TCRBD02-01*02	TCRBJ02-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCACACTGCGGGACAGGTGTACAATGAGCAGTTCTTCGGGCCA	CASSHTAGQVYNEQFF	In	VDJ	10	504	0.001182701581394039	0.0014846541551169017	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	0	4	4	6	2	23	37	51	43	53	TCRBV01,TCRBV04													CASSHTAGQVYNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGATTATCCGGCCTCGGGAGAGACCCAGTACTTCGGGCCA	CASSQDYPASGETQYF	In	VDJ	10	506	0.0011873948416376663	0.0014905456398594291	48	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	0	8	4	4	11	0	23	40	-1	51	55	TCRBV01,TCRBV04					01,02								CASSQDYPASGETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTCTACTCAGACCGGAAACACCATATATTTTGGAGAG	CASSSTQTGNTIYF	In	VDJ	10	513	0.0012038212524903612	0.0015111658364582751	42	unresolved						TCRBJ01	TCRBJ01-03	01	4	2	7	4	7	1	18	31	41	38	42	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSTQTGNTIYF+X+TCRBJ01-03	unresolved		TCRBJ01-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGCCCCTAGGGGGCTCGTCCTACAATGAGCAGTTCTTCGGGCCA	CSARPLGGSSYNEQFF	In	VDJ	10	522	0.0012249409235866834	0.0015376775177996483	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	5	0	1	6	3	26	37	50	43	53		TCRBV20-01,TCRBV20-or09_02												CSARPLGGSSYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCTTGGACAGGGGGTGGGCTACACCTTCGGTTCG	CSALGQGVGYTF	In	VDJ	11	527	0.0012366740741957512	0.0015524062296559667	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	1	1	8	4	2	26	34	48	38	50		TCRBV20-01,TCRBV20-or09_02												CSALGQGVGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCAGTGCTATGGGGCTAACTTTATACAATGAGCAGTTCTTCGGGCCA	CSASAMGLTLYNEQFF	In	VDJ	11	528	0.0012390207043175647	0.0015553519720272304	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	7	0	4	9	8	26	34	48	43	56		TCRBV20-01,TCRBV20-or09_02												CSASAMGLTLYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACCTCGACAGGGGGCCCCCTTTACGGCTTCGGTTCG	CSATSTGGPLYGF	In	VDJ	11	554	0.0013000330874847175	0.0016319412736800864	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	2	0	16	4	11	26	36	50	40	61		TCRBV20-01,TCRBV20-or09_02												CSATSTGGPLYGF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTTGCAGGGAGGAGATACGCAGTATTTTGGCCCA	CSALQGGDTQYF	In	VDJ	11	576	0.0013516589501646162	0.0016967476058478877	36	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	9	1	5	5	0	26	35	-1	40	46		TCRBV20-01,TCRBV20-or09_02												CSALQGGDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTATCCCCCTAGCGGGAGGGCACGAGCAGTACTTCGGGCCG	CSAIPLAGGHEQYF	In	VDJ	12	591	0.0013868584019918198	0.0017409337414168431	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	4	0	5	5	1	26	36	53	41	54		TCRBV20-01,TCRBV20-or09_02												CSAIPLAGGHEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCTCTAGCGAGGGCCAAGAGACCCAGTACTTCGGGCCA	CSASSEGQETQYF	In	VDJ	13	631	0.0014807236068643623	0.001858763436267391	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	6	4	6	1	2	4	26	34	42	36	46		TCRBV20-01,TCRBV20-or09_02				01,02								CSASSEGQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTTTCGGGGGGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	13	633	0.0014854168671079896		40	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	8	2	1	0	0	22	-1	-1	36	42		TCRBV12-03,TCRBV12-04												X+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGAAGCTCAACTCGAGGGGGCCAGAGACCCAGTACTTCGGGCCA		Out	VDJ	13	635	0.0014901101273516167		44				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	5	0	4	7	1	18	31	45	38	46	TCRBV05,TCRBV11	TCRBV05-03,TCRBV11-03												X+X+TCRBJ02-05		TCRBD01-01*01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCATACCTTTGGGGGGGCCGCAAACAAAGCTTTCTTTGGACAA	CASSHTFGGAANKAFF	In	VDJ	13	637	0.001494803387595244	0.001876437890494973	48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	3	9	0	9	7	9	23	37	51	44	60	TCRBV01,TCRBV04													CASSHTFGGAANKAFF+X+TCRBJ01-01	unresolved	TCRBD02-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGTTACGACAGGGTCCTACGAGCAGTACTTCGGGCCG	CSVTTGSYEQYF	In	VDJ	13	650	0.0015253095791788202	0.001914732541321401	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	2	3	1	4	0	26	33	-1	37	44		TCRBV20-01,TCRBV20-or09_02												CSVTTGSYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCCCCGGGACAGGGGAAGGACTGAAGCTTTCTTTGGACAA	CSAPRDRGRTEAFF	In	VDJ	14	678	0.0015910152225896003	0.0019972133277167846	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	0	2	5	5	4	26	34	49	39	53		TCRBV20-01,TCRBV20-or09_02												CSAPRDRGRTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGTGCCGGGACAGGGTATTCAGATACGCAGTATTTTGGCCCA	CASSAGTGYSDTQYF	In	VDJ	14	707	0.0016590674961221936	0.0020826398564834318	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	0	3	4	4	4	26	37	50	41	54		TCRBV03-01,TCRBV03-02												CASSAGTGYSDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD01-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAATTTTTCGACCAAGAGACCCAGTACTTCGGGCCA	CASSQFFDQETQYF	In	VDJ	14	717	0.0016825337973403293	0.0021120972801960685	42	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	2	8	6	0	5	0	26	41	-1	46	48		TCRBV03-01,TCRBV03-02				01,02								CASSQFFDQETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCTTCGAGGCTAGCGTTTACAATGAGCAGTTCTTCGGGCCA	CSAFEASVYNEQFF	In	VDJ	14	717	0.0016825337973403293	0.0021120972801960685	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	4	6	4	8	2	26	34	48	42	50		TCRBV20-01,TCRBV20-or09_02				01,02								CSAFEASVYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGCCTCTTATAGATTCAAGACTCCAAACCCCCCATACGTCGGGCCG		Out	VDJ	15	730	0.0017130399889239058		52	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	2	10	17	17	16	26	39	60	56	76		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGGTCATGAAAAACTGTTTTTTGGCAGT	CASSQGHEKLFF	In	VJ	15	742	0.0017411995503856686	0.002185740839477661	36	unresolved						TCRBJ01	TCRBJ01-04	01	1	0	0	6	0	3	23	-1	39	-1	42	TCRBV01,TCRBV04													CASSQGHEKLFF+X+TCRBJ01-04	unresolved		TCRBJ01-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTGGGCCTAATTGGGAGCAGTTCTTCGGGCCA	CASSGPNWEQFF	In	VDJ	15	745	0.0017482394407511094	0.002194578066591452	36	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	8	0	10	0	8	26	-1	42	38	50		TCRBV12-03,TCRBV12-04												CASSGPNWEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD01-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTACGGACTAGCGGGGGGCTATGAGCAGTTCTTCGGGCCA	CSAYGLAGGYEQFF	In	VDJ	15	747	0.0017529327009947364	0.0022004695513339794	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	1	1	8	3	2	26	35	52	38	54		TCRBV20-01,TCRBV20-or09_02												CSAYGLAGGYEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATGGACAGACCTTCTATGGCTACACCTTCGGTTCG	CSARDGQTFYGYTF	In	VDJ	15	769	0.0018045585636746351	0.0022652758835017806	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	1	5	4	1	5	26	40	47	41	52		TCRBV20-01,TCRBV20-or09_02												CSARDGQTFYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCGGTCCCAATTCTGGAAACACCATATATTTTGGAGAG	CATGPNSGNTIYF	In	VDJ	16	821	0.0019265833300089407	0.0024184544868074928	39	TCRBV24						TCRBJ01	TCRBJ01-03	01	9	0	10	1	0	7	24	-1	35	33	42		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATGPNSGNTIYF+TCRBV24-X+TCRBJ01-03	TCRBV24		TCRBJ01-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTTTACAGGGGGGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSLQGGSYNEQFF	In	VDJ	17	843	0.001978209192688839	0.002483260818975294	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	3	1	0	2	1	24	36	46	38	47	TCRBV24,TCRBV27													CASSLQGGSYNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGAGAGGATAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CSARGEDSSYNEQFF	In	VDJ	18	906	0.002126046890363094	0.002668842588364907	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	1	11	1	0	2	4	26	39	45	41	49		TCRBV20-01,TCRBV20-or09_02												CSARGEDSSYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTCCAGTCCCCACTAGCGGGGGGGTTCTACAATGAGCAGTTCTTCGGGCCA	CASSLQSPLAGGFYNEQFF	In	VDJ	18	917	0.002151859821703043	0.0027012457544488074	57	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	3	0	3	10	2	24	37	60	47	62		TCRBV03-01,TCRBV03-02												CASSLQSPLAGGFYNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCGACTAGCRGGATAGATGAGCAGTTCTTCGGGCCA	CASSLATSXIDEQFF	In	VDJ	18	924	0.0021682862325557383	0.0027218659510476534	45				TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	2	3	8	0	3	18	-1	46	35	49	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03				unresolved								CASSLATSXIDEQFF+X+TCRBJ02-01		TCRBD02-01*02	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGGTGGGGAGCTCCTACGAGCAGTACGTCGGGCCG		Out	VDJ	20	998	0.0023419368615699423		38	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	9	2	17	3	17	26	37	45	40	62		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01*02	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTCCCACCGGGATGCTAGCGGGAGTCGATGAGCAGTTCTTCGGGCCA	CASSPTGMLAGVDEQFF	In	VDJ	21	1030	0.002417029025467977	0.0030341146424016046	51	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	4	2	8	12	3	24	36	58	48	61	TCRBV24,TCRBV27													CASSPTGMLAGVDEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATTCCGACTCACTTCTCACAGATACGCAGTATTTTGGCCCA	CSARDSDSLLTDTQYF	In	VDJ	21	1075	0.0025226273809495874	0.0031666730491084713	48	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	2	10	2	4	7	26	40	48	44	55		TCRBV20-01,TCRBV20-or09_02				01,02								CSARDSDSLLTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGGTGGCAGGGGGCTGAAGCTTTCTTTGGACAA	CASSQGWQGAEAFF	In	VDJ	25	1231	0.002888701679952504	0.0036262088590256073	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	4	1	6	5	0	26	42	-1	47	54		TCRBV03-01,TCRBV03-02												CASSQGWQGAEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCAGAGAAGGGACGGCTCCCCGAGCAGTACTTCGGGCCG	CSAEKGRLPEQYF	In	VDJ	27	1359	0.003189070335544641	0.00400326388254736	39	TCRBV20						TCRBJ02	TCRBJ02-07	01	6	0	7	6	6	7	26	34	45	40	52		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAEKGRLPEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGATGGGAGGGTTGAAAAACTGTTTTTTGGCAGT		Out	VDJ	29	1450	0.003402613676629676		37	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	2	9	0	7	1	1	26	38	46	39	47		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD02-01*02	TCRBJ01-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCTTGGTGGGGGAGAGACCCAGTACTTCGGGCCA	CSALGGGETQYF	In	VDJ	31	1574	0.0036935958117345585	0.004636598492369054	36	TCRBV20						TCRBJ02	TCRBJ02-05	01	5	6	1	4	6	0	26	35	-1	41	46		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSALGGGETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20		TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGATGGGGTTAGCGGGCAAGAGACCCAGTACTTCGGGCCA	CASSQDGVSGQETQYF	In	VDJ	31	1574	0.0036935958117345585	0.004636598492369054	48				TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	0	5	4	2	6	0	18	35	-1	41	48	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03				01,02								CASSQDGVSGQETQYF+X+TCRBJ02-05		TCRBD02-01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCTGTCCTCTAACTAGCGGGGGTTTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	33	1643	0.003855513290139695		56	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	3	2	1	9	2	23	36	56	45	58	TCRBV01,TCRBV04													X+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGGACAGGGCCTCAATCAGCCCCAGCATTTTGGTGAT	CASSQGQGLNQPQHF	In	VDJ	36	1783	0.004184041507193595	0.005252258647963167	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	1	2	3	3	0	3	23	-1	46	39	49	TCRBV01,TCRBV04													CASSQGQGLNQPQHF+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGTTACCCTTTGGGCAGTTCTTCGGGCCA	CSARLPFGQFF	In	VDJ	36	1805	0.004235667369873493	0.0053170649801309675	33	TCRBV20						TCRBJ02	TCRBJ02-01	01	3	0	10	12	10	0	26	37	-1	47	49		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARLPFGQFF+TCRBV20-X+TCRBJ02-01	TCRBV20		TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATACGGAAGCCGGGGAGCTGTTTTTTGGAGAA	CSARDTEAGELFF	In	VDJ	43	2139	0.005019441830559225	0.006300942932133041	39	TCRBV20						TCRBJ02	TCRBJ02-02	01	0	1	8	6	3	2	26	40	46	43	48		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDTEAGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20		TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCACCTCACTCCTAGAGGGAGTCACCGGGGAGCTGTTTTTTGGAGAA	CASTSLLEGVTGELFF	In	VDJ	48	2424	0.005688231415276092	0.007140479507943194	48	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	7	9	2	4	13	1	26	36	54	49	55		TCRBV03-01,TCRBV03-02												CASTSLLEGVTGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD02-01*02	TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATGCGGGACTAAATTACGAGCAGTACTTCGGGCCG	CSARDAGLNYEQYF	In	VDJ	84	4202	0.00986053977186062	0.012378009444050042	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	0	9	4	3	3	26	40	50	43	53		TCRBV20-01,TCRBV20-or09_02				01,02								CSARDAGLNYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAAAATCCGGGACTAGCGGGCCGCCTACGAGCAGTACGTCGGGCCG		Out	VDJ	119	5951	0.013964795854912553		53	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	2	0	4	17	6	18	26	41	59	47	77		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCAAGGGCAGGTTCTGGAGGTAAACTGTTTTTTGGCAGT	CASSPRAGSGGKLFF	In	VDJ	140	7015	0.01646161030452219	0.020664382734414812	45	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	4	10	1	11	14	1	26	39	58	53	59		TCRBV03-01,TCRBV03-02												CASSPRAGSGGKLFF+TCRBV03-X+TCRBJ01-04	TCRBV03	TCRBD02-01*02	TCRBJ01-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCTCCGGGACAGGGGGTTACGAGCAGTACTTCGGGCCG		Out	VDJ	183	9176	0.021532677997761315		47				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	0	1	4	3	1	18	35	49	38	50	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03												X+X+TCRBJ02-07		TCRBD01-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
ACGACTCGGCCCTGTATCTCTGTGCCAGCAGCTTAGAACAGACCTACGAGCAGTACTTCGGGCCG	CASSLEQTYEQYF	In	VDJ	1	30	7.03989036544071E-5	8.837227113791082E-5	39	TCRBV05	TCRBV05-04	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	3	5	2	3	1	20	34	41	37	42														CASSLEQTYEQYF+TCRBV05-04+TCRBJ02-07	TCRBV05-04*01	TCRBD01-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCTTATGGGGCGGGTTAAGCACAGATACGCAGTATTTTGGCCCA	CASSLWGGLSTDTQYF	In	VDJ	1	13	3.0506191583576405E-5	3.8294650826428025E-5	48	TCRBV07	TCRBV07-02	01				TCRBJ02	TCRBJ02-03	01	2	7	0	0	1	6	18	33	39	34	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLWGGLSTDTQYF+TCRBV07-02+TCRBJ02-03	TCRBV07-02*01		TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCTTCCAGACAAGAGTAGGAGCTTTCTTTGGACAA	CASSFQTRVGAFF	In	VDJ	1	13	3.0506191583576405E-5	3.8294650826428025E-5	39	TCRBV07	TCRBV07-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	2	6	10	3	8	18	32	39	35	47														CASSFQTRVGAFF+TCRBV07-02+TCRBJ01-01	TCRBV07-02*01	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCTTAACAGGGGGCGGAGGCTACACCTTCGGTTCG	CASSLTGGGGYTF	In	VDJ	1	14	3.285282170538997E-5	4.1240393197691716E-5	39	TCRBV07	TCRBV07-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	3	0	8	0	3	18	-1	42	33	45														CASSLTGGGGYTF+TCRBV07-02+TCRBJ01-02	TCRBV07-02*01	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATCTCTGTGCTAGCAGCTTAACTCTGACAGGGTCCCAGTACTTCGGGCCA	CASSLTLTGSQYF	In	VDJ	1	16	3.7546081949017114E-5	4.7131877940219106E-5	39	TCRBV07	TCRBV07-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	2	3	9	5	1	18	33	45	38	46														CASSLTLTGSQYF+TCRBV07-02+TCRBJ02-05	TCRBV07-02*01	TCRBD01-01*01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCACTGGGGGTCCCTTTAGCAATCAGCCCCAGCATTTTGGTGAT	CASSTGGPFSNQPQHF	In	VDJ	1	17	3.989271207083068E-5	5.00776203114828E-5	48	TCRBV07	TCRBV07-02	01				TCRBJ01	TCRBJ01-05	01	5	6	1	0	3	6	18	30	38	33	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSTGGPFSNQPQHF+TCRBV07-02+TCRBJ01-05	TCRBV07-02*01		TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCTCGTCTACAGGGGGTGGTTACACCTTCGGTTCG	CASSSSTGGGYTF	In	VDJ	1	17	3.989271207083068E-5	5.00776203114828E-5	39	TCRBV07	TCRBV07-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	3	1	11	5	4	18	31	44	36	48														CASSSSTGGGYTF+TCRBV07-02+TCRBJ01-02	TCRBV07-02*01	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGTTATCGACTAGCGGGAGGATACACCGGGGAGCTGTTTTTTGGAGAA	CASSYRLAGGYTGELFF	In	VDJ	1	22	5.162586267989853E-5	6.480633216780127E-5	51	TCRBV07	TCRBV07-02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	6	2	1	3	5	2	18	29	47	34	49														CASSYRLAGGYTGELFF+TCRBV07-02+TCRBJ02-02	TCRBV07-02*01	TCRBD02-01*02	TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCTCCCTGGAATTCTACGAGCAGTACTTCGGGCCG	CASSSLEFYEQYF	In	VDJ	1	23	5.39724928017121E-5	6.775207453906497E-5	39	TCRBV07	TCRBV07-02	01				TCRBJ02	TCRBJ02-07	01	4	1	8	3	4	3	18	31	38	35	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSLEFYEQYF+TCRBV07-02+TCRBJ02-07	TCRBV07-02*01		TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCAAACAGTGGGGGGAGACCCAGTACTTCGGGCCA	CASSKQWGETQYF	In	VDJ	1	27	6.335901328896638E-5	7.953504402411973E-5	39	TCRBV07	TCRBV07-02	01				TCRBJ02	TCRBJ02-05	01	5	6	1	5	7	0	18	30	-1	37	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSKQWGETQYF+TCRBV07-02+TCRBJ02-05	TCRBV07-02*01		TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCCCACGGAACAGTTACGAGCAGTACGTCGGGCCG	CASSPRNSYEQYV	In	VDJ	1	27	6.335901328896638E-5	7.953504402411973E-5	39	TCRBV07	TCRBV07-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	3	5	17	7	14	18	30	41	37	55														CASSPRNSYEQYV+TCRBV07-02+TCRBJ02-07	TCRBV07-02*01	TCRBD01-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCTTCAGCGGGGCTTACGAGCAGTACGTCGGGCCG	CASSFSGAYEQYV	In	VDJ	1	31	7.274553377622066E-5	9.131801350917451E-5	39	TCRBV07	TCRBV07-02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	3	6	3	17	1	15	18	32	40	33	55														CASSFSGAYEQYV+TCRBV07-02+TCRBJ02-07	TCRBV07-02*01	TCRBD02-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCTCCAGGGCCCTATATGGCTACACCTTCGGTTCG	CASSSRALYGYTF	In	VDJ	1	42	9.855846511616992E-5	1.2372117959307514E-4	39	TCRBV07	TCRBV07-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	4	3	5	1	5	18	31	37	32	42														CASSSRALYGYTF+TCRBV07-02+TCRBJ01-02	TCRBV07-02*01	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCCCTGGACAGGGATTCTCGGCTTTCTTTGGACAA	CASSPGQGFSAFF	In	VDJ	1	52	1.2202476633430562E-4	1.531786033057121E-4	39	TCRBV07	TCRBV07-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	1	3	11	3	7	18	30	41	33	48														CASSPGQGFSAFF+TCRBV07-02+TCRBJ01-01	TCRBV07-02*01	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCCGTAGCGATTAAGAGACCCAGTACTTCGGGCCA	CASSRSD*ETQYF	Stop	VDJ	1	61	1.4314443743062774E-4		39	TCRBV07	TCRBV07-02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	5	6	3	2	3	18	30	37	32	40						01,02								CASSRSD*ETQYF+TCRBV07-02+TCRBJ02-05	TCRBV07-02*01	TCRBD02-01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCCAACCTGGGAAGACTGAAGCTTTCTTTGGACAA	CASSQPGKTEAFF	In	VDJ	1	62	1.4549106755244132E-4	1.8263602701834903E-4	39	TCRBV07	TCRBV07-02	01				TCRBJ01	TCRBJ01-01	01	5	0	8	5	6	2	18	30	40	36	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQPGKTEAFF+TCRBV07-02+TCRBJ01-01	TCRBV07-02*01		TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCTTAATATCGAACACTGAAGCTTTCTTTGGACAA	CASSLISNTEAFF	In	VDJ	2	82	1.924236699887127E-4	2.4155087444362292E-4	39	TCRBV07	TCRBV07-02	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	2	5	9	1	1	2	18	33	36	34	38						01,02								CASSLISNTEAFF+TCRBV07-02+TCRBJ01-01	TCRBV07-02*01	TCRBD02-01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCTCCTCAATTTCAGATACGCAGTATTTTGGCCCA	CASSSSISDTQYF	In	VDJ	2	97	2.2762312181591625E-4	2.857370100125783E-4	39	TCRBV07	TCRBV07-02	01				TCRBJ02	TCRBJ02-03	01	4	4	6	4	3	4	18	31	36	34	40				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSSISDTQYF+TCRBV07-02+TCRBJ02-03	TCRBV07-02*01		TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCCACAAGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSHKNTGELFF	In	VDJ	2	106	2.487427929122384E-4	3.1224869135395157E-4	39	TCRBV07	TCRBV07-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	3	6	1	1	1	18	30	34	31	35														CASSHKNTGELFF+TCRBV07-02+TCRBJ02-02	TCRBV07-02*01	TCRBD01-01*01	TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCTCTACTATCACTAATGAGCAGTTCTTCGGGCCA	CASSSTITNEQFF	In	VDJ	2	125	2.933287652266962E-4	3.6821779640796177E-4	39	TCRBV07	TCRBV07-02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	3	9	7	2	5	18	31	37	33	42						01,02								CASSSTITNEQFF+TCRBV07-02+TCRBJ02-01	TCRBV07-02*01	TCRBD02-01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCCAACAGGGGCGATACGAGCAGTACGTCGGGCCG	CASSQQGRYEQYV	In	VDJ	3	128	3.003686555921369E-4	3.7705502352175285E-4	39	TCRBV07	TCRBV07-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	3	2	17	2	16	18	30	39	32	55														CASSQQGRYEQYV+TCRBV07-02+TCRBJ02-07	TCRBV07-02*01	TCRBD01-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCTTAAGCAGAAGTTACGAGCAGTACGTCGGGCCG	CASSLSRSYEQYV	In	VDJ	3	130	3.050619158357641E-4	3.829465082642802E-4	39	TCRBV07	TCRBV07-02	01				TCRBJ02	TCRBJ02-07	01	2	4	5	17	2	17	18	33	38	35	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLSRSYEQYV+TCRBV07-02+TCRBJ02-07	TCRBV07-02*01		TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCTTTGCCGGGACTAGCGGGGGGTATTTTGGCCCA	CASSFAGTSGGYF	In	VDJ	3	138	3.238349568102726E-4	4.0651244723438975E-4	39	TCRBV07	TCRBV07-02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	0	2	14	4	0	18	32	-1	36	50														CASSFAGTSGGYF+TCRBV07-02+TCRBJ02-03	TCRBV07-02*01	TCRBD02-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCGCTCAGGGGGTCTACGAGCAGTACGTCGGGCCG	CASSAQGVYEQYV	In	VDJ	3	146	3.4260799778478116E-4	4.3007838620449934E-4	39	TCRBV07	TCRBV07-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	4	1	17	3	15	18	30	40	33	55														CASSAQGVYEQYV+TCRBV07-02+TCRBJ02-07	TCRBV07-02*01	TCRBD01-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCTTAGGGGGCTTAGGGGAGCTGTTTTTTGGAGAA	CASSLGGLGELFF	In	VDJ	4	208	4.880990653372225E-4	6.127144132228484E-4	39	TCRBV07	TCRBV07-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	1	7	0	8	0	3	18	-1	39	34	42														CASSLGGLGELFF+TCRBV07-02+TCRBJ02-02	TCRBV07-02*01	TCRBD01-01*01	TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCACACAGAGGTCCTACGAGCAGTACGTCGGGCCG	CASSTQRSYEQYV	In	VDJ	5	228	5.350316677734939E-4	6.716292606481222E-4	39	TCRBV07	TCRBV07-02	01				TCRBJ02	TCRBJ02-07	01	5	3	5	17	2	19	18	30	36	32	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSTQRSYEQYV+TCRBV07-02+TCRBJ02-07	TCRBV07-02*01		TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCTCAGGGGCTTCCGATACGCAGTATTTTGGCCCA	CASSSGASDTQYF	In	VDJ	5	241	5.655378593570703E-4	7.099239114745502E-4	39	TCRBV07	TCRBV07-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	4	2	6	0	5	18	-1	37	31	42														CASSSGASDTQYF+TCRBV07-02+TCRBJ02-03	TCRBV07-02*01	TCRBD01-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCTCGGGGCCCACAGATACGCAGTATTTTGGCCCA	CASSSGPTDTQYF	In	VDJ	5	248	5.819642702097653E-4	7.305441080733961E-4	39	TCRBV07	TCRBV07-02	01				TCRBJ02	TCRBJ02-03	01	4	7	0	2	1	1	18	31	37	32	38				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSGPTDTQYF+TCRBV07-02+TCRBJ02-03	TCRBV07-02*01		TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCGCCTCGACAGGGTCCGAGCAGTACTTCGGGCCG	CASSASTGSEQYF	In	VDJ	5	263	6.171637220369688E-4	7.747302436423516E-4	39	TCRBV07	TCRBV07-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	2	3	6	5	2	18	30	42	35	44														CASSASTGSEQYF+TCRBV07-02+TCRBJ02-07	TCRBV07-02*01	TCRBD01-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCTGGGGGATCCAAGAGACCCAGTACTTCGGGCCA	CASSWGIQETQYF	In	VDJ	7	343	8.048941317820544E-4	0.0010103896333434471	39	TCRBV07	TCRBV07-02	01				TCRBJ02	TCRBJ02-05	01	4	6	1	1	0	2	18	-1	36	31	38				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSWGIQETQYF+TCRBV07-02+TCRBJ02-05	TCRBV07-02*01		TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCCGTAGCGACCAAGAGACCCAGTACTTCGGGCCA	CASSRSDQETQYF	In	VDJ	112	5587	0.013110622490572413	0.016457862628250258	39	TCRBV07	TCRBV07-02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	5	6	0	2	0	18	30	-1	32	37						01,02								CASSRSDQETQYF+TCRBV07-02+TCRBJ02-05	TCRBV07-02*01	TCRBD02-01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCCAGTCGCCCAGGGTGATAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	13	3.0506191583576405E-5		50	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	4	3	1	10	3	18	31	46	41	49														X+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAACTGTAGCGGGGCCATACAATGAGCAGTTCTTCGGGCCA	CASSLTVAGPYNEQFF	In	VDJ	1	13	3.0506191583576405E-5	3.8294650826428025E-5	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	2	5	3	4	4	3	18	33	45	37	48														CASSLTVAGPYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCTTACAGGGGATCAATCAGCCCCAGCATTTTGGTGAT	CASSLQGINQPQHF	In	VDJ	1	14	3.285282170538997E-5	4.1240393197691716E-5	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	4	2	3	0	2	18	-1	39	33	41														CASSLQGINQPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGCCAGGACTAGCTGAGACTTTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	14	3.285282170538997E-5		47	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	1	7	4	4	8	18	30	42	34	50						01,02								X+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCCGATTAGCGACAAGCACAGATACGCAGTATTTTGGCCCA	CASSSRLATSTDTQYF	In	VDJ	1	14	3.285282170538997E-5	4.1240393197691716E-5	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	5	6	0	6	3	18	31	42	37	45						01,02								CASSSRLATSTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTATTGCGAGCGGGACCCACAGATACGCAGTATTTTGGCCCA	CASSLLRAGPTDTQYF	In	VDJ	1	14	3.285282170538997E-5	4.1240393197691716E-5	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	2	6	3	2	5	2	18	33	45	38	47														CASSLLRAGPTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCTTGCGGGAGGTTCTACCCTACGAGCAGTACTTCGGGCCG	CASSLREVLPYEQYF	In	VDJ	1	14	3.285282170538997E-5	4.1240393197691716E-5	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	7	1	2	0	6	18	-1	40	32	46														CASSLREVLPYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGTTCTAACTGGGAGTTTACGAGCAGTACGTCGGGCCG		Out	VDJ	1	14	3.285282170538997E-5		41	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	9	2	17	8	15	18	29	42	37	57														X+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCACCCTGGGCGGGGTAAACACTGAAGCTTTCTTTGGACAA	CASSTLGGVNTEAFF	In	VDJ	1	15	3.519945182720355E-5	4.418613556895541E-5	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	5	7	3	2	7	2	18	30	43	37	45														CASSTLGGVNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCAGTCAATACAGCTTTACCACGTGGCTACACCTTCGGTTCG	CASSPVNTALPRGYTF	In	VDJ	1	15	3.519945182720355E-5	4.418613556895541E-5	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	3	5	7	9	10	18	30	43	39	53														CASSPVNTALPRGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTTGAGACGGGCTCTGGAAACACCATATATTTTGGAGAG	CASSFETGSGNTIYF	In	VDJ	1	15	3.519945182720355E-5	4.418613556895541E-5	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	3	8	4	0	5	0	18	32	-1	37	41						01,02								CASSFETGSGNTIYF+TCRBV11-03+TCRBJ01-03	TCRBV11-03*01	TCRBD02-01	TCRBJ01-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAATCCAGGACTAGCTACCGCGAGCAGTACTTCGGGCCG	CASSQSRTSYREQYF	In	VDJ	1	16	3.7546081949017114E-5	4.7131877940219106E-5	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	1	7	6	7	5	18	30	45	37	50						01,02								CASSQSRTSYREQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGCCGTAGCGGGGGGAATTGAACAGTTCTTCGGGCCA	CASSAVAGGIEQFF	In	VDJ	1	16	3.7546081949017114E-5	4.7131877940219106E-5	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	5	1	13	4	7	18	30	44	34	51														CASSAVAGGIEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCTTAAGTGGGCTAGCTCCAGATACGCAGTATTTTGGCCCA	CASSLSGLAPDTQYF	In	VDJ	1	17	3.989271207083068E-5	5.00776203114828E-5	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	4	7	4	6	2	18	33	44	39	46						01,02								CASSLSGLAPDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCACTTGGGACTCCGAGGGGAACGAGCAGTACTTCGGGCCA	CASSTWDSEGNEQYF	In	VDJ	1	17	3.989271207083068E-5	5.00776203114828E-5	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	0	10	11	4	14	18	30	40	34	54						01,02								CASSTWDSEGNEQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAGACAGGGGTAAGGTACAATGAGCAGTTCTTCGGGCCA	CASSQTGVRYNEQFF	In	VDJ	1	17	3.989271207083068E-5	5.00776203114828E-5	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	2	2	4	2	5	18	30	40	32	45														CASSQTGVRYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGGACAGGGAAGAAGCTATGGCTACACCTTCGGTTCG	CASSGQGRSYGYTF	In	VDJ	1	17	3.989271207083068E-5	5.00776203114828E-5	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	1	3	4	0	6	18	-1	38	30	44														CASSGQGRSYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCGCATAGGCCCACCTATTACAATGAGCAGTTCTTCGGGCCA	CASSSHRPTYYNEQFF	In	VDJ	1	17	3.989271207083068E-5	5.00776203114828E-5	48	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-01	01	4	5	4	4	5	9	18	31	39	36	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSHRPTYYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01		TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGAAAAGGACAGGGTATTTGGCTACACCTTCGGTTCG	CASSLEKDRVFGYTF	In	VDJ	1	17	3.989271207083068E-5	5.00776203114828E-5	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	1	3	7	3	4	18	35	46	38	50														CASSLEKDRVFGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGATTTGGGCAGGGGGACCCAGTACTTCGGGCCA	CASSLDLGRGTQYF	In	VDJ	1	17	3.989271207083068E-5	5.00776203114828E-5	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	0	4	2	7	6	0	18	35	-1	41	47														CASSLDLGRGTQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGTGGGGCTGTAGGTACGCAGTATTTTGGCCCA	CASSLGGAVGTQYF	In	VDJ	1	17	3.989271207083068E-5	5.00776203114828E-5	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	1	7	0	8	2	6	18	34	41	36	47														CASSLGGAVGTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCGGGCATGGTTCAACCGGGGAGCTGTTTTTTGGAGAA	CASSPGHGSTGELFF	In	VDJ	1	18	4.2239342192644256E-5	5.302336268274649E-5	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-02	01	5	8	0	5	3	8	18	30	37	33	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPGHGSTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01		TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGGGACAGGAACGAGGTGAAGCTTTCTTTGGACAA		Out	VDJ	1	18	4.2239342192644256E-5		43	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	0	4	7	1	7	18	32	41	33	48														X+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTATCCGGGGCTAGCCATCAGCCCCAGCATTTTGGTGAT	CASSLSGASHQPQHF	In	VDJ	1	19	4.4585972314457824E-5	5.596910505401019E-5	45	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-05	01	2	7	0	5	3	5	18	33	41	36	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLSGASHQPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01		TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGTAGCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSLVAGANVLTF	In	VDJ	1	19	4.4585972314457824E-5	5.596910505401019E-5	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	3	5	8	2	2	0	18	32	-1	34	37						01,02								CASSLVAGANVLTF+TCRBV11-03+TCRBJ02-06	TCRBV11-03*01	TCRBD02-01	TCRBJ02-06*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCTCGCGGGGGACCCAAACCCCCGGATACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	19	4.4585972314457824E-5		49	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	8	7	2	5	2	16	18	27	36	29	52														X+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCCGGGACAGGGAGTACGAGCAGTACTTCGGGCCG	CASSFRDREYEQYF	In	VDJ	1	21	4.927923255808496E-5	6.186058979653757E-5	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	0	3	4	2	2	18	32	43	34	45														CASSFRDREYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGAGAGCCGAGCGCGCGGTTACAATGAGCAGTTCTTCGGGCCA	CASSESRARGYNEQFF	In	VDJ	1	22	5.162586267989853E-5	6.480633216780127E-5	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	6	6	4	8	6	18	30	42	38	48						01,02								CASSESRARGYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTTTTCGCCCGTTTCGGCGTCCATGAGCAGTTCTTCGGGCCA	CASSFFARFGVHEQFF	In	VDJ	1	22	5.162586267989853E-5	6.480633216780127E-5	48	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-01	01	3	9	0	8	13	4	18	32	48	45	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFFARFGVHEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01		TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAACAGCTTGGGGGTCCTGGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	23	5.39724928017121E-5		44	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-06	01	3	6	1	2	0	2	18	-1	37	32	39				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV11-03+TCRBJ02-06	TCRBV11-03*01		TCRBJ02-06*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCGGACTAGCGAGAAGCTCCTACGAGCAGTACTTCGGGCCG	CASSSGLARSSYEQYF	In	VDJ	1	23	5.39724928017121E-5	6.775207453906497E-5	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	1	6	0	2	5	18	31	42	33	47						01,02								CASSSGLARSSYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCGAATAGCGGGGGAAGGACAACAGATACGCAGTATTTTGGCCCA	CASSSNSGGRTTDTQYF	In	VDJ	1	23	5.39724928017121E-5	6.775207453906497E-5	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	5	2	3	4	7	18	31	44	35	51														CASSSNSGGRTTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCGGACAGGGATTTTACACCGGGGAGCTGTTTTTTGGAGAA	CASSSGQGFYTGELFF	In	VDJ	1	24	5.631912292352567E-5	7.069781691032865E-5	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	1	3	3	2	5	18	31	41	33	46														CASSSGQGFYTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCTCGGGGGCCTACTACGAGCAGTACGTCGGGCCG	CASSFSGAYYEQYV	In	VDJ	1	24	5.631912292352567E-5	7.069781691032865E-5	42	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-07	01	3	6	0	17	3	17	18	32	41	35	58				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFSGAYYEQYV+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01		TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTAGGGATAAGCGCCATGAAGCTTTCTTTGGACAA		Out	VDJ	1	25	5.866575304533924E-5		41	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	1	6	6	7	5	3	18	34	43	39	46						01,02								X+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD02-01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCGGGACTCCCTACAATGAGCAGTTCTTCGGGCCA	CASSFGTPYNEQFF	In	VDJ	1	25	5.866575304533924E-5	7.364355928159235E-5	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	0	10	2	1	1	18	32	39	33	40						01,02								CASSFGTPYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCAACCAATCTTATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSNQSYSNQPQHF	In	VDJ	1	26	6.101238316715281E-5	7.658930165285605E-5	45	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-05	01	5	3	7	0	1	8	18	30	33	31	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSNQSYSNQPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01		TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGCAGTTCTAGCGCAATCCTCCTACGAGCAGTACTTCGGGCCG	CASSAVLAQSSYEQYF	In	VDJ	1	27	6.335901328896638E-5	7.953504402411973E-5	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	4	6	0	6	5	18	30	42	36	47						01,02								CASSAVLAQSSYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCAACAGGGCGGGCACTGAAGCTTTCTTTGGACAA	CASSFNRAGTEAFF	In	VDJ	1	27	6.335901328896638E-5	7.953504402411973E-5	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	3	3	4	2	4	18	32	40	34	44														CASSFNRAGTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTTGGAGGGCTTTACAATGAGCAGTTCTTCGGGCCA	CASSFGGLYNEQFF	In	VDJ	1	27	6.335901328896638E-5	7.953504402411973E-5	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	10	0	4	1	3	18	32	39	33	42														CASSFGGLYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCTAGCAGCTCACGGACAGGGGGAAGTGGCTACACCTTCGGTTCG	CASSSRTGGSGYTF	In	VDJ	1	27	6.335901328896638E-5	7.953504402411973E-5	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	1	1	7	3	3	18	31	44	34	47														CASSSRTGGSGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCTTAGGACAGCTCGGGGGGATGGCTACACCTTCGGTTCG		Out	VDJ	1	28	6.570564341077994E-5		44	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	1	8	1	6	7	0	18	34	-1	41	48														X+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD02-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAACAGCCAGGTTAAAGGGACAGCTGGGGCCAACGTCCTGACTTTCGGGGCC	CANSQVKGTAGANVLTF	In	VDJ	1	29	6.805227353259351E-5	8.542652876664713E-5	51	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	0	5	2	9	0	18	30	-1	39	46														CANSQVKGTAGANVLTF+TCRBV11-03+TCRBJ02-06	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-06*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTTCGACTAGCGGGGAGCACAGATACGCAGTATTTTGGCCCA	CASSFRLAGSTDTQYF	In	VDJ	1	29	6.805227353259351E-5	8.542652876664713E-5	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	2	3	0	2	0	18	32	-1	34	45														CASSFRLAGSTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCGGGACAGCCTTACAACGAGCAGTACTTCGGGCCG	CASSPGQPYNEQYF	In	VDJ	1	30	7.03989036544071E-5	8.837227113791082E-5	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	5	5	2	7	18	30	39	32	46														CASSPGQPYNEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGTCTAGCGGGGGGCCCTTTACGCAGTATTTTGGCCCA	CASSLSSGGPFTQYF	In	VDJ	1	30	7.03989036544071E-5	8.837227113791082E-5	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	4	1	8	2	5	18	32	45	34	50														CASSLSSGGPFTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATCTCTGTGCTAGCGGATCCCGGGACGTCCACGAGGAAGAGACCCAGTACTTCGGGCCA	CASGSRDVHEEETQYF	In	VDJ	1	32	7.509216389803423E-5	9.426375588043821E-5	48	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-05	01	8	0	7	3	7	10	18	27	39	34	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASGSRDVHEEETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01		TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTTTCGACAGGGGATGGAGATACGCAGTATTTTGGCCCA	CASSLSTGDGDTQYF	In	VDJ	1	32	7.509216389803423E-5	9.426375588043821E-5	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	2	2	5	5	4	18	30	43	35	47														CASSLSTGDGDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGACGGACCCCCCAGACCTACGAGCAGTACGTCGGGCCG	CASRRTPQTYEQYV	In	VDJ	1	33	7.74387940198478E-5	9.72094982517019E-5	42	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-07	01	6	1	7	17	2	23	18	29	35	31	58				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRRTPQTYEQYV+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01		TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCCTGGACAGGGCGGGAGGCTACACCTTCGGTTCG	CASSSLDRAGGYTF	In	VDJ	1	33	7.74387940198478E-5	9.72094982517019E-5	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	1	3	8	4	5	18	31	43	35	48														CASSSLDRAGGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGACACAGCTAACTATGGCTACACCTTCGGTTCG	CASSLDTANYGYTF	In	VDJ	1	33	7.74387940198478E-5	9.72094982517019E-5	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	1	6	0	0	3	18	-1	37	32	40														CASSLDTANYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCACCCCCCTAGCGGGGACAGGGGGCGAAAAACTGTTTTTTGGCAGT	CASTPLAGTGGEKLFF	In	VDJ	1	34	7.978542414166136E-5	1.001552406229656E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	7	0	0	8	11	0	18	28	-1	39	51														CASTPLAGTGGEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCGGCTAGCGGGGGGATCACAGATACGCAGTATTTTGGCCCA	CASSPASGGITDTQYF	In	VDJ	1	34	7.978542414166136E-5	1.001552406229656E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	4	1	2	4	2	18	30	45	34	47														CASSPASGGITDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGCCTTCAGCTCGTACGAGCAGTACGTCGGGCCG	CASSLAFSSYEQYV	In	VDJ	1	35	8.213205426347493E-5	1.031009829942293E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-07	01	3	4	5	17	6	17	18	32	41	38	58				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLAFSSYEQYV+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01		TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCGCTGGGAGCGCAGTTCCTCAAGAGACCCAGTACTTCGGGCCA	CASAGSAVPQETQYF	In	VDJ	1	35	8.213205426347493E-5	1.031009829942293E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	8	9	2	2	3	10	18	27	35	30	45														CASAGSAVPQETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCAAACAGGGGCGGGTCAACACTGAAGCTTTCTTTGGACAA	CASSKQGRVNTEAFF	In	VDJ	1	40	9.386520487254278E-5	1.1782969485054776E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	3	2	2	2	6	18	30	39	32	45														CASSKQGRVNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCAGGGGGGCGATGCAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	41	9.621183499435635E-5		43	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	4	1	6	2	6	18	30	39	32	45														X+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAAGGACAGACAATCAGCCCCAGCATTTTGGTGAT	CASSLRTDNQPQHF	In	VDJ	1	45	1.0559835548161063E-4	1.3255840670686622E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	1	5	3	1	1	18	33	40	34	41														CASSLRTDNQPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGAGGCCGGCCGATCCTACGAGCAGTACTTCGGGCCG	CASSLEAGRSYEQYF	In	VDJ	1	45	1.0559835548161063E-4	1.3255840670686622E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-07	01	0	9	0	1	0	7	18	-1	38	35	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLEAGRSYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01		TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGACTAGCGGGAGGGGATACGCAGTATTTTGGCCCA	CASSLGLAGGDTQYF	In	VDJ	1	47	1.1029161572523777E-4	1.3844989144939362E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	1	2	0	6	0	0	18	-1	-1	34	48														CASSLGLAGGDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCACGGACAGGGTTTTTATAATTCACCCCTCCACTTTGGGAAC	CASSHGQGFYNSPLHF	In	VDJ	1	50	1.1733150609067848E-4	1.472871185631847E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	1	3	4	3	4	18	30	41	33	45														CASSHGQGFYNSPLHF+TCRBV11-03+TCRBJ01-06	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-06*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTATCGTCAAACAAGGGCGGGGAGCTGTTTTTTGGAGAA	CASSLSSNKGGELFF	In	VDJ	1	50	1.1733150609067848E-4	1.472871185631847E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-02	01	2	5	3	7	10	0	18	33	-1	43	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLSSNKGGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01		TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCGGACAGGGGGCGTCGGAGTACAATGAGCAGTTCTTCGGGCCA	CASSPGQGASEYNEQFF	In	VDJ	1	51	1.1967813621249205E-4	1.502328609344484E-4	51	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	1	0	4	3	7	18	30	44	33	51														CASSPGQGASEYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGGAAGGGACTCTGGAAACACCATATATTTTGGAGAG	CASSGRDSGNTIYF	In	VDJ	1	51	1.1967813621249205E-4	1.502328609344484E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-03	01	5	0	8	0	4	0	18	30	-1	34	38				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSGRDSGNTIYF+TCRBV11-03+TCRBJ01-03	TCRBV11-03*01		TCRBJ01-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGTGGCATCTTATAATTCACCCCTCCACTTTGGGAAC	CASSLVASYNSPLHF	In	VDJ	1	51	1.1967813621249205E-4	1.502328609344484E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	1	9	0	4	1	4	18	34	38	35	42														CASSLVASYNSPLHF+TCRBV11-03+TCRBJ01-06	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-06*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAGACATTGGACAGCAATGAGCAGTTCTTCGGGCCA	CASSQTLDSNEQFF	In	VDJ	1	53	1.243713964561192E-4	1.5612434567697578E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	1	5	6	8	0	18	30	-1	38	44														CASSQTLDSNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTCGCACAGGGGTACACTGAAGCTTTCTTTGGACAA	CASSLAQGYTEAFF	In	VDJ	1	53	1.243713964561192E-4	1.5612434567697578E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	3	2	3	5	1	18	30	42	35	43														CASSLAQGYTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTTGGGACAGGGGGCAATGAGCAGTTCTTCGGGCCA	CASSFGTGGNEQFF	In	VDJ	1	56	1.314112868215599E-4	1.6496157279076687E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	0	1	6	1	0	18	32	-1	33	44														CASSFGTGGNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCTCCGTCGGGGCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSVGANTGELFF	In	VDJ	1	56	1.314112868215599E-4	1.6496157279076687E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	8	8	3	0	5	0	18	27	-1	32	37														CASSVGANTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGAGGGTGATTGGGATGTAGAGACCGGGGAGCTGTTTTTTGGAGAA	CASSLEGDWDVETGELFF	In	VDJ	1	58	1.3610454706518703E-4	1.7085305753329426E-4	54	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-02	01	0	0	8	5	8	7	18	35	47	43	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLEGDWDVETGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01		TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGATCCCAGTAACTCCCAAGAGACCCAGTACTTCGGGCCA	CASSLDPSNSQETQYF	In	VDJ	1	61	1.4314443743062774E-4	1.7969028464708534E-4	48	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-05	01	0	4	5	1	3	6	18	35	41	38	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLDPSNSQETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01		TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTTAGCCGATCCGACACCGGGGAGCTGTTTTTTGGAGAA	CASSFSRSDTGELFF	In	VDJ	1	61	1.4314443743062774E-4	1.7969028464708534E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	3	5	7	3	0	7	18	-1	36	32	43						01,02								CASSFSRSDTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD02-01	TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGGAGAGTTTCTAGCGGGGGCCACAGATACGCAGTATTTTGGCCCA	CASSGEFLAGATDTQYF	In	VDJ	1	64	1.5018432779606846E-4	1.8852751176087643E-4	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	4	2	2	9	1	18	30	49	39	50														CASSGEFLAGATDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGGGACCGACGGTATGAGCAGTTCTTCGGGCCA	CASSLGDRRYEQFF	In	VDJ	1	64	1.5018432779606846E-4	1.8852751176087643E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-01	01	1	0	7	8	0	7	18	-1	39	34	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGDRRYEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01		TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGGGACAGTCGTTCTTCCATGAACACTGAAGCTTTCTTTGGACAA	CASRDSRSSMNTEAFF	In	VDJ	1	65	1.5253095791788204E-4	1.914732541321401E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	1	5	0	0	11	18	-1	35	29	46														CASRDSRSSMNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAAGTTTGGCTAGCGGGATATTGGATACGCAGTATTTTGGCCCA	CASSLSLASGILDTQYF	In	VDJ	1	67	1.5722421816150917E-4	1.973647388746675E-4	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	2	4	3	6	7	5	18	33	49	40	54														CASSLSLASGILDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGGGACAGAATTTACAATGAGCAGTTCTTCGGGCCA	CASSLGDRIYNEQFF	In	VDJ	1	69	1.619174784051363E-4	2.0325622361719488E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	1	0	5	4	0	4	18	-1	41	34	45														CASSLGDRIYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGGTTAGGGCTACTCTCCTACGAGCAGTACTTCGGGCCG	CASSLGLGLLSYEQYF	In	VDJ	1	70	1.6426410852694986E-4	2.062019659884586E-4	48	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-07	01	1	5	3	0	4	5	18	34	42	38	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGLGLLSYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01		TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCATCATAACAGGGGGTCGTTTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	71	1.6661073864876344E-4		47	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	3	1	9	7	4	18	30	45	37	49														X+TCRBV11-03+TCRBJ01-06	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-06*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTATCGGACCACTTGGGGAGAGACCCAGTACTTCGGGCCA	CASSYRTTWGETQYF	In	VDJ	1	71	1.6661073864876344E-4	2.0914770835972227E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-05	01	4	1	7	4	3	9	18	31	38	34	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYRTTWGETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01		TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCTCTAGCGGGACTTTAAACAATGAGCAGTTCTTCGGGCCA	CASSFSSGTLNNEQFF	In	VDJ	1	73	1.7130399889239058E-4	2.1503919310224967E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	4	3	5	2	6	18	32	43	34	49														CASSFSSGTLNNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCCCACACAAGGGGCTGCGAGCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSPHKGLRANTGELFF	In	VDJ	2	76	1.783438892578313E-4	2.2387642021604075E-4	54	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	5	2	0	7	7	18	30	42	37	49														CASSPHKGLRANTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGATGGGACAGGGGGTGAAAAACTGTTTTTTGGCAGT	CASSDGTGGEKLFF	In	VDJ	2	80	1.8773040974508556E-4	2.3565938970109552E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	0	1	7	3	0	18	30	-1	33	44														CASSDGTGGEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTATCGAATAGCCGCTATGGCTACACCTTCGGTTCG	CASSLSNSRYGYTF	In	VDJ	2	80	1.8773040974508556E-4	2.3565938970109552E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	2	5	7	4	5	2	18	33	42	38	44						01,02								CASSLSNSRYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD02-01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTTTTGCAGGGCCGTCAGGTTGGCTACACCTTCGGTTCG	CASSFLQGRQVGYTF	In	VDJ	2	80	1.8773040974508556E-4	2.3565938970109552E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	4	3	7	4	9	18	32	41	36	50														CASSFLQGRQVGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTGGGGATACCGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSWGYRSGANVLTF	In	VDJ	2	81	1.9007703986689915E-4	2.386051320723592E-4	48	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-06	01	4	0	8	0	1	5	18	31	36	32	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSWGYRSGANVLTF+TCRBV11-03+TCRBJ02-06	TCRBV11-03*01		TCRBJ02-06*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGCCCGGGACAACTAACTATGGCTACACCTTCGGTTCG	CASSLPGTTNYGYTF	In	VDJ	2	81	1.9007703986689915E-4	2.386051320723592E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	0	6	0	4	1	18	32	42	36	43														CASSLPGTTNYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCACATACCGACAGGGGAGTGGGTGGCTACACCTTCGGTTCG	CASSPHTDRGVGGYTF	In	VDJ	2	85	1.9946356035415342E-4	2.50388101557414E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	2	2	7	9	6	18	30	47	39	53														CASSPHTDRGVGGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCCTTGGGGGCAACACTGAAGCTTTCTTTGGACAA	CASSFLGGNTEAFF	In	VDJ	2	86	2.01810190475967E-4	2.533338439286777E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	6	0	2	4	0	18	32	-1	36	42														CASSFLGGNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGAGGCAAGGGGCCGCGGCTACACCTTCGGTTCG	CASSLEARGRGYTF	In	VDJ	2	89	2.0885008084140769E-4	2.621710710424688E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	5	2	8	4	4	18	35	44	39	48														CASSLEARGRGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTTCGGGAGCAGTCGGGGGGCACAGATACGCAGTATTTTGGCCCA	CASSFREQSGGTDTQYF	In	VDJ	2	89	2.0885008084140769E-4	2.621710710424688E-4	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	8	2	1	11	0	18	32	-1	43	49						01,02								CASSFREQSGGTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCGCAACACTGAACACTGAAGCTTTCTTTGGACAA	CASSFATLNTEAFF	In	VDJ	2	90	2.1119671096322127E-4	2.6511681341373245E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	3	6	0	4	1	18	32	39	36	40														CASSFATLNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGATCTGTGGGGGGAAAGCTACACCTTCGGTTCG	CASSLDLWGESYTF	In	VDJ	2	93	2.1823660132866198E-4	2.7395404052752353E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	0	9	1	9	5	3	18	35	46	40	49														CASSLDLWGESYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD02-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGAGGGACAGCACTCTGGAAACACCATATATTTTGGAGAG	CASSEGQHSGNTIYF	In	VDJ	2	94	2.2058323145047554E-4	2.7689978289878724E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	0	5	0	2	2	18	30	39	32	41														CASSEGQHSGNTIYF+TCRBV11-03+TCRBJ01-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTACCAAGGGCAGGGGGTGAGGGACTCTATGGCTACACCTTCGGTTCG	CASSLPRAGGEGLYGYTF	In	VDJ	2	99	2.323163820595434E-4	2.916284947551057E-4	54	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	4	1	4	7	9	18	33	47	40	56														CASSLPRAGGEGLYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGGCGGCTAGCGATATCCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	2	99	2.323163820595434E-4		49	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	1	4	6	2	5	5	18	34	45	39	50						01,02								X+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGGCCCTCTGGGACTGCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASRPSGTANTGELFF	In	VDJ	2	102	2.393562724249841E-4	3.004657218688968E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	6	0	10	0	7	1	18	29	42	36	43						01,02								CASRPSGTANTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD02-01	TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGGCTAGCGGTACGAGACCCAGTACTTCGGGCCA	CASSLG*RYETQYF	Stop	VDJ	2	103	2.4170290254679766E-4		42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	3	4	5	5	3	3	18	32	42	35	45						01,02								CASSLG*RYETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGGACTAGCACCGGGGAGCTGTTTTTTGGAGAA	CASSLGTSTGELFF	In	VDJ	2	106	2.487427929122384E-4	3.1224869135395157E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	1	1	8	4	0	0	18	-1	-1	34	41						01,02								CASSLGTSTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD02-01	TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGACAGGGGGCATAGAAGGCTACACCTTCGGTTCG	CASSLTGGIEGYTF	In	VDJ	2	111	2.6047594352130625E-4	3.2697740321027E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	2	0	8	0	6	18	-1	42	32	48														CASSLTGGIEGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTATGGTACTAAGATGAGGTTTAACAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	2	113	2.6516920376493336E-4		55	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	2	3	9	3	4	13	18	33	41	37	54						01,02								X+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD02-01	TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGACAGGAGTTATAAAAAACTATGGCTACACCTTCGGTTCG		Out	VDJ	2	118	2.769023543740012E-4		49	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	1	4	2	0	10	18	-1	39	32	49														X+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGTCAGCGGACAGGGCACAATGAGCAGTTCTTCGGGCCA	CASSQRTGHNEQFF	In	VDJ	2	122	2.862888748612555E-4	3.593805692941707E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	1	3	5	5	1	18	29	42	34	43														CASSQRTGHNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCATACAGGGTCTGAACAATCAGCCCCAGCATTTTGGTGAT	CASSIQGLNNQPQHF	In	VDJ	2	123	2.8863550498306906E-4	3.6232631166543435E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	3	3	3	2	6	18	30	38	32	44														CASSIQGLNNQPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGTTACGGAATCTTACTTACTAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	2	123	2.8863550498306906E-4		55	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-03	01	3	1	8	0	5	12	18	32	40	37	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01		TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTGTGGGACAGGGGTTACGAGCAGTACGTCGGGCCG		Out	VDJ	2	124	2.9098213510488264E-4		41	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	0	2	17	2	14	18	31	43	33	57														X+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCTCGGACAGGGATTAACTATGGCTACACCTTCGGTTCG	CASSPRTGINYGYTF	In	VDJ	3	126	2.9567539534850975E-4	3.7116353877922543E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	1	3	1	4	2	18	30	42	34	44														CASSPRTGINYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCTTACAGGGACCCTAATGAAAAACTGTTTTTTGGCAGT	CASSPYRDPNEKLFF	In	VDJ	3	127	2.9802202547032333E-4	3.7410928115048914E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	3	3	3	4	3	18	30	40	34	43														CASSPYRDPNEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCGGGGTATCTTCCTCCTACGAGCAGTACGTCGGGCCG	CASSFGVSSSYEQYV	In	VDJ	3	127	2.9802202547032333E-4	3.7410928115048914E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	3	8	3	17	0	24	18	-1	37	32	61														CASSFGVSSSYEQYV+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTTGCGGGAGGGGCCCACTACGAGCAGTACTTCGGGCCG	CASSLAGGAHYEQYF	In	VDJ	3	131	3.074085459575776E-4	3.8589225063554393E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	7	0	3	3	5	18	30	42	33	47														CASSLAGGAHYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCAACAGGGAACTCTAATGAAAAACTGTTTTTTGGCAGT	CASSSTGNSNEKLFF	In	VDJ	3	133	3.1210180620120477E-4	3.917837353780713E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	3	3	3	2	4	18	31	39	33	43														CASSSTGNSNEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGTGAGCACGACAGGGGCCCCAGTAGATACGCAGTATTTTGGCCCA	CASSVSTTGAPVDTQYF	In	VDJ	3	134	3.1444843632301835E-4	3.94729477749335E-4	51	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	2	2	5	8	7	18	30	46	38	53														CASSVSTTGAPVDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAACTGGGGGAAAGCTCCTACGAGCAGTACTTCGGGCCG	CASSQLGESSYEQYF	In	VDJ	3	137	3.2148832668845904E-4	4.035667048631261E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-07	01	5	6	1	0	5	4	18	30	40	35	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQLGESSYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01		TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAACCCCGGCCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSLTPASYNEQFF	In	VDJ	3	140	3.285282170538997E-4	4.124039319769172E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-01	01	2	9	0	0	5	0	18	33	-1	38	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLTPASYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01		TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCAAAGGGAGCAATCAGCCCCAGCATTTTGGTGAT	CASSFKGSNQPQHF	In	VDJ	3	141	3.308748471757133E-4	4.1534967434818084E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-05	01	3	5	3	1	3	0	18	32	-1	35	39				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFKGSNQPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01		TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCGACAGGGCGGTCGACAATGAGCAGTTCTTCGGGCCA	CASSPDRAVDNEQFF	In	VDJ	3	146	3.4260799778478116E-4	4.3007838620449934E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	2	3	5	3	6	18	30	40	33	46														CASSPDRAVDNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCGGGACTAGCTCATAATGAGCAGTTCTTCGGGCCA	CASSPGLAHNEQFF	In	VDJ	3	146	3.4260799778478116E-4	4.3007838620449934E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	0	7	7	2	4	18	30	41	32	45						01,02								CASSPGLAHNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGAGGCGGGGGGGGAAGAGACCCAGTACTTCGGGCCA	CASSLEAGGEETQYF	In	VDJ	3	150	3.5199451827203543E-4	4.418613556895541E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	0	7	0	3	1	1	18	35	45	36	46														CASSLEAGGEETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGTTCTCCCTGGGCCGTGAACACTGAAGCTTTCTTTGGACAA	CASSSPWAVNTEAFF	In	VDJ	3	150	3.5199451827203543E-4	4.418613556895541E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	8	0	0	8	2	18	29	41	37	43														CASSSPWAVNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGCAGAGCCCAGGGGCCTGAAGCTTTCTTTGGACAA		Out	VDJ	3	152	3.566877785156626E-4		43	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	4	2	6	8	1	18	32	46	40	47														X+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGCCTCTAGCGGGATGACAGATACGCAGTATTTTGGCCCA	CASSLASSGMTDTQYF	In	VDJ	3	155	3.637276688811033E-4	4.565900675458726E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	4	3	3	5	2	18	32	46	37	48														CASSLASSGMTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCGCACCCGGTGGGACTCGGAACACTGAAGCTTTCTTTGGACAA	CASAPGGTRNTEAFF	In	VDJ	3	155	3.637276688811033E-4	4.565900675458726E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	8	0	10	1	9	2	18	27	42	36	44						01,02								CASAPGGTRNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD02-01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAAATCTACGGGGTTACGAGCAGTACTTCGGGCCG	CASSQNLRGYEQYF	In	VDJ	3	157	3.6842092912473044E-4	4.6248155228839996E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	5	8	3	4	9	1	18	30	44	39	45														CASSQNLRGYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGAGTGGACCGACAGGGGACTATGGCTACACCTTCGGTTCG	CASSLSGPTGDYGYTF	In	VDJ	3	162	3.801540797337983E-4	4.772102641447184E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	2	2	3	9	0	18	32	-1	41	49														CASSLSGPTGDYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCACTAGCAGGGAGCGAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	3	166	3.8954060022105256E-4		44	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-02	01	7	4	3	0	4	2	18	28	37	32	39				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01		TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTATTTAGCGGGAGGGCCACAGATACGCAGTATTTTGGCCCA	CASSLFSGRATDTQYF	In	VDJ	3	167	3.9188723034286614E-4	4.919389760010369E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	2	5	0	2	2	1	18	33	46	35	47														CASSLFSGRATDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTAAATCTAGGGGACAATGAGCAGTTCTTCGGGCCA	CASSLNLGDNEQFF	In	VDJ	3	170	3.9892712070830683E-4	5.00776203114828E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	5	2	5	8	0	18	30	-1	38	43														CASSLNLGDNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCAGCGACAGGGGACGGGGAGACCCAGTACTTCGGGCCA	CASSPATGDGETQYF	In	VDJ	3	171	4.012737508301204E-4	5.037219454860917E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	2	2	5	5	5	18	30	43	35	48														CASSPATGDGETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTACGTTCCCGAGAGGAGGAGACCCAGTACTTCGGGCCA	CASSLRSREEETQYF	In	VDJ	3	171	4.012737508301204E-4	5.037219454860917E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	2	10	2	5	11	0	18	33	-1	44	48														CASSLRSREEETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTGACTAGCGGGACGTTCGAGACCCAGTACTTCGGGCCA	CASSLTSGTFETQYF	In	VDJ	4	176	4.1300690143918826E-4	5.184506573424102E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	5	2	3	5	2	5	18	30	43	32	48														CASSLTSGTFETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGAAAGGGGGGTCGTCGCTGGCTACACCTTCGGTTCG	CASSLERGVVAGYTF	In	VDJ	4	186	4.3647320265732397E-4	5.479080810550471E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-02	01	0	5	1	7	1	8	18	35	42	36	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLERGVVAGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01		TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCATCATTGTCGGGGTTTTATATGCACTGAAGCTTTCTTTGGACAA		Out	VDJ	4	191	4.482063532663918E-4		47	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	7	8	3	4	7	9	18	28	40	35	49														X+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGTGGCTAGCGGAGGCACAGATACGCAGTATTTTGGCCCA	CASSLVASGGTDTQYF	In	VDJ	4	201	4.716726544845275E-4	5.920942166240025E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	1	4	5	1	3	2	18	34	44	37	46						01,02								CASSLVASGGTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGGTCCGGAGGGGCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSLGSGGAGANVLTF	In	VDJ	4	204	4.787125448499682E-4	6.009314437377935E-4	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-06	01	1	10	0	2	5	1	18	34	45	39	46														CASSLGSGGAGANVLTF+TCRBV11-03+TCRBJ02-06	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-06*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCGACCCTACAGGGGGCGGGGGAAAAACTGTTTTTTGGCAGT	CASSSTLQGAGEKLFF	In	VDJ	4	206	4.834058050935953E-4	6.06822928480321E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	3	0	8	7	4	18	31	47	38	51														CASSSTLQGAGEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGATCCCCCGGACTAGCGGGGGCCTCCTGAATGAGCAGTTCTTCGGGCCA	CASSLIPRTSGGLLNEQFF	In	VDJ	4	207	4.857524352154089E-4	6.097686708515847E-4	57	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	3	1	2	7	8	7	18	32	53	40	60														CASSLIPRTSGGLLNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGACACTAGCGGATTCAAAGAGACCCAGTACTTCGGGCCA	CASSLDTSGFKETQYF	In	VDJ	4	212	4.974855858244768E-4	6.244973827079031E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	3	3	5	3	4	5	18	32	44	36	49						01,02								CASSLDTSGFKETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCTAGCAGCTTTCCCGAGACTAGTATCTTTACAGATACGCAGTATTTTGGCCCA	CASSFPETSIFTDTQYF	In	VDJ	4	212	4.974855858244768E-4	6.244973827079031E-4	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	2	8	3	6	7	18	32	44	38	51						01,02								CASSFPETSIFTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCACTACCGGGACAGGGTATCCCTACGAGCAGTACTTCGGGCCG	CASSSTTGTGYPYEQYF	In	VDJ	4	214	5.021788460681039E-4	6.303888674504306E-4	51	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	0	3	2	8	4	18	31	48	39	52														CASSSTTGTGYPYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGGCTAGCGGGAGCCGGCTACAATGAGCAGTTCTTCGGGCCA	CASRLAGAGYNEQFF	In	VDJ	4	219	5.139119966771717E-4	6.45117579306749E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	4	2	3	1	4	18	29	40	30	44														CASRLAGAGYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGAACTAAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	4	220	5.162586267989853E-4		41	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	3	3	9	1	2	0	18	32	-1	34	38						01,02								X+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD02-01	TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCTCACCGCTGCGCCTTAATGAAAAACTGTTTTTTGGCAGT	CASSPLRLNEKLFF	In	VDJ	4	223	5.23298517164426E-4	6.569005487918038E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	8	7	6	4	8	3	18	27	38	35	41						01,02								CASSPLRLNEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD02-01	TCRBJ01-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCGGGACGGGGGTCCTACAATGAGCAGTTCTTCGGGCCA	CASSPGRGSYNEQFF	In	VDJ	5	229	5.373782978953074E-4	6.745750030193859E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	8	2	1	6	0	18	30	-1	36	42														CASSPGRGSYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTACGTCGTGGGGCAGATACGCAGTATTTTGGCCCA	CASSLRRGADTQYF	In	VDJ	5	231	5.420715581389346E-4	6.804664877619133E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-03	01	2	6	2	4	6	0	18	33	-1	39	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLRRGADTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01		TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGCGCCAGCGAACACTGAAGCTTTCTTTGGACAA	CASSLAPANTEAFF	In	VDJ	5	233	5.467648183825617E-4	6.863579725044407E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-01	01	3	4	5	1	5	1	18	32	40	37	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLAPANTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01		TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTACGACAGTCGAACACTGAAGCTTTCTTTGGACAA	CASSLRQSNTEAFF	In	VDJ	5	235	5.514580786261889E-4	6.922494572469681E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	2	5	1	1	2	18	33	39	34	41														CASSLRQSNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCTAGCTTAGTAGACCTTAGCGGGTGAGAAACACAGATACGCAGTATTTTGGCCCA	CAS*LSRP*RVRNTDTQYF	Stop	VDJ	5	235	5.514580786261889E-4		57	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	8	5	4	2	15	7	18	27	49	42	56						01,02								CAS*LSRP*RVRNTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGAGGGAGGGGGGCAAGAGCAGTACTTCGGGCCG	CASSLEGGGQEQYF	In	VDJ	5	236	5.538047087480024E-4	6.951951996182318E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	9	0	7	3	6	18	32	42	35	48														CASSLEGGGQEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCAGCAGGGGGTATGGCACTGAAGCTTTCTTTGGACAA	CASSSRGYGTEAFF	In	VDJ	5	241	5.655378593570703E-4	7.099239114745502E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	4	1	4	2	5	18	30	39	32	44														CASSSRGYGTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGTCAGCAGCTTAAACTTGAACACCGGGGAGCTGTTTTTTGGAGAA	CVSSLNLNTGELFF	In	VDJ	5	245	5.749243798443246E-4	7.217068809596051E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	2	3	10	1	1	1	18	33	37	34	38						01,02								CVSSLNLNTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD02-01	TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGAGCTAGCGGGAGGTCGGGAGACCCAGTACTTCGGGCCA	CASSLELAGGRETQYF	In	VDJ	5	271	6.359367630114774E-4	7.982961826124611E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	3	4	1	5	4	4	18	32	47	36	51														CASSLELAGGRETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCAAGTGGGACAAGATACGAGCAGTACTTCGGGCCG	CASSSSGTRYEQYF	In	VDJ	5	272	6.382833931332909E-4	8.012419249837248E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	0	6	4	5	3	18	31	42	36	45														CASSSSGTRYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTAACGCCAGGGCCCAATGAGCAGTTCTTCGGGCCA	CASSLTPGPNEQFF	In	VDJ	5	273	6.406300232551045E-4	8.041876673549885E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	4	3	6	7	2	18	30	42	37	44														CASSLTPGPNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAAATGGGTGGGGCCGGGGGCAGTTCTTCGGGCCA	CASSLNGWGRGQFF	In	VDJ	5	274	6.429766533769181E-4	8.071334097262522E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-01	01	2	7	0	12	7	5	18	33	45	40	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLNGWGRGQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01		TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCTGGGACAGGGGAGATGAGCAGTTCTTCGGGCCA	CASSSWDRGDEQFF	In	VDJ	6	276	6.476699136205452E-4	8.130248944687795E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	0	2	8	3	2	18	31	44	34	46														CASSSWDRGDEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGTGTCGGGGACAGAGGGGAACCACAAGCAGTACTTCGGGCCG	CASSLVSGTEGNHKQYF	In	VDJ	6	287	6.734828449604945E-4	8.454280605526802E-4	51	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	0	5	8	5	12	18	34	46	39	58														CASSLVSGTEGNHKQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGACTGGACAGGGCTAACACTGAAGCTTTCTTTGGACAA	CASRLDRANTEAFF	In	VDJ	6	305	7.157221871531387E-4	8.984514232354267E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	1	3	2	3	2	18	29	40	32	42														CASRLDRANTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCTCCCAGGGACAGGTGTACAATGAGCAGTTCTTCGGGCCA	CASSPSQGQVYNEQFF	In	VDJ	6	309	7.25108707640393E-4	9.102343927204815E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	0	4	4	8	2	18	30	46	38	48														CASSPSQGQVYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGACAGCCGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSDSRSGANVLTF	In	VDJ	6	314	7.368418582494609E-4	9.249631045767999E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	2	5	0	0	3	18	-1	35	30	38														CASSDSRSGANVLTF+TCRBV11-03+TCRBJ02-06	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-06*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGGCGGGACACATTTAAAATCGACGAGCAGTACTTCGGGCCG	CASRRDTFKIDEQYF	In	VDJ	7	335	7.861210908075458E-4	9.868236943733374E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-07	01	6	0	6	5	2	12	18	29	37	31	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRRDTFKIDEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01		TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCACTTACAGTTAAAGAGACCCAGTACTTCGGGCCA	CASSSLTVKETQYF	In	VDJ	7	340	7.978542414166137E-4	0.001001552406229656	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	3	5	3	5	3	18	31	40	36	43														CASSSLTVKETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGCGCAGGTGGGTGAAAAACTGTTTTTTGGCAGT	CASSLAQVGEKLFF	In	VDJ	7	344	8.07240761903868E-4	0.0010133353757147108	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	4	4	7	4	4	18	32	40	36	44														CASSLAQVGEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGGGCAGGTGGCTCCGCGTCCTACGAGCAGTACTTCGGGCCG	CASSLGAGGSASYEQYF	In	VDJ	7	351	8.236671727565629E-4	0.0010339555723135566	51	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	4	4	1	3	10	18	34	41	37	51														CASSLGAGGSASYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCCAGCGGGATCAAGAGACCCAGTACTTCGGGCCA	CASSSQRDQETQYF	In	VDJ	7	369	8.659065149492072E-4	0.0010869789349963032	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	4	6	3	2	3	1	18	31	41	34	42														CASSSQRDQETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCGAATCTAGCGGACACCTCCTACGAGCAGTACTTCGGGCCG	CASSPNLADTSYEQYF	In	VDJ	8	379	8.893728161673428E-4	0.00111643635870894	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	4	5	0	6	4	18	30	43	36	47						01,02								CASSPNLADTSYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCACCCGGACTAGCGGGGGGACGCAGTATTTTGGCCCA	CASSTRTSGGTQYF	In	VDJ	8	385	9.034525968982243E-4	0.0011341108129365222	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	1	1	9	4	0	18	30	-1	34	48														CASSTRTSGGTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTACTGACAGTCACAGATACGCAGTATTTTGGCCCA	CASSLLTVTDTQYF	In	VDJ	8	394	9.245722679945464E-4	0.0011606224942778953	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	2	5	2	2	1	18	33	40	35	41														CASSLLTVTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGACGCCGGCTAGCGGGACAAGAGACCCAGTACTTCGGGCCA	CASRRRLAGQETQYF	In	VDJ	8	402	9.43345308969055E-4	0.001184188433248005	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	6	4	3	2	7	0	18	29	-1	36	45														CASRRRLAGQETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGAGCGGAAGGGGGCGCCGGAGTATGGCTACACCTTCGGTTCG		Out	VDJ	9	427	0.0010020110620143942		50	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	5	0	5	7	7	18	32	46	39	53														X+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGACAGGGGGGGCACAGATACGCAGTATTTTGGCCCA	CASSDRGGTDTQYF	In	VDJ	9	442	0.0010372105138415977	0.0013020181280985527	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	2	1	1	0	1	18	-1	39	30	40														CASSDRGGTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGTACCGGGGCGAGGGCAATCAGCCCCAGCATTTTGGTGAT	CASSLYRGEGNQPQHF	In	VDJ	9	459	0.0010771032259124283	0.0013520957484100355	48	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-05	01	3	7	0	2	5	4	18	32	42	37	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLYRGEGNQPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01		TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCACTTGGGACTCCGGGGGGAACGAGCAGTACTTCGGGCCG	CASSTWDSGGNEQYF	In	VDJ	10	494	0.0011592352801759033	0.0014551967314042648	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	5	8	1	5	11	1	18	30	48	41	49														CASSTWDSGGNEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGGTTAGCGGGAGAGGAGCAGTTCTTCGGGCCA	CASSLGLAGEEQFF	In	VDJ	10	498	0.0011686218006631576	0.0014669797008893197	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	1	5	2	10	3	2	18	34	46	37	48														CASSLGLAGEEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCGGCTAGCGGGGGATCCACAGATACGCAGTATTTTGGCCCA	CASSPASGGSTDTQYF	In	VDJ	10	506	0.0011873948416376663	0.0014905456398594291	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	4	2	2	4	3	18	30	44	34	47														CASSPASGGSTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTTACACTAGCGGGAGATGCCTACGAGCAGTACTTCGGGCCG	CASSLTLAGDAYEQYF	In	VDJ	10	513	0.0012038212524903612	0.0015111658364582751	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	3	2	2	5	3	18	30	46	35	49														CASSLTLAGDAYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGGTCAGGGACAGGAGGTAATCAGCCCCAGCATTTTGGTGAT	CASRSGTGGNQPQHF	In	VDJ	10	513	0.0012038212524903612	0.0015111658364582751	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	0	4	4	4	4	18	29	41	33	45														CASRSGTGGNQPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTACCAGCCAGGGACTAGCGGGACCAATGAGCAGTTCTTCGGGCCA	CASSYQPGTSGTNEQFF	In	VDJ	11	535	0.0012554471151702596	0.0015759721686260763	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	0	3	6	8	1	18	31	52	39	53														CASSYQPGTSGTNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCGGATGGATGAACACTGAAGCTTTCTTTGGACAA	CASSFGWMNTEAFF	In	VDJ	11	535	0.0012554471151702596	0.0015759721686260763	42	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-01	01	3	1	8	0	1	4	18	32	36	33	40				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFGWMNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01		TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGCCCGAGGACAGGGGGGGACCTACGAGCAGTACTTCGGGCCG	CASSLARGQGGTYEQYF	In	VDJ	11	541	0.0012695268959011412	0.0015936466228536584	51	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	1	1	2	7	3	18	32	49	39	52														CASSLARGQGGTYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGGACAGGGAGGGAGTGAAGCTTTCTTTGGACAA	CASSLGQGGSEAFF	In	VDJ	11	547	0.0012836066766320226	0.0016113210770812407	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	0	3	7	0	6	18	-1	41	32	47														CASSLGQGGSEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCGGACTAGCGAAAAGCTCCTACGAGCAGTACTTCGGGCCG	CASSPGLAKSSYEQYF	In	VDJ	11	563	0.0013211527585810397	0.0016584529550214596	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	1	6	0	3	5	18	30	42	33	47						01,02								CASSPGLAKSSYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCGACAGACAGGGCTCAGGGAGCTGTTTTTTGGAGAA	CASSRQTGLRELFF	In	VDJ	13	629	0.0014760303466207353	0.0018528719515248635	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	2	3	9	5	4	18	30	42	35	46														CASSRQTGLRELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGTTGCCGGGACAGGGTCTTACAATGAGCAGTTCTTCGGGCCA	CASSLVAGTGSYNEQFF	In	VDJ	13	635	0.0014901101273516167	0.0018705464057524458	51	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	1	0	3	4	5	3	18	34	48	39	51														CASSLVAGTGSYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGTGATGAGAAGGTGAAAAACTGAAGCTTTCTTTGGACAA	CASSLVMRR*KTEAFF	Stop	VDJ	13	640	0.0015018432779606845		48	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-01	01	3	5	4	5	10	6	18	32	45	42	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLVMRR*KTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01		TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCAGGACTAGCGGAGAGTATCTACGAGCAGTACGTCGGGCCG	CASSSGLAESIYEQYV	In	VDJ	14	688	0.001614481523807736	0.0020266707514294217	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	1	5	17	2	21	18	31	43	33	64						01,02								CASSSGLAESIYEQYV+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGGTCGCCTGACGAGGGTGATACGCAGTATTTTGGCCCA	CASRSPDEGDTQYF	In	VDJ	15	736	0.0017271197696547872	0.002168066385250079	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	11	0	6	10	1	18	29	44	39	45														CASRSPDEGDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCCGTCCTCAGGTGGTGAGATACGAGCAGTACTTCGGGCCG	CASSSRPQVVRYEQYF	In	VDJ	15	745	0.0017482394407511094	0.002194578066591452	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	4	4	4	8	8	18	31	43	39	51														CASSSRPQVVRYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGGACGGAGCGGCTCGGACTATGGCTACACCTTCGGTTCG	CASSGRSGSDYGYTF	In	VDJ	16	811	0.001903117028790805	0.0023889970630948556	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	5	6	5	3	6	5	18	30	41	36	46						01,02								CASSGRSGSDYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD02-01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTGGGGATACAGCTCCTACGAGCAGTACTTCGGGCCG	CASSWGYSSYEQYF	In	VDJ	17	849	0.0019922889734197207	0.0025009352732028763	42	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-07	01	4	0	8	0	1	5	18	31	36	32	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSWGYSSYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01		TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTGAGAATTCGACTAGCGATCGGAGATACGCAGTATTTTGGCCCA		Out	VDJ	19	976	0.002290310998890044		50	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	2	6	5	4	5	18	35	47	39	52						01,02								X+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGACGGGACTAGATACAATGAGCAGTTCTTCGGGCCA	CASSDGTRYNEQFF	In	VDJ	20	994	0.002332550341082688	0.002928067917036112	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	0	8	4	3	1	18	30	41	33	42						01,02								CASSDGTRYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGAAACAGGGAAAAACTATGGCTACACCTTCGGTTCG	CASSLETGKNYGYTF	In	VDJ	21	1046	0.0024545751074169938	0.003081246520341824	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	3	3	2	1	3	18	35	42	36	45														CASSLETGKNYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGTTGCATAGCAGGACGAGCAGTACGTCGGGCCG	CASSLVA*QDEQYV	Stop	VDJ	55	2776	0.006514245218154469		42	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-07	01	1	1	7	17	10	10	18	34	48	44	58				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLVA*QDEQYV+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01		TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAACTAGCGGGGAAGAGACCCAGTACTTCGGGCCA	CASSLTSGEETQYF	In	VDJ	104	5204	0.012211863153917816	0.015329643300056263	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	2	3	3	3	0	0	18	-1	-1	33	43														CASSLTSGEETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGCCGCGGACTAGCGGGGCCAGACAATGAGCAGTTCTTCGGGCCA	CASGRGLAGPDNEQFF	In	VDJ	1	13	3.0506191583576405E-5	3.8294650826428025E-5	48	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	1	3	5	4	4	26	37	53	41	57														CASGRGLAGPDNEQFF+TCRBV12-05+TCRBJ02-01	TCRBV12-05*01	TCRBD02-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGGTACACGAGGGGACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	15	3.519945182720355E-5		44	TCRBV12	TCRBV12-05	01				TCRBJ02	TCRBJ02-01	01	0	5	2	5	5	0	26	43	-1	48	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV12-05+TCRBJ02-01	TCRBV12-05*01		TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGAGGCAGGCAGGTACCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	16	3.7546081949017114E-5		47	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	4	4	0	3	5	26	41	48	44	53														X+TCRBV12-05+TCRBJ02-05	TCRBV12-05*01	TCRBD01-01*01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TGGCAAGCCACGTTTGGTGGAACCCAGGGACTCAGCTGTGTATTTTGTGCCAGCAAAGGGACAGTTGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	17	3.989271207083068E-5		35	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	17	0	5	5	11	2	46	46	64	57	66														X+TCRBV12-05+TCRBJ02-05	TCRBV12-05*01	TCRBD01-01*01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GTTTGGTGGAACCCAGGACTCAGCTGTGTATTTTTGTGCTAGGATCCCCGCCTCCGGAAGCACACCTACGAGCAGTACGTCGGGCCG		Out	VDJ	1	18	4.2239342192644256E-5		47	TCRBV12	TCRBV12-05	01				TCRBJ02	TCRBJ02-07	01	9	1	8	17	13	21	34	42	58	55	79				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV12-05+TCRBJ02-07	TCRBV12-05*01		TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGACAGACCTATAATTCACCCCTCCACTTTGGGAAC	CASGQTYNSPLHF	In	VDJ	1	22	5.162586267989853E-5	6.480633216780127E-5	39	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	6	3	5	2	0	1	26	-1	41	37	42														CASGQTYNSPLHF+TCRBV12-05+TCRBJ01-06	TCRBV12-05*01	TCRBD01-01*01	TCRBJ01-06*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GTTTGGTGGAACCCAGGGACTCAGCTGTGTATTTTGTGCTAGGATCCCCGCCTCCGGAAGCACACCTACGAGCAGTACGTCGGGCCG		Out	VDJ	1	24	5.631912292352567E-5		46	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	17	4	8	17	3	37	35	35	42	38	79						01,02								X+TCRBV12-05+TCRBJ02-07	TCRBV12-05*01	TCRBD02-01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTCAAGCAGGGGGTAGCAATCAGCCCCAGCATTTTGGTGAT	CASGQAGGSNQPQHF	In	VDJ	1	31	7.274553377622066E-5	9.131801350917451E-5	45	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	4	1	0	4	0	26	38	-1	42	49														CASGQAGGSNQPQHF+TCRBV12-05+TCRBJ01-05	TCRBV12-05*01	TCRBD01-01*01	TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCACCATCCTTCGGACAGGGAATGGGTAAGACACTGAAGCTTTCTTTGGACAA	CASTILRTGNG*DTEAFF	Stop	VDJ	1	45	1.0559835548161063E-4		54	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	12	1	3	3	14	10	26	31	53	45	63														CASTILRTGNG*DTEAFF+TCRBV12-05+TCRBJ01-01	TCRBV12-05*01	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCGGGCTTGAGTACAATGAGCAGTTCTTCGGGCCA	CASGLEYNEQFF	In	VDJ	1	49	1.1498487596886492E-4	1.4434137619192102E-4	36	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	12	6	4	4	1	6	26	31	38	32	44						01,02								CASGLEYNEQFF+TCRBV12-05+TCRBJ02-01	TCRBV12-05*01	TCRBD02-01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGCCGTGCGTGGGGGGAGTGGGTGGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	57	1.3375791694337347E-4		53	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	9	1	1	8	8	26	37	51	45	59														X+TCRBV12-05+TCRBJ02-03	TCRBV12-05*01	TCRBD02-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGGACAGGAACACTGAAGCTTTCTTTGGACAA	CASGLDRNTEAFF	In	VDJ	1	69	1.619174784051363E-4	2.0325622361719488E-4	39	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	3	5	1	0	0	26	-1	-1	42	46														CASGLDRNTEAFF+TCRBV12-05+TCRBJ01-01	TCRBV12-05*01	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGCCACGGACACCCCAAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	2	93	2.1823660132866198E-4		47	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	1	6	4	4	5	26	41	50	45	55														X+TCRBV12-05+TCRBJ01-05	TCRBV12-05*01	TCRBD01-01*01	TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGGACCCTGCGATACGCAGTATTTTGGCCCA		Out	VDJ	2	97	2.2762312181591625E-4		38	TCRBV12	TCRBV12-05	01				TCRBJ02	TCRBJ02-03	01	1	3	7	6	0	5	26	-1	44	42	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV12-05+TCRBJ02-03	TCRBV12-05*01		TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGCTCCGCGGGACAGGGTCGAACACCATATATTTTGGAGAG		Out	VDJ	3	127	2.9802202547032333E-4		44	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	6	0	3	7	6	3	26	37	52	43	55														X+TCRBV12-05+TCRBJ01-03	TCRBV12-05*01	TCRBD01-01*01	TCRBJ01-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTCTAGACTAGCGGGTTATACGCAGTATTTTGGCCCA	CASGSRLAGYTQYF	In	VDJ	3	169	3.9658049058649325E-4	4.978304607435643E-4	42	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	2	4	7	3	2	26	39	52	42	54						01,02								CASGSRLAGYTQYF+TCRBV12-05+TCRBJ02-03	TCRBV12-05*01	TCRBD02-01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGCCAGATGGAGGGTTTGCTCACAGATACGCAGTATTTTGGCCCA	CASGQMEGLLTDTQYF	In	VDJ	4	215	5.045254761899175E-4	6.333346098216942E-4	48	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	10	0	2	6	6	26	37	49	43	55														CASGQMEGLLTDTQYF+TCRBV12-05+TCRBJ02-03	TCRBV12-05*01	TCRBD02-01*02	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGACGGGACAGGCGAGAGGAAAAACTGTTTTTTGGCAGT	CASGRDRREEKLFF	In	VDJ	5	237	5.56151338869816E-4	6.981409419894955E-4	42	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	0	4	8	2	6	26	37	47	39	53														CASGRDRREEKLFF+TCRBV12-05+TCRBJ01-04	TCRBV12-05*01	TCRBD01-01*01	TCRBJ01-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGCTGGCAGGGGGTCCGAACGGCTACACCTTCGGTTCG	CASGLLAGGPNGYTF	In	VDJ	5	246	5.772710099661381E-4	7.246526233308687E-4	45	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	4	1	8	4	7	26	41	52	45	59														CASGLLAGGPNGYTF+TCRBV12-05+TCRBJ01-02	TCRBV12-05*01	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGCCCTCCCGGGACTAGCAGGTCGAGCAGTACTTCGGGCCG	CASGLPSRD*QVEQYF	Stop	VDJ	5	262	6.148170919151552E-4		48	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	2	0	7	6	7	4	26	41	57	48	61						01,02								CASGLPSRD*QVEQYF+TCRBV12-05+TCRBJ02-07	TCRBV12-05*01	TCRBD02-01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTCGCGGGGATTGAAGCTTTCTTTGGACAA	CASGFAGIEAFF	In	VDJ	6	302	7.08682296787698E-4	8.896141961216356E-4	36	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	3	7	3	7	1	2	26	40	47	41	49														CASGFAGIEAFF+TCRBV12-05+TCRBJ01-01	TCRBV12-05*01	TCRBD02-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGGATCCCCGCCTCCGGAAGCACACCTACGAGCAGTACGTCGGGCCG		Out	VDJ	74	3712	0.00871069101217197		47	TCRBV12	TCRBV12-05	01				TCRBJ02	TCRBJ02-07	01	9	1	8	17	13	21	26	34	50	47	71				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV12-05+TCRBJ02-07	TCRBV12-05*01		TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAAAGGGACAGTTGAGACCCAGTACTTCGGGCCA	CASKGTVETQYF	In	VDJ	112	5592	0.013122355641181482	0.016472591340106577	36	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	12	0	5	5	7	2	26	31	45	38	47														CASKGTVETQYF+TCRBV12-05+TCRBJ02-05	TCRBV12-05*01	TCRBD01-01*01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCCCCTTCGGCCAGCTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	14	3.285282170538997E-5		47	TCRBV23	TCRBV23-01	01				TCRBJ02	TCRBJ02-01	01	4	4	5	0	9	0	20	33	-1	42	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV23-01+TCRBJ02-01	TCRBV23-01*01		TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GAGACACGGCACTGTATCTCTGCGTCAGCAGCCAAGAAAGGGCAGTCTATGGCTACACCTTCGGTTCG	CVSSQERAVYGYTF	In	VDJ	1	18	4.2239342192644256E-5	5.302336268274649E-5	42	TCRBV23	TCRBV23-01	01				TCRBJ01	TCRBJ01-02	01	2	5	3	4	3	4	20	35	42	38	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CVSSQERAVYGYTF+TCRBV23-01+TCRBJ01-02	TCRBV23-01*01		TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCACGGGTTCCCAGGGTGGCTACACCTTCGGTTCG	CASSTGSQGGYTF	In	VDJ	1	19	4.4585972314457824E-5	5.596910505401019E-5	39	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	4	3	7	10	0	20	31	-1	41	46														CASSTGSQGGYTF+TCRBV23-01+TCRBJ01-02	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCTTGGTGGCGAGTGGGGAGCAGTACTTCGGGCCG	CASSLVASGEQYF	In	VDJ	1	20	4.693260243627139E-5	5.891484742527388E-5	39	TCRBV23	TCRBV23-01	01				TCRBJ02	TCRBJ02-07	01	6	0	9	7	13	0	20	31	-1	44	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLVASGEQYF+TCRBV23-01+TCRBJ02-07	TCRBV23-01*01		TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCACCTGACAGGGGGCCGATACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	26	6.101238316715281E-5		46	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	2	0	5	3	4	20	34	47	37	51														X+TCRBV23-01+TCRBJ01-01	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGGACCCGGGACAGGGGTGAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	29	6.805227353259351E-5		44	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	0	2	5	5	2	20	31	46	36	48														X+TCRBV23-01+TCRBJ02-03	TCRBV23-01*01	TCRBD01-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCCCTCTTTGACGGGACAGTCTTACAATGAGCAGTTCTTCGGGCCA	CASSPSLTGQSYNEQFF	In	VDJ	1	38	8.917194462891565E-5	1.1193821010802038E-4	51	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	0	5	4	10	3	20	33	50	43	53														CASSPSLTGQSYNEQFF+TCRBV23-01+TCRBJ02-01	TCRBV23-01*01	TCRBD01-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCGGACAGGAGGGGACATACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	38	8.917194462891565E-5		47	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	1	4	3	0	9	20	-1	40	33	49														X+TCRBV23-01+TCRBJ02-03	TCRBV23-01*01	TCRBD01-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAATCCCATCCGGGACTGAGGAACACTGAAGCTTTCTTTGGACAA	CASSQSHPGLRNTEAFF	In	VDJ	1	40	9.386520487254278E-5	1.1782969485054776E-4	51	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	0	0	10	1	6	3	20	37	49	43	52						01,02								CASSQSHPGLRNTEAFF+TCRBV23-01+TCRBJ01-01	TCRBV23-01*01	TCRBD02-01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCCCGAGGGACAGGGGGCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	41	9.621183499435635E-5		47	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	0	1	3	4	0	20	33	-1	37	48														X+TCRBV23-01+TCRBJ02-01	TCRBV23-01*01	TCRBD01-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCGCTCCGGCTCGTACTATGGCTACACCTTCGGTTCG	CASSRSGSYYGYTF	In	VDJ	1	61	1.4314443743062774E-4	1.7969028464708534E-4	42	TCRBV23	TCRBV23-01	01				TCRBJ01	TCRBJ01-02	01	6	9	0	3	7	4	20	31	41	38	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRSGSYYGYTF+TCRBV23-01+TCRBJ01-02	TCRBV23-01*01		TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAAACCCCGTCGACCAGGCACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	62	1.4549106755244132E-4		44	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	4	4	3	12	1	20	30	46	42	47														X+TCRBV23-01+TCRBJ01-02	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCCCTCTTCGAAGGAGGTTGCTTTCTTTGGACAA	CASSPSSKEVAFF	In	VDJ	1	71	1.6661073864876344E-4	2.0914770835972227E-4	39	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	6	10	1	11	12	2	20	31	48	43	50														CASSPSSKEVAFF+TCRBV23-01+TCRBJ01-01	TCRBV23-01*01	TCRBD02-01*02	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAATGCGGGGTGTCAACGCTGGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	2	103	2.4170290254679766E-4		53	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-06	01	1	7	3	2	0	8	20	-1	42	36	50														X+TCRBV23-01+TCRBJ02-06	TCRBV23-01*01	TCRBD02-01*01	TCRBJ02-06*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAAGGTGTCAAGAACACTGAAGCTTTCTTTGGACAA	CASSQGVKNTEAFF	In	VDJ	3	131	3.074085459575776E-4	3.8589225063554393E-4	42	TCRBV23	TCRBV23-01	01				TCRBJ01	TCRBJ01-01	01	2	0	10	1	0	6	20	-1	37	35	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQGVKNTEAFF+TCRBV23-01+TCRBJ01-01	TCRBV23-01*01		TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGAAGAGGGACAGGGATGATGGGATGGCTACACCTTCGGTTCG		Out	VDJ	3	134	3.1444843632301835E-4		46	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	0	3	6	4	8	20	31	44	35	52														X+TCRBV23-01+TCRBJ01-02	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GAGACACGGCACTGTATCTCTGCGCCAACAGTACACGACGGGAACCGAACACCGGGGAGCTATTTTTTGGAGAA	CANSTRREPNTGELFF	In	VDJ	3	138	3.238349568102726E-4	4.0651244723438975E-4	48	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	8	3	17	20	5	20	32	57	52	62						01,02								CANSTRREPNTGELFF+TCRBV23-01+TCRBJ02-02	TCRBV23-01*01	TCRBD02-01	TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCCAGCATAGGGAGAGACGAGCAGTACGTCGGGCCG		Out	VDJ	5	246	5.772710099661381E-4		41	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	9	2	17	9	14	20	31	45	40	59														X+TCRBV23-01+TCRBJ02-07	TCRBV23-01*01	TCRBD02-01*02	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GAGACACGGCACTGTATCTCTGCGCCAGTAGTCACCCCTGGGGGAACACTGAAGCTTTCTTTGGACAA	CASSHPWGNTEAFF	In	VDJ	8	377	8.846795559237158E-4	0.0011105448739664127	42	TCRBV23	TCRBV23-01	01				TCRBJ01	TCRBJ01-01	01	3	6	2	1	5	0	20	34	-1	39	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSHPWGNTEAFF+TCRBV23-01+TCRBJ01-01	TCRBV23-01*01		TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCTAGCGGGAGTGGGGATTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	8	401	9.409986788472414E-4		49	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	4	2	1	0	7	20	-1	41	31	48														X+TCRBV23-01+TCRBJ02-01	TCRBV23-01*01	TCRBD02-01*02	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAATGCAGGGACAGGGTGAGCAATGAGCAGTTCTTCGGGCCA	CASSQCRDRVSNEQFF	In	VDJ	32	1595	0.0037428750442926434	0.004698459082165592	48	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	1	0	3	6	3	4	20	36	48	39	52														CASSQCRDRVSNEQFF+TCRBV23-01+TCRBJ02-01	TCRBV23-01*01	TCRBD01-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCACCGGGACAGGGGGTCCCCGGTAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	13	3.0506191583576405E-5		46	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	10	0	1	1	2	7	23	30	43	32	50														X+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGCTCCGGGACAGGGGCTACTCAACTATGGCTACACCTTCGGTTCG	CASSAPGQGLLNYGYTF	In	VDJ	1	13	3.0506191583576405E-5	3.8294650826428025E-5	51	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	2	2	5	6	23	35	50	40	56														CASSAPGQGLLNYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGGGAGGACAGTCACAATGAGCAGTTCTTCGGGCCA	CAIREDSHNEQFF	In	VDJ	1	13	3.0506191583576405E-5	3.8294650826428025E-5	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	1	5	5	3	2	23	34	43	37	45														CAIREDSHNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGACCTAGCACAGATACGCAGTATTTTGGCCCA	CASRPSTDTQYF	In	VDJ	1	14	3.285282170538997E-5	4.1240393197691716E-5	36	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-03	01	6	3	7	0	0	2	23	-1	36	34	38				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRPSTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01		TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGGGGGGGAGGGGATCATCGGCAATCAGCCCCAGCATTTTGGTGAT	CASSGGEGIIGNQPQHF	In	VDJ	1	14	3.285282170538997E-5	4.1240393197691716E-5	51	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	5	9	0	2	0	12	23	-1	42	35	54						01,02								CASSGGEGIIGNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD02-01	TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGGCAACTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSYGNSGANVLTF	In	VDJ	1	14	3.285282170538997E-5	4.1240393197691716E-5	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	2	9	0	0	0	2	23	-1	41	38	43														CASSYGNSGANVLTF+TCRBV06-08+TCRBJ02-06	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-06*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTAGGGGGGCACCACAGATACGCAGTATTTTGGCCCA	CASSY*GGTTDTQYF	Stop	VDJ	1	14	3.285282170538997E-5		45	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-03	01	1	5	1	2	0	4	23	-1	45	39	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSY*GGTTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01		TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCAGACATCTGTGTACTTGTGTGCCAGTAGTTACTCGAACTTCAGGGATAGAAAGCTTCTGGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	15	3.519945182720355E-5		62	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	0	4	3	1	6	10	19	36	47	42	57														X+TCRBV06-08+TCRBJ02-06	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-06*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCACCGAGACAGGCTTTGGCAATGAGCAGTTCTTCGGGCCA	CATETGFGNEQFF	In	VDJ	1	15	3.519945182720355E-5	4.418613556895541E-5	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	10	2	4	6	4	6	23	30	40	34	46														CATETGFGNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGAGAAGGGGAAGGGGAGCTGTTTTTTGGAGAA	CASREGEGELFF	In	VDJ	1	15	3.519945182720355E-5	4.418613556895541E-5	36	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	5	2	8	3	2	23	34	42	37	44														CASREGEGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGGATGGGGACAGAACTCTGAAGCTTTCTTTGGACAA	CASSGWGQNSEAFF	In	VDJ	1	15	3.519945182720355E-5	4.418613556895541E-5	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	5	6	5	4	23	35	47	40	51														CASSGWGQNSEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGGGACTAGCGGGAGGAGTGAGCAGTTCTTCGGGCCA	CASSYGTSGRSEQFF	In	VDJ	1	15	3.519945182720355E-5	4.418613556895541E-5	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	0	1	9	0	2	23	-1	53	38	55														CASSYGTSGRSEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGCGCGGGGACATACACTGAAGCTTTCTTTGGACAA	CAISAGTYTEAFF	In	VDJ	1	15	3.519945182720355E-5	4.418613556895541E-5	39	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	6	0	6	3	4	1	23	34	44	38	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CAISAGTYTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGGGGGGACAGGTAATCAGCCCCAGCATTTTGGTGAT	CASSGGTGNQPQHF	In	VDJ	1	16	3.7546081949017114E-5	4.7131877940219106E-5	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	0	4	4	3	1	23	35	46	38	47														CASSGGTGNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCCTAAAGACGGGAGAATGATGGTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	16	3.7546081949017114E-5		56	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	8	2	4	7	8	23	40	53	47	61														X+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCTGGAGGGACAGGGGCTTCTAACTATGGCTACACCTTCGGTTCG	CASSYSGGTGASNYGYTF	In	VDJ	1	16	3.7546081949017114E-5	4.7131877940219106E-5	54	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	0	2	0	4	3	23	40	54	44	57														CASSYSGGTGASNYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCACCGGGGGGTACTCCTACAATGAGCAGTTCTTCGGGCCA	CATGGYSYNEQFF	In	VDJ	1	17	3.989271207083068E-5	5.00776203114828E-5	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	10	8	1	0	1	2	23	30	38	31	40														CATGGYSYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACGGGCAGCTCAATCAGCCCCAGTATTTTGGTGAT	CASSDGQLNQPQYF	In	VDJ	1	17	3.989271207083068E-5	5.00776203114828E-5	42	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-05	01	5	8	0	17	3	18	23	35	42	38	60				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSDGQLNQPQYF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01		TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCGCGGGGCCAGTGGCTACACCTTCGGTTCG	CASSYRGASGYTF	In	VDJ	1	17	3.989271207083068E-5	5.00776203114828E-5	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	2	7	3	7	1	4	23	38	45	39	49														CASSYRGASGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTATACCCCTCAAGCTAACTATGGCTACACCTTCGGTTCG	CASSYTPQANYGYTF	In	VDJ	1	17	3.989271207083068E-5	5.00776203114828E-5	45	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-02	01	3	3	7	0	1	8	23	37	40	38	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYTPQANYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01		TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCGGAAGGACAGACTCTAGCACAGATACGCAGTATTTTGGCCCA	CASGRTDSSTDTQYF	In	VDJ	1	17	3.989271207083068E-5	5.00776203114828E-5	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	8	1	5	0	4	5	23	32	42	36	47														CASGRTDSSTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCCGGCCCTCGCGGGAGCAATCAGCCCCAGCATTTTGGTGAT	CASSPGPRGSNQPQHF	In	VDJ	1	18	4.2239342192644256E-5	5.302336268274649E-5	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	5	7	4	1	10	0	23	35	-1	45	50						01,02								CASSPGPRGSNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD02-01	TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGAGATCCTCCCACAGGGAGGGCACAGATACGCAGTATTTTGGCCCA	CASSYSRSSHREGTDTQYF	In	VDJ	1	18	4.2239342192644256E-5	5.302336268274649E-5	57	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-03	01	0	3	3	1	11	3	23	40	57	51	60				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSRSSHREGTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01		TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTAGACAGGGGGCAGAGCCCCAGCATTTTGGTGAT	CASSRQGAEPQHF	In	VDJ	1	19	4.4585972314457824E-5	5.596910505401019E-5	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	2	0	8	1	2	23	35	46	36	48														CASSRQGAEPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGAATTCGGGCGGGCAGTTCTTCGGGCCA	CASSYSNSGGQFF	In	VDJ	1	19	4.4585972314457824E-5	5.596910505401019E-5	39	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-01	01	0	8	0	12	6	2	23	40	50	46	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSNSGGQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01		TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGTAGTGGGACAGGGCCGGAGACCCAGTACTTCGGGCCA	CASSGTGPETQYF	In	VDJ	1	19	4.4585972314457824E-5	5.596910505401019E-5	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	0	3	5	0	3	23	-1	44	35	47														CASSGTGPETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAGGACAGGGCCGGGGAGCTGTTTTTTGGAGAA	CASSEDRAGELFF	In	VDJ	1	20	4.693260243627139E-5	5.891484742527388E-5	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	1	3	6	2	0	23	35	-1	37	45														CASSEDRAGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCAGGGTCAGGTCCGCTACACCTTCGGTTCG	CASSYQGQVRYTF	In	VDJ	1	20	4.693260243627139E-5	5.891484742527388E-5	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	4	3	9	0	8	23	-1	43	38	51														CASSYQGQVRYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGTTTTACCGCGGGGTTCAGCACAGATACGCAGTATTTTGGCCCA	CASFTAGFSTDTQYF	In	VDJ	1	20	4.693260243627139E-5	5.891484742527388E-5	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	9	7	3	0	7	3	23	31	44	38	47														CASFTAGFSTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCACCCAGTTAGGATACAATGAGCAGTTCTTCGGGCCA	CATQLGYNEQFF	In	VDJ	1	21	4.927923255808496E-5	6.186058979653757E-5	36	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-01	01	10	1	8	4	8	0	23	30	-1	38	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATQLGYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01		TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGATCCGGGACAGACCTACGAGCAGTACTTCGGGCCG	CASSDPGQTYEQYF	In	VDJ	1	21	4.927923255808496E-5	6.186058979653757E-5	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	5	2	5	1	23	35	47	40	48														CASSDPGQTYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGGGTTGGGCCCTAGAAGCTTTCTTTGGACAA	CASSYSGWALEAFF	In	VDJ	1	21	4.927923255808496E-5	6.186058979653757E-5	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	8	0	8	5	4	23	40	49	45	53														CASSYSGWALEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCTACCGACAGGGGTGGCAATCAGCCCCAGCATTTTGGTGAT	CASSSTDRGGNQPQHF	In	VDJ	1	21	4.927923255808496E-5	6.186058979653757E-5	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	2	2	2	5	2	23	36	49	41	51														CASSSTDRGGNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCGGCGCGTGACACTGAAGCTTTCTTTGGACAA	CASSPARDTEAFF	In	VDJ	1	22	5.162586267989853E-5	6.480633216780127E-5	39	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	5	9	0	3	2	5	23	35	40	37	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPARDTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTATGGGCTTCGAGGGACCCAGTACTTCGGGCCA	CASSYYGLRGTQYF	In	VDJ	1	22	5.162586267989853E-5	6.480633216780127E-5	42	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-05	01	1	8	0	7	2	7	23	39	45	41	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYYGLRGTQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01		TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCGCGGGGAGCGGGTTGAATGAGCAGTTCTTCGGGCCA	CASAGSGLNEQFF	In	VDJ	1	22	5.162586267989853E-5	6.480633216780127E-5	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	8	6	4	7	6	3	23	32	44	38	47						01,02								CASAGSGLNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCACCCCGAAGAGGACAGAGGGTCTTACGAGCAGTACGTCGGGCCG		Out	VDJ	1	23	5.39724928017121E-5		44	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	10	1	5	17	9	20	23	30	45	39	65														X+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGAGGATCGGGACAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	23	5.39724928017121E-5		40	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-02	01	6	0	7	2	6	0	23	34	-1	40	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01		TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCAAGTCAGGAGCAGTTCTTCGGGCCA	CASSYSSQEQFF	In	VDJ	1	23	5.39724928017121E-5	6.775207453906497E-5	36	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	4	5	10	4	0	23	40	-1	44	47														CASSYSSQEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGGCACCGGGGAGCTGTTTTTTGGAGAA	CASSYGTGELFF	In	VDJ	1	24	5.631912292352567E-5	7.069781691032865E-5	36	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-02	01	2	0	10	4	0	0	23	-1	-1	38	40				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYGTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01		TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGGGGGGGCCTGGAACATTCAGTACTTCGGCGCC	CASSGGAWNIQYF	In	VDJ	1	26	6.101238316715281E-5	7.658930165285605E-5	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-04	01	5	9	0	7	0	5	23	-1	42	35	47														CASSGGAWNIQYF+TCRBV06-08+TCRBJ02-04	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCTGACAACAGGGGCCACAGATACGCAGTATTTTGGCCCA	CASSLTTGATDTQYF	In	VDJ	1	27	6.335901328896638E-5	7.953504402411973E-5	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	3	2	2	7	1	23	34	48	41	49														CASSLTTGATDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGACCCCTCCTACGAGCAGTACGTCGGGCCG	CASSYDPSYEQYV	In	VDJ	1	27	6.335901328896638E-5	7.953504402411973E-5	39	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	2	2	7	17	0	19	23	-1	41	38	60				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYDPSYEQYV+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGACAGCGGACACTGAAGCTTTCTTTGGACAA	CASSYSTADTEAFF	In	VDJ	1	27	6.335901328896638E-5	7.953504402411973E-5	42	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	0	2	5	3	0	3	23	-1	45	40	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSTADTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGCTATGTTCAGGGGGCTTCAGCCCCAGCATTTTGGTGAT	CASSAMFRGLQPQHF	In	VDJ	1	28	6.570564341077994E-5	8.248078639538343E-5	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	4	0	6	8	1	23	35	51	43	52														CASSAMFRGLQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCTCTTTGGGTTGTACTAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	28	6.570564341077994E-5		50	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-02	01	0	0	9	0	5	5	23	40	48	45	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01		TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTATAACGGAGATCACGGCTATGGCTACACCTTCGGTTCG	CASSYNGDHGYGYTF	In	VDJ	1	28	6.570564341077994E-5	8.248078639538343E-5	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	3	10	2	4	4	7	23	37	45	41	52														CASSYNGDHGYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACCAAGAGCCGTTTAATGAAAAACTGTTTTTTGGCAGT	CASSDQEPFNEKLFF	In	VDJ	1	29	6.805227353259351E-5	8.542652876664713E-5	45	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-04	01	5	2	7	4	0	11	23	-1	38	35	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSDQEPFNEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01		TCRBJ01-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCACAAGGCCCAAAAGAAGCAATCAGCCCCAGCATTTTGGTGAT	CASSTRPKRSNQPQHF	In	VDJ	1	30	7.03989036544071E-5	8.837227113791082E-5	48	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-05	01	6	3	6	1	1	12	23	34	38	35	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSTRPKRSNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01		TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCTGGGTGGGGCAATGAGCAGTTCTTCGGGCCA	CASSPGWGNEQFF	In	VDJ	1	30	7.03989036544071E-5	8.837227113791082E-5	39	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-01	01	5	6	2	6	7	0	23	35	-1	42	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPGWGNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01		TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCCTCACAGGGAGGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	30	7.03989036544071E-5		47	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	3	3	2	4	2	23	38	48	42	50														X+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGGACAGGGGACTGAAGCTTTCTTTGGACAA	CASSYGQGTEAFF	In	VDJ	1	30	7.03989036544071E-5	8.837227113791082E-5	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	1	2	5	0	0	23	-1	-1	38	47														CASSYGQGTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCGGCAGGACAACGTACTCAGATACGCAGTATTTTGGCCCA	CASGRTTYSDTQYF	In	VDJ	1	30	7.03989036544071E-5	8.837227113791082E-5	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	8	1	6	4	4	7	23	32	41	36	48														CASGRTTYSDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCTAGTAGGGGGACAGTTGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	30	7.03989036544071E-5		40	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	12	0	5	0	7	1	23	28	42	35	43														X+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACTTATAGGGACCTCGGTGGGGAGACCCAGTACTTCGGGCCA	CASTYRDLGGETQYF	In	VDJ	1	32	7.509216389803423E-5	9.426375588043821E-5	45	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-05	01	3	0	7	5	2	9	23	37	44	39	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASTYRDLGGETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01		TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGAGTTCCGGGGTACCGGGGAGCTGTTTTTTGGAGAA	CASSYEFRGTGELFF	In	VDJ	1	32	7.509216389803423E-5	9.426375588043821E-5	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	2	8	3	5	6	1	23	38	49	44	50														CASSYEFRGTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCAAACAGGGAACCACTGAAGCTTTCTTTGGACAA	CASSKQGTTEAFF	In	VDJ	1	34	7.978542414166136E-5	1.001552406229656E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	3	3	4	3	3	23	34	43	37	46														CASSKQGTTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCCTAGCGGGACTTTACGAGCAGTACTTCGGGCCG	CASLAGLYEQYF	In	VDJ	1	35	8.213205426347493E-5	1.031009829942293E-4	36	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	8	4	3	4	0	3	23	-1	41	32	44														CASLAGLYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGATAATTGGACAGGAGTGGCTACACCTTCGGTTCG		Out	VDJ	1	36	8.447868438528851E-5		41	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	1	4	7	7	2	23	35	49	42	51														X+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGTGATGGAACAGGGAAGAACCATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	36	8.447868438528851E-5		50	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	3	3	5	8	7	23	35	49	43	56														X+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAACCTGAGGGCCGGGGGGGCTAGAAATGAGCAGTTCTTCGGGCCA	CASNLRAGGARNEQFF	In	VDJ	1	37	8.682531450710208E-5	1.0899246773675668E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	7	8	0	7	10	5	23	33	51	43	56														CASNLRAGGARNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCTCCCTCACCATACCCTCCTACGAGCAGTACTTCGGGCCG	CASSLTIPSYEQYF	In	VDJ	1	39	9.151857475072921E-5	1.1488395247928406E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	8	3	7	0	6	6	23	32	40	38	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLTIPSYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCTAGAGTCGATCACTTCTGTCGCGAATACGCAGTATTTTGGCCCA	CASSLESITSVANTQYF	In	VDJ	1	40	9.386520487254278E-5	1.1782969485054776E-4	51	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	4	8	7	1	21	23	34	39	35	60						01,02								CASSLESITSVANTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGAAGGGACCCTGGGGAGCAGTTCTTCGGGCCA	CASRRDPGEQFF	In	VDJ	1	41	9.621183499435635E-5	1.2077543722181146E-4	36	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-01	01	6	0	7	10	2	6	23	34	41	36	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRRDPGEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01		TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGAAGGGGGCCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASRRGPGANVLTF	In	VDJ	1	41	9.621183499435635E-5	1.2077543722181146E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	6	5	0	2	1	0	23	34	-1	35	42														CASRRGPGANVLTF+TCRBV06-08+TCRBJ02-06	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-06*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGACGGGGACCGGCAACTAATGAAAAACTGTTTTTTGGCAGT	CASRRGPATNEKLFF	In	VDJ	1	42	9.855846511616992E-5	1.2372117959307514E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-04	01	6	0	7	0	3	3	23	34	42	37	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRRGPATNEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01		TCRBJ01-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACAGGGATGGAATCACAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	43	1.009050952379835E-4		43	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-05	01	2	0	8	7	1	8	23	38	43	39	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01		TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCGCGGACAGGGAGGCACTGAAGCTTTCTTTGGACAA	CASSYRGQGGTEAFF	In	VDJ	1	43	1.009050952379835E-4	1.2666692196433885E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	1	3	4	3	3	23	38	49	41	52														CASSYRGQGGTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTAATCGGTGAGACCCAGTACTTCGGGCCA	CASSLIGETQYF	In	VDJ	1	43	1.009050952379835E-4	1.2666692196433885E-4	36	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	4	8	5	5	4	1	23	36	43	40	44						01,02								CASSLIGETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGCTCCGGGACAGGGGCCCGCACAGATACGCAGTATTTTGGCCCA	CAISSGTGARTDTQYF	In	VDJ	1	43	1.009050952379835E-4	1.2666692196433885E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	0	2	1	4	3	23	34	48	38	51														CAISSGTGARTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATAACCGGGACAGGACTGAATGAGCAGTTCTTCGGGCCA	CAITGTGLNEQFF	In	VDJ	1	44	1.0325172535979707E-4	1.2961266433560254E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	10	0	4	7	5	4	23	30	43	35	47														CAITGTGLNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACCCCGGGGGGGCTGGACAAAAACATTCAGTACTTCGGCGCC	CASTPGGLDKNIQYF	In	VDJ	1	46	1.079449856034242E-4	1.3550414907812994E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-04	01	7	8	0	3	3	5	23	33	44	36	49														CASTPGGLDKNIQYF+TCRBV06-08+TCRBJ02-04	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACCAGGGGATTGGGGACGAGCAGTACTTCGGGCCG	CASSDQGIGDEQYF	In	VDJ	1	46	1.079449856034242E-4	1.3550414907812994E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	4	2	5	3	7	23	35	44	38	51														CASSDQGIGDEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCATAGGCGGGGGTTTGAACATTCAGTACTTCGGCGCC	CASIGGGLNIQYF	In	VDJ	1	46	1.079449856034242E-4	1.3550414907812994E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-04	01	7	7	2	7	3	4	23	33	43	36	47														CASIGGGLNIQYF+TCRBV06-08+TCRBJ02-04	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGTTGCGTTACTACTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	48	1.1263824584705134E-4		40	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	3	9	3	8	0	23	35	-1	43	47						01,02								X+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGAAAGGGGGCCGCGTCTCGGAACTGTTTTTTGGCAGT	CASSYSKGGRVSELFF	In	VDJ	1	48	1.1263824584705134E-4	1.413956338206573E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	5	0	12	3	10	23	40	50	43	60														CASSYSKGGRVSELFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCTACCAACTTACATTTGACTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	49	1.1498487596886492E-4		49	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-03	01	2	3	6	2	6	5	23	38	47	44	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01		TCRBJ01-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTAACAATCGGGCCCAAAATCAGCCCCAGCATTTTGGTGAT	CASSNNRAQNQPQHF	In	VDJ	1	50	1.1733150609067848E-4	1.472871185631847E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-05	01	5	8	0	4	7	4	23	35	46	42	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSNNRAQNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01		TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGACCATCGACGGTAACCCTCGGGAAACTGTTTTTTGGCAGT	CASRPSTVTLGKLFF	In	VDJ	1	53	1.243713964561192E-4	1.5612434567697578E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	6	8	4	11	18	0	23	34	-1	52	56						01,02								CASRPSTVTLGKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD02-01	TCRBJ01-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACCAAAGCGGGCAGGGAGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	54	1.2671802657793275E-4		41	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	7	6	4	8	4	6	23	33	43	37	49						01,02								X+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD02-01	TCRBJ01-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGATCGACGGTTTTGAGGCAGGGCTACACCTTCGGTTCG	CASRSTVLRQGYTF	In	VDJ	1	54	1.2671802657793275E-4	1.5907008804823947E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	6	11	1	8	12	3	23	34	50	46	53														CASRSTVLRQGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGGGGCGGGACAGCTCTACAATGAGCAGTTCTTCGGGCCA	CASSYGAGQLYNEQFF	In	VDJ	1	54	1.2671802657793275E-4	1.5907008804823947E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	0	5	3	5	2	23	38	50	43	52														CASSYGAGQLYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCGGGACCGCCAAGAGACCCAGTACTTCGGGCCA	CASSRDRQETQYF	In	VDJ	1	55	1.2906465669974634E-4	1.6201583041950318E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-05	01	5	0	7	1	1	2	23	35	41	36	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRDRQETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01		TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGGGGGGTATGGTAGCAATCAGCCCCAGCATTTTGGTGAT	CASSGGYGSNQPQHF	In	VDJ	1	55	1.2906465669974634E-4	1.6201583041950318E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	5	9	1	0	0	5	23	-1	41	35	46														CASSGGYGSNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD02-01*01	TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTTATCCTTGGAAGGTAGCAATACTGAAGCTTTCTTTGGACAA	CASSYLSLEGSNTEAFF	In	VDJ	1	56	1.314112868215599E-4	1.6496157279076687E-4	51	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	1	5	7	5	13	3	23	39	56	52	59						01,02								CASSYLSLEGSNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCATCTTTAGGGCTTTACGAGCAGTACTTCGGGCCG	CASSSSLGLYEQYF	In	VDJ	1	56	1.314112868215599E-4	1.6496157279076687E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	4	5	3	4	7	3	23	36	47	43	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSSLGLYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCGAAGGGGGATTGGGCAATCAGCCCCAGCATTTTGGTGAT	CASEGGLGNQPQHF	In	VDJ	1	57	1.3375791694337347E-4	1.6790731516203055E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	8	5	1	2	2	5	23	32	40	34	45														CASEGGLGNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGGGAGCCGGGGTGGCACCGGGGAGCTGTTTTTTGGAGAA	CASSGSRGGTGELFF	In	VDJ	1	60	1.407978073088142E-4	1.7674454227582163E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	8	3	4	6	3	23	35	46	41	49						01,02								CASSGSRGGTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01	TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGACCTGACCATTTCTACAATGAGCAGTTCTTCGGGCCA	CASRPDHFYNEQFF	In	VDJ	1	63	1.4783769767425488E-4	1.8558176938961271E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-01	01	6	2	7	3	4	5	23	34	41	38	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRPDHFYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01		TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCACCGGGACTAGCGATTCAGAAAACCCCACAGATACGCAGTATTTTGGCCCA	CATGTSDSENPTDTQYF	In	VDJ	1	66	1.548775880396956E-4	1.944189965034038E-4	51	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	10	0	6	2	2	13	23	30	42	32	55						01,02								CATGTSDSENPTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGAACGGACACGTTCAATCAGCCCCAGCATTTTGGTGAT	CASRTDTFNQPQHF	In	VDJ	1	68	1.5957084828332273E-4	2.003104812459312E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	1	6	3	3	4	23	34	42	37	46														CASRTDTFNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAGCGGGGGCTCCGCACAGATACGCAGTATTTTGGCCCA	CASSERGLRTDTQYF	In	VDJ	1	68	1.5957084828332273E-4	2.003104812459312E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	6	2	1	1	4	23	35	44	36	48														CASSERGLRTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCCTCTGGGAGGGACCATCTATGGTGCTACACCTTCGGTTCG		Out	VDJ	1	68	1.5957084828332273E-4		50	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	2	9	0	9	5	12	23	38	50	43	62														X+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCCCCTACAGGGCAAAGTGGTGAAGCTTTCTTTGGACAA		Out	VDJ	1	68	1.5957084828332273E-4		40	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	8	3	3	7	4	8	23	32	42	36	50														X+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAGGGACTAGCCCACGGGGAGCTGTTTTTTGGAGAA	CASSEGLAHGELFF	In	VDJ	1	70	1.6426410852694986E-4	2.062019659884586E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	0	7	7	2	3	23	35	46	37	49						01,02								CASSEGLAHGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01	TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCCCCGGGACTAATGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSYSPGLMNTGELFF	In	VDJ	1	71	1.6661073864876344E-4	2.0914770835972227E-4	51	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	0	0	9	1	3	2	23	40	50	43	52						01,02								CASSYSPGLMNTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01	TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCGTGGGGCAGACGAGCAGTACTTCGGGCCG	CASSYRGADEQYF	In	VDJ	1	73	1.7130399889239058E-4	2.1503919310224967E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	7	0	5	3	2	23	38	46	41	48														CASSYRGADEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGGACAGGGGGAACACTGAAGCTTTCTTTGGACAA	CASRDRGNTEAFF	In	VDJ	1	74	1.7365062901420416E-4	2.1798493547351336E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	1	2	1	0	0	23	-1	-1	34	43														CASRDRGNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCTTATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSPYSNQPQHF	In	VDJ	1	74	1.7365062901420416E-4	2.1798493547351336E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	5	4	10	0	1	2	23	35	38	36	40						01,02								CASSPYSNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD02-01	TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGGCGCAAGGGGCAGCTACGCAGTATTTTGGCCCA	CASRAQGAATQYF	In	VDJ	1	75	1.7599725913601771E-4	2.2093067784477704E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	5	2	8	6	4	23	34	45	40	49														CASRAQGAATQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCTGCCGGCAATCAGCCCCAGCATTTTGGTGAT	CASSYSAGNQPQHF	In	VDJ	1	75	1.7599725913601771E-4	2.2093067784477704E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-05	01	0	10	0	2	1	2	23	40	43	41	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSAGNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01		TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCTAACAGGGGGCGGGGTGAAGCTTTCTTTGGACAA	CASSSNRGRGEAFF	In	VDJ	2	77	1.8069051937964485E-4	2.2682216258730444E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	3	0	7	3	4	23	36	48	39	52														CASSSNRGRGEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAGCGAAGCGGGGGGGCCTGGGAAACAGATACGCAGTATTTTGGCCCA	CASSERSGGAWETDTQYF	In	VDJ	2	78	1.8303714950145843E-4	2.2976790495856812E-4	54	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	6	0	3	6	8	23	35	51	41	59														CASSERSGGAWETDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACCGGGACAGGGCTCCACGAGCAGTACTTCGGGCCG	CASTGTGLHEQYF	In	VDJ	2	79	1.85383779623272E-4	2.3271364732983183E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	0	3	5	2	4	23	33	44	35	48														CASTGTGLHEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTATTAGGACAGGGGATCGAAGTAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	2	79	1.85383779623272E-4		55	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	1	2	0	3	7	23	37	49	40	56														X+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTTAGGACAGCTCCTACGAGCAGTACGTCGGGCCG	CAIS*DSSYEQYV	Stop	VDJ	2	82	1.924236699887127E-4		39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	1	5	17	0	17	23	-1	43	37	60														CAIS*DSSYEQYV+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCAGGGCAATCAGCCCCAGCATTTTGGTGAT	CASSYQGNQPQHF	In	VDJ	2	86	2.01810190475967E-4	2.533338439286777E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	4	4	2	0	0	23	-1	-1	38	42														CASSYQGNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGGGACAGGGGCGGGCACTGAAGCTTTCTTTGGACAA	CASSYGTGAGTEAFF	In	VDJ	2	88	2.0650345071959413E-4	2.592253286712051E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	0	2	4	0	4	23	-1	48	38	52														CASSYGTGAGTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTGGAGCGGAGTCGAGCAGTACTTCGGGCCG	CASSWSGVEQYF	In	VDJ	2	90	2.1119671096322127E-4	2.6511681341373245E-4	36	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	6	5	6	2	3	23	36	43	38	46						01,02								CASSWSGVEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCGGGACAGGGTACATCAAGAGACCCAGTACTTCGGGCCA	CASSRDRVHQETQYF	In	VDJ	2	96	2.2527649169410267E-4	2.827912676413146E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	0	3	2	2	5	23	34	45	36	50														CASSRDRVHQETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACCACCGACATGAAGGGGCACCATGAAAAACTGTTTTTTGGCAGT	CASTTDMKGHHEKLFF	In	VDJ	2	97	2.2762312181591625E-4	2.857370100125783E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	7	5	2	6	12	4	23	33	50	45	54														CASTTDMKGHHEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGTGACAGTGAACACTGAAGCTTTCTTTGGACAA	CASSVTVNTEAFF	In	VDJ	2	97	2.2762312181591625E-4	2.857370100125783E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	2	5	0	2	0	23	35	-1	37	42														CASSVTVNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCGCGAACAGGGGTAATAGGCCCGGGGAGCTGTTTTTTGGAGAA	CASANRGNRPGELFF	In	VDJ	2	98	2.2996975193772983E-4	2.8868275238384204E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	8	3	2	6	4	8	23	32	43	36	51														CASANRGNRPGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTTCAGGACAGAAATCAATCAGCCCCAGCATTTTGGTGAT	CASSYFRTEINQPQHF	In	VDJ	2	99	2.323163820595434E-4	2.916284947551057E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	1	1	5	3	3	4	23	39	48	42	52														CASSYFRTEINQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCACCATTCAGAGTGTTGAGACAGAAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	2	100	2.3466301218135697E-4		46	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	10	2	5	3	16	1	23	30	51	46	52														X+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCGACAGGGGAGGTGAAAAACTGTTTTTTGGCAGT	CASDRGGEKLFF	In	VDJ	2	102	2.393562724249841E-4	3.004657218688968E-4	36	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	8	2	2	7	0	3	23	-1	40	32	43														CASDRGGEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCACCCAGGGTGGCAATCAGCCCCAGCATTTTGGTGAT	CASSTQGGNQPQHF	In	VDJ	2	106	2.487427929122384E-4	3.1224869135395157E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	4	3	2	4	2	23	34	43	38	45														CASSTQGGNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTATGGGAACCGATTCTACGAGCAGTACTTCGGGCCG	CASSYYGNRFYEQYF	In	VDJ	2	106	2.487427929122384E-4	3.1224869135395157E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	1	0	8	3	2	7	23	39	45	41	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYYGNRFYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACTGGAGCCGGGACGAACGAGCAGTACTTCGGGCCG	CASTGAGTNEQYF	In	VDJ	2	110	2.5812931339949267E-4	3.2403166083900636E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	7	0	7	5	8	2	23	33	46	41	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASTGAGTNEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTACACCAGGGGCTGGACAGCCCCAGCATTTTGGTGAT	CASSTPGAGQPQHF	In	VDJ	2	124	2.9098213510488264E-4	3.6527205403669806E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	4	2	7	4	5	23	35	45	39	50														CASSTPGAGQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCTCAGGGAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSGSSYNEQFF	In	VDJ	3	129	3.027152857139505E-4	3.800007658930165E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-01	01	8	4	3	0	1	2	23	32	38	33	40				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSGSSYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01		TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGTGGGTCAGACAGTACAGAAGGGCCCTGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	3	130	3.050619158357641E-4		53	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	9	2	5	0	7	13	23	31	43	38	56														X+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTATTCTCCCCCGGGGGCGTCGCTAAATGAGCAGTTCTTCGGGCCA	CASSYSPPGASLNEQFF	In	VDJ	3	133	3.1210180620120477E-4	3.917837353780713E-4	51	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-01	01	3	6	0	7	9	7	23	37	52	46	59				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSPPGASLNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01		TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTACCTCCAGGGGCACTGAAGCTTTCTTTGGACAA	CASSTSRGTEAFF	In	VDJ	3	135	3.167950664448319E-4	3.9767522012059867E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	4	2	4	5	0	23	35	-1	40	46														CASSTSRGTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGACAGCCCTAGGGGCTACACCTTCGGTTCG	CASSYDSPRGYTF	In	VDJ	3	135	3.167950664448319E-4	3.9767522012059867E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	2	5	8	0	7	23	-1	43	38	50														CASSYDSPRGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTACTCCGGGACTCTCGTTTCCCAGTACTTCGGGCCA	CASSYYSGTLVSQYF	In	VDJ	3	140	3.285282170538997E-4	4.124039319769172E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	1	0	10	9	5	7	23	39	50	44	57						01,02								CASSYYSGTLVSQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCCTAGGGGGATATAGCGGCAATCAGCCCCAGCATTTTGGTGAT	CASLGGYSGNQPQHF	In	VDJ	3	140	3.285282170538997E-4	4.124039319769172E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	8	5	1	2	2	8	23	32	40	34	48														CASLGGYSGNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTTCGCGGGGGACAATGAGCAGTTCTTCGGGCCA	CASSYFAGDNEQFF	In	VDJ	3	147	3.4495462790659474E-4	4.33024128575763E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	1	7	2	5	2	0	23	39	-1	41	48														CASSYFAGDNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCACCCAGGGAGCTAACTATGGCTACACCTTCGGTTCG	CATQGANYGYTF	In	VDJ	3	148	3.473012580284083E-4	4.359698709470267E-4	36	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-02	01	10	4	3	0	2	2	23	30	37	32	39				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATQGANYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01		TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGACCCTCYCCCCTAGCGGGAGAATACAATGAGCAGTTCTTCGGGCCA	CASRPSPLAGEYNEQFF	In	VDJ	3	151	3.54341148393849E-4	4.448070980608178E-4	51	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	4	2	4	10	2	23	34	54	44	56														CASRPSPLAGEYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACACTTACAACTACAGGGATACGAACACTGAAGCTTTCTTTGGACAA	CASSYTYNYRDTNTEAFF	In	VDJ	3	153	3.5903440863747617E-4	4.5069858280334516E-4	54	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	3	3	1	10	4	23	38	54	48	58														CASSYTYNYRDTNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCCCCAATGGGACGGCCCATAAGCTAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	3	163	3.825007098556119E-4		50	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-03	01	11	0	7	0	6	12	23	29	40	35	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01		TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGGGGACAGATTTATAGCTCCTACGAGCAGTACGTCGGGCCG		Out	VDJ	3	168	3.9423386046467967E-4		46	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	5	17	1	25	23	34	42	35	67														X+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGGACTGAAGAAAGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	3	171	4.012737508301204E-4		43	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	5	1	10	4	0	10	23	-1	40	35	50						01,02								X+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCTCACGGTCAGGACTGCTCCCGGCATCGGGAATGAGCAGTTCTTCGGGCCA	CASSYLTVRTAPGIGNEQFF	In	VDJ	3	171	4.012737508301204E-4	5.037219454860917E-4	60	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	1	10	7	10	15	21	36	51	46	66						01,02								CASSYLTVRTAPGIGNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCACGGCCCAGGGGGCGCTTATCAGCCCCAGCATTTTGGTGAT	CASSHGPGGAYQPQHF	In	VDJ	4	177	4.1535353156100185E-4	5.213963997136739E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	4	0	5	7	4	23	35	50	42	54														CASSHGPGGAYQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCGACGCTAAGGGGGGAGCTGTTTTTTGGAGAA	CASSSTLRGELFF	In	VDJ	4	177	4.1535353156100185E-4	5.213963997136739E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-02	01	4	2	7	8	1	7	23	36	40	37	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSTLRGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01		TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGTGGCTCGGGCTTCACCCCTCCACTTTGGGAAC	CASSVARASPLHF	In	VDJ	4	179	4.2004679180462895E-4	5.272878844562012E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-06	01	5	8	0	9	7	0	23	35	-1	42	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVARASPLHF+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01		TCRBJ01-06*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCACAGGGCCCAAAGGAAGCAATCAGCCCCAGCATTTTGGTGAT	CASSTGPKGSNQPQHF	In	VDJ	4	183	4.294333122918832E-4	5.39070853941256E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	3	3	1	1	9	23	34	41	35	50														CASSTGPKGSNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCACCCGGACAGGGATATATGGCTACACCTTCGGTTCG	CATRTGIYGYTF	In	VDJ	4	188	4.411664629009511E-4	5.537995657975745E-4	36	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	10	1	3	5	3	3	23	30	41	33	44														CATRTGIYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTATAGCGGGCCCAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSYSGPSSYNEQFF	In	VDJ	4	188	4.411664629009511E-4	5.537995657975745E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	5	4	0	0	5	23	-1	44	37	49						01,02								CASSYSGPSSYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCGACTAGCTTCCGGACAGATACGCAGTATTTTGGCCCA	CASSPTSFRTDTQYF	In	VDJ	4	192	4.5055298338820534E-4	5.655825352826292E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	2	7	3	2	6	23	35	44	37	50						01,02								CASSPTSFRTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGAGGGCATATAATTCACCCCTCCACTTTGGGAAC	CASSYSRAYNSPLHF	In	VDJ	4	198	4.646327641190868E-4	5.832569895102114E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-06	01	0	11	0	4	0	2	23	-1	45	40	47														CASSYSRAYNSPLHF+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-06*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCATCCTAGCGGGGGCAGATACGCAGTATTTTGGCCCA	CASILAGADTQYF	In	VDJ	4	223	5.23298517164426E-4	6.569005487918038E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	7	4	2	4	2	0	23	33	-1	35	45														CASILAGADTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCCGGACTAGCGGGGCTACGGGAGACCCAGTACTTCGGGCCA	CASSPGLAGLRETQYF	In	VDJ	5	242	5.678844894788838E-4	7.12869653845814E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	5	1	3	5	3	6	23	35	50	38	56														CASSPGLAGLRETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCCCCCGGACTACCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	5	243	5.702311196006974E-4		46	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	1	9	2	5	0	23	38	-1	43	49						01,02								X+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTCTGTGGGTAGATGAAAGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	5	248	5.819642702097653E-4		47	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-02	01	5	0	9	4	4	12	23	35	42	39	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01		TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCATTGGGGGAATGAACACTGAAGCTTTCTTTGGACAA	CASIGGMNTEAFF	In	VDJ	5	251	5.89004160575206E-4	7.393813351871873E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	7	6	1	0	2	2	23	33	40	35	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASIGGMNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCCATTTGACCCCGGGACTAACATGAGCAGTTCTTCGGGCCA	CASSSI*PRD*HEQFF	Stop	VDJ	5	252	5.913507906970195E-4		48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	0	9	8	12	2	23	36	55	48	57						01,02								CASSSI*PRD*HEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCGCCCGAGGATTAACTATGGCTACACCTTCGGTTCG		Out	VDJ	5	264	6.195103521587824E-4		38	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	8	11	1	1	4	2	23	32	40	36	42														X+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCCTCCACCGACCCTTTGGATACGCAGTATTTTGGCCCA	CASSYSSTDPLDTQYF	In	VDJ	6	289	6.781761052041216E-4	8.513195452952075E-4	48	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-03	01	0	2	7	6	7	6	23	40	50	47	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSSTDPLDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01		TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGGGGGCAAGACTGGGGAAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	6	294	6.899092558131895E-4		41	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	9	7	0	3	0	11	23	-1	36	31	47														X+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCGCGGGGAGGTGGCTCTCTACAATGAGCAGTTCTTCGGGCCA	CASSRGEVALYNEQFF	In	VDJ	6	299	7.016424064222573E-4	8.807769690078446E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	7	3	3	2	10	23	34	42	36	52						01,02								CASSRGEVALYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCCGGGATCCTTAGCAATCAGCCCCAGCATTTTGGTGAT	CASSYSGILSNQPQHF	In	VDJ	7	349	8.189739125129358E-4	0.0010280640875710292	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	0	8	3	0	0	4	23	-1	45	40	49														CASSYSGILSNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCACGGGGCCTACAATGAGCAGTTCTTCGGGCCA	CASSHGAYNEQFF	In	VDJ	7	364	8.541733643401394E-4	0.0010722502231399846	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	8	3	2	2	0	23	35	-1	37	42														CASSHGAYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCGCCGGGACTAGCACAGATACGCAGTATTTTGGCCCA	CAIAGTSTDTQYF	In	VDJ	8	411	9.644649800653771E-4	0.0012107001145893782	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	10	0	10	0	5	0	23	30	-1	35	41						01,02								CAIAGTSTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGGACGGTGACAATGAGCAGTTCTTCGGGCCA	CASSYSDGDNEQFF	In	VDJ	9	450	0.0010559835548161064	0.0013255840670686623	42	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-01	01	0	1	7	5	0	4	23	-1	44	40	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSDGDNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01		TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGATCCTCAGGGAGTCTACAATGAGCAGTTCTTCGGGCCA	CASSDPQGVYNEQFF	In	VDJ	10	501	0.0011756616910285984	0.0014758169280031108	45	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-01	01	5	4	3	3	6	3	23	35	46	41	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSDPQGVYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01		TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCATGGGGCCTAGGGGTAGCAATCAGCCCCAGCATTTTGGTGAT	CASSMGPRGSNQPQHF	In	VDJ	11	568	0.0013328859091901075	0.0016731816668777782	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	5	2	0	10	0	23	34	-1	44	49														CASSMGPRGSNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCGACCACAGGGCCTAACGGGGAGCTGTTTTTTGGAGAA	CASSPTTGPNGELFF	In	VDJ	12	590	0.001384511771870006	0.0017379879990455794	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	3	3	7	6	5	23	35	47	41	52														CASSPTTGPNGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCAACGCCCACATGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	13	642	0.0015065365382043118		44	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	3	6	0	8	0	23	36	-1	44	47														X+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCGCTCACCTGGAAAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSAHLESSYNEQFF	In	VDJ	13	647	0.0015182696888133796	0.0019058953142076101	48	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-01	01	6	1	8	0	9	3	23	34	46	43	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSAHLESSYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01		TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCGGCGGAGACTGGGACACCGGGGAGCTGTTTTTTGGAGAA	CASGGDWDTGELFF	In	VDJ	14	695	0.0016309079346604309	0.0020472909480282672	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	8	2	10	3	6	3	23	32	42	38	45						01,02								CASGGDWDTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01	TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACACCTACAATGAGCAGTTCTTCGGGCCA	CASSYTYNEQFF	In	VJ	17	836	0.001961782781836144	0.002462640622376448	36	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-01	01	2	0	0	2	0	1	23	-1	38	-1	39														CASSYTYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01		TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCACACCGGCTGTTTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CATPAVSGANVLTF	In	VDJ	18	920	0.002158899712068484	0.0027100829815625985	42	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-06	01	10	9	0	1	4	4	23	30	37	34	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATPAVSGANVLTF+TCRBV06-08+TCRBJ02-06	TCRBV06-08*01		TCRBJ02-06*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCTCAACGTGGGGTTGGAGCAGTACTTCGGGCCG	CASSYLNVGLEQYF	In	VDJ	19	927	0.002175326122921179	0.0027307031781614445	42	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	2	6	2	7	8	3	23	38	50	46	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYLNVGLEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACTTAGCGGGAGGGGAGTTTGAGCAGTTCTTCGGGCCA	CASSDLAGGEFEQFF	In	VDJ	20	1017	0.0023865228338844	0.002995819991575177	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	1	5	0	9	0	5	23	-1	50	39	55														CASSDLAGGEFEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACCAATCCGGGCAGTGGATACGCAGTATTTTGGCCCA		Out	VDJ	22	1108	0.002600066174969435		40	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-03	01	7	8	0	6	7	4	23	33	44	40	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01		TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGGCCGGGGACAATGAGCAGTTCTTCGGGCCA	CASSYSAGDNEQFF	In	VDJ	23	1151	0.0027009712702074184	0.0033905494693245116	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	8	3	5	3	0	23	40	-1	43	48														CASSYSAGDNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTATGACAGGCAAAGGAGATACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	24	1214	0.0028488089678816737		47	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	2	4	4	2	9	23	35	43	37	52														X+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGCGGACAGGAAAGAGGCTCAAACTATGGCTACACCTTCGGTTCG		Out	VDJ	46	2322	0.005448875142851108		55	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	1	4	2	2	11	23	40	49	42	60														X+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACCGGTACAGGGCTAAATGAGCAGTTCTTCGGGCCA	CASTGTGLNEQFF	In	VDJ	56	2793	0.0065541379302253	0.008227458442939498	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	7	3	3	7	5	3	23	33	44	38	47														CASTGTGLNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGTACTAAGACGGGAACTCTGAAGCTTTCTTTGGACAA	CASSPY*DGNSEAFF	Stop	VDJ	1	13	3.0506191583576405E-5		45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	3	8	3	6	9	3	24	38	52	47	55													Vb 18	CASSPY*DGNSEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD02-01*02	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAGCCACGTTTGGTGGCGAGGAGATTCGGCAGCTTATTCTGTGCCAGCTCACCCAAACCAGGAAGATTGGCTACACCTTCGGTTCG		Out	VDJ	1	14	3.285282170538997E-5		40	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	19	4	4	7	20	5	41	39	63	59	68													Vb 18	X+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCGGGCCTTCCAGGTGTTAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	14	3.285282170538997E-5		49	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-06	01	3	4	4	6	9	3	24	38	51	47	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	X+TCRBV18-01+TCRBJ01-06	TCRBV18-01*01		TCRBJ01-06*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCGCTGGGACTAGCGTGAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	14	3.285282170538997E-5		41	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	0	6	7	3	2	24	35	48	38	50						01,02							Vb 18	X+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD02-01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCTTCCTCAACTAATGAAAAACTGTTTTTTGGCAGT	CASSPSSTNEKLFF	In	VDJ	1	16	3.7546081949017114E-5	4.7131877940219106E-5	42	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	3	4	10	0	3	0	24	38	-1	41	43						01,02							Vb 18	CASSPSSTNEKLFF+TCRBV18-01+TCRBJ01-04	TCRBV18-01*01	TCRBD02-01	TCRBJ01-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGAAGACACCGGGGAGCTGTTTTTTGGAGAA	CASSPEDTGELFF	In	VDJ	1	17	3.989271207083068E-5	5.00776203114828E-5	39	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-02	01	2	2	8	3	0	2	24	-1	41	39	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPEDTGELFF+TCRBV18-01+TCRBJ02-02	TCRBV18-01*01		TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCTCGTTTAGTGAGCAGTTCTTCGGGCCA	CASSPSFSEQFF	In	VDJ	1	17	3.989271207083068E-5	5.00776203114828E-5	36	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	5	8	9	6	0	24	38	-1	44	47						01,02							Vb 18	CASSPSFSEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD02-01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCTTCCGACTCGGGGAAGCAGTTCTTCGGGCCA	CASSSDSGKQFF	In	VDJ	1	17	3.989271207083068E-5	5.00776203114828E-5	36	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	8	3	11	8	1	24	35	48	43	49													Vb 18	CASSSDSGKQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD02-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CAAGCCACGTTTGGTGGCGAGGAGATTCGGCAGCTATTTCTGTGCCAGCTCACCCAAACCAGGAAGATTGGCTACACCTTCGGTTCG		Out	VDJ	1	18	4.2239342192644256E-5		41	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	4	4	7	5	5	40	54	63	59	68													Vb 18	X+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCCCAGAGTCATGGGGGCACCGGGGAGCTGTTTTTTGGAGAA	CASSQSHGGTGELFF	In	VDJ	1	19	4.4585972314457824E-5	5.596910505401019E-5	45	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-02	01	6	6	1	4	10	0	24	35	-1	45	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSQSHGGTGELFF+TCRBV18-01+TCRBJ02-02	TCRBV18-01*01		TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGCAGAAAACTATGGCTACACCTTCGGTTCG	CASSPAENYGYTF	In	VDJ	1	20	4.693260243627139E-5	5.891484742527388E-5	39	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	4	5	2	1	2	24	39	43	40	45													Vb 18	CASSPAENYGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCCTCACAGGGGTTCTGTCCGAGCAGTACTTCGGGCCG	CASSPLTGVLSEQYF	In	VDJ	1	20	4.693260243627139E-5	5.891484742527388E-5	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	3	2	6	4	7	24	38	49	42	56													Vb 18	CASSPLTGVLSEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACGGACAGGGGTGAACACTGAAGCTTTCTTTGGACAA	CASSRTGVNTEAFF	In	VDJ	1	20	4.693260243627139E-5	5.891484742527388E-5	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	1	2	0	0	0	24	-1	-1	37	46													Vb 18	CASSRTGVNTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCCGACCCGGGACAGGGCATAGATACGCAGTATTTTGGCCCA	CASSDPGQGIDTQYF	In	VDJ	1	21	4.927923255808496E-5	6.186058979653757E-5	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	0	3	5	6	3	24	35	50	41	53													Vb 18	CASSDPGQGIDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCGTGACAGGCATTCCCCTAGTGGCTACACCTTCGGTTCG		Out	VDJ	1	21	4.927923255808496E-5		43	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	2	4	7	2	11	24	35	43	37	54													Vb 18	X+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACGAGCAGGGCTCACTGAAGCTTTCTTTGGACAA	CASSPRAGLTEAFF	In	VDJ	1	25	5.866575304533924E-5	7.364355928159235E-5	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	4	3	4	3	2	24	40	48	43	50													Vb 18	CASSPRAGLTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGGCACGACAGGGGGGAAATACAGATACGCAGTATTTTGGCCCA	CASSPARQGGNTDTQYF	In	VDJ	1	25	5.866575304533924E-5	7.364355928159235E-5	51	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	2	1	3	5	5	24	38	52	43	57													Vb 18	CASSPARQGGNTDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCCTCCTGGGGGCTGGACTACGAGCAGTACTTCGGGCCG	CASSSWGLDYEQYF	In	VDJ	1	25	5.866575304533924E-5	7.364355928159235E-5	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	6	0	3	5	4	24	35	46	40	50													Vb 18	CASSSWGLDYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGGACGACCCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSPDDPNTGELFF	In	VDJ	1	26	6.101238316715281E-5	7.658930165285605E-5	45	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-02	01	3	1	7	0	0	4	24	-1	42	38	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPDDPNTGELFF+TCRBV18-01+TCRBJ02-02	TCRBV18-01*01		TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCGCCGGAACAGAACACTGAAGCTTTCTTTGGACAA	CASSPEQNTEAFF	In	VDJ	1	27	6.335901328896638E-5	7.953504402411973E-5	39	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-01	01	6	1	8	1	3	3	24	35	41	38	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPEQNTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01		TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCTGGACAGCCTACCGAGCAGTACTTCGGGCCG	CASSPGQPTEQYF	In	VDJ	1	28	6.570564341077994E-5	8.248078639538343E-5	39	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	1	5	6	1	5	24	38	45	39	50													Vb 18	CASSPGQPTEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACAGAGGTGGTACGGTGGCCACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	29	6.805227353259351E-5		49	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	1	11	1	4	1	12	24	40	45	41	57													Vb 18	X+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD02-01*02	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCTTCGCGGACCACAGATACGCAGTATTTTGGCCCA	CASSPSRTTDTQYF	In	VDJ	1	30	7.03989036544071E-5	8.837227113791082E-5	42	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-03	01	3	1	7	2	5	0	24	38	-1	43	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPSRTTDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01		TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACGTCTGGGGTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	31	7.274553377622066E-5		43	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-04	01	1	6	2	4	4	0	24	40	-1	44	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	X+TCRBV18-01+TCRBJ01-04	TCRBV18-01*01		TCRBJ01-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCCAGGTCGGCTAGCACAGATACGCAGTATTTTGGCCCA	CASSRSASTDTQYF	In	VDJ	1	31	7.274553377622066E-5	9.131801350917451E-5	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	4	4	0	0	6	24	-1	39	35	45													Vb 18	CASSRSASTDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCGGTTCAGGGAGATACGCAGTATTTTGGCCCA	CASSPPVQGDTQYF	In	VDJ	1	33	7.74387940198478E-5	9.72094982517019E-5	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	4	3	5	4	0	24	41	-1	45	50													Vb 18	CASSPPVQGDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACGAGTAGCGGGGGGCACAGATACGCAGTATTTTGGCCCA	CASSPRVAGGTDTQYF	In	VDJ	1	33	7.74387940198478E-5	9.72094982517019E-5	48	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	1	5	2	1	3	0	24	40	-1	43	52													Vb 18	CASSPRVAGGTDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD02-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCCTACAGGGGGCCTTAACCGAGGAGCTGTTTTTTGGAGAA	CASSPLQGALTEELFF	In	VDJ	1	34	7.978542414166136E-5	1.001552406229656E-4	48	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	3	0	10	3	9	24	38	50	41	59													Vb 18	CASSPLQGALTEELFF+TCRBV18-01+TCRBJ02-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCGCCGAATTACTCTGGAAACACCATATATTTTGGAGAG	CASSPNYSGNTIYF	In	VDJ	1	35	8.213205426347493E-5	1.031009829942293E-4	42	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-03	01	6	2	8	0	3	4	24	35	40	38	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPNYSGNTIYF+TCRBV18-01+TCRBJ01-03	TCRBV18-01*01		TCRBJ01-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
GGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGGAAGAGACCCTTATTATTCAAACTAGCACAGATACGCAGTATTTTGGCCCA	CASSPEETLIIQTSTDTQYF	In	VDJ	1	35	8.213205426347493E-5	1.031009829942293E-4	60	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-03	01	3	1	8	0	0	22	21	-1	38	35	60				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPEETLIIQTSTDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01		TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCGGCGGACAGGGGGCAGGGGGAGACCCAGTACTTCGGGCCA	CASSADRGQGETQYF	In	VDJ	1	37	8.682531450710208E-5	1.0899246773675668E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	1	0	5	3	5	24	35	49	38	54													Vb 18	CASSADRGQGETQYF+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGCCAAGCGGGGGGGTCAATACGCAGTATTTTGGCCCA	CASSPPSGGVNTQYF	In	VDJ	1	38	8.917194462891565E-5	1.1193821010802038E-4	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	6	0	7	4	3	24	38	52	42	55													Vb 18	CASSPPSGGVNTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD02-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
TTCTGTGCCAGCTCACCACCGCGGGACTAGCGGGGGGGCTTGGTCGGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSPPRD*RGGLVGSYNEQFF	Stop	VDJ	1	39	9.151857475072921E-5		66	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	0	0	0	2	9	3	20	38	22	47													Vb 18	CASSPPRD*RGGLVGSYNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD02-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGGGCGGACGCAGAACACTGAAGCTTTCTTTGGACAA	CASSPGRTQNTEAFF	In	VDJ	1	40	9.386520487254278E-5	1.1782969485054776E-4	45	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-01	01	2	1	7	1	4	3	24	39	47	43	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPGRTQNTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01		TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCACCGGGGACAGGGGGCTTGGCAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	41	9.621183499435635E-5		46	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	8	0	0	4	4	4	24	33	49	37	53													Vb 18	X+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACGAGGGCCCAACTATGGCTACACCTTCGGTTCG	CASSRGPNYGYTF	In	VDJ	1	44	1.0325172535979707E-4	1.2961266433560254E-4	39	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	4	11	0	2	0	3	24	-1	42	37	45													Vb 18	CASSRGPNYGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01	TCRBD02-01*02	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACGTGACTAGCGAGTAGCCAAAAACATTCAGTACTTCGGCGCC	CASSRD*RVAKNIQYF	Stop	VDJ	1	45	1.0559835548161063E-4		48	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	4	2	6	0	2	3	24	37	47	39	50						01,02							Vb 18	CASSRD*RVAKNIQYF+TCRBV18-01+TCRBJ02-04	TCRBV18-01*01	TCRBD02-01	TCRBJ02-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGGGGATAACTATGGCTACACCTTCGGTTCG	CASSPGDNYGYTF	In	VDJ	1	48	1.1263824584705134E-4	1.413956338206573E-4	39	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-02	01	2	0	8	1	1	0	24	39	-1	40	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPGDNYGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01		TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGACCCAGGGCAGGGAGCCGGCGGGCAGTACTTCGGGCCG	CASSPDPGQGAGGQYF	In	VDJ	1	50	1.1733150609067848E-4	1.472871185631847E-4	48	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-07	01	2	4	3	9	4	14	24	39	48	43	62				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPDPGQGAGGQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01		TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGGGACAGGGGACCTATGGCTACACCTTCGGTTCG	CASSPGQGTYGYTF	In	VDJ	1	56	1.314112868215599E-4	1.6496157279076687E-4	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	0	2	4	0	2	24	-1	48	38	50													Vb 18	CASSPGQGTYGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGACAGGGGAAGGCTACACCTTCGGTTCG	CASSPTGEGYTF	In	VDJ	1	69	1.619174784051363E-4	2.0325622361719488E-4	36	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	2	2	8	0	2	24	-1	46	38	48													Vb 18	CASSPTGEGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACGACGACAGGGCGGGAACATTCAGTACTTCGGCGCC	CASSRRQGGNIQYF	In	VDJ	1	69	1.619174784051363E-4	2.0325622361719488E-4	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	4	2	3	7	3	4	24	37	47	40	51													Vb 18	CASSRRQGGNIQYF+TCRBV18-01+TCRBJ02-04	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACGGACAGGGGGAGCCCAAGAGACCCAGTACTTCGGGCCA	CASSRTGGAQETQYF	In	VDJ	1	70	1.6426410852694986E-4	2.062019659884586E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	1	1	1	0	3	24	-1	47	37	50													Vb 18	CASSRTGGAQETQYF+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCTACAGGGTCCAGAGATACGCAGTATTTTGGCCCA	CASSPTGSRDTQYF	In	VDJ	1	71	1.6661073864876344E-4	2.0914770835972227E-4	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	3	3	5	1	5	24	38	45	39	50													Vb 18	CASSPTGSRDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTACATATCGGTGGGGGGGGCCTCAAATGAGCAGTTCTTCGGGCCA	CASYISVGGASNEQFF	In	VDJ	2	78	1.8303714950145843E-4	2.2976790495856812E-4	48	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	7	9	0	7	10	6	24	34	51	44	57													Vb 18	CASYISVGGASNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD02-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCAGAAGAGGAGGGGGAGACAGATACGCAGTATTTTGGCCCA	CASSEEEGETDTQYF	In	VDJ	2	78	1.8303714950145843E-4	2.2976790495856812E-4	45	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-03	01	5	5	1	3	7	2	24	36	49	43	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSEEEGETDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01		TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCTTTTGACGGGACCAACAATGAGCAGTTCTTCGGGCCA	CASSPFDGTNNEQFF	In	VDJ	2	79	1.85383779623272E-4	2.3271364732983183E-4	45	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-01	01	3	0	7	5	7	2	24	38	50	45	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPFDGTNNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01		TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCGCCCAAAAGGACAGGGGACGAGCAGTACTTCGGGCCG	CASSPKRTGDEQYF	In	VDJ	2	83	1.9477030011052628E-4	2.4449661681488663E-4	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	1	2	5	8	0	24	35	-1	43	52													Vb 18	CASSPKRTGDEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTACGACTCCAGGGGGCCCCGAAATGARCAGTTCTTCGGGCCA	CASYDSRGPRNEQFF	In	VDJ	2	93	2.1823660132866198E-4	2.7395404052752353E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	7	4	0	7	7	5	24	34	49	41	54													Vb 18	CASYDSRGPRNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGGGCTGAACACTGAAGCTTTCTTTGGACAA	CASSPGLNTEAFF	In	VDJ	2	96	2.2527649169410267E-4	2.827912676413146E-4	39	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	8	0	0	0	0	24	-1	-1	39	43													Vb 18	CASSPGLNTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCGGGCGTTCAAGAGACCCAGTACTTCGGGCCA	CASSPPGVQETQYF	In	VDJ	2	100	2.3466301218135697E-4	2.945742371263694E-4	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	0	8	0	2	0	3	24	-1	45	41	48													Vb 18	CASSPPGVQETQYF+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCTCCGAGCGGAGGATACAATGAGCAGTTCTTCGGGCCA	CASSPPSGGYNEQFF	In	VDJ	2	100	2.3466301218135697E-4	2.945742371263694E-4	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	6	5	4	4	4	24	38	47	42	51						01,02							Vb 18	CASSPPSGGYNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD02-01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCGAGTAGGGAGCACACCATATATTTTGGAGAG	CASSPPSREHTIYF	In	VDJ	2	107	2.5108942303405193E-4	3.151944337252153E-4	42	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	0	9	2	8	5	1	24	41	51	46	52													Vb 18	CASSPPSREHTIYF+TCRBV18-01+TCRBJ01-03	TCRBV18-01*01	TCRBD02-01*02	TCRBJ01-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACAACGGACGGTGGACACTGAAGCTTTCTTTGGACAA	CASSPQRTVDTEAFF	In	VDJ	2	108	2.534360531558655E-4	3.1814017609647894E-4	45	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-01	01	1	1	7	3	3	5	24	40	47	43	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPQRTVDTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01		TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCGCGGGCGGGGTTGACAGATACGCAGTATTTTGGCCCA	CASSPPRAGLTDTQYF	In	VDJ	2	116	2.7220909413037405E-4	3.417061150665885E-4	48	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	7	3	3	4	3	24	41	51	45	54													Vb 18	CASSPPRAGLTDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD02-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGGACAGGGGGTATGGCTACACCTTCGGTTCG	CASSPDRGYGYTF	In	VDJ	2	120	2.815956146176284E-4	3.5348908455164326E-4	39	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	1	1	5	0	0	24	-1	-1	38	48													Vb 18	CASSPDRGYGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCACAGGGCTCTGGAAACACCATATATTTTGGAGAG	CASSPPQGSGNTIYF	In	VDJ	2	124	2.9098213510488264E-4	3.6527205403669806E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	0	3	3	0	0	0	24	-1	-1	41	47													Vb 18	CASSPPQGSGNTIYF+TCRBV18-01+TCRBJ01-03	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGGATAGGACTTACAATGAGCAGTTCTTCGGGCCA	CASSPDRTYNEQFF	In	VDJ	2	125	2.933287652266962E-4	3.6821779640796177E-4	42	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	1	10	4	5	0	24	38	-1	43	48						01,02							Vb 18	CASSPDRTYNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD02-01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCCGGGGGGAACACAGATACGCAGTATTTTGGCCCA	CASSGGNTDTQYF	In	VDJ	3	140	3.285282170538997E-4	4.124039319769172E-4	39	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	8	1	2	0	2	24	-1	42	35	44													Vb 18	CASSGGNTDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD02-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACTTAGCGGAAGCACAGATACGCAGTATTTTGGCCCA	CASSLSGSTDTQYF	In	VDJ	3	146	3.4260799778478116E-4	4.3007838620449934E-4	42	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	5	5	0	1	1	24	37	44	38	45						01,02							Vb 18	CASSLSGSTDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD02-01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCTAGCGGGGGTTACAATGAGCAGTTCTTCGGGCCA	CASSPPSGGYNEQFF	In	VDJ	3	155	3.637276688811033E-4	4.565900675458726E-4	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	5	2	4	0	1	24	-1	50	41	51													Vb 18	CASSPPSGGYNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD02-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGGCAAGGACAGGGGGAATTCACCCCTCCACTTTGGGAAC	CASSPGKDRGNSPLHF	In	VDJ	3	169	3.9658049058649325E-4	4.978304607435643E-4	48	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	2	1	1	7	5	0	24	39	-1	44	54													Vb 18	CASSPGKDRGNSPLHF+TCRBV18-01+TCRBJ01-06	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-06*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCCCAGGCGGGAGGAACAGATACGCAGTATTTTGGCCCA		Out	VDJ	3	171	4.012737508301204E-4		46	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	7	1	3	5	1	24	38	51	43	52													Vb 18	X+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCGCGATAATGAACACTGAAGCTTTCTTTGGACAA	CASSPAIMNTEAFF	In	VDJ	4	179	4.2004679180462895E-4	5.272878844562012E-4	42	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	3	7	6	0	1	4	24	38	42	39	46						01,02							Vb 18	CASSPAIMNTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD02-01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCCCTGACCCGGGACAGCTTACCGAATGGCTACACCTTCGGTTCG	CASSLTRDSLPNGYTF	In	VDJ	4	180	4.2239342192644253E-4	5.302336268274649E-4	48	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	0	5	6	8	8	24	35	50	43	58													Vb 18	CASSLTRDSLPNGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCTTGGGAACGTATGGAAACACCATATATTTTGGAGAG		Out	VDJ	4	201	4.716726544845275E-4		47	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-03	01	0	0	8	3	2	5	24	41	47	43	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	X+TCRBV18-01+TCRBJ01-03	TCRBV18-01*01		TCRBJ01-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACAGGAAGTGGGCGGCGGCGAGCAGTACTTCGGGCCG	CASSQEVGGGEQYF	In	VDJ	5	228	5.350316677734939E-4	6.716292606481222E-4	42	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-07	01	4	8	0	6	7	5	24	37	48	44	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSQEVGGGEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01		TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCCCCTCGGACAGGCGCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSPRTGANTGELFF	In	VDJ	5	246	5.772710099661381E-4	7.246526233308687E-4	48	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	1	4	0	5	2	24	35	47	40	49													Vb 18	CASSPRTGANTGELFF+TCRBV18-01+TCRBJ02-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCGTCAGGAGGGGAAAACATTCAGTACTTCGGCGCC	CASSPPSGGENIQYF	In	VDJ	5	256	6.007373111842738E-4	7.541100470435057E-4	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	0	10	0	5	4	1	24	41	51	45	52													Vb 18	CASSPPSGGENIQYF+TCRBV18-01+TCRBJ02-04	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACAAGTCCTTCACTCTAACACTGAAGCTTTCTTTGGACAA	CASSPQVLHSNTEAFF	In	VDJ	5	259	6.077772015497145E-4	7.629472741572967E-4	48	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	1	3	10	2	9	2	24	40	52	49	54						01,02							Vb 18	CASSPQVLHSNTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD02-01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCGAGCGGGGGCCGCAATGAGCAGTTCTTCGGGCCA	CASSPPSGGRNEQFF	In	VDJ	6	284	6.664429545950538E-4	8.365908334388891E-4	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	6	2	6	1	3	24	41	50	42	53													Vb 18	CASSPPSGGRNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD02-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACTCTGGAGTCAGACTGAAGCTTTCTTTGGACAA	CASSPLWSQTEAFF	In	VDJ	6	292	6.852159955695623E-4	8.601567724089987E-4	42	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	1	10	2	5	3	4	24	40	47	43	51													Vb 18	CASSPLWSQTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD02-01*02	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCAACGCTAAGAAGGACTAAATACAATGAGCAGTTCTTCGGGCCA	CASSTLRRTKYNEQFF	In	VDJ	6	314	7.368418582494609E-4	9.249631045767999E-4	48	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	1	9	4	10	2	24	36	52	46	54						01,02							Vb 18	CASSTLRRTKYNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD02-01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACGGTTGCTTTGGGCGCCCAAAAACATTCAGTACTTCGGCGCC	CASSPRLLWAPKNIQYF	In	VDJ	6	320	7.509216389803423E-4	9.426375588043821E-4	51	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	1	8	0	2	9	2	24	40	53	49	55													Vb 18	CASSPRLLWAPKNIQYF+TCRBV18-01+TCRBJ02-04	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-04*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGGGGAACTAGTAGGCTACACCTTCGGTTCG	CASSPGELVGYTF	In	VDJ	7	327	7.673480498330373E-4	9.63257755403228E-4	39	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	2	3	8	8	5	2	24	39	49	44	51						01,02							Vb 18	CASSPGELVGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01	TCRBD02-01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACGGAGCGGGAACTATCAAGAGACCCAGTACTTCGGGCCA	CASSPRSGNYQETQYF	In	VDJ	7	340	7.978542414166137E-4	0.001001552406229656	48	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	1	6	3	2	2	5	24	40	49	42	54													Vb 18	CASSPRSGNYQETQYF+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCGTCGGGGGGGTACAATAAGCAGTTCTTCGGGCCA	CASSPPSGGYNKQFF	In	VDJ	7	356	8.354003233656307E-4	0.0010486842841698752	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	8	0	11	2	7	24	41	51	43	58													Vb 18	CASSPPSGGYNKQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD02-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCATTAAGGGGCTGTCCGAAACTGAAGCTTTCTTTGGACAA	CAIKGLSETEAFF	In	VDJ	8	424	9.949711716489536E-4	0.0012489947654158063	39	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	10	5	2	5	3	9	24	31	39	34	48													Vb 18	CAIKGLSETEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCGTACCTTTAATGAACACTGAAGCTTTCTTTGGACAA	CASSPVPLMNTEAFF	In	VDJ	9	431	0.0010113975825016485	0.001269614962014652	45	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-01	01	3	3	7	0	3	6	24	38	43	41	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPVPLMNTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01		TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACGACGACAGGGCCCTACGAACACTGAAGCTTTCTTTGGACAA	CASSRRQGPTNTEAFF	In	VDJ	9	444	0.001041903774085225	0.00130790961284108	48	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	2	3	1	3	6	24	37	47	40	53													Vb 18	CASSRRQGPTNTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCGGGGACAGGGTCTGTTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSPPGTGSVGANVLTF	In	VDJ	12	592	0.0013892050321136333	0.0017438794837881068	54	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	0	0	3	3	1	5	24	41	51	42	56													Vb 18	CASSPPGTGSVGANVLTF+TCRBV18-01+TCRBJ02-06	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-06*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGTTTCCCCCCGGAGCGGGAGTTACAATGAGCAGTTCTTCGGGCCA	CASSPVSPRSGSYNEQFF	In	VDJ	12	610	0.0014314443743062774	0.0017969028464708534	54	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	6	2	4	12	1	24	39	59	51	60													Vb 18	CASSPVSPRSGSYNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCAACAGGGATTTGCCGTTCTTCGGGCCA	CASSPNRDLPFF	In	VDJ	13	657	0.0015417359900315153	0.001935352737920247	36	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	3	3	15	2	7	24	38	46	40	53													Vb 18	CASSPNRDLPFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACGCGGGACTAGCGGGAGGGCTTACAATGAGCAGTTCTTCGGGCCA	CASSRGTSGRAYNEQFF	In	VDJ	13	664	0.0015581624008842102	0.001955972934519093	51	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	0	0	4	2	2	24	37	55	39	57													Vb 18	CASSRGTSGRAYNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCCCCGGCCTTCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSPAFSYNEQFF	In	VDJ	16	780	0.0018303714950145844	0.0022976790495856814	42	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-01	01	6	9	0	0	3	3	24	35	41	38	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPAFSYNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01		TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCTAGCGGGGGATTCAATGAGCAGTTCTTCGGGCCA	CASSPPSGGFNEQFF	In	VDJ	16	799	0.0018749574673290422	0.0023536481546396915	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	5	2	6	0	3	24	-1	50	41	53													Vb 18	CASSPPSGGFNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD02-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACTTAACAGGGGGAACACTGAAGCTTTCTTTGGACAA	CASSLNRGNTEAFF	In	VDJ	19	950	0.0022292986157228913	0.0027984552527005094	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	3	2	1	3	0	24	37	-1	40	47													Vb 18	CASSLNRGNTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCTCCTAGCCCCATCGTATACGAGCAGTACTTCGGGCCG	CASSPSPIVYEQYF	In	VDJ	20	1011	0.002372443053153519	0.0029781455373475946	42	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	4	7	4	2	9	24	35	42	37	51						01,02							Vb 18	CASSPSPIVYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD02-01	TCRBJ02-07*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCAAGGTCAGGGTCGATGAGCAGTTCTTCGGGCCA	CASSPKVRVDEQFF	In	VDJ	22	1081	0.002536707161680469	0.003184347503336053	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	4	3	8	6	3	24	38	49	44	52													Vb 18	CASSPKVRVDEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCGTCGCAAAAAGAGACCCAGTACTTCGGGCCA	CASSPPSQKETQYF	In	VDJ	24	1196	0.0028065696256890293	0.0035231078760313782	42	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-05	01	0	4	6	3	4	2	24	41	47	45	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPPSQKETQYF+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01		TCRBJ02-05*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACGGACAGTTAGCACAGATACGCAGTATTTTGGCCCA	CASSPRTVSTDTQYF	In	VDJ	25	1238	0.002905128090805199	0.0036468290556244533	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	1	1	5	0	0	2	24	-1	46	40	48													Vb 18	CASSPRTVSTDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-03*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCCCTGGACGTGTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	27	1343	0.003151524253595624		43	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-01	01	3	1	7	4	4	3	24	38	46	42	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	X+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01		TCRBJ02-01*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCAAACCAGGAAGATTGGCTACACCTTCGGTTCG		Out	VDJ	107	5383	0.012631909945722445		41	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	4	4	7	5	5	24	38	47	43	52													Vb 18	X+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-02*01	9717B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				9011	7178	1699	133	0	2266	1893	345	28	0	426143	339473	80371	6299	0	0.146983936	9.2863245	0.154595956	9.42281628				180708	0.0467833094	0.0382003859	0.0304310992	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/08/2016 11:12:54	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.7965819336758856	MSKCC- Snyder- P01-01		8454.0	
